<!DOCTYPE html>
<!-- saved from url=(0050)https://www.hindawi.com/journals/bmri/2013/690835/ -->
<html lang="en" data-triggered="true"><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><style class="vjs-styles-defaults">
      .video-js {
        width: 300px;
        height: 150px;
      }

      .vjs-fluid {
        padding-top: 56.25%
      }
    </style><script type="text/javascript" async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/js"></script><script type="text/javascript" async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/hotjar-625463.js.download"></script><script async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/script.js.download"></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/ytc.js.download" async=""></script><script async="" src="https://connect.facebook.net/en_US/fbevents.js"></script><script async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/obtp.js.download" type="text/javascript"></script><script type="text/javascript" async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/analytics.js.download"></script><script type="text/javascript" async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/bat.js.download"></script><script type="text/javascript" async="" src="https://static.ads-twitter.com/uwt.js"></script><script type="text/javascript" async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/analytics.js.download"></script><script type="text/javascript" id="www-widgetapi-script" src="https://s.ytimg.com/yts/jsbin/www-widgetapi-vflXnwWCE/www-widgetapi.js" async=""></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/iframe_api"></script><script async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/gtm.js.download"></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/polyfill.min.js.download"></script><meta name="viewport" content="width=device-width, initial-scale=1" class="next-head"><title class="next-head">Understanding the Dengue Viruses and Progress towards Their Control</title><link rel="canonical" href="https://www.hindawi.com/journals/bmri/2013/690835/" class="next-head"><meta name="title" content="Understanding the Dengue Viruses and Progress towards Their Control"><meta rel="canonical" href="https://www.hindawi.com/journals/bmri/2013/690835/"><meta name="description" content="Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this &amp;#x201c;scourge&amp;#x201d; of the tropical and subtropical world."><meta property="og:url" content="https://www.hindawi.com/journals/bmri/2013/690835/"><meta property="og:type" content="website"><meta property="og:image" content="https://images.hindawi.com/journals/bmri/bmri.banner.jpg"><meta property="og:image:type" content="image/jpeg"><meta property="og:image:width" content="600"><meta property="og:image:height" content="315"><meta property="og:title" content="Understanding the Dengue Viruses and Progress towards Their Control"><meta name="twitter:site" content="website"><meta name="twitter:card" content="summary_large_image"><meta name="twitter:image" content="https://images.hindawi.com/journals/bmri/bmri.banner.jpg"><meta name="twitter:title" content="Understanding the Dengue Viruses and Progress towards Their Control"><meta property="og:description" content="Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this &amp;#x201c;scourge&amp;#x201d; of the tropical and subtropical world."><meta name="twitter:description" content="Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this &amp;#x201c;scourge&amp;#x201d; of the tropical and subtropical world."><meta name="citation_author" content="Rodriguez-Roche, Rosmari"><meta name="citation_author" content="Gould, Ernest A."><meta name="citation_title" content="Understanding the Dengue Viruses and Progress towards Their Control"><meta name="citation_publisher" content="Hindawi"><meta name="citation_volume" content="2013"><meta name="citation_date" content="2013"><meta name="citation_year" content="2013"><meta name="citation_abstract" content="Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this &amp;#x201c;scourge&amp;#x201d; of the tropical and subtropical world."><meta name="citation_pdf_url" content="http://downloads.hindawi.com/journals/bmri/2013/690835.pdf"><meta name="citation_xml_url" content="http://downloads.hindawi.com/journals/bmri/2013/690835.xml"><meta name="citation_fulltext_html_url" content="https://www.hindawi.com/journals/bmri/2013/690835/"><meta name="citation_doi" content="https://doi.org/10.1155/2013/690835"><meta name="citation_online_date" content="2013/07/09"><meta name="dcterms.issued" content="2013/07/09"><meta name="dc.creator" content="Rodriguez-Roche, Rosmari"><meta name="dc.creator" content="Gould, Ernest A."><meta name="dc.title" content="Understanding the Dengue Viruses and Progress towards Their Control"><meta name="dc.description" content="Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this &amp;#x201c;scourge&amp;#x201d; of the tropical and subtropical world."><meta name="dc.publisher" content="Hindawi"><meta name="dc.format" content="text/html"><meta name="dc.language" content="en"><meta name="dc.identifier" content="https://doi.org/10.1155/2013/690835"><meta name="dc.type" content="Review Article"><meta name="dc.date" content="2013/07/09"><meta name="dcterms.issued" content="2013/07/09"><meta name="prism.publicationDate" content="2013/07/09"><meta name="prism.volume" content="2013"><meta name="prism.number" content=""><meta name="prism.startingPage" content=""><meta name="prism.section" content="Review Article"><meta name="prism.doi" content="https://doi.org/10.1155/2013/690835"><meta name="citation_issn" content="2314-6133"><meta name="prism.issn" content="2314-6133"><meta name="dc.source" content="BioMed Research International"><meta name="citation_journal_title" content="BioMed Research International"><meta name="prism.publicationName" content="BioMed Research International"><meta name="authors" content="Rosmari Rodriguez-Roche | Ernest A. Gould"><link rel="stylesheet" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/css"><link rel="shortcut icon" type="image/x-icon" href="https://static-01.hindawi.com/next_assets/Jvy0o2KWP7OlB1-MPkheK/_next/static/static/favicon.ico"><meta name="Author" content="Hindawi"><meta name="robots" content="index"><meta name="google-site-verification" content="AxEuDsL7vXGOxRe53-uFhOk2ODN0bbXMeuBy6Pfq4ww"><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/otSDKStub.js.download" type="text/javascript" charset="UTF-8" data-domain-script="790048b6-f010-4ac2-b5f6-108356336b09"></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/jquery.js.download" class="next-head"></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/otBannerSdk.js.download" async="" type="text/javascript"></script><script class="next-head">
        (function(w,d,s,l,i){w[l]=w[l]||[];
            w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js', });
            var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';
            j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl
            ;
            f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-MQ4MGW');</script><link rel="preload" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/journal_article.js.download" as="script"><link rel="preload" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/_app.js.download" as="script"><link rel="preload" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/webpack-8ed9452df514b4d17d80.js.download" as="script"><link rel="preload" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/common.2a9dff3f2099883d2806.js.download" as="script"><link rel="preload" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/_error.js_stat_b7deff4b.0ab4c1ff25f2c21719fe.js.download" as="script"><link rel="preload" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/main-842359be17b4237f7e99.js.download" as="script"><link rel="preload" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/main.js.e4b62d8672acbfaed35d.js.download" as="script"><link rel="stylesheet" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/common.ba477f16.chunk.css"><link rel="stylesheet" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/journal_article.js.4467a088.chunk.css"><style data-styled="" data-styled-version="4.4.1"></style><style type="text/css">.vjs-youtube .vjs-iframe-blocker { display: none; }.vjs-youtube.vjs-user-inactive .vjs-iframe-blocker { display: block; }.vjs-youtube .vjs-poster { background-size: cover; }.vjs-youtube-mobile .vjs-big-play-button { display: none; }</style><script defer="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/owl.carousel.min.js.download" type="text/javascript"></script><link href="./Understanding the Dengue Viruses and Progress towards Their Control_files/basictable.css" rel="stylesheet" media="all" onload="if(media!=&#39;all&#39;)media=&#39;all&#39;" class="next-head"><link rel="stylesheet" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/owl.carousel.min.css" media="all" onload="if(media!=&#39;all&#39;)media=&#39;all&#39;" class="next-head"><link rel="stylesheet" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/owl.theme.default.min.css" media="all" onload="if(media!=&#39;all&#39;)media=&#39;all&#39;" class="next-head"><script async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/modules.4fb2c8f41d571985b5a1.js.download" charset="utf-8"></script><style type="text/css">iframe#_hjRemoteVarsFrame {display: none !important; width: 1px !important; height: 1px !important; opacity: 0 !important; pointer-events: none !important;}</style><script type="text/javascript" async="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/location"></script><style type="text/css" id="onetrust-style">#onetrust-banner-sdk{-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%}#onetrust-banner-sdk .onetrust-vendors-list-handler{cursor:pointer;color:#1f96db;font-size:inherit;font-weight:bold;text-decoration:none;margin-left:5px}#onetrust-banner-sdk .onetrust-vendors-list-handler:hover{color:#1f96db}#onetrust-banner-sdk .close-icon,#onetrust-pc-sdk .close-icon{background-image:url("data:image/svg+xml;base64,PHN2ZyB2ZXJzaW9uPSIxLjEiIHhtbG5zPSJodHRwOi8vd3d3LnczLm9yZy8yMDAwL3N2ZyIgeG1sbnM6eGxpbms9Imh0dHA6Ly93d3cudzMub3JnLzE5OTkveGxpbmsiIHg9IjBweCIgeT0iMHB4IiB3aWR0aD0iMzQ4LjMzM3B4IiBoZWlnaHQ9IjM0OC4zMzNweCIgdmlld0JveD0iMCAwIDM0OC4zMzMgMzQ4LjMzNCIgc3R5bGU9ImVuYWJsZS1iYWNrZ3JvdW5kOm5ldyAwIDAgMzQ4LjMzMyAzNDguMzM0OyIgeG1sOnNwYWNlPSJwcmVzZXJ2ZSI+PGc+PHBhdGggZmlsbD0iIzU2NTY1NiIgZD0iTTMzNi41NTksNjguNjExTDIzMS4wMTYsMTc0LjE2NWwxMDUuNTQzLDEwNS41NDljMTUuNjk5LDE1LjcwNSwxNS42OTksNDEuMTQ1LDAsNTYuODVjLTcuODQ0LDcuODQ0LTE4LjEyOCwxMS43NjktMjguNDA3LDExLjc2OWMtMTAuMjk2LDAtMjAuNTgxLTMuOTE5LTI4LjQxOS0xMS43NjlMMTc0LjE2NywyMzEuMDAzTDY4LjYwOSwzMzYuNTYzYy03Ljg0Myw3Ljg0NC0xOC4xMjgsMTEuNzY5LTI4LjQxNiwxMS43NjljLTEwLjI4NSwwLTIwLjU2My0zLjkxOS0yOC40MTMtMTEuNzY5Yy0xNS42OTktMTUuNjk4LTE1LjY5OS00MS4xMzksMC01Ni44NWwxMDUuNTQtMTA1LjU0OUwxMS43NzQsNjguNjExYy0xNS42OTktMTUuNjk5LTE1LjY5OS00MS4xNDUsMC01Ni44NDRjMTUuNjk2LTE1LjY4Nyw0MS4xMjctMTUuNjg3LDU2LjgyOSwwbDEwNS41NjMsMTA1LjU1NEwyNzkuNzIxLDExLjc2N2MxNS43MDUtMTUuNjg3LDQxLjEzOS0xNS42ODcsNTYuODMyLDBDMzUyLjI1OCwyNy40NjYsMzUyLjI1OCw1Mi45MTIsMzM2LjU1OSw2OC42MTF6Ii8+PC9nPjwvc3ZnPg==");background-size:contain;background-repeat:no-repeat;background-position:center;height:12px;width:12px}#onetrust-banner-sdk .powered-by-logo,#onetrust-pc-sdk .powered-by-logo{background-image:url("data:image/svg+xml;base64,<svg id="svg-test" width="152px" height="25px" viewBox="0 0 1152 149" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><title>Powered By OneTrust</title><desc>Link to OneTrust Website</desc><g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g transform="translate(-23.000000, -20.000000)"><g transform="translate(658.000000, 0.000000)"><g transform="translate(-90.000000, 35.000000)"><path d="M76.18,42.6 C76.18,55.8533333 72.8466667,66.2733333 66.18,73.86 C59.5133333,81.4466667 50.18,85.24 38.18,85.24 C25.98,85.24 16.5866667,81.4933333 10,74 C3.41333333,66.5066667 0.08,56 0,42.48 C0,29 3.33333333,18.5466667 10,11.12 C16.6666667,3.69333333 26.0933333,-0.0133333333 38.28,1.77635684e-15 C50.1733333,1.77635684e-15 59.46,3.77333333 66.14,11.32 C72.82,18.8666667 76.1666667,29.2933333 76.18,42.6 Z M10.18,42.6 C10.18,53.8133333 12.5666667,62.32 17.34,68.12 C22.1133333,73.92 29.06,76.8133333 38.18,76.8 C47.3533333,76.8 54.28,73.9133333 58.96,68.14 C63.64,62.3666667 65.9866667,53.8533333 66,42.6 C66,31.4666667 63.6666667,23.02 59,17.26 C54.3333333,11.5 47.4266667,8.61333333 38.28,8.6 C29.1066667,8.6 22.1333333,11.5 17.36,17.3 C12.5866667,23.1 10.2,31.5333333 10.2,42.6 L10.18,42.6 Z" fill="#6FBE4A" fill-rule="nonzero"/><path d="M135.72,84.12 L135.72,44 C135.72,38.9466667 134.566667,35.1733333 132.26,32.68 C129.953333,30.1866667 126.346667,28.94 121.44,28.94 C114.946667,28.94 110.186667,30.6933333 107.16,34.2 C104.133333,37.7066667 102.62,43.5 102.62,51.58 L102.62,84.12 L93.22,84.12 L93.22,22 L100.86,22 L102.38,30.5 L102.84,30.5 C104.780291,27.4233208 107.554629,24.9610956 110.84,23.4 C114.470407,21.6846501 118.445153,20.822657 122.46,20.88 C129.94,20.88 135.566667,22.68 139.34,26.28 C143.113333,29.88 145,35.6466667 145,43.58 L145,84.12 L135.72,84.12 Z" fill="#6FBE4A"/><path d="M190.66,85.24 C181.486667,85.24 174.246667,82.4466667 168.94,76.86 C163.633333,71.2733333 160.966667,63.5133333 160.94,53.58 C160.94,43.58 163.406667,35.6333333 168.34,29.74 C173.222618,23.8619885 180.564734,20.5938964 188.2,20.9 C195.191819,20.5728329 201.963481,23.390079 206.66,28.58 C211.193333,33.7 213.46,40.4466667 213.46,48.82 L213.46,54.82 L170.72,54.82 C170.906667,62.1133333 172.746667,67.6466667 176.24,71.42 C180.111752,75.3496799 185.493487,77.4134078 191,77.08 C197.824056,77.0472126 204.569172,75.6178743 210.82,72.88 L210.82,81.26 C207.784089,82.5993483 204.62163,83.6311676 201.38,84.34 C197.846459,85.0029495 194.254614,85.3045037 190.66,85.24 Z M188.1,28.78 C183.576143,28.5578443 179.184858,30.3436337 176.1,33.66 C172.914845,37.4526836 171.072627,42.1918234 170.86,47.14 L203.4,47.14 C203.4,41.2066667 202.066667,36.6666667 199.4,33.52 C196.561539,30.287927 192.394836,28.5401241 188.1,28.78 Z" fill="#6FBE4A" fill-rule="nonzero"/><polygon fill="#6FBE4A" points="256.42 84.12 246.8 84.12 246.8 9.86 220.56 9.86 220.56 1.3 282.56 1.3 282.56 9.86 256.42 9.86"/><path d="M322,20.9 C324.48997,20.8750435 326.976043,21.1028777 329.42,21.58 L328.12,30.3 C325.889928,29.7774437 323.610197,29.4958299 321.32,29.46 C316.323224,29.4523319 311.590139,31.7012821 308.44,35.58 C304.813079,39.8125217 302.90106,45.2489337 303.08,50.82 L303.08,84.12 L293.68,84.12 L293.68,22 L301.44,22 L302.52,33.5 L302.98,33.5 C304.992512,29.7842967 307.840708,26.5869227 311.3,24.16 C314.452189,22.0105692 318.184815,20.8733393 322,20.9 Z" fill="#6FBE4A"/><path d="M349.86,22 L349.86,62.3 C349.86,67.3666667 351.013333,71.14 353.32,73.62 C355.626667,76.1 359.233333,77.3466667 364.14,77.36 C370.633333,77.36 375.38,75.5866667 378.38,72.04 C381.38,68.4933333 382.88,62.7 382.88,54.66 L382.88,22 L392.28,22 L392.28,84 L384.52,84 L383.16,75.68 L382.66,75.68 C380.727841,78.743999 377.949086,81.1823564 374.66,82.7 C370.991669,84.3784377 366.993434,85.2122576 362.96,85.14 C355.413333,85.14 349.76,83.3466667 346,79.76 C342.24,76.1733333 340.36,70.4333333 340.36,62.54 L340.36,22 L349.86,22 Z" fill="#6FBE4A"/><path d="M452.28,67.18 C452.529463,72.4402379 450.097935,77.468908 445.82,80.54 C441.513333,83.6733333 435.473333,85.24 427.7,85.24 C419.473333,85.24 413.053333,83.9066667 408.44,81.24 L408.44,72.62 C411.49933,74.1561274 414.718808,75.3500172 418.04,76.18 C421.266269,77.0234754 424.585353,77.460197 427.92,77.48 C431.834779,77.6966769 435.737934,76.8829448 439.24,75.12 C441.583454,73.7828873 443.095052,71.3546069 443.260342,68.6615928 C443.425631,65.9685788 442.222343,63.3736661 440.06,61.76 C436.269882,59.2036735 432.144032,57.1844972 427.8,55.76 C423.50696,54.2668622 419.378631,52.3367347 415.48,50 C413.257528,48.6430125 411.381372,46.7873987 410,44.58 C408.763803,42.349914 408.149068,39.8288107 408.22,37.28 C408.088421,32.4854659 410.420431,27.9572929 414.4,25.28 C418.52,22.36 424.166667,20.9 431.34,20.9 C438.077303,20.8872356 444.746467,22.2482895 450.94,24.9 L447.6,32.54 C442.257853,30.1646415 436.503864,28.8535201 430.66,28.68 C427.20827,28.4478044 423.756906,29.1380773 420.66,30.68 C418.540364,31.8248718 417.230811,34.0511135 417.26,36.46 C417.2194,37.9742343 417.66829,39.4611799 418.54,40.7 C419.654581,42.0912551 421.052121,43.2297394 422.64,44.04 C426.164605,45.7986068 429.79879,47.3284384 433.52,48.62 C440.88,51.2866667 445.853333,53.9533333 448.44,56.62 C451.1093,59.4673386 452.496866,63.2831466 452.28,67.18 L452.28,67.18 Z" fill="#6FBE4A"/><path d="M487.62,77.48 C489.23364,77.4871099 490.84532,77.3667354 492.44,77.12 C493.680906,76.9413132 494.90983,76.6875137 496.12,76.36 L496.12,83.56 C494.682408,84.1692639 493.168469,84.5797094 491.62,84.78 C489.848898,85.081951 488.056572,85.2424578 486.26,85.26 C474.26,85.26 468.26,78.9333333 468.26,66.28 L468.26,29.34 L459.36,29.34 L459.36,24.8 L468.26,20.8 L472.26,7.54 L477.7,7.54 L477.7,22 L495.7,22 L495.7,29.3 L477.7,29.3 L477.7,65.88 C477.493629,68.9768594 478.441207,72.0404588 480.36,74.48 C482.214928,76.5077751 484.874725,77.6068649 487.62,77.48 L487.62,77.48 Z" fill="#6FBE4A"/></g></g><text font-family="Arial" font-size="90" font-weight="500" fill="#696969"><tspan x="14.2548828" y="113">Powered by</tspan></text></g></g></svg>");background-size:contain;background-repeat:no-repeat;background-position:center;height:25px;width:152px;display:block}#onetrust-banner-sdk h3 *,#onetrust-banner-sdk h4 *,#onetrust-banner-sdk h6 *,#onetrust-banner-sdk button *,#onetrust-banner-sdk a[data-parent-id] *,#onetrust-pc-sdk h3 *,#onetrust-pc-sdk h4 *,#onetrust-pc-sdk h6 *,#onetrust-pc-sdk button *,#onetrust-pc-sdk a[data-parent-id] *{font-size:inherit;font-weight:inherit;color:inherit}#onetrust-banner-sdk .hide,#onetrust-pc-sdk .hide{display:none !important}#onetrust-pc-sdk .ot-sdk-row .ot-sdk-column{padding:0}#onetrust-pc-sdk .ot-sdk-container{padding-right:0}#onetrust-pc-sdk .ot-sdk-row{flex-direction:initial;width:100%}#onetrust-pc-sdk [type="checkbox"]:checked,#onetrust-pc-sdk [type="checkbox"]:not(:checked){pointer-events:initial}#onetrust-pc-sdk [type="checkbox"]:disabled+label::before,#onetrust-pc-sdk [type="checkbox"]:disabled+label:after,#onetrust-pc-sdk [type="checkbox"]:disabled+label{pointer-events:none;opacity:0.7}#onetrust-pc-sdk #vendor-list-content{transform:translate3d(0, 0, 0)}#onetrust-pc-sdk li input[type="checkbox"]{z-index:1}#onetrust-pc-sdk li .ot-checkbox label{z-index:2}#onetrust-pc-sdk li .ot-checkbox input[type="checkbox"]{height:auto;width:auto}#onetrust-pc-sdk li .host-title a,#onetrust-pc-sdk li .accordion-text{z-index:2;position:relative}#onetrust-pc-sdk input{margin:3px 0.1ex}#onetrust-pc-sdk .toggle-always-active{opacity:0.6;cursor:default}#onetrust-pc-sdk .screen-reader-only{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}#onetrust-pc-sdk .pc-logo{height:60px;width:180px;background:url("data:image/svg+xml;base64,<svg width="497" height="149" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="M76.18 42.6c0 13.25-3.33 23.67-10 31.26s-16 11.38-28 11.38c-12.2 0-21.6-3.75-28.18-11.24C3.41 66.5.08 56 0 42.48 0 29 3.33 18.55 10 11.12S26.1-.01 38.28 0c11.9 0 21.18 3.77 27.86 11.32 6.68 7.55 10.03 17.97 10.04 31.28zm-66 0c0 11.21 2.39 19.72 7.16 25.52 4.77 5.8 11.72 8.7 20.84 8.68 9.17 0 16.1-2.89 20.78-8.66S65.99 53.85 66 42.6c0-11.13-2.33-19.58-7-25.34-4.67-5.76-11.57-8.65-20.72-8.66-9.17 0-16.15 2.9-20.92 8.7-4.77 5.8-7.16 14.23-7.16 25.3h-.02z" fill="#6FBE4A" fill-rule="nonzero"/><path d="M135.72 84.12V44c0-5.05-1.15-8.83-3.46-11.32-2.3-2.5-5.91-3.74-10.82-3.74-6.5 0-11.25 1.75-14.28 5.26-3.03 3.5-4.54 9.3-4.54 17.38v32.54h-9.4V22h7.64l1.52 8.5h.46a19.2 19.2 0 0 1 8-7.1 26.32 26.32 0 0 1 11.62-2.52c7.48 0 13.1 1.8 16.88 5.4 3.77 3.6 5.66 9.37 5.66 17.3v40.54h-9.28z" fill="#6FBE4A"/><path d="M190.66 85.24c-9.17 0-16.41-2.8-21.72-8.38-5.3-5.59-7.97-13.35-8-23.28 0-10 2.47-17.95 7.4-23.84a24.54 24.54 0 0 1 19.86-8.84c7-.33 13.76 2.49 18.46 7.68 4.53 5.12 6.8 11.87 6.8 20.24v6h-42.74c.19 7.3 2.03 12.83 5.52 16.6A19.1 19.1 0 0 0 191 77.08a50 50 0 0 0 19.82-4.2v8.38a49.68 49.68 0 0 1-9.44 3.08c-3.53.66-7.13.96-10.72.9zm-2.56-56.46a15.36 15.36 0 0 0-12 4.88 22.46 22.46 0 0 0-5.24 13.48h32.54c0-5.93-1.33-10.47-4-13.62a14 14 0 0 0-11.3-4.74z" fill="#6FBE4A" fill-rule="nonzero"/><path fill="#6FBE4A" d="M256.42 84.12h-9.62V9.86h-26.24V1.3h62v8.56h-26.14zM322 20.9c2.49-.02 4.98.2 7.42.68l-1.3 8.72a32 32 0 0 0-6.8-.84c-5 0-9.73 2.24-12.88 6.12a22.32 22.32 0 0 0-5.36 15.24v33.3h-9.4V22h7.76l1.08 11.5h.46a27.28 27.28 0 0 1 8.32-9.34A18.76 18.76 0 0 1 322 20.9zM349.86 22v40.3c0 5.07 1.15 8.84 3.46 11.32 2.3 2.48 5.91 3.73 10.82 3.74 6.5 0 11.24-1.77 14.24-5.32 3-3.55 4.5-9.34 4.5-17.38V22h9.4v62h-7.76l-1.36-8.32h-.5a18.74 18.74 0 0 1-8 7.02 26.96 26.96 0 0 1-11.7 2.44c-7.55 0-13.2-1.8-16.96-5.38-3.76-3.59-5.64-9.33-5.64-17.22V22h9.5zM452.28 67.18a15.54 15.54 0 0 1-6.46 13.36c-4.3 3.13-10.35 4.7-18.12 4.7-8.23 0-14.65-1.33-19.26-4v-8.62a46.54 46.54 0 0 0 9.6 3.56 40 40 0 0 0 9.88 1.3c3.91.22 7.82-.6 11.32-2.36a8 8 0 0 0 .82-13.36 49.52 49.52 0 0 0-12.26-6A66.38 66.38 0 0 1 415.48 50a16.78 16.78 0 0 1-5.48-5.42 14.24 14.24 0 0 1-1.78-7.3 14 14 0 0 1 6.18-12c4.12-2.92 9.77-4.38 16.94-4.38a49.56 49.56 0 0 1 19.6 4l-3.34 7.64a44.98 44.98 0 0 0-16.94-3.86 19.5 19.5 0 0 0-10 2 6.48 6.48 0 0 0-3.4 5.78c-.04 1.51.4 3 1.28 4.24a12.58 12.58 0 0 0 4.1 3.34 91.76 91.76 0 0 0 10.88 4.58c7.36 2.67 12.33 5.33 14.92 8a14.28 14.28 0 0 1 3.84 10.56zM487.62 77.48c1.61 0 3.23-.11 4.82-.36a31 31 0 0 0 3.68-.76v7.2c-1.44.6-2.95 1.02-4.5 1.22-1.77.3-3.56.46-5.36.48-12 0-18-6.33-18-18.98V29.34h-8.9V24.8l8.9-4 4-13.26h5.44V22h18v7.3h-18v36.58c-.2 3.1.74 6.16 2.66 8.6a9.26 9.26 0 0 0 7.26 3z"/><path d="M23.84 124.76a6.4 6.4 0 0 1-2.36 5.24 10.72 10.72 0 0 1-6.78 2H12v8.98H9.36V118.1h6c5.65 0 8.48 2.22 8.48 6.66zM12 129.68h2.4a8.88 8.88 0 0 0 5.1-1.14 4.2 4.2 0 0 0 1.58-3.66 4 4 0 0 0-1.48-3.38 7.76 7.76 0 0 0-4.62-1.1H12v9.28z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M37.5 123.5c.67 0 1.34.05 2 .18l-.36 2.4a8.84 8.84 0 0 0-1.88-.24c-1.38 0-2.69.61-3.56 1.68a6.16 6.16 0 0 0-1.48 4.2v9.18h-2.6v-17.08h2.14l.3 3.18h.12a7.54 7.54 0 0 1 2.3-2.58 5.18 5.18 0 0 1 3.02-.92z" fill="#5A5B5D"/><path d="M44 119.18c-.04-.48.12-.95.44-1.3a1.62 1.62 0 0 1 2.18 0c.33.35.5.82.46 1.3.03.48-.13.95-.46 1.3-.29.28-.68.43-1.08.42-.4.02-.8-.14-1.1-.42a1.76 1.76 0 0 1-.44-1.3zm2.82 21.76h-2.6v-17.12h2.6v17.12z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M57.46 140.94l-6.5-17.12h2.78l3.7 10.18a48.2 48.2 0 0 1 1.46 4.62h.12c.3-1.16.66-2.3 1.08-3.42.61-1.73 1.98-5.52 4.1-11.36H67l-6.5 17.12-3.04-.02z" fill="#5A5B5D"/><path d="M81.72 140.94l-.52-2.44h-.12a7.16 7.16 0 0 1-2.56 2.18c-1 .41-2.1.61-3.18.58a5.72 5.72 0 0 1-4-1.32 4.78 4.78 0 0 1-1.34-3.72c0-3.45 2.77-5.27 8.3-5.44h2.9v-1.06a4.34 4.34 0 0 0-.86-2.98 3.56 3.56 0 0 0-2.78-.96c-1.7.07-3.35.52-4.84 1.32l-.8-2a12.3 12.3 0 0 1 2.68-1.1 12 12 0 0 1 3.02-.4 6.52 6.52 0 0 1 4.54 1.36 5.68 5.68 0 0 1 1.48 4.36V141l-1.92-.06zm-5.86-1.82c1.4.08 2.76-.4 3.8-1.32a4.92 4.92 0 0 0 1.38-3.8v-1.54l-2.6.1A9.46 9.46 0 0 0 74 133.6a2.9 2.9 0 0 0-1.36 2.64c-.05.8.26 1.6.86 2.14.67.52 1.51.79 2.36.74z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M97.26 141.26a7.3 7.3 0 0 1-5.76-2.28 9.4 9.4 0 0 1-2-6.48 9.7 9.7 0 0 1 2-6.64 7.46 7.46 0 0 1 5.9-2.34 11.8 11.8 0 0 1 4.46.88l-.8 2.2c-.61-.24-1.24-.44-1.88-.58a8.42 8.42 0 0 0-1.8-.22c-3.48 0-5.22 2.22-5.22 6.66a8 8 0 0 0 1.28 4.84 4.44 4.44 0 0 0 3.78 1.68c1.51-.04 3-.37 4.38-.98v2.3c-1.35.66-2.84 1-4.34.96zM104.38 123.82h2.78l3.76 9.76a37.28 37.28 0 0 1 1.54 4.82h.12c.13-.53.42-1.44.86-2.72.44-1.28 1.85-5.23 4.24-11.86h2.78l-7.36 19.5a9.7 9.7 0 0 1-2.56 4.1 5.44 5.44 0 0 1-3.58 1.22c-.79 0-1.57-.09-2.34-.26v-2c.66.13 1.33.2 2 .18a4 4 0 0 0 3.82-3l.96-2.44-7.02-17.3zM144.92 140.94l-7.76-20.24h-.12c.15 1.6.22 3.5.22 5.72v14.54h-2.46V118.1h4l7.2 18.84h.12l7.3-18.84h4v22.84h-2.64v-14.72c0-1.7.07-3.53.22-5.5h-.12l-7.82 20.22h-2.14z" fill="#5A5B5D"/><path d="M175.28 140.94l-.52-2.44h-.12c-.7.93-1.6 1.68-2.64 2.18-1 .41-2.1.61-3.18.58a5.72 5.72 0 0 1-4-1.32 4.78 4.78 0 0 1-1.44-3.74c0-3.45 2.77-5.27 8.3-5.44h2.9v-1.06a4.34 4.34 0 0 0-.86-2.98 3.56 3.56 0 0 0-2.78-.96c-1.7.07-3.35.52-4.84 1.32l-.8-2c.9-.48 1.87-.84 2.86-1.08a12 12 0 0 1 3.02-.4 6.52 6.52 0 0 1 4.54 1.36 5.68 5.68 0 0 1 1.48 4.36V141l-1.92-.06zm-5.86-1.82c1.4.08 2.76-.4 3.8-1.32a4.92 4.92 0 0 0 1.38-3.8v-1.54l-2.6.1a9.46 9.46 0 0 0-4.46.96 2.9 2.9 0 0 0-1.36 2.64c-.05.8.26 1.6.86 2.14.67.56 1.51.85 2.38.82z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M195.7 140.94v-11.08a4.48 4.48 0 0 0-.96-3.12 3.88 3.88 0 0 0-2.98-1.04 4.92 4.92 0 0 0-4 1.46 7.34 7.34 0 0 0-1.24 4.8v8.98H184v-17.12h2l.42 2.34h.12a5.3 5.3 0 0 1 2.24-2c1-.47 2.1-.71 3.2-.7a6.5 6.5 0 0 1 4.66 1.5 6.36 6.36 0 0 1 1.56 4.78v11.18l-2.5.02z" fill="#5A5B5D"/><path d="M215.6 140.94l-.52-2.44h-.12a7.16 7.16 0 0 1-2.56 2.18c-1 .41-2.1.61-3.18.58a5.72 5.72 0 0 1-4-1.32 4.78 4.78 0 0 1-1.44-3.74c0-3.45 2.77-5.27 8.3-5.44h2.9v-1.06a4.34 4.34 0 0 0-.86-2.98 3.56 3.56 0 0 0-2.78-.96c-1.7.07-3.35.52-4.84 1.32l-.8-2a12.3 12.3 0 0 1 5.8-1.48 6.52 6.52 0 0 1 4.54 1.36 5.68 5.68 0 0 1 1.48 4.36V141l-1.92-.06zm-5.86-1.82c1.4.08 2.76-.4 3.8-1.32.96-1 1.46-2.34 1.38-3.72v-1.54l-2.6.1a9.46 9.46 0 0 0-4.46.96 2.9 2.9 0 0 0-1.36 2.64c-.05.8.26 1.6.86 2.14.68.53 1.52.79 2.38.74zM238.32 123.82v1.64l-3.18.38a5.58 5.58 0 0 1 1.12 3.42c.06 1.52-.57 3-1.72 4a6.94 6.94 0 0 1-4.72 1.5 7.8 7.8 0 0 1-1.44-.12 2.56 2.56 0 0 0-1.66 2.2c-.02.43.2.83.58 1.04.63.27 1.32.4 2 .34h3.04c1.52-.1 3.03.32 4.28 1.18a4 4 0 0 1 1.5 3.4 4.86 4.86 0 0 1-2.28 4.34 12.22 12.22 0 0 1-6.66 1.5 9.08 9.08 0 0 1-5.18-1.24 4 4 0 0 1-1.82-3.54 4 4 0 0 1 1-2.7 5.1 5.1 0 0 1 2.82-1.56 2.7 2.7 0 0 1-1.1-.92c-.3-.43-.45-.94-.44-1.46-.01-.59.16-1.16.5-1.64.43-.55.97-1.02 1.58-1.36a4.62 4.62 0 0 1-2.16-1.86 5.46 5.46 0 0 1-.84-3 5.54 5.54 0 0 1 1.68-4.34 6.88 6.88 0 0 1 4.78-1.52c.82 0 1.63.1 2.42.32h5.9zm-13.66 20c-.03.87.43 1.68 1.18 2.1 1.03.54 2.2.79 3.36.72a9.38 9.38 0 0 0 4.84-.98 2.98 2.98 0 0 0 1.58-2.64 2 2 0 0 0-.86-2 6.68 6.68 0 0 0-3.24-.54h-3.12a4 4 0 0 0-2.74.84 3.02 3.02 0 0 0-1 2.5zm1.4-14.52c-.07 1.01.3 2 1.02 2.72a4 4 0 0 0 2.82.92 3.3 3.3 0 0 0 3.8-3.68 3.4 3.4 0 0 0-3.84-3.86 3.8 3.8 0 0 0-2.82.98 4 4 0 0 0-1.04 2.92h.06zM250.5 141.26a7.86 7.86 0 0 1-6-2.32 8.96 8.96 0 0 1-2.2-6.42 10 10 0 0 1 2-6.58 6.78 6.78 0 0 1 5.48-2.44c1.93-.1 3.8.69 5.1 2.12a8.12 8.12 0 0 1 1.88 5.58v1.64h-11.8a6.8 6.8 0 0 0 1.52 4.58 5.26 5.26 0 0 0 4 1.56c1.88-.01 3.74-.4 5.46-1.16v2.32c-.84.37-1.7.66-2.6.86-.94.18-1.89.27-2.84.26zm-.7-15.58a4.24 4.24 0 0 0-3.28 1.34 6.2 6.2 0 0 0-1.44 3.72H254a5.7 5.7 0 0 0-1.1-3.76 3.86 3.86 0 0 0-3.1-1.3z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M284.5 140.94V129.8c.08-1.1-.23-2.2-.88-3.08-.7-.73-1.7-1.1-2.72-1.02a4.4 4.4 0 0 0-3.58 1.4 6.6 6.6 0 0 0-1.16 4.28v9.56h-2.6V129.8c.08-1.1-.23-2.2-.88-3.08a3.4 3.4 0 0 0-2.74-1.02 4.24 4.24 0 0 0-3.58 1.46 8 8 0 0 0-1.14 4.78v8.98h-2.6v-17.1h2.1l.42 2.34h.12a5.12 5.12 0 0 1 2-2 6.32 6.32 0 0 1 3-.7c2.2-.28 4.33.89 5.26 2.9h.12a5.46 5.46 0 0 1 2.36-2.08 6.9 6.9 0 0 1 3.32-.78 5.8 5.8 0 0 1 4.36 1.5 6.68 6.68 0 0 1 1.44 4.78v11.18l-2.62-.02z" fill="#5A5B5D"/><path d="M301.1 141.26a7.86 7.86 0 0 1-6-2.32 8.96 8.96 0 0 1-2.2-6.42 10 10 0 0 1 2-6.58 6.78 6.78 0 0 1 5.48-2.44c1.93-.1 3.8.69 5.1 2.12a8.12 8.12 0 0 1 1.88 5.58v1.64h-11.8a6.8 6.8 0 0 0 1.52 4.58 5.26 5.26 0 0 0 4 1.56c1.88-.01 3.74-.4 5.46-1.16v2.32c-.84.37-1.7.66-2.6.86-.94.18-1.89.27-2.84.26zm-.7-15.58a4.24 4.24 0 0 0-3.28 1.34 6.2 6.2 0 0 0-1.44 3.72h8.96a5.7 5.7 0 0 0-1.1-3.76 3.86 3.86 0 0 0-3.14-1.3z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M324.98 140.94v-11.08a4.48 4.48 0 0 0-.96-3.12 3.88 3.88 0 0 0-2.98-1.04 4.92 4.92 0 0 0-4 1.46 7.34 7.34 0 0 0-1.24 4.8v8.98h-2.6v-17.12h2.1l.42 2.34h.28a5.3 5.3 0 0 1 2.24-2c1-.47 2.1-.71 3.2-.7a6.5 6.5 0 0 1 4.66 1.5 6.36 6.36 0 0 1 1.56 4.78v11.18l-2.68.02zM339.88 139.12a8.4 8.4 0 0 0 2.34-.32v2c-.4.17-.81.28-1.24.34a9.4 9.4 0 0 1-1.48.14c-3.3 0-4.96-1.75-4.96-5.24v-10.2H332v-1.24l2.46-1.08 1.1-3.66h1.5v4H342v2h-4.96v10c-.06.86.2 1.7.74 2.38.52.6 1.3.93 2.1.88zM370.12 134.86a5.6 5.6 0 0 1-2.12 4.72 9.48 9.48 0 0 1-6 1.68c-2.13.1-4.26-.25-6.24-1.04v-2.58a16.38 16.38 0 0 0 6.34 1.28c1.4.1 2.8-.25 4-1a3.3 3.3 0 0 0 1.34-2.8 3.6 3.6 0 0 0-.48-2 4.46 4.46 0 0 0-1.6-1.4 22.5 22.5 0 0 0-3.4-1.46 10.84 10.84 0 0 1-4.56-2.7 6 6 0 0 1-1.36-4c-.05-1.64.7-3.2 2-4.2a8.24 8.24 0 0 1 5.26-1.56 15.5 15.5 0 0 1 6.26 1.26l-.82 2.32a14.16 14.16 0 0 0-5.5-1.18 5.32 5.32 0 0 0-3.3.9 3 3 0 0 0-1.18 2.52c-.04.7.12 1.39.44 2a4.1 4.1 0 0 0 1.48 1.4 18.3 18.3 0 0 0 3.18 1.4 12.6 12.6 0 0 1 4.94 2.76 5.42 5.42 0 0 1 1.32 3.68z" fill="#5A5B5D"/><path d="M390.62 132.36c.15 2.37-.6 4.7-2.1 6.54a7.42 7.42 0 0 1-5.82 2.36 7.72 7.72 0 0 1-4-1.08 7.12 7.12 0 0 1-2.74-3.1c-.67-1.48-1-3.1-.96-4.72a9.44 9.44 0 0 1 2-6.52 7.4 7.4 0 0 1 5.82-2.34c2.17-.1 4.27.78 5.72 2.4a9.4 9.4 0 0 1 2.08 6.46zm-13.04 0a8.12 8.12 0 0 0 1.32 5 5.2 5.2 0 0 0 7.72 0 8 8 0 0 0 1.32-5 8 8 0 0 0-1.32-4.96 4.64 4.64 0 0 0-3.9-1.7c-1.48-.1-2.9.53-3.84 1.68a8 8 0 0 0-1.3 4.98z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M404.32 125.84H400v15.1h-2.6v-15.1h-3.06v-1.18l3.06-.94v-.96c0-4.21 1.84-6.32 5.52-6.32 1.08.03 2.15.21 3.18.54l-.68 2a8.6 8.6 0 0 0-2.56-.48 2.5 2.5 0 0 0-2.18.98 5.46 5.46 0 0 0-.7 3.14v1.1h4.36l-.02 2.12zM414.42 139.12a8.4 8.4 0 0 0 2.34-.32v2c-.4.17-.81.28-1.24.34a9.4 9.4 0 0 1-1.48.14c-3.3 0-4.96-1.75-4.96-5.24v-10.2h-2.46v-1.24l2.46-1.08 1.1-3.66h1.5v4h4.96v2h-4.96v10c-.06.86.2 1.7.74 2.38.5.58 1.24.9 2 .88zM435.6 140.94l-3.14-10c-.2-.61-.57-2-1.1-4.18h-.12a51.1 51.1 0 0 1-1.1 4.22l-3.24 10H424l-4.68-17.12H422l2.52 9.82a40 40 0 0 1 1 4.54h.12a43.1 43.1 0 0 1 1.22-4.54l3.14-9.86h2.82l3.06 9.82c.5 1.48.9 2.99 1.18 4.52h.12c.08-.59.2-1.17.34-1.74.19-.79 1.27-4.99 3.26-12.6h2.68l-4.74 17.12h-3.12z" fill="#5A5B5D"/><path d="M458.48 140.94l-.48-2.44h-.12a7.16 7.16 0 0 1-2.56 2.18c-1 .41-2.1.61-3.18.58a5.72 5.72 0 0 1-4-1.32 4.78 4.78 0 0 1-1.44-3.74c0-3.45 2.77-5.27 8.3-5.44h2.9v-1.06a4.34 4.34 0 0 0-.86-2.98 3.56 3.56 0 0 0-2.78-.96c-1.7.07-3.35.52-4.84 1.32l-.8-2a12.3 12.3 0 0 1 5.8-1.48 6.52 6.52 0 0 1 4.54 1.36 5.68 5.68 0 0 1 1.48 4.36V141l-1.96-.06zm-5.86-1.82c1.4.08 2.76-.4 3.8-1.32.96-1 1.46-2.34 1.38-3.72v-1.54l-2.6.1a9.46 9.46 0 0 0-4.46.96 2.9 2.9 0 0 0-1.36 2.64c-.05.8.26 1.6.86 2.14.68.53 1.52.79 2.38.74z" fill="#5A5B5D" fill-rule="nonzero"/><path d="M475 123.5c.67 0 1.34.05 2 .18l-.36 2.4a8.84 8.84 0 0 0-1.88-.24c-1.38 0-2.69.61-3.56 1.68a6.16 6.16 0 0 0-1.48 4.2v9.18h-2.6v-17.08h2.14l.3 3.18h.12a7.54 7.54 0 0 1 2.32-2.58c.88-.6 1.93-.93 3-.92z" fill="#5A5B5D"/><path d="M488.92 141.26a7.86 7.86 0 0 1-6-2.32 8.96 8.96 0 0 1-2.2-6.42 10 10 0 0 1 2-6.58 6.78 6.78 0 0 1 5.48-2.44c1.93-.1 3.8.69 5.1 2.12a8.12 8.12 0 0 1 1.88 5.58v1.64h-11.8a6.8 6.8 0 0 0 1.52 4.58 5.26 5.26 0 0 0 4 1.56c1.88-.01 3.74-.4 5.46-1.16v2.32c-.84.37-1.7.66-2.6.86-.94.18-1.89.27-2.84.26zm-.7-15.58a4.24 4.24 0 0 0-3.28 1.34 6.2 6.2 0 0 0-1.44 3.72h8.96a5.7 5.7 0 0 0-1.1-3.76 3.86 3.86 0 0 0-3.14-1.3z" fill="#5A5B5D" fill-rule="nonzero"/></g></svg>");background-position:center;background-size:contain;background-repeat:no-repeat}#onetrust-pc-sdk.fade-in,.onetrust-pc-dark-filter.fade-in{animation-name:onetrust-fade-in;animation-duration:400ms;animation-timing-function:ease-in-out}#onetrust-pc-sdk.hide{display:none !important}.onetrust-pc-dark-filter.hide{display:none !important}#ot-sdk-btn.ot-sdk-show-settings,#ot-sdk-btn.optanon-show-settings{color:#68b631;border:1px solid #68b631;height:auto;white-space:normal;word-wrap:break-word;padding:0.8em 2em;font-size:0.8em;line-height:1.2;cursor:pointer;-moz-transition:0.1s ease;-o-transition:0.1s ease;-webkit-transition:1s ease;transition:0.1s ease}#ot-sdk-btn.ot-sdk-show-settings:hover,#ot-sdk-btn.optanon-show-settings:hover{color:#fff;background-color:#68b631}#ot-sdk-btn.ot-sdk-show-settings:focus,#ot-sdk-btn.optanon-show-settings:focus{outline:none}.onetrust-pc-dark-filter{background:rgba(0,0,0,0.5);z-index:2147483646;width:100%;height:100%;overflow:hidden;position:fixed;top:0;bottom:0;left:0}@keyframes onetrust-fade-in{0%{opacity:0}100%{opacity:1}}@media only screen and (min-width: 426px) and (max-width: 896px) and (orientation: landscape){#onetrust-pc-sdk p{font-size:0.75em}}
#onetrust-banner-sdk,#onetrust-pc-sdk,#ot-sdk-cookie-policy{font-size:16px}#onetrust-banner-sdk *,#onetrust-banner-sdk ::after,#onetrust-banner-sdk ::before,#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before,#ot-sdk-cookie-policy *,#ot-sdk-cookie-policy ::after,#ot-sdk-cookie-policy ::before{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}#onetrust-banner-sdk div,#onetrust-banner-sdk span,#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-banner-sdk p,#onetrust-banner-sdk img,#onetrust-banner-sdk svg,#onetrust-banner-sdk button,#onetrust-banner-sdk section,#onetrust-banner-sdk a,#onetrust-banner-sdk label,#onetrust-banner-sdk input,#onetrust-banner-sdk ul,#onetrust-banner-sdk li,#onetrust-banner-sdk nav,#onetrust-banner-sdk table,#onetrust-banner-sdk thead,#onetrust-banner-sdk tr,#onetrust-banner-sdk td,#onetrust-banner-sdk tbody,#onetrust-banner-sdk .main-content,#onetrust-banner-sdk .toggle,#onetrust-banner-sdk #content,#onetrust-banner-sdk .checkbox,#onetrust-pc-sdk div,#onetrust-pc-sdk span,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#onetrust-pc-sdk p,#onetrust-pc-sdk img,#onetrust-pc-sdk svg,#onetrust-pc-sdk button,#onetrust-pc-sdk section,#onetrust-pc-sdk a,#onetrust-pc-sdk label,#onetrust-pc-sdk input,#onetrust-pc-sdk ul,#onetrust-pc-sdk li,#onetrust-pc-sdk nav,#onetrust-pc-sdk table,#onetrust-pc-sdk thead,#onetrust-pc-sdk tr,#onetrust-pc-sdk td,#onetrust-pc-sdk tbody,#onetrust-pc-sdk .main-content,#onetrust-pc-sdk .toggle,#onetrust-pc-sdk #content,#onetrust-pc-sdk .checkbox,#ot-sdk-cookie-policy div,#ot-sdk-cookie-policy span,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6,#ot-sdk-cookie-policy p,#ot-sdk-cookie-policy img,#ot-sdk-cookie-policy svg,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy section,#ot-sdk-cookie-policy a,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy input,#ot-sdk-cookie-policy ul,#ot-sdk-cookie-policy li,#ot-sdk-cookie-policy nav,#ot-sdk-cookie-policy table,#ot-sdk-cookie-policy thead,#ot-sdk-cookie-policy tr,#ot-sdk-cookie-policy td,#ot-sdk-cookie-policy tbody,#ot-sdk-cookie-policy .main-content,#ot-sdk-cookie-policy .toggle,#ot-sdk-cookie-policy #content,#ot-sdk-cookie-policy .checkbox{font-family:inherit;font-size:initial;font-weight:normal;-webkit-font-smoothing:auto;letter-spacing:normal;line-height:normal;padding:0;margin:0;height:auto;min-height:0;max-height:none;width:auto;min-width:0;max-width:none;border-radius:0;border:none;clear:none;float:none;position:static;bottom:auto;left:auto;right:auto;top:auto;text-align:left;text-decoration:none;text-indent:0;text-shadow:none;text-transform:none;white-space:normal;background:none;overflow:visible;vertical-align:baseline;visibility:visible;z-index:auto;box-shadow:none}#onetrust-banner-sdk label:before,#onetrust-banner-sdk label:after,#onetrust-banner-sdk .checkbox:after,#onetrust-banner-sdk .checkbox:before,#onetrust-pc-sdk label:before,#onetrust-pc-sdk label:after,#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before,#ot-sdk-cookie-policy label:before,#ot-sdk-cookie-policy label:after,#ot-sdk-cookie-policy .checkbox:after,#ot-sdk-cookie-policy .checkbox:before{content:"";content:none}
#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{position:relative;width:100%;max-width:100%;margin:0 auto;padding:0 20px;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{width:100%;float:left;box-sizing:border-box;padding:0;display:initial}@media (min-width: 400px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:90%;padding:0}}@media (min-width: 550px){#onetrust-banner-sdk .ot-sdk-container,#onetrust-pc-sdk .ot-sdk-container,#ot-sdk-cookie-policy .ot-sdk-container{width:100%}#onetrust-banner-sdk .ot-sdk-column,#onetrust-banner-sdk .ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-column,#onetrust-pc-sdk .ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-columns{margin-left:4%}#onetrust-banner-sdk .ot-sdk-column:first-child,#onetrust-banner-sdk .ot-sdk-columns:first-child,#onetrust-pc-sdk .ot-sdk-column:first-child,#onetrust-pc-sdk .ot-sdk-columns:first-child,#ot-sdk-cookie-policy .ot-sdk-column:first-child,#ot-sdk-cookie-policy .ot-sdk-columns:first-child{margin-left:0}#onetrust-banner-sdk .ot-sdk-one.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-one.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-one.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-one.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-one.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-one.ot-sdk-columns{width:4.66666666667%}#onetrust-banner-sdk .ot-sdk-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-two.ot-sdk-columns{width:13.3333333333%}#onetrust-banner-sdk .ot-sdk-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-three.ot-sdk-columns{width:22%}#onetrust-banner-sdk .ot-sdk-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-four.ot-sdk-columns{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-five.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-five.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-five.ot-sdk-columns{width:39.3333333333%}#onetrust-banner-sdk .ot-sdk-six.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-six.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-six.ot-sdk-columns{width:48%}#onetrust-banner-sdk .ot-sdk-seven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-seven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-seven.ot-sdk-columns{width:56.6666666667%}#onetrust-banner-sdk .ot-sdk-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eight.ot-sdk-columns{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-nine.ot-sdk-columns{width:74%}#onetrust-banner-sdk .ot-sdk-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-ten.ot-sdk-columns{width:82.6666666667%}#onetrust-banner-sdk .ot-sdk-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-eleven.ot-sdk-columns{width:91.3333333333%}#onetrust-banner-sdk .ot-sdk-twelve.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-twelve.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-twelve.ot-sdk-columns{width:100%;margin-left:0}#onetrust-banner-sdk .ot-sdk-one-third.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-one-third.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-one-third.ot-sdk-column{width:30.6666666667%}#onetrust-banner-sdk .ot-sdk-two-thirds.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-two-thirds.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-two-thirds.ot-sdk-column{width:65.3333333333%}#onetrust-banner-sdk .ot-sdk-one-half.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-one-half.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-one-half.ot-sdk-column{width:48%}#onetrust-banner-sdk .ot-sdk-offset-by-one.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-one.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-one.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-one.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-one.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-one.ot-sdk-columns{margin-left:8.66666666667%}#onetrust-banner-sdk .ot-sdk-offset-by-two.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-two.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-two.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-two.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-two.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-two.ot-sdk-columns{margin-left:17.3333333333%}#onetrust-banner-sdk .ot-sdk-offset-by-three.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-three.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-three.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-three.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-three.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-three.ot-sdk-columns{margin-left:26%}#onetrust-banner-sdk .ot-sdk-offset-by-four.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-four.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-four.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-four.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-four.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-four.ot-sdk-columns{margin-left:34.6666666667%}#onetrust-banner-sdk .ot-sdk-offset-by-five.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-five.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-five.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-five.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-five.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-five.ot-sdk-columns{margin-left:43.3333333333%}#onetrust-banner-sdk .ot-sdk-offset-by-six.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-six.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-six.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-six.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-six.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-six.ot-sdk-columns{margin-left:52%}#onetrust-banner-sdk .ot-sdk-offset-by-seven.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-seven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-seven.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-seven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-seven.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-seven.ot-sdk-columns{margin-left:60.6666666667%}#onetrust-banner-sdk .ot-sdk-offset-by-eight.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-eight.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-eight.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-eight.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-eight.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-eight.ot-sdk-columns{margin-left:69.3333333333%}#onetrust-banner-sdk .ot-sdk-offset-by-nine.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-nine.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-nine.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-nine.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-nine.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-nine.ot-sdk-columns{margin-left:78%}#onetrust-banner-sdk .ot-sdk-offset-by-ten.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-ten.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-ten.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-ten.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-ten.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-ten.ot-sdk-columns{margin-left:86.6666666667%}#onetrust-banner-sdk .ot-sdk-offset-by-eleven.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-eleven.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-eleven.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-eleven.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-eleven.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-eleven.ot-sdk-columns{margin-left:95.3333333333%}#onetrust-banner-sdk .ot-sdk-offset-by-one-third.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-one-third.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-one-third.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-one-third.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-one-third.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-one-third.ot-sdk-columns{margin-left:34.6666666667%}#onetrust-banner-sdk .ot-sdk-offset-by-two-thirds.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-two-thirds.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-two-thirds.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-two-thirds.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-two-thirds.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-two-thirds.ot-sdk-columns{margin-left:69.3333333333%}#onetrust-banner-sdk .ot-sdk-offset-by-one-half.ot-sdk-column,#onetrust-banner-sdk .ot-sdk-offset-by-one-half.ot-sdk-columns,#onetrust-pc-sdk .ot-sdk-offset-by-one-half.ot-sdk-column,#onetrust-pc-sdk .ot-sdk-offset-by-one-half.ot-sdk-columns,#ot-sdk-cookie-policy .ot-sdk-offset-by-one-half.ot-sdk-column,#ot-sdk-cookie-policy .ot-sdk-offset-by-one-half.ot-sdk-columns{margin-left:52%}}#onetrust-banner-sdk h1,#onetrust-banner-sdk h2,#onetrust-banner-sdk h3,#onetrust-banner-sdk h4,#onetrust-banner-sdk h5,#onetrust-banner-sdk h6,#onetrust-pc-sdk h1,#onetrust-pc-sdk h2,#onetrust-pc-sdk h3,#onetrust-pc-sdk h4,#onetrust-pc-sdk h5,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h1,#ot-sdk-cookie-policy h2,#ot-sdk-cookie-policy h3,#ot-sdk-cookie-policy h4,#ot-sdk-cookie-policy h5,#ot-sdk-cookie-policy h6{margin-top:0;font-weight:600;font-family:inherit}#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem;line-height:1.2}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem;line-height:1.25}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem;line-height:1.3}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem;line-height:1.35}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem;line-height:1.5}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem;line-height:1.6}@media (min-width: 550px){#onetrust-banner-sdk h1,#onetrust-pc-sdk h1,#ot-sdk-cookie-policy h1{font-size:1.5rem}#onetrust-banner-sdk h2,#onetrust-pc-sdk h2,#ot-sdk-cookie-policy h2{font-size:1.5rem}#onetrust-banner-sdk h3,#onetrust-pc-sdk h3,#ot-sdk-cookie-policy h3{font-size:1.5rem}#onetrust-banner-sdk h4,#onetrust-pc-sdk h4,#ot-sdk-cookie-policy h4{font-size:1.5rem}#onetrust-banner-sdk h5,#onetrust-pc-sdk h5,#ot-sdk-cookie-policy h5{font-size:1.5rem}#onetrust-banner-sdk h6,#onetrust-pc-sdk h6,#ot-sdk-cookie-policy h6{font-size:1.5rem}}#onetrust-banner-sdk p,#onetrust-pc-sdk p,#ot-sdk-cookie-policy p{margin:0 0 1em 0;font-family:inherit;line-height:normal}#onetrust-banner-sdk a,#onetrust-pc-sdk a,#ot-sdk-cookie-policy a{color:#565656;text-decoration:underline}#onetrust-banner-sdk a:hover,#onetrust-pc-sdk a:hover,#ot-sdk-cookie-policy a:hover{color:#565656;text-decoration:none}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button{margin-bottom:1rem;font-family:inherit}#onetrust-banner-sdk .ot-sdk-button,#onetrust-banner-sdk button,#onetrust-banner-sdk input[type="submit"],#onetrust-banner-sdk input[type="reset"],#onetrust-banner-sdk input[type="button"],#onetrust-pc-sdk .ot-sdk-button,#onetrust-pc-sdk button,#onetrust-pc-sdk input[type="submit"],#onetrust-pc-sdk input[type="reset"],#onetrust-pc-sdk input[type="button"],#ot-sdk-cookie-policy .ot-sdk-button,#ot-sdk-cookie-policy button,#ot-sdk-cookie-policy input[type="submit"],#ot-sdk-cookie-policy input[type="reset"],#ot-sdk-cookie-policy input[type="button"]{display:inline-block;height:38px;padding:0 30px;color:#555;text-align:center;font-size:0.9em;font-weight:400;line-height:38px;letter-spacing:0.01em;text-decoration:none;white-space:nowrap;background-color:transparent;border-radius:2px;border:1px solid #bbb;cursor:pointer;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-button:hover,#onetrust-banner-sdk button:hover,#onetrust-banner-sdk input[type="submit"]:hover,#onetrust-banner-sdk input[type="reset"]:hover,#onetrust-banner-sdk input[type="button"]:hover,#onetrust-banner-sdk .ot-sdk-button:focus,#onetrust-banner-sdk button:focus,#onetrust-banner-sdk input[type="submit"]:focus,#onetrust-banner-sdk input[type="reset"]:focus,#onetrust-banner-sdk input[type="button"]:focus,#onetrust-pc-sdk .ot-sdk-button:hover,#onetrust-pc-sdk button:hover,#onetrust-pc-sdk input[type="submit"]:hover,#onetrust-pc-sdk input[type="reset"]:hover,#onetrust-pc-sdk input[type="button"]:hover,#onetrust-pc-sdk .ot-sdk-button:focus,#onetrust-pc-sdk button:focus,#onetrust-pc-sdk input[type="submit"]:focus,#onetrust-pc-sdk input[type="reset"]:focus,#onetrust-pc-sdk input[type="button"]:focus,#ot-sdk-cookie-policy .ot-sdk-button:hover,#ot-sdk-cookie-policy button:hover,#ot-sdk-cookie-policy input[type="submit"]:hover,#ot-sdk-cookie-policy input[type="reset"]:hover,#ot-sdk-cookie-policy input[type="button"]:hover,#ot-sdk-cookie-policy .ot-sdk-button:focus,#ot-sdk-cookie-policy button:focus,#ot-sdk-cookie-policy input[type="submit"]:focus,#ot-sdk-cookie-policy input[type="reset"]:focus,#ot-sdk-cookie-policy input[type="button"]:focus{color:#333;border-color:#888;outline:0;opacity:0.7}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-banner-sdk button.ot-sdk-button-primary,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary,#onetrust-pc-sdk button.ot-sdk-button-primary,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary,#ot-sdk-cookie-policy button.ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary{color:#fff;background-color:#33c3f0;border-color:#33c3f0}#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-banner-sdk button.ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary:hover,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary:hover,#onetrust-banner-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-banner-sdk button.ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="submit"].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="reset"].ot-sdk-button-primary:focus,#onetrust-banner-sdk input[type="button"].ot-sdk-button-primary:focus,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:hover,#onetrust-pc-sdk button.ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary:hover,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary:hover,#onetrust-pc-sdk .ot-sdk-button.ot-sdk-button-primary:focus,#onetrust-pc-sdk button.ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="submit"].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="reset"].ot-sdk-button-primary:focus,#onetrust-pc-sdk input[type="button"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy button.ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary:hover,#ot-sdk-cookie-policy .ot-sdk-button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy button.ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="submit"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="reset"].ot-sdk-button-primary:focus,#ot-sdk-cookie-policy input[type="button"].ot-sdk-button-primary:focus{color:#fff;background-color:#1eaedb;border-color:#1eaedb}#onetrust-banner-sdk input[type="email"],#onetrust-banner-sdk input[type="number"],#onetrust-banner-sdk input[type="search"],#onetrust-banner-sdk input[type="text"],#onetrust-banner-sdk input[type="tel"],#onetrust-banner-sdk input[type="url"],#onetrust-banner-sdk input[type="password"],#onetrust-banner-sdk textarea,#onetrust-banner-sdk select,#onetrust-pc-sdk input[type="email"],#onetrust-pc-sdk input[type="number"],#onetrust-pc-sdk input[type="search"],#onetrust-pc-sdk input[type="text"],#onetrust-pc-sdk input[type="tel"],#onetrust-pc-sdk input[type="url"],#onetrust-pc-sdk input[type="password"],#onetrust-pc-sdk textarea,#onetrust-pc-sdk select,#ot-sdk-cookie-policy input[type="email"],#ot-sdk-cookie-policy input[type="number"],#ot-sdk-cookie-policy input[type="search"],#ot-sdk-cookie-policy input[type="text"],#ot-sdk-cookie-policy input[type="tel"],#ot-sdk-cookie-policy input[type="url"],#ot-sdk-cookie-policy input[type="password"],#ot-sdk-cookie-policy textarea,#ot-sdk-cookie-policy select{height:38px;padding:6px 10px;background-color:#fff;border:1px solid #d1d1d1;border-radius:4px;box-shadow:none;box-sizing:border-box}#onetrust-banner-sdk input[type="email"],#onetrust-banner-sdk input[type="number"],#onetrust-banner-sdk input[type="search"],#onetrust-banner-sdk input[type="text"],#onetrust-banner-sdk input[type="tel"],#onetrust-banner-sdk input[type="url"],#onetrust-banner-sdk input[type="password"],#onetrust-banner-sdk textarea,#onetrust-pc-sdk input[type="email"],#onetrust-pc-sdk input[type="number"],#onetrust-pc-sdk input[type="search"],#onetrust-pc-sdk input[type="text"],#onetrust-pc-sdk input[type="tel"],#onetrust-pc-sdk input[type="url"],#onetrust-pc-sdk input[type="password"],#onetrust-pc-sdk textarea,#ot-sdk-cookie-policy input[type="email"],#ot-sdk-cookie-policy input[type="number"],#ot-sdk-cookie-policy input[type="search"],#ot-sdk-cookie-policy input[type="text"],#ot-sdk-cookie-policy input[type="tel"],#ot-sdk-cookie-policy input[type="url"],#ot-sdk-cookie-policy input[type="password"],#ot-sdk-cookie-policy textarea{-webkit-appearance:none;-moz-appearance:none;appearance:none}#onetrust-banner-sdk textarea,#onetrust-pc-sdk textarea,#ot-sdk-cookie-policy textarea{min-height:65px;padding-top:6px;padding-bottom:6px}#onetrust-banner-sdk input[type="email"]:focus,#onetrust-banner-sdk input[type="number"]:focus,#onetrust-banner-sdk input[type="search"]:focus,#onetrust-banner-sdk input[type="text"]:focus,#onetrust-banner-sdk input[type="tel"]:focus,#onetrust-banner-sdk input[type="url"]:focus,#onetrust-banner-sdk input[type="password"]:focus,#onetrust-banner-sdk textarea:focus,#onetrust-banner-sdk select:focus,#onetrust-pc-sdk input[type="email"]:focus,#onetrust-pc-sdk input[type="number"]:focus,#onetrust-pc-sdk input[type="search"]:focus,#onetrust-pc-sdk input[type="text"]:focus,#onetrust-pc-sdk input[type="tel"]:focus,#onetrust-pc-sdk input[type="url"]:focus,#onetrust-pc-sdk input[type="password"]:focus,#onetrust-pc-sdk textarea:focus,#onetrust-pc-sdk select:focus,#ot-sdk-cookie-policy input[type="email"]:focus,#ot-sdk-cookie-policy input[type="number"]:focus,#ot-sdk-cookie-policy input[type="search"]:focus,#ot-sdk-cookie-policy input[type="text"]:focus,#ot-sdk-cookie-policy input[type="tel"]:focus,#ot-sdk-cookie-policy input[type="url"]:focus,#ot-sdk-cookie-policy input[type="password"]:focus,#ot-sdk-cookie-policy textarea:focus,#ot-sdk-cookie-policy select:focus{border:1px solid #33c3f0;outline:0}#onetrust-banner-sdk label,#onetrust-banner-sdk legend,#onetrust-pc-sdk label,#onetrust-pc-sdk legend,#ot-sdk-cookie-policy label,#ot-sdk-cookie-policy legend{display:block;margin-bottom:0.5rem;font-weight:600}#onetrust-banner-sdk fieldset,#onetrust-pc-sdk fieldset,#ot-sdk-cookie-policy fieldset{padding:0;border-width:0}#onetrust-banner-sdk input[type="checkbox"],#onetrust-banner-sdk input[type="radio"],#onetrust-pc-sdk input[type="checkbox"],#onetrust-pc-sdk input[type="radio"],#ot-sdk-cookie-policy input[type="checkbox"],#ot-sdk-cookie-policy input[type="radio"]{display:inline}#onetrust-banner-sdk label>.label-body,#onetrust-pc-sdk label>.label-body,#ot-sdk-cookie-policy label>.label-body{display:inline-block;margin-left:0.5rem;font-weight:normal}#onetrust-banner-sdk ul,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ul{list-style:circle inside}#onetrust-banner-sdk ol,#onetrust-pc-sdk ol,#ot-sdk-cookie-policy ol{list-style:decimal inside}#onetrust-banner-sdk ol,#onetrust-banner-sdk ul,#onetrust-pc-sdk ol,#onetrust-pc-sdk ul,#ot-sdk-cookie-policy ol,#ot-sdk-cookie-policy ul{padding-left:0;margin-top:0}#onetrust-banner-sdk ul ul,#onetrust-banner-sdk ul ol,#onetrust-banner-sdk ol ol,#onetrust-banner-sdk ol ul,#onetrust-pc-sdk ul ul,#onetrust-pc-sdk ul ol,#onetrust-pc-sdk ol ol,#onetrust-pc-sdk ol ul,#ot-sdk-cookie-policy ul ul,#ot-sdk-cookie-policy ul ol,#ot-sdk-cookie-policy ol ol,#ot-sdk-cookie-policy ol ul{margin:1.5rem 0 1.5rem 3rem;font-size:90%}#onetrust-banner-sdk li,#onetrust-pc-sdk li,#ot-sdk-cookie-policy li{margin-bottom:1rem}#onetrust-banner-sdk code,#onetrust-pc-sdk code,#ot-sdk-cookie-policy code{padding:0.2rem 0.5rem;margin:0 0.2rem;font-size:90%;white-space:nowrap;background:#f1f1f1;border:1px solid #e1e1e1;border-radius:4px}#onetrust-banner-sdk pre>code,#onetrust-pc-sdk pre>code,#ot-sdk-cookie-policy pre>code{display:block;padding:1rem 1.5rem;white-space:pre}#onetrust-banner-sdk th,#onetrust-banner-sdk td,#onetrust-pc-sdk th,#onetrust-pc-sdk td,#ot-sdk-cookie-policy th,#ot-sdk-cookie-policy td{padding:12px 15px;text-align:left;border-bottom:1px solid #e1e1e1}#onetrust-banner-sdk .ot-sdk-u-full-width,#onetrust-pc-sdk .ot-sdk-u-full-width,#ot-sdk-cookie-policy .ot-sdk-u-full-width{width:100%;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-u-max-full-width,#onetrust-pc-sdk .ot-sdk-u-max-full-width,#ot-sdk-cookie-policy .ot-sdk-u-max-full-width{max-width:100%;box-sizing:border-box}#onetrust-banner-sdk .ot-sdk-u-pull-right,#onetrust-pc-sdk .ot-sdk-u-pull-right,#ot-sdk-cookie-policy .ot-sdk-u-pull-right{float:right}#onetrust-banner-sdk .ot-sdk-u-pull-left,#onetrust-pc-sdk .ot-sdk-u-pull-left,#ot-sdk-cookie-policy .ot-sdk-u-pull-left{float:left}#onetrust-banner-sdk hr,#onetrust-pc-sdk hr,#ot-sdk-cookie-policy hr{margin-top:3rem;margin-bottom:3.5rem;border-width:0;border-top:1px solid #e1e1e1}#onetrust-banner-sdk .ot-sdk-container:after,#onetrust-banner-sdk .ot-sdk-row:after,#onetrust-banner-sdk .ot-sdk-u-cf,#onetrust-pc-sdk .ot-sdk-container:after,#onetrust-pc-sdk .ot-sdk-row:after,#onetrust-pc-sdk .ot-sdk-u-cf,#ot-sdk-cookie-policy .ot-sdk-container:after,#ot-sdk-cookie-policy .ot-sdk-row:after,#ot-sdk-cookie-policy .ot-sdk-u-cf{content:"";display:table;clear:both}#onetrust-banner-sdk .ot-sdk-row,#onetrust-pc-sdk .ot-sdk-row,#ot-sdk-cookie-policy .ot-sdk-row{margin:0;max-width:none;display:block;margin:0}
#onetrust-banner-sdk.otFlat{position:fixed;z-index:2147483645;bottom:0;right:0;left:0;background-color:#fff;max-height:90%;overflow-x:hidden;overflow-y:auto}#onetrust-banner-sdk::-webkit-scrollbar{width:11px}#onetrust-banner-sdk::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-banner-sdk{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-banner-sdk #onetrust-policy{margin:1em 0 0 5em}#onetrust-banner-sdk #onetrust-policy-title{font-size:1.2em;line-height:1.3}#onetrust-banner-sdk #onetrust-policy-text{clear:both;text-align:left;font-size:.88em;line-height:1.4}#onetrust-banner-sdk #onetrust-policy-text *{font-size:inherit}#onetrust-banner-sdk #onetrust-policy-title,#onetrust-banner-sdk #onetrust-policy-text{color:dimgray;float:left}#onetrust-banner-sdk #onetrust-button-group-parent{min-height:1px;text-align:center}#onetrust-banner-sdk #onetrust-button-group{display:inline-block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler{background-color:#68b631;color:#fff;border-color:#68b631;margin-right:1em;min-width:125px}#onetrust-banner-sdk #onetrust-pc-btn-handler{background-color:#68b631;border:1px solid #68b631;color:#fff;min-width:125px;margin-right:1em}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:12px 10px;line-height:1.2}#onetrust-banner-sdk #onetrust-pc-btn-handler.cookie-setting-link{background-color:#fff;border:none;color:#68b631;text-decoration:underline;padding-right:0}#onetrust-banner-sdk #onetrust-close-btn-container{text-align:center}#onetrust-banner-sdk .onetrust-close-btn-ui{width:.8em;margin:50% 0 0 50%;height:18px;border:none}#onetrust-banner-sdk .onetrust-close-btn-ui.onetrust-lg{top:50%;margin:auto;transform:translate(-50%, -50%);position:absolute;padding:0}#onetrust-banner-sdk .banner_logo{display:none}#onetrust-banner-sdk #banner-options{float:left;display:table;margin-right:0;margin-left:1em;width:calc(100% - 1em)}#onetrust-banner-sdk #banner-options label{margin:0;display:inline-block}#onetrust-banner-sdk #banner-options .banner-option{margin-bottom:12px;border:none;float:left;padding:0}#onetrust-banner-sdk #banner-options .banner-option:not(:first-child){padding:0;border:none}#onetrust-banner-sdk #banner-options .banner-option-input{position:absolute;cursor:pointer;width:auto;height:20px;opacity:0}#onetrust-banner-sdk #banner-options .banner-option-input:checked~label .banner-option-header .arrow-container{transform:rotate(90deg)}#onetrust-banner-sdk #banner-options .banner-option-input:checked~.banner-option-details{height:auto;display:block}#onetrust-banner-sdk #banner-options .banner-option-header{margin-bottom:6px;cursor:pointer;display:inline-block}#onetrust-banner-sdk #banner-options .banner-option-header :first-child{font-size:.82em;line-height:1.4;color:dimgray;font-weight:bold;float:left}#onetrust-banner-sdk #banner-options .banner-option-header .arrow-container{display:inline-block;border-top:6px solid transparent;border-bottom:6px solid transparent;border-left:6px solid dimgray;margin-left:10px;margin-top:2px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk #banner-options .banner-option-details{display:none;font-size:.83em;line-height:1.5;height:0px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-banner-sdk #banner-options .banner-option-details *{font-size:inherit;line-height:inherit;color:dimgray}@media only screen and (max-width: 425px){#onetrust-banner-sdk #onetrust-policy{margin-left:0}#onetrust-banner-sdk .hide-small{display:none}#onetrust-banner-sdk #onetrust-button-group{display:block}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{width:100%}#onetrust-banner-sdk .onetrust-close-btn-ui{width:.8em;height:18px;margin:5px 0 0 0;float:right}#onetrust-banner-sdk #onetrust-close-btn-container-mobile{display:inline;float:none}#onetrust-banner-sdk #onetrust-policy-title{display:inline}#onetrust-banner-sdk #banner-options{margin:0;padding:0;width:100%}}@media only screen and (min-width: 426px)and (max-width: 896px){#onetrust-banner-sdk #onetrust-policy{margin-left:1em}#onetrust-banner-sdk .onetrust-close-btn-ui.onetrust-lg{top:25%;right:2%}#onetrust-banner-sdk #onetrust-group-container{width:82.6666666667%}#onetrust-banner-sdk #onetrust-button-group-parent{width:100%;position:relative;margin-left:0}#onetrust-banner-sdk .hide-large{display:none}}@media only screen and (min-width: 1024px){#onetrust-banner-sdk #onetrust-group-container{width:60%}#onetrust-banner-sdk #onetrust-button-group-parent{margin:auto;width:36%}#onetrust-banner-sdk.vertical-align-content #onetrust-button-group-parent{position:absolute;top:50%;left:60%;transform:translateY(-50%)}#onetrust-banner-sdk #onetrust-button-group{margin-right:auto !important}#onetrust-banner-sdk #onetrust-policy{margin-left:2em}#onetrust-banner-sdk #onetrust-close-btn-container{float:right}#onetrust-banner-sdk #onetrust-accept-btn-handler,#onetrust-banner-sdk #onetrust-reject-all-handler,#onetrust-banner-sdk #onetrust-pc-btn-handler{margin-top:1em}}@media only screen and (min-width: 769px){#onetrust-banner-sdk .hide-large{display:none}#onetrust-banner-sdk #onetrust-button-group{margin-right:30%}#onetrust-banner-sdk #banner-options{margin-left:2em;margin-right:5em;margin-bottom:1em;width:calc(100% - 7em)}#onetrust-banner-sdk #banner-options .banner-option{float:none;display:table-cell}}@media only screen and (min-width: 550px){#onetrust-banner-sdk #banner-options .banner-option:not(:first-child){border-left:1px solid #d8d8d8;padding-left:25px}}
        #onetrust-consent-sdk #onetrust-banner-sdk {background-color: #FFFFFF;}
            #onetrust-consent-sdk #onetrust-policy-title,
                           #onetrust-consent-sdk #onetrust-policy-text {
                               color: #696969;
                            }
            #onetrust-consent-sdk #onetrust-accept-btn-handler,
                         #onetrust-banner-sdk #onetrust-reject-all-handler,
                         #onetrust-consent-sdk #onetrust-pc-btn-handler {
                            background-color: #68b631;border-color: #68b631;
                            color: #FFFFFF;
                        }#onetrust-consent-sdk #onetrust-pc-btn-handler.cookie-setting-link {
                            border-color: #FFFFFF;
                            background-color: #FFFFFF;
                            color: #68b631
                        }#onetrust-pc-sdk.otPcTab{position:fixed;width:730px;max-width:730px;height:580px;left:0;right:0;top:0;bottom:0;margin:auto;font-size:16px;z-index:2147483647;border:1px solid #d7d7d7;border-radius:2px;background-color:#fff;box-shadow:0 2px 4px 0 rgba(0,0,0,0),0 7px 14px 0 rgba(50,50,93,.1)}#onetrust-pc-sdk *,#onetrust-pc-sdk ::after,#onetrust-pc-sdk ::before{box-sizing:content-box}#onetrust-pc-sdk #content{height:calc(100% - 196px)}#onetrust-pc-sdk .main-content{height:100%}#onetrust-pc-sdk .privacy-notice-link{text-decoration:underline}#onetrust-pc-sdk .privacy-notice-link:focus{outline:1px solid #63a3f8}#onetrust-pc-sdk li{list-style:none}#onetrust-pc-sdk ul,#onetrust-pc-sdk li{margin:0}#onetrust-pc-sdk a{text-decoration:none}#onetrust-pc-sdk .pc-content::-webkit-scrollbar,#onetrust-pc-sdk .groups-container::-webkit-scrollbar,#onetrust-pc-sdk #vendor-list-content::-webkit-scrollbar,#onetrust-pc-sdk .vendor-content::-webkit-scrollbar,#onetrust-pc-sdk #filter-modal .group-options::-webkit-scrollbar{width:11px}#onetrust-pc-sdk .pc-content::-webkit-scrollbar-thumb,#onetrust-pc-sdk .groups-container::-webkit-scrollbar-thumb,#onetrust-pc-sdk #vendor-list-content::-webkit-scrollbar-thumb,#onetrust-pc-sdk .vendor-content::-webkit-scrollbar-thumb,#onetrust-pc-sdk #filter-modal .group-options::-webkit-scrollbar-thumb{border-radius:10px;background:#c1c1c1}#onetrust-pc-sdk .pc-content,#onetrust-pc-sdk .groups-container,#onetrust-pc-sdk #vendor-list-content,#onetrust-pc-sdk .vendor-content,#onetrust-pc-sdk #filter-modal .group-options{scrollbar-arrow-color:#c1c1c1;scrollbar-darkshadow-color:#c1c1c1;scrollbar-face-color:#c1c1c1;scrollbar-shadow-color:#c1c1c1}#onetrust-pc-sdk .pc-header{height:auto;padding:20px;display:inline-block;vertical-align:middle;width:calc(100% - 40px);border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk .pc-logo-container{float:left}#onetrust-pc-sdk .pc-title-container{float:right;width:calc(100% - 190px);margin-left:10px}#onetrust-pc-sdk .always-active{font-size:1em;line-height:1.3;color:#1a73e8}#onetrust-pc-sdk .pc-close-btn-container{float:right;position:absolute;right:15px;margin-top:18px}#onetrust-pc-sdk .pc-content{position:relative;height:100%;overflow-y:auto;overflow-x:hidden}#onetrust-pc-sdk .groups-container{height:100%;overflow-y:auto}#onetrust-pc-sdk .group{cursor:pointer;border-left:10px solid transparent;background-color:#f4f4f4;border-bottom:1px solid #d7d7d7;padding-top:16px;padding-right:5px;padding-bottom:16px;padding-left:12px}#onetrust-pc-sdk .group h3{float:left;text-align:left;margin:0;color:dimgray;line-height:1.4;font-size:1em;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .active-group{border-left:10px solid #68b631;background-color:#fff;border-bottom:none}#onetrust-pc-sdk .active-group h3{color:#263238;font-weight:bold}#onetrust-pc-sdk .description-container{word-break:break-word;word-wrap:break-word;padding-top:20px;padding-right:16px;padding-bottom:15px;position:absolute;left:30%}#onetrust-pc-sdk .group-description{word-break:break-word;word-wrap:break-word;text-align:left;font-size:.82em;line-height:1.3;margin:0}#onetrust-pc-sdk #pc-policy-text{clear:both;float:left}#onetrust-pc-sdk #pc-policy-text a{color:#1a73e8;cursor:pointer;font-size:1em}#onetrust-pc-sdk #pc-policy-text a:hover{color:#1883fd}#onetrust-pc-sdk #pc-policy-text *{font-size:inherit}#onetrust-pc-sdk #pc-policy-text ul li{padding:10px 0px;border-bottom:1px solid #e2e2e2}#onetrust-pc-sdk .close-icon{background-image:url("data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB4PSIwcHgiIHk9IjBweCIgd2lkdGg9IjQ3Ljk3MSIgaGVpZ2h0PSI0Ny45NzEiIHZpZXdCb3g9IjAgMCA0Ny45NzEgNDcuOTcxIiBzdHlsZT0iZW5hYmxlLWJhY2tncm91bmQ6bmV3IDAgMCA0Ny45NzEgNDcuOTcxOyIgeG1sOnNwYWNlPSJwcmVzZXJ2ZSI+PGc+PHBhdGggZD0iTTI4LjIyOCwyMy45ODZMNDcuMDkyLDUuMTIyYzEuMTcyLTEuMTcxLDEuMTcyLTMuMDcxLDAtNC4yNDJjLTEuMTcyLTEuMTcyLTMuMDctMS4xNzItNC4yNDIsMEwyMy45ODYsMTkuNzQ0TDUuMTIxLDAuODhjLTEuMTcyLTEuMTcyLTMuMDctMS4xNzItNC4yNDIsMGMtMS4xNzIsMS4xNzEtMS4xNzIsMy4wNzEsMCw0LjI0MmwxOC44NjUsMTguODY0TDAuODc5LDQyLjg1Yy0xLjE3MiwxLjE3MS0xLjE3MiwzLjA3MSwwLDQuMjQyQzEuNDY1LDQ3LjY3NywyLjIzMyw0Ny45NywzLDQ3Ljk3czEuNTM1LTAuMjkzLDIuMTIxLTAuODc5bDE4Ljg2NS0xOC44NjRMNDIuODUsNDcuMDkxYzAuNTg2LDAuNTg2LDEuMzU0LDAuODc5LDIuMTIxLDAuODc5czEuNTM1LTAuMjkzLDIuMTIxLTAuODc5YzEuMTcyLTEuMTcxLDEuMTcyLTMuMDcxLDAtNC4yNDJMMjguMjI4LDIzLjk4NnoiLz48L2c+PC9zdmc+");background-size:100%;background-repeat:no-repeat;background-position:center;height:22px;width:22px;display:inline-block}#onetrust-pc-sdk .group-toggle{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .group-toggle .checkbox{background-color:#fff}#onetrust-pc-sdk .group-toggle .toggle{float:right;background-color:#fff}#onetrust-pc-sdk .group-toggle .toggle-group{float:right}#onetrust-pc-sdk .group-toggle .toggle-group p{margin:0}#onetrust-pc-sdk .group-toggle .toggle-group:focus{outline:#3b99fc auto 5px}#onetrust-pc-sdk .group-toggle .toggle-group .checkbox input[type=checkbox]:focus+label::before{outline:#3b99fc auto 5px}#onetrust-pc-sdk .description-container h3{color:#263238;float:left;margin:0;font-weight:bold;font-size:1em;line-height:1.3;max-width:85%;top:3px}#onetrust-pc-sdk #pc-privacy-header{margin-bottom:10px}#onetrust-pc-sdk .category-vendors-list-handler,#onetrust-pc-sdk .category-host-list-handler{display:block;float:left;margin-top:10px;color:#1a73e8;font-size:.8em;font-weight:bold;line-height:1.1;cursor:pointer}#onetrust-pc-sdk .category-vendors-list-handler:hover,#onetrust-pc-sdk .category-host-list-handler:hover{color:#1883fd}#onetrust-pc-sdk .cookie-subgroups-container{margin-top:15px}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups{margin:0;font-size:inherit}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups .cookie-subgroup-toggle{float:right}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups .toggle{background-color:#fff}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups li{padding:0;border:none;position:relative}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups li h6,#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups li p{font-size:.82em;line-height:1.4}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups li p{color:dimgray;clear:both;float:left;margin-top:10px;margin-bottom:0;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups li h6{color:#263238;font-weight:bold;margin-bottom:0;float:left;position:relative;top:3px}#onetrust-pc-sdk .cookie-subgroups-container ul.cookie-subgroups li.cookie-subgroup{margin-left:30px;display:inline-block;width:calc(100% - 30px)}#onetrust-pc-sdk .cookie-subgroups-container .arrow{top:-3px}#onetrust-pc-sdk .button-group-parent{height:34px;padding:30px;bottom:0;border-top:1px solid #d8d8d8}#onetrust-pc-sdk .button-group{float:right;text-align:center}#onetrust-pc-sdk .footer-logo{float:left;text-align:center;background-repeat:no-repeat;background-position:center;background-size:contain;width:155px;height:25px;position:relative;top:10px}#onetrust-pc-sdk #accept-recommended-btn-handler{float:right;margin-right:16px;margin-left:15px;text-align:center}#onetrust-pc-sdk .save-preference-btn-handler{height:38px;min-width:155px;background-color:#68b631;border-radius:2px;color:#fff;font-size:.9em;line-height:1.1;text-align:center;margin-left:15px;margin-right:15px}#onetrust-pc-sdk #pc-title{float:left;margin-left:10px;margin-top:10px;max-width:85%;overflow:hidden;position:relative;line-height:1.2em;max-height:2.4em}#onetrust-pc-sdk #pc-title:before{content:"...";right:20px;bottom:0;position:absolute}#onetrust-pc-sdk #pc-title:after{position:absolute;content:"";width:1em;height:1em;margin-top:.2em;right:20px}#onetrust-pc-sdk #vendors-list{height:100%;width:100%}#onetrust-pc-sdk #vendors-list .accordion-header{padding-top:17px;padding-right:15px;padding-bottom:17px;padding-left:20px;display:inline-block;width:calc(100% - 35px);vertical-align:middle}#onetrust-pc-sdk #vendors-list .accordion-text{padding-top:6px;padding-right:50px;padding-bottom:10px;padding-left:50px}#onetrust-pc-sdk .vendor-content{height:100%}#onetrust-pc-sdk #vendors-list-header{padding-top:15px;padding-right:30px;padding-bottom:15px;padding-left:20px;display:inline-block;width:calc(100% - 50px);height:20px;border-bottom:1px solid #d8d8d8}#onetrust-pc-sdk #vendors-list-header input{border:1px solid #d7d7d7;height:32px;width:300px;border-radius:50px;font-size:.8em;padding-right:35px;padding-left:15px;float:left}#onetrust-pc-sdk #vendors-list-header input::placeholder{color:#d4d4d4;font-style:italic}#onetrust-pc-sdk #vendor-list-content{height:calc(100% - 86px);width:calc(100% - 183px);padding-left:80px;padding-right:100px;padding-top:20px;margin-top:8px;margin-right:3px;margin-bottom:4px;margin-left:0;overflow-x:hidden;overflow-y:auto}#onetrust-pc-sdk #back-arrow{height:17px;width:20px;vertical-align:middle;display:inline-block;color:dimgray;font-size:1em;line-height:1;text-align:center}#onetrust-pc-sdk #vendors-list-title{color:dimgray;font-size:.9em;font-weight:bold;line-height:1;display:inline-block;vertical-align:middle;margin:0;padding-left:5px}#onetrust-pc-sdk .navigation-container{float:left}#onetrust-pc-sdk .back-btn-handler{display:inline-block}#onetrust-pc-sdk .action-container{float:right;position:relative;bottom:6px}#onetrust-pc-sdk #search-container{float:left}#onetrust-pc-sdk #search-container svg{position:absolute;right:35px;width:30px;height:30px;font-size:1em;line-height:1;top:3px}#onetrust-pc-sdk .label-text{display:none}#onetrust-pc-sdk #filter-container{display:inline-block;top:8px;position:relative;margin-left:20px}#onetrust-pc-sdk #filter-btn-handler svg{cursor:pointer;width:15px;height:15px}#onetrust-pc-sdk #select-all-container{min-width:200px;min-height:30px;padding-left:20px}#onetrust-pc-sdk #select-all-text-container{display:inline-block;padding-left:30px}#onetrust-pc-sdk #select-all-text-container p{color:#2c3643;font-size:.8em;font-weight:bold;line-height:1.1;margin:0;display:inline-block}#onetrust-pc-sdk #select-all-vendors-input-container,#onetrust-pc-sdk #select-all-hosts-input-container{float:left;height:100%}#onetrust-pc-sdk #select-all-vendors-input-container label,#onetrust-pc-sdk #select-all-hosts-input-container label{height:100%;padding-left:0}#onetrust-pc-sdk .ot-checkbox input[type=checkbox]{display:block;opacity:0}#onetrust-pc-sdk .ot-checkbox input:checked~label::before{background-color:#4285f4}#onetrust-pc-sdk .ot-checkbox label{position:relative;height:20px;padding-left:30px}#onetrust-pc-sdk .ot-checkbox label::before,#onetrust-pc-sdk .ot-checkbox label::after{position:absolute;content:"";display:inline-block;border-radius:3px}#onetrust-pc-sdk .ot-checkbox label::before{height:18px;width:18px;border:1px solid #1a73e8;left:0px}#onetrust-pc-sdk .ot-checkbox label::after{height:5px;width:9px;border-left:3px solid;border-bottom:3px solid;transform:rotate(-45deg);-o-transform:rotate(-45deg);-ms-transform:rotate(-45deg);-webkit-transform:rotate(-45deg);left:4px;top:5px}#onetrust-pc-sdk .ot-checkbox input[type=checkbox]+label::after{content:none;color:#fff}#onetrust-pc-sdk .ot-checkbox input[type=checkbox]:checked+label::after{content:""}#onetrust-pc-sdk .ot-checkbox input[type=checkbox]:focus+label::before{outline:#1a73e8 auto 2px}#onetrust-pc-sdk .ot-checkbox.line-through label::after{height:auto;border-left:0;left:5px;top:10.5px;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none}#onetrust-pc-sdk .ot-checkbox{float:left}#onetrust-pc-sdk .vendor-title,#onetrust-pc-sdk .host-title{color:#2c3643;font-weight:bold;font-size:.8em;line-height:1.2;margin:0;height:auto;text-align:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .host-title{position:relative;vertical-align:middle}#onetrust-pc-sdk .host-title a{font-size:1em;font-weight:bold}#onetrust-pc-sdk .cookie-name-container a{font-size:1em}#onetrust-pc-sdk .host-description{font-size:.69em;line-height:1.4;margin-top:5px;margin-bottom:5px;float:left;color:dimgray}#onetrust-pc-sdk .vendor-info{width:88%;float:right}#onetrust-pc-sdk .vendor-purposes{margin-top:3px}#onetrust-pc-sdk .vendor-purposes p{font-size:.8em;line-height:1.2;margin-bottom:0;font-weight:500;text-align:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #select-all-hosts-input-container input[type=checkbox],#onetrust-pc-sdk #select-all-vendors-input-container input[type=checkbox]{position:absolute}#onetrust-pc-sdk #vendors-list-container input[type=checkbox],#onetrust-pc-sdk #hosts-list-container input[type=checkbox],#onetrust-pc-sdk .cookie-subgroups input[type=checkbox]{position:absolute;cursor:pointer;width:100%;height:100%;opacity:0;margin:0;top:0;left:0}#onetrust-pc-sdk #vendors-list-container input[type=checkbox]~.accordion-header,#onetrust-pc-sdk #hosts-list-container input[type=checkbox]~.accordion-header,#onetrust-pc-sdk .cookie-subgroups input[type=checkbox]~.accordion-header{cursor:pointer}#onetrust-pc-sdk #vendors-list-container input[type=checkbox]:not(:checked)~.accordion-text,#onetrust-pc-sdk #hosts-list-container input[type=checkbox]:not(:checked)~.accordion-text,#onetrust-pc-sdk .cookie-subgroups input[type=checkbox]:not(:checked)~.accordion-text{margin-top:0;max-height:0;opacity:0;overflow:hidden;width:100%;transition:.25s ease-out;display:none}#onetrust-pc-sdk #vendors-list-container input[type=checkbox]:checked~.accordion-text,#onetrust-pc-sdk #hosts-list-container input[type=checkbox]:checked~.accordion-text,#onetrust-pc-sdk .cookie-subgroups input[type=checkbox]:checked~.accordion-text{transition:.1s ease-in;display:block}#onetrust-pc-sdk #vendors-list-container .ot-checkbox input[type=checkbox],#onetrust-pc-sdk #hosts-list-container .ot-checkbox input[type=checkbox],#onetrust-pc-sdk .cookie-subgroups .ot-checkbox input[type=checkbox]{width:auto;height:auto}#onetrust-pc-sdk #vendors-list-container .ot-checkbox label,#onetrust-pc-sdk #hosts-list-container .ot-checkbox label,#onetrust-pc-sdk .cookie-subgroups .ot-checkbox label{z-index:2}#onetrust-pc-sdk #vendors-list-container,#onetrust-pc-sdk #hosts-list-container{width:100%}#onetrust-pc-sdk #vendors-list-container li,#onetrust-pc-sdk #hosts-list-container li{border:1px solid #d7d7d7;border-radius:2px;position:relative;margin-top:10px}#onetrust-pc-sdk #vendors-list-container .toggle-group{width:65%}#onetrust-pc-sdk #hosts-list-container .toggle-group{width:65%}#onetrust-pc-sdk label{margin-bottom:0}#onetrust-pc-sdk .vendor-notice,#onetrust-pc-sdk .host-notice{float:right}#onetrust-pc-sdk .vendor-privacy-notice-container,#onetrust-pc-sdk .third-party-cookies-container{float:left}#onetrust-pc-sdk .vendor-privacy-notice-container{position:relative}#onetrust-pc-sdk .vendor-privacy-notice-container a:hover{text-decoration:underline}#onetrust-pc-sdk .vendor-privacy-notice,#onetrust-pc-sdk .third-party-cookie-notice{color:dimgray;font-size:.7em;line-height:.9;display:inline-block}#onetrust-pc-sdk .vendor-privacy-notice{position:relative;z-index:2}#onetrust-pc-sdk .arrow{margin-left:20px}#onetrust-pc-sdk .vendor-options{display:inline-block;width:100%;padding-bottom:10px;border-radius:2px;background-color:#f8f8f8}#onetrust-pc-sdk .vendor-options p{font-size:.69em;color:gray;text-align:left;display:table-cell;vertical-align:middle;word-break:break-word;word-wrap:break-word;margin:0;padding-left:15px;color:#2e3644}#onetrust-pc-sdk #hosts-list-container .host-info{float:left;width:calc(100% - 50px)}#onetrust-pc-sdk #hosts-list-container .host-option-group{display:inline-block;width:100%;margin:0;font-size:inherit}#onetrust-pc-sdk #hosts-list-container .host-option-group li.vendor-host{border:none;padding:0;font-size:.8em;color:#6e8290;float:left;text-align:left;padding:10px;margin-bottom:10px;width:calc(100% - 10px);background-color:#f8f8f8}#onetrust-pc-sdk #hosts-list-container .host-option-group li.vendor-host a{color:#6e8290}#onetrust-pc-sdk #hosts-list-container .host-option-group li>div div{font-size:.81em;padding:5px 0}#onetrust-pc-sdk #hosts-list-container .host-option-group li>div div:nth-child(1){width:30%;float:left}#onetrust-pc-sdk #hosts-list-container .host-option-group li>div div:nth-child(2){width:70%;float:left;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk .vendor-purpose-groups .vendor-option-purpose{border-top:1px solid #e9e9e9;border-bottom:1px solid #e9e9e9;margin-bottom:10px;min-height:30px;max-height:50px;width:100%;display:table}#onetrust-pc-sdk .vendor-purpose-groups .vendor-option-purpose:first-child,#onetrust-pc-sdk .vendor-purpose-groups .vendor-option-purpose:first-of-type{border-top:none}#onetrust-pc-sdk .vendor-purpose-groups .vendor-option-purpose p{font-weight:bold}#onetrust-pc-sdk .vendor-purpose-groups .vendor-consent-group{display:inline-block;width:100%;margin-bottom:10px}#onetrust-pc-sdk .vendor-purpose-groups .legitimate-interest-group .consent-category{float:left}#onetrust-pc-sdk .vendor-purpose-groups .vendor-opt-out-handler{text-decoration:none;float:right;font-size:.69em;line-height:1.4;color:#1a73e8;right:15px;position:relative}#onetrust-pc-sdk .vendor-purpose-groups .vendor-opt-out-handler span{font-size:.69em;line-height:1.4}#onetrust-pc-sdk .vendor-purpose-groups .vendor-opt-out-handler svg{width:20px;vertical-align:middle}#onetrust-pc-sdk #no-results{text-align:center;margin-top:30px}#onetrust-pc-sdk #no-results p{font-size:1em;color:#2e3644;word-break:break-word;word-wrap:break-word}#onetrust-pc-sdk #no-results p span{font-weight:bold}#onetrust-pc-sdk .toggle .checkbox label:after{cursor:pointer}#onetrust-pc-sdk .group-option{height:25px}#onetrust-pc-sdk .checkbox{position:relative;display:inline-block}#onetrust-pc-sdk .checkbox label{background:#d6d6d6;border:none;height:10px;width:35px;position:relative;display:inline-block;border-radius:46px;transition:.4s}#onetrust-pc-sdk .checkbox label:after{content:"";position:absolute;width:20px;height:20px;border-radius:100%;left:0;top:-5px;z-index:2;background:#7b7b7b;transition:.4s}#onetrust-pc-sdk .checkbox input{position:absolute;left:0;top:0;width:100%;height:100%;z-index:5;opacity:0;cursor:pointer}#onetrust-pc-sdk .checkbox input:checked+label:after{left:40px}#onetrust-pc-sdk .checkbox input:focus+label::after{outline:#3b99fc auto 5px}#onetrust-pc-sdk .checkbox:after,#onetrust-pc-sdk .checkbox:before{-webkit-font-feature-settings:normal;font-feature-settings:normal;-webkit-font-kerning:auto;font-kerning:auto;-webkit-font-language-override:normal;font-language-override:normal;font-stretch:normal;font-style:normal;font-synthesis:weight style;font-variant:normal;font-weight:normal;text-rendering:auto}#onetrust-pc-sdk .toggle{background-color:#f8f8f8}#onetrust-pc-sdk .toggle .checkbox input:checked+label{background:#cddcf2}#onetrust-pc-sdk .toggle .checkbox input:checked+label:after{background:#4285f4;left:16px}#onetrust-pc-sdk .toggle-group,#onetrust-pc-sdk .toggle{display:inline-block;vertical-align:middle}#onetrust-pc-sdk .arrow-container{float:right}#onetrust-pc-sdk .arrow{top:2px;position:relative;width:10px;height:10px;margin-left:5px;transition:all 300ms ease-in 0s;-webkit-transition:all 300ms ease-in 0s;-moz-transition:all 300ms ease-in 0s;-o-transition:all 300ms ease-in 0s}#onetrust-pc-sdk input:checked~.accordion-header .arrow{transform:rotate(90deg);-o-transform:rotate(90deg);-ms-transform:rotate(90deg);-webkit-transform:rotate(90deg)}#onetrust-pc-sdk button.pill{font-size:.75em;text-align:center;background-color:#1a73e8;border-color:#1a73e8;font-weight:600;box-shadow:0 0 10px 1px #cce1ff;width:170px;max-width:180px;color:#fff;height:auto;white-space:normal;word-break:break-word;word-wrap:break-word;padding:10px;line-height:1.2;letter-spacing:.05em}#onetrust-pc-sdk button.pill:first-child{margin-top:10px}#onetrust-pc-sdk #triangle{border:12px solid transparent;display:none;position:absolute;z-index:2147483647;top:140px;right:40px;transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);-webkit-transform:rotate(45deg);background-color:#fff;-webkit-box-shadow:-3px -3px 5px -2px #c7c5c7;-moz-box-shadow:-3px -3px 5px -2px #c7c5c7;box-shadow:-3px -3px 5px -2px #c7c5c7}#onetrust-pc-sdk #filter-modal{width:300px;position:absolute;z-index:2147483646;top:146px;height:auto;display:none;-moz-transition:.2s ease;-o-transition:.2s ease;-webkit-transition:2s ease;transition:.2s ease;overflow-x:hidden;opacity:1;right:0}#onetrust-pc-sdk #filter-modal .pill{width:130px;float:right}#onetrust-pc-sdk #options{background-color:#fff;height:auto;margin:5px;border-radius:3px;height:350px;-webkit-box-shadow:0px 0px 12px 2px #c7c5c7;-moz-box-shadow:0px 0px 12px 2px #c7c5c7;box-shadow:0px 0px 12px 2px #c7c5c7}#onetrust-pc-sdk .group-options{overflow-y:auto;width:100%;max-height:65%}#onetrust-pc-sdk .group-option{margin-bottom:25px;margin-left:15px;clear:both}#onetrust-pc-sdk .group-option span{cursor:pointer;color:dimgray;font-size:.8em;line-height:1.1;font-weight:normal}#onetrust-pc-sdk #clear-filters-handler{float:right;max-width:200px;margin-bottom:30px;text-decoration:none}#onetrust-pc-sdk #clear-filters-handler p{float:right;font-weight:bold;color:#1a73e8;font-size:.9em;margin:0}#onetrust-pc-sdk #clear-filters-handler p:hover{color:#1883fd}#onetrust-pc-sdk #clear-filters-container{float:right;padding-right:15px;height:auto;margin-top:20px}#onetrust-pc-sdk #filter-apply-handler{margin-right:10px;float:right}#onetrust-pc-sdk.otPcTab[dir=rtl] .footer-logo svg{direction:rtl}#onetrust-pc-sdk.otPcTab[dir=rtl] .ot-checkbox.line-through label::after{height:auto;border-left:0;transform:none;-o-transform:none;-ms-transform:none;-webkit-transform:none;left:4px;top:10.5px}#onetrust-pc-sdk.otPcTab[dir=rtl] input~.accordion-header .arrow,#onetrust-pc-sdk.otPcTab[dir=rtl] #back-arrow{transform:rotate(180deg);-o-transform:rotate(180deg);-ms-transform:rotate(180deg);-webkit-transform:rotate(180deg)}#onetrust-pc-sdk.otPcTab[dir=rtl] input:checked~.accordion-header .arrow{transform:rotate(270deg);-o-transform:rotate(270deg);-ms-transform:rotate(270deg);-webkit-transform:rotate(270deg)}#onetrust-pc-sdk.otPcTab[dir=rtl] #search-container svg{right:52px}#onetrust-pc-sdk.otPcTab[dir=rtl] .ot-checkbox label::after{transform:rotate(45deg);-webkit-transform:rotate(45deg);-o-transform:rotate(45deg);-ms-transform:rotate(45deg);border-left:0;border-right:3px solid}@media(max-width: 767px){#onetrust-pc-sdk.otPcTab{width:100%;height:100%;border:none}#onetrust-pc-sdk.otPcTab .ot-sdk-container,#onetrust-pc-sdk.otPcTab .button-group-parent,#onetrust-pc-sdk.otPcTab .footer-logo{width:100%}#onetrust-pc-sdk.otPcTab .ot-sdk-container{padding:0;margin:0}#onetrust-pc-sdk.otPcTab #pc-title{margin-left:10px;margin-top:10px;max-width:60%}#onetrust-pc-sdk.otPcTab .description-container{margin:0;padding-top:20px;padding-right:20px;padding-bottom:15px;padding-left:20px;position:relative;left:auto}#onetrust-pc-sdk.otPcTab .groups-container{max-height:none;height:auto;overflow:hidden}#onetrust-pc-sdk.otPcTab .button-group-parent{padding-left:0;padding-right:0;position:relative}#onetrust-pc-sdk.otPcTab .button-group,#onetrust-pc-sdk.otPcTab #accept-recommended-btn-handler{float:none}#onetrust-pc-sdk.otPcTab .save-preference-btn-handler,#onetrust-pc-sdk.otPcTab #accept-recommended-btn-handler{width:calc(100% - 33px)}}@media(max-width: 640px){#onetrust-pc-sdk.otPcTab .pc-header{padding:10px;width:calc(100% - 20px)}#onetrust-pc-sdk.otPcTab #content{height:calc(100% - 275px)}#onetrust-pc-sdk.otPcTab .button-group-parent{padding:15px;margin:0;width:calc(100% - 30px)}#onetrust-pc-sdk.otPcTab .ot-sdk-row .ot-sdk-columns{width:100%}#onetrust-pc-sdk.otPcTab .description-container{margin:0}#onetrust-pc-sdk.otPcTab .vendor-info{max-width:80%}#onetrust-pc-sdk.otPcTab #filter-container{bottom:5px;position:relative;float:right;right:15px}#onetrust-pc-sdk.otPcTab #vendor-list-content{height:calc(100% - 305px);width:calc(100% - 18px);padding-top:13px;padding-right:5px;padding-left:10px}#onetrust-pc-sdk.otPcTab #triangle{top:190px}#onetrust-pc-sdk.otPcTab #filter-modal{top:196px}#onetrust-pc-sdk.otPcTab .footer-logo a{width:auto}}@media(max-width: 600px){#onetrust-pc-sdk.otPcTab .vendor-content{overflow-y:scroll}#onetrust-pc-sdk.otPcTab #vendor-list-content{height:auto;overflow:hidden}#onetrust-pc-sdk.otPcTab #vendors-list-header{height:70px;padding:15px 0;width:100%}#onetrust-pc-sdk.otPcTab #search-container{display:inline-block;width:85%;position:absolute}#onetrust-pc-sdk.otPcTab .navigation-container{display:block;text-align:left;float:none;border-bottom:1px solid #d7d7d7;padding-bottom:15px;padding-left:15px}#onetrust-pc-sdk.otPcTab .action-container{width:calc(100% - 15px);float:none;bottom:auto;display:inline-block;padding-top:8px;padding-left:15px}#onetrust-pc-sdk.otPcTab #vendor-search-handler{width:90%}#onetrust-pc-sdk.otPcTab .button-group-parent{display:inline-block;height:auto;margin-bottom:10px}}@media(max-width: 425px){#onetrust-pc-sdk.otPcTab #vendors-list .accordion-text{padding-top:6px;padding-right:25px;padding-bottom:10px;padding-left:25px}#onetrust-pc-sdk.otPcTab #vendors-list-container .toggle-group,#onetrust-pc-sdk.otPcTab #hosts-list-container .toggle-group{width:100%}#onetrust-pc-sdk.otPcTab #vendors-list-container .host-notice,#onetrust-pc-sdk.otPcTab #vendors-list-container .vendor-notice,#onetrust-pc-sdk.otPcTab #hosts-list-container .host-notice,#onetrust-pc-sdk.otPcTab #hosts-list-container .vendor-notice{width:100%;float:left;margin-left:30px}#onetrust-pc-sdk.otPcTab #vendors-list-container .arrow-container,#onetrust-pc-sdk.otPcTab #hosts-list-container .arrow-container{float:left}#onetrust-pc-sdk.otPcTab #vendors-list-container .vendor-info{float:left;width:100%;max-width:85%}#onetrust-pc-sdk.otPcTab #pc-title{max-width:100%}}@media only screen and (min-width: 320px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk.otPcTab{height:100%}#onetrust-pc-sdk.otPcTab #content{height:calc(100% - 162px)}#onetrust-pc-sdk.otPcTab .pc-header{padding:10px;width:calc(100% - 20px)}#onetrust-pc-sdk.otPcTab .button-group-parent{padding:20px;width:calc(100% - 40px)}#onetrust-pc-sdk.otPcTab .vendor-content{overflow-y:scroll}#onetrust-pc-sdk.otPcTab #vendor-list-content{height:auto;overflow:hidden}#onetrust-pc-sdk.otPcTab .button-group,#onetrust-pc-sdk.otPcTab #accept-recommended-btn-handler{float:right}#onetrust-pc-sdk.otPcTab .footer-logo,#onetrust-pc-sdk.otPcTab .save-preference-btn-handler,#onetrust-pc-sdk.otPcTab #accept-recommended-btn-handler{width:auto}}@media only screen and (min-width: 320px)and (max-width: 640px)and (orientation: landscape){#onetrust-pc-sdk.otPcTab .ot-sdk-row .ot-sdk-columns{width:100%}}@media only screen and (min-width: 641px)and (max-width: 896px)and (orientation: landscape){#onetrust-pc-sdk.otPcTab .description-container{position:absolute;left:30%}}@media(max-width: 425px),(max-width: 896px)and (max-height: 425px)and (orientation: landscape){#onetrust-pc-sdk.otPcTab .pc-header{padding-right:20px}#onetrust-pc-sdk.otPcTab .pc-logo-container{margin-left:0px;margin-top:5px}#onetrust-pc-sdk.otPcTab .pc-logo{height:40px;width:150px}#onetrust-pc-sdk.otPcTab .pc-close-btn-container{margin-top:10px}#onetrust-pc-sdk.otPcTab .pc-close-btn-container .close-icon{width:12px;height:12px}#onetrust-pc-sdk.otPcTab .group-toggle{float:right;margin-left:10px;width:auto}#onetrust-pc-sdk.otPcTab #pc-privacy-header,#onetrust-pc-sdk.otPcTab .group-toggle .category-header{display:none}}@media only screen and (min-device-width: 768px)and (max-device-width: 1024px)and (orientation: landscape)and (-webkit-min-device-pixel-ratio: 1){#onetrust-pc-sdk.otPcTab #vendors-list-header input{min-width:250px;max-width:300px}}
            
            
            #onetrust-consent-sdk #onetrust-pc-sdk .category-vendors-list-handler:hover { opacity: .7;}
        .ot-sdk-cookie-policy{font-family:inherit;font-size:16px}.ot-sdk-cookie-policy h3,.ot-sdk-cookie-policy h4,.ot-sdk-cookie-policy h6,.ot-sdk-cookie-policy p,.ot-sdk-cookie-policy li,.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy #cookie-policy-description,.ot-sdk-cookie-policy .ot-sdk-cookie-policy-group,.ot-sdk-cookie-policy #cookie-policy-title{color:dimgray}.ot-sdk-cookie-policy #cookie-policy-description{margin-bottom:1em}.ot-sdk-cookie-policy h4{font-size:1.2em}.ot-sdk-cookie-policy h6{font-size:1em;margin-top:2em}.ot-sdk-cookie-policy th{min-width:75px}.ot-sdk-cookie-policy a,.ot-sdk-cookie-policy a:hover{background:#fff}.ot-sdk-cookie-policy thead{background-color:#f6f6f4;font-weight:bold}.ot-sdk-cookie-policy .mobile-border{display:none}.ot-sdk-cookie-policy section{margin-bottom:2em}.ot-sdk-cookie-policy table{border-collapse:inherit}.ot-sdk-cookie-policy[dir=rtl]{text-align:left}@media only screen and (max-width: 530px){.ot-sdk-cookie-policy table,.ot-sdk-cookie-policy thead,.ot-sdk-cookie-policy tbody,.ot-sdk-cookie-policy th,.ot-sdk-cookie-policy td,.ot-sdk-cookie-policy tr{display:block}.ot-sdk-cookie-policy thead tr{position:absolute;top:-9999px;left:-9999px}.ot-sdk-cookie-policy tr{margin:0 0 1rem 0}.ot-sdk-cookie-policy tr:nth-child(odd),.ot-sdk-cookie-policy tr:nth-child(odd) a{background:#f6f6f4}.ot-sdk-cookie-policy td{border:none;border-bottom:1px solid #eee;position:relative;padding-left:50%}.ot-sdk-cookie-policy td:before{position:absolute;height:100%;left:6px;width:40%;padding-right:10px}.ot-sdk-cookie-policy .mobile-border{display:inline-block;background-color:#e4e4e4;position:absolute;height:100%;top:0;left:45%;width:2px}.ot-sdk-cookie-policy td:before{content:attr(data-label);font-weight:bold}.ot-sdk-cookie-policy li{word-break:break-word;word-wrap:break-word}}
                
                    
                    
                    
            
                      @keyframes slide-down-custom {
                          0% {
                              bottom: 567px !important;
                          }
                          100% {
                              bottom: 0px;
                          }
                      }
                      @-webkit-keyframes slide-down-custom {
                          0% {
                              bottom: 567px !important;
                          }
                          100% {
                              bottom: 0px;
                          }
                      }
                      @-moz-keyframes slide-down-custom {
                          0% {
                              bottom: 567px !important;
                          }
                          100% {
                              bottom: 0px;
                          }
                      }
                      </style></head><body style="margin:0;box-sizing:border-box"><div id="__next"><div class="static_page"><div class="page no__focus__outline"><header class="sc-VigVT ftGovq"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd header__padding"><div class="sc-jzJRlG iePnMt mobileLogoFlex zcLX0olDTtYQdNV7ZvAP _1QGj87dn1MEuB6Fi6FoW9I"><a class="sc-htpNat bUhGXt link" href="https://www.hindawi.com/" aria-label="Home"><img alt=" " class="sc-EHOje bPvxKk" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/logo.svg" height="39"></a></div><div class="sc-jTzLTM gqNMKO mobileButtonFlex _1pGcpJ5HafXatoLq8DevpB _1IgBDS1hz5rtMn03pU8bYI E_HUmlU2Hj3PpkDmWzKPd"><nav class="sc-bxivhb ivbKJD"><ul class="sc-ifAKCX fopjOz sc-kgoBCf kVSTZj"><li class="navigation__link"><a class="sc-htpNat bUhGXt link active link" href="https://www.hindawi.com/journals/" aria-label="Journals">Journals</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="https://www.hindawi.com/publish-research/" aria-label="Publish with us">Publish with us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="https://www.hindawi.com/publishing-partnerships/" aria-label="Publishing partnerships">Publishing partnerships</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="https://www.hindawi.com/about/" aria-label="About us">About us</a></li><li class="navigation__link"><a class="sc-htpNat bUhGXt link link" href="https://www.hindawi.com/blog/" aria-label="Blog">Blog</a></li></ul></nav><button class="sc-cSHVUG dKTpXq icon__search" aria-label="Search"><img alt=" " class="sc-EHOje fEOMwM icon__search" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/search.svg" height="24"></button><button aria-label="Hamburger Menu" class="sc-fjdhpX kQnvJl"><img alt=" " class="sc-EHOje fEOMwM hamburger" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/hamburger.svg" height="24"></button></div></div></header><div class="sc-bZQynM bNmdOy"></div><main class="baseContent__Main-sc-134g3di-2 cbInhs  article__BaseStyle-sc-10qhnp8-0 gnduKR DADtd11SJ4KyWZ2l6zAnr base_style journal_article__ArticleBaseStyle-sc-12fk6zy-4 grtaJI"><div class="sc-bZQynM bNmdOy width_wrapper"><div id="journal__navigation" class="sc-hZSUBg cYkyoQ article__StickyStyle-sc-10qhnp8-1 bomGMi" style="top: 70px;"><a class="sc-htpNat bUhGXt link article__WhiteWrapper-sc-10qhnp8-5 eywbjC" href="https://www.hindawi.com/journals/bmri/" aria-label=""><h2 class="sc-kkGfuU fGHSnJ article__SubtitleStyled-sc-10qhnp8-2 hdSPnx _1ZrXcsbATVL_kHOpFAan9k">BioMed Research International</h2></a><button class="article__JournalMenuTitle-sc-10qhnp8-3 dvluaJ journalNavCheck" id="journalMenuTitle"><span>+</span>Journal Menu </button><div class="sc-bdVaJa EwsTm isHide" id="fadeOut"></div><div class="sc-exkUMo bvMPcE"><a class="sc-htpNat bUhGXt link sc-kcDeIU ecRsKc" href="http://downloads.hindawi.com/journals/bmri/2013/690835.pdf" aria-label="" target="_blank"><img alt=" " class="sc-EHOje fEOMwM sc-BngTV jYfclp article_toolbar_icon" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/pdf.svg" height="24">PDF<img alt=" " class="sc-EHOje fEOMwM sc-bFADNz WmYxG" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/downloadWhite.svg" height="24"></a></div><nav id="journal__nav" class="sc-fOKMvo gtcNnc article__JournalNavigationStyle-sc-10qhnp8-4 gaRePw isHide journalNavCheck"><div class="sc-gJWqzi eeIixx journalNavCheck"><button class="sc-kEYyzF gRIXYh sc-dUjcNx iKFnpS journalNavCheck" color="">Journal overview<img alt=" " class="sc-EHOje cPuqxU sc-eilVRo cUsyiK journalNavCheck icon__inactive" title="" role="presentation" src="data:image/svg+xml;base64,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" height="16"><img alt=" " class="sc-EHOje cPuqxU sc-eilVRo cUsyiK journalNavCheck icon__active icon__hidden" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="16"></button></div><a class="sc-htpNat bUhGXt link sc-gHboQg dEQFGg" href="https://www.hindawi.com/journals/bmri/guidelines/" aria-label="For authors">For authors</a><a class="sc-htpNat bUhGXt link sc-gHboQg dEQFGg" href="https://www.hindawi.com/publish-research/reviewers/" aria-label="For reviewers">For reviewers</a><a class="sc-htpNat bUhGXt link sc-gHboQg dEQFGg" href="https://www.hindawi.com/publish-research/editors/" aria-label="For editors">For editors</a><a class="sc-htpNat bUhGXt link sc-gHboQg dEQFGg" href="https://www.hindawi.com/journals/bmri/contents/year/2020/" aria-label="Table of Contents">Table of Contents</a><div class="sc-gJWqzi eeIixx journalNavCheck"><button class="sc-kEYyzF gRIXYh sc-dUjcNx dDIAoe journalNavCheck" color="">Special Issues<img alt=" " class="sc-EHOje cPuqxU sc-eilVRo cUsyiK journalNavCheck icon__inactive" title="" role="presentation" src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIiB3aWR0aD0iOCIgaGVpZ2h0PSIxNCIgdmlld0JveD0iMCAwIDggMTQiPjxkZWZzPjxjbGlwUGF0aCBpZD0iYSI+PHBhdGggZD0iTTcsNS41ODYsMS43MDcuMjkzQTEsMSwwLDAsMCwuMjkzLDEuNzA3bDYsNmExLDEsMCwwLDAsMS40MTQsMGw2LTZBMSwxLDAsMCwwLDEyLjI5My4yOTNaIi8+PC9jbGlwUGF0aD48L2RlZnM+PGcgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoMCAxNCkgcm90YXRlKC05MCkiIGNsaXAtcGF0aD0idXJsKCNhKSI+PGcgdHJhbnNmb3JtPSJ0cmFuc2xhdGUoLTUgLTgpIj48cmVjdCB3aWR0aD0iMjQiIGhlaWdodD0iMjQiIGZpbGw9InJnYmEoMCwwLDAsMCkiLz48cmVjdCB3aWR0aD0iMjQiIGhlaWdodD0iMjQiIGZpbGw9IiNmZmYiLz48L2c+PC9nPjwvc3ZnPg==" height="16"><img alt=" " class="sc-EHOje cPuqxU sc-eilVRo cUsyiK journalNavCheck icon__active icon__hidden" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="16"></button></div><a class="sc-htpNat bUhGXt link sc-cbkKFq hCNoKM submit__button journalNavCheck" href="https://mts.hindawi.com/submit/journals/bmri" aria-label="" target="_blank"><span><img alt=" " class="sc-EHOje fEOMwM sc-krvtoX byuWaL" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/addfile.svg" height="24"><span class="text">Submit</span></span><img alt=" " class="sc-EHOje cPuqxU sc-fYiAbW eBEQa fileArrow" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/rightArrowWhite.svg" height="16"></a><div class="sc-eerKOB gqVbba hide__submenu journalSubmenuCheck" id="journalnav__submenu"><button class="sc-cpmLhU jGWESP journalSubmenuCheck"><img alt=" " class="sc-EHOje fEOMwM sc-bnXvFD gKBnvW journalSubmenuCheck" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="24"></button></div><div class="sc-emmjRN gHJrTQ hide__submenu journal__nav__desktop" id="journalnav__submenudesktop"><div order="0" class="sc-jzgbtB bLOcAi"><div class="sc-gFaPwZ iuVChU"></div><div class="sc-gFaPwZ iuVChU"></div></div><div class="sc-fhYwyz iGNTxM"></div><span class="sc-rBLzX izYUwv"></span></div></nav></div><div class="sc-jxGEyO fDPtHo breadcrumb__wrapper journal_article__BreadCrumbStyle-sc-12fk6zy-3 eztxCB article"><a class="sc-htpNat bUhGXt link sc-gacfCG inRqQX breadCrumb" href="https://www.hindawi.com/journals/bmri/" aria-label="BioMed Research International">BioMed Research International</a> / <a class="sc-htpNat bUhGXt link sc-gacfCG inRqQX breadCrumb" href="https://www.hindawi.com/journals/bmri/contents/year/2013/" aria-label="2013">2013</a> / <span class="sc-dEfkYy cxVvOc">Article</span></div><div class="threeColumn__ThreeColumnWrapper-sc-1bf4078-0 uVYyF threeColumnWrapper"><div class="threeColumn__LeftWrapper-sc-1bf4078-1 fkVFlF leftWrapper"><button type="button" class="sc-clNaTc knnahC section__button " id="sectionButton"><img alt=" " class="sc-EHOje jEoUSB icon__dots dots__detector" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/dots.svg" height="6">Article Sections</button><div class="sc-iSDuPN hKBkaE static_contents__section_links
           links__hidden "><div id="leftSectionMenu" class="sc-hZSUBg gogxKe sc-RcBXQ eDANAO left_section_menu" style="top: 241px;"><p>On this page</p><span class="sc-fQejPQ fTFtno grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-fZwumE cLQMJq" href="https://www.hindawi.com/journals/bmri/2013/690835/#abstract" aria-label="">Abstract</a></span><span class="sc-fQejPQ fTFtno grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-fZwumE cLQMJq" href="https://www.hindawi.com/journals/bmri/2013/690835/#introduction" aria-label="">Introduction</a></span><span class="sc-fQejPQ fTFtno grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-fZwumE cLQMJq" href="https://www.hindawi.com/journals/bmri/2013/690835/#acknowledgments" aria-label="">Acknowledgments</a></span><span class="sc-fQejPQ fTFtno grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-fZwumE cLQMJq" href="https://www.hindawi.com/journals/bmri/2013/690835/#references" aria-label="">References</a></span><span class="sc-fQejPQ fTFtno grey" property="background-color" color="#D8D8D8"><a class="sc-htpNat bUhGXt link sc-fZwumE cLQMJq" href="https://www.hindawi.com/journals/bmri/2013/690835/#copyright" aria-label="">Copyright</a></span></div></div></div><div class="threeColumn__ContentWrapper-sc-1bf4078-3 bbzREB contentWrapper"><div class="threeColumn__Content-sc-1bf4078-4 jknsZc content"><div class="articleContent__ArticleContentsWrapper-sc-2yl9jy-0 eSvjPB article_contents"><div class="articleContent__ArticleContentsSectionsWrapper-sc-2yl9jy-1 jntdRu article_contents__sections_wrapper"><div class="articleContent__ArticleWrapper-sc-2yl9jy-2 hAzjHP"><div class="sc-cqCuEk dDomlX article_header_class"><div class="sc-dliRfk HhtZN"><span class="sc-kLIISr dybYoM">Special Issue</span><h2 class="sc-qrIAp kXQHAo">Human Arthropod-Borne Viral Infections</h2><a class="sc-htpNat bUhGXt link sc-iqzUVk gFkWAn" href="https://www.hindawi.com/journals/bmri/si/186796/" aria-label="">View this Special Issue</a><hr class="sc-ebFjAB jhQWaL"></div><p class="sc-ipZHIp hDKZCZ article_type">Review Article | Open Access</p><div class="sc-iGrrsa eZlme article_citation">Volume 2013 <span class="sc-dEoRIm gusDuS">|</span>Article ID 690835 <span class="sc-dEoRIm gusDuS">|</span> 20 pages <span class="sc-dEoRIm gusDuS">| </span><a class="sc-htpNat bUhGXt link sc-jtggT iUDBGe" href="https://doi.org/10.1155/2013/690835" aria-label="Doi-link" target="_blank">https://doi.org/10.1155/2013/690835</a></div><h1 class="sc-jAaTju cxkaTM sc-bmyXtO gYwSlP article_title">Understanding the Dengue Viruses and Progress towards Their Control</h1></div><div class="sc-jeCdPy bpzNtR article_authors"><hr class="sc-likbZx PHYWq hr__author"><span class=""><b>Rosmari Rodriguez-Roche</b><a class="sc-htpNat bUhGXt link" href="mailto:" aria-label="Mail to Author Option"><img alt=" " class="sc-EHOje cPuqxU sc-jtRlXQ jIaDFG" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/socialMail.svg" height="16"></a><a class="sc-htpNat bUhGXt link" href="http://orcid.org/0000-0002-6851-4222" aria-label="Redirect to Doi" target="_blank"><img alt=" " class="sc-EHOje cPuqxU sc-bGbJRg flqdYJ" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/doi.svg" height="16"></a><sup>1</sup> and </span><span class="">Ernest A. Gould<sup>2,3</sup></span><div class="sc-ePZHVD eecoTM isHide"><p><sup>1</sup><span>“Pedro Kouri” Tropical Medicine Institute, WHO/PAHO Collaborating Centre for the Study of Dengue and Its Vector, Autopista Novia del Mediodía, Km 6 1/2, La Lisa, P.O. Box 601, Marianao 13, 11300 Havana, Cuba</span></p><p><sup>2</sup><span>UMR190, Emergence des Pathologies Virales, Aix-Marseille Universite, Institut de Recherche pour le Développement, Ecole des Hautes Etudes en Santé Publique, Unité des Virus Emergents, Faculté de Médecine de Marseille, 27 Boulevard Jean Moulin, 13005 Marseille cedex 05, France</span></p><p><sup>3</sup><span>CEH Wallingford, Maclean Building, Benson Lane, Crowmarsh Gifford, Oxfordshire OX10 8BB, UK</span></p></div><button class="sc-kEYyzF gRIXYh sc-bEjcJn cFrLKZ" color="">Show more</button></div><div class="articleContent__EditorWrapper-sc-2yl9jy-3 evMkvU"><div class="articleContent__TextWrapper-sc-2yl9jy-8 fYrLtk"><b>Academic Editor: </b>Vittorio Sambri</div><div class="articleContent__PublicationTimeLineWrapper-sc-2yl9jy-4 fjviok"><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Received</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">13 Mar 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC notPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Accepted</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">08 May 2013</span></div><div class="articleContent__PublcationCol-sc-2yl9jy-5 hgKieC isPublished"><span class="articleContent__PublicationField-sc-2yl9jy-6 cIribm">Published</span><span class="articleContent__PublicationValue-sc-2yl9jy-7 khHUcu">09 Jul 2013</span></div></div></div><article class="sc-kZmsYB jyvGhN article_body "><div><div class="xml-content"><h4 class="header" id="abstract">Abstract</h4><p>Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this “scourge” of the tropical and subtropical world.</p><span class="end-abs"></span><h4 id="introduction">1. Introduction</h4><p>Dengue fever is a mosquito-borne virus disease of humans. In terms of numbers of individuals infected, it is by far the most devastating of all the recognised arthropod-transmitted virus diseases. It is estimated that more than 3 billion humans live in dengue endemic regions of the world, and currently, more than 50 million infections occur annually with at least 500,000 individuals requiring hospitalisation [<a class="refAnchor">1<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="1"><li>F. P. Pinheiro and S. J. Corber, “Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas,” <i>World Health Statistics Quarterly</i>, vol. 50, no. 3-4, pp. 161–169, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Global%20situation%20of%20dengue%20and%20dengue%20haemorrhagic%20fever,%20and%20its%20emergence%20in%20the%20Americas&amp;author=F.%20P.%20Pinheiro%20&amp;author=S.%20J.%20Corber&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B1" class="seeRef">See in References</a>
          </div></a>]. Of these, tens of thousands have a high risk of developing haemorrhagic disease, potentially with fatal consequences depending to a large extent on the quality of the available medical services. </p><p>The dengue viruses are positive stranded RNA viruses in the genus <i>Flavivirus</i>, family <i>Flaviviridae </i>[<a class="refAnchor">2<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="2"><li>D. J. Gubler, “The global emergence/resurgence of arboviral diseases as public health problems,” <i>Archives of Medical Research</i>, vol. 33, no. 4, pp. 330–342, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0188-4409(02)00378-8" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20global%20emergence/resurgence%20of%20arboviral%20diseases%20as%20public%20health%20problems&amp;author=D.%20J.%20Gubler&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B2" class="seeRef">See in References</a>
          </div></a>]. There are four distinct dengue virus (DENV) serotypes that share antigenic relationships (DENV-1, DENV-2, DENV-3, and DENV-4), and although infection with one serotype confers lifelong protection against that serotype, it does not necessarily protect against a secondary infection with a heterologous serotype. Indeed, nonprotective but cross-reactive antibodies may enhance disease severity [<a class="refAnchor">3<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="3"><li>S. B. Halstead, “Dengue,” <i>The Lancet</i>, vol. 370, no. 9599, pp. 1644–1652, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(07)61687-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue&amp;author=S.%20B.%20Halstead&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B3" class="seeRef">See in References</a>
          </div></a>]. Currently, there are no effective vaccines or antiviral drugs against these viruses. This problem is being addressed as a matter of urgency as failure to develop effective DENV control strategies will inevitably result in a further increase in the number of infected humans, as predicted more than a decade ago [<a class="refAnchor">4<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="4"><li>P. M. De A. Zanotto, E. A. Gould, G. F. Gao, P. H. Harvey, and E. C. Holmes, “Population dynamics of flaviviruses revealed by molecular phylogenies,” <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 93, no. 2, pp. 548–553, 1996. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.93.2.548" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Population%20dynamics%20of%20flaviviruses%20revealed%20by%20molecular%20phylogenies&amp;author=P.%20M.%20De%20A.%20Zanotto&amp;author=E.%20A.%20Gould&amp;author=G.%20F.%20Gao&amp;author=P.%20H.%20Harvey&amp;author=&amp;author=E.%20C.%20Holmes&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B4" class="seeRef">See in References</a>
          </div></a>]. This problem is also exacerbated by the continuing dispersal of these viruses to new geographic regions. </p><p>This review therefore focuses on our current understanding of dengue virus pathology, epidemiology, pathogenesis, evolution, biogeography, and disease control. </p><h4 id="dengue-fever/haemorrhagic-fever/shock-syndrome">2. Dengue Fever/Haemorrhagic Fever/Shock Syndrome</h4><h5 id="sec2.1">2.1. Clinical Picture</h5><p>In most cases asymptomatic or relatively mild disease follows infection with dengue virus. However, to take into account the increasing number of clinical cases, the World Health Organization (WHO) produced guidelines [<a class="refAnchor">5<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="5"><li> WHO, <i>Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control</i>, WHO, Geneva, Switzerland, 2nd edition, 1997. <span class="reflinks"></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B5" class="seeRef">See in References</a>
          </div></a>] in which they identified the clinical pictures resulting from infection with dengue virus. The first, known as dengue fever (DF), is characterised by an abrupt onset of fever accompanied by frontal headache and retroorbital pain, followed by a variety of possible clinical symptoms such as myalgia, arthralgia, vomiting, and weakness. A generalised maculopapular rash appears one or two days after fever defervescence. Minor haemorrhagic manifestations such as petechiae may be observed in some patients. DF is generally self-limiting and rarely fatal. Most patients recover without complications around ten days after the onset of illness. </p><p>The second clinical picture, dengue haemorrhagic fever (DHF), is a more severe form of the disease and occurs in up to 5% of dengue cases. It is initially characterized by the same variety of clinical symptoms as are seen in DF. The critical period in DHF starts at the moment of defervescence but haemorrhagic manifestations may occur 24 hours earlier. A positive tourniquet test indicates that the patient has increased capillary fragility. Petechiae, bleeding at venepuncture sites, epistaxis, gum bleeding, and haematemesis may also be observed. High fever, haemorrhagic manifestations, thrombocytopenia (platelet count 100 000/mm<sup>3</sup> or less), and haemoconcentration (&gt;20% difference) characterize DHF. Plasma leakage is the most significant pathophysiological event in determining the severity of the disease. Signs of circulatory failure such as irritability, cold clammy extremities, flushed face, and restlessness may be observed. This crisis usually persists for 24–36 hours. With appropriate supportive medicine and carefully monitored intravenous isotonic crystalloid therapy, to ensure adequate fluid replacement, most patients recover. However, during this critical period, it is essential to look for characteristic warning signs of worse to come. Patients progressing to shock (dengue shock syndrome—DSS) show intense abdominal pain or tenderness, persistent vomiting, weak pulse, and hypotension. If increased vascular permeability progresses to vascular collapse the outcome is usually fatal as a result of irreversible DSS. In addition to DF, DHF, and DSS, it is now recognised that other clinical manifestations can be associated with infection by dengue virus, for example, encephalitis, myocarditis, hepatitis, cholecystitis, myelitis, and acute colitis [<a class="refAnchor">6<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="6"><li>L. M. Ling, A. Wilder-Smith, and Y. S. Leo, “Fulminant hepatitis in dengue haemorrhagic fever,” <i>Journal of Clinical Virology</i>, vol. 38, no. 3, pp. 265–268, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jcv.2006.12.011" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Fulminant%20hepatitis%20in%20dengue%20haemorrhagic%20fever&amp;author=L.%20M.%20Ling&amp;author=A.%20Wilder-Smith&amp;author=&amp;author=Y.%20S.%20Leo&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B6" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">11<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="11"><li>S. B. Park, S. Y. Ryu, K. B. Jin et al., “Acute colitis associated with dengue fever in a renal transplant recipient,” <i>Transplantation Proceedings</i>, vol. 40, no. 7, pp. 2431–2432, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.transproceed.2008.07.037" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Acute%20colitis%20associated%20with%20dengue%20fever%20in%20a%20renal%20transplant%20recipient&amp;author=S.%20B.%20Park&amp;author=S.%20Y.%20Ryu&amp;author=K.%20B.%20Jin%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B11" class="seeRef">See in References</a>
          </div></a>]. </p><p>Despite the rigour of the DF/DHF/DSS classification and its intrinsic worth in clinical case management, in recent years, a growing number of clinicians and authors have argued that the 1997 WHO scheme for dengue clinical classification should be reassessed [<a class="refAnchor">12<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="12"><li>A. Balmaseda, S. N. Hammond, M. A. Pérez et al., “Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 73, no. 6, pp. 1059–1062, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Short%20report:%20assessment%20of%20the%20World%20Health%20Organization%20scheme%20for%20classification%20of%20dengue%20severity%20in%20Nicaragua&amp;author=A.%20Balmaseda&amp;author=S.%20N.%20Hammond&amp;author=M.%20A.%20P%C3%A9rez%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B12" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">14<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="14"><li>J. G. Rigau-Pérez, “Severe dengue: the need for new case definitions,” <i>Lancet Infectious Diseases</i>, vol. 6, no. 5, pp. 297–302, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S1473-3099(06)70465-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Severe%20dengue:%20the%20need%20for%20new%20case%20definitions&amp;author=J.%20G.%20Rigau-P%C3%A9rez&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B14" class="seeRef">See in References</a>
          </div></a>] because it distinguishes strictly between DF, DHF, and DSS, whereas it is now recognised that the point of transition between DF and DHF is not easily defined. The requirements for the WHO definition of DHF (fever, haemorrhage, thrombocytopenia, and signs of plasma leakage) are not always satisfied; severe thrombocytopenia may be observed in uncomplicated as well as severe cases associated with “unusual manifestations” and therefore may not be consistent with the DHF/DSS classification [<a class="refAnchor">15<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="15"><li>J. L. Deen, E. Harris, B. Wills et al., “The WHO dengue classification and case definitions: time for a reassessment,” <i>The Lancet</i>, vol. 368, no. 9530, pp. 170–173, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(06)69006-5" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20WHO%20dengue%20classification%20and%20case%20definitions:%20time%20for%20a%20reassessment&amp;author=J.%20L.%20Deen&amp;author=E.%20Harris&amp;author=B.%20Wills%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B15" class="seeRef">See in References</a>
          </div></a>]. A WHO/TDR-supported prospective clinical multicentre study across dengue-endemic regions was established to collect and coordinate specific criteria for classifying clinical cases into levels of severity [<a class="refAnchor">16<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="16"><li>N. Alexander, A. Balmaseda, I. C. B. Coelho et al., “Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries,” <i>Tropical Medicine and International Health</i>, vol. 16, no. 8, pp. 936–948, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-3156.2011.02793.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Multicentre%20prospective%20study%20on%20dengue%20classification%20in%20four%20South-east%20Asian%20and%20three%20Latin%20American%20countries&amp;author=N.%20Alexander&amp;author=A.%20Balmaseda&amp;author=I.%20C.%20B.%20Coelho%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B16" class="seeRef">See in References</a>
          </div></a>]. The study confirmed that, by using a set of clinical and/or laboratory parameters, one sees a clear-cut difference between patients with severe dengue fever and those with nonsevere dengue fever. However, for practical reasons it was considered necessary to split the large group of patients with nonsevere dengue into two subgroups: patients with warning signs (abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy, restlessness, liver enlargement &gt;2 cm, and increase in hematocrit concurrent with rapid decrease in platelet count) and those without these warning signs. On the other hand, the criteria for severe dengue fever include extensive plasma leakage, severe bleeding, or severe organ impairment. </p><p>The third and most recent edition of the WHO/TDR dengue guidelines for diagnosis, treatment, prevention, and control includes a new clinical classification [<a class="refAnchor">17<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="17"><li> WHO/TDR, <i>Dengue Guidelines for Diagnosis, Treatment, Prevention and Control</i>, WHO Press, Geneva, Switzerland, 2009. <span class="reflinks"></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B17" class="seeRef">See in References</a>
          </div></a>]. This publication serves as an authoritative reference source for health workers and researchers. These new guidelines provide a revised case classification which is intended to facilitate effective triage and patient management and collection of improved comparative surveillance data [<a class="refAnchor">18<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="18"><li>N. A. Akbar, I. Allende, A. Balmaseda et al., “Regarding “Dengue—how best to classify it”,” <i>Clinical Infectious Diseases</i>, vol. 54, no. 12, pp. 1820–1821, 2012, author reply 1821-1822. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cis328" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Regarding%20%E2%80%9CDengue%E2%80%94how%20best%20to%20classify%20it%E2%80%9D&amp;author=N.%20A.%20Akbar&amp;author=I.%20Allende&amp;author=A.%20Balmaseda%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B18" class="seeRef">See in References</a>
          </div></a>]. However, due to the recommendation that cases of dengue fever with warning signs and also cases of severe dengue fever should be admitted to hospital, there is concern that this could result in overadmission of patients to hospitals during epidemics, inevitably reducing the efficiency of patient triage and adversely affecting the quality of clinical case management [<a class="refAnchor">19<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="19"><li>A. Srikiatkhachorn, A. L. Rothman, R. V. Gibbons et al., “Dengue-how best to classify it,” <i>Clinical Infectious Diseases</i>, vol. 53, no. 6, pp. 563–567, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cir451" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue-how%20best%20to%20classify%20it&amp;author=A.%20Srikiatkhachorn&amp;author=A.%20L.%20Rothman&amp;author=R.%20V.%20Gibbons%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B19" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">20<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="20"><li>S. Kalayanarooj, “Dengue classification: current WHO vs. the newly suggested classification for better clinical application?” <i>Journal of the Medical Association of Thailand</i>, vol. 94, pp. S74–84, 2011. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20classification:%20current%20WHO%20vs.%20the%20newly%20suggested%20classification%20for%20better%20clinical%20application?&amp;author=S.%20Kalayanarooj&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B20" class="seeRef">See in References</a>
          </div></a>]. Furthermore there is additional concern that the WHO/TDR classification may impact significantly on dengue pathogenesis research since it requires the identification and study of distinct dengue syndromes. Because the 2009 WHO case definitions do not require laboratory tests for the diagnosis of severe dengue, it is considered that retrospective identification of patients with clinically significant vascular permeability, from data on hospital charts, may be difficult if not impossible [<a class="refAnchor">21<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="21"><li>S. B. Halstead, “Dengue: the syndromic basis to pathogenesis research. Inutility of the 2009 WHO case definition,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 88, no. 2, pp. 212–215, 2013. <span class="reflinks">View at: <a href="https://doi.org/10.4269/ajtmh.12-0197" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue:%20the%20syndromic%20basis%20to%20pathogenesis%20research.%20Inutility%20of%20the%202009%20WHO%20case%20definition&amp;author=S.%20B.%20Halstead&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B21" class="seeRef">See in References</a>
          </div></a>]. The previous discussion highlights the difficulties of designing a totally acceptable classification scheme for dengue pathogenesis.</p><h5 id="sec2.2">2.2. History of DF and DHF</h5><p>Clinically diagnosed DF was widespread during the 18th and 19th centuries in North and South America, the Caribbean Basin, Asia, and Australia. In the Americas, this was largely due to the repeated introduction from Africa of <i>Stegomyia (St.) aegypti </i>(formerly <i>Aedes aegypti</i>) [<a class="refAnchor">22<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="22"><li>J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Ochlerotatus and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” <i>Zoological Journal of the Linnean Society</i>, vol. 153, no. 1, pp. 29–114, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1096-3642.2008.00382.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Ochlerotatus%20and%20allied%20taxa%20(Diptera:%20Culicidae:%20Aedini)%20based%20on%20morphological%20data%20from%20all%20life%20stages&amp;author=J.%20F.%20Reinert&amp;author=R.%20E.%20Harbach&amp;author=&amp;author=I.%20J.%20Kitching&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B22" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">24<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="24"><li>J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Finlaya and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” <i>Zoological Journal of the Linnean Society</i>, vol. 148, no. 1, pp. 1–101, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1096-3642.2006.00254.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Finlaya%20and%20allied%20taxa%20(Diptera:%20Culicidae:%20Aedini)%20based%20on%20morphological%20data%20from%20all%20life%20stages&amp;author=J.%20F.%20Reinert&amp;author=R.%20E.%20Harbach&amp;author=&amp;author=I.%20J.%20Kitching&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B24" class="seeRef">See in References</a>
          </div></a>]. Moreover, together with yellow fever virus (YFV), DENV-infected humans and mosquitoes were introduced via the slave ships and other commercial vessels that crossed the Atlantic Ocean from Africa during the past five or more centuries [<a class="refAnchor">25<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="25"><li>E. A. Gould, X. de Lamballerie, P. M. D. A. Zanotto, and E. C. Holmes, “Origins, evolution, and vector{plus 45 degree rule}host coadaptations within the Genus Flavivirus,” <i>Advances in Virus Research</i>, vol. 59, pp. 277–314, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0065-3527(03)59008-X" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Origins,%20evolution,%20and%20vector{plus%2045%20degree%20rule}host%20coadaptations%20within%20the%20Genus%20Flavivirus&amp;author=E.%20A.%20Gould&amp;author=X.%20de%20Lamballerie&amp;author=P.%20M.%20D.%20A.%20Zanotto&amp;author=&amp;author=E.%20C.%20Holmes&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B25" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">31<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="31"><li>K. J. Bloom, <i>The Mississippi Valley's Great Yellow Fever Epidemic of 1978</i>, Louisiana State University Press, Baton Rouge, Lo, USA, 1993. <span class="reflinks"></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B31" class="seeRef">See in References</a>
          </div></a>]. </p><p>It is also important to note that disease clinically compatible with the more severe and often fatal syndromes, DHF and DSS, was sporadically reported from 1780 onwards [<a class="refAnchor">32<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="32"><li>B. Rush, “An account of the bilious remitting fever. As it appeared in philadelphia, in the summer and autumn of the year 1780,” <i>The American Journal of Medicine</i>, vol. 11, no. 5, pp. 546–550, 1951. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=An%20account%20of%20the%20bilious%20remitting%20fever.%20As%20it%20appeared%20in%20philadelphia,%20in%20the%20summer%20and%20autumn%20of%20the%20year%201780&amp;author=B.%20Rush&amp;publication_year=1951" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B32" class="seeRef">See in References</a>
          </div></a>] although it is not clear if the more severe cases were confined to individuals of European descent. </p><p>DF thus became endemic in Latin America and the Caribbean region, periodically causing epidemics. At the same time, YFV was also causing epidemics in South America, prompting the Pan American Health Organisation (PAHO) to introduce a mosquito-eradication programme which lasted from 1946 until the late 1970s. Since both DENV and YFV are transmitted to humans via <i>St. aegypti</i> this eradication campaign in South America also resulted in a lower incidence of DF in South America. Thus, DF was confined mainly to the Caribbean basin [<a class="refAnchor">33<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="33"><li>S. B. Halstead, “Dengue in the Americas and Southeast Asia: do they differ?” <i>Revista Panamericana de Salud Publica</i>, vol. 20, no. 6, pp. 407–415, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20in%20the%20Americas%20and%20Southeast%20Asia:%20do%20they%20differ?&amp;author=S.%20B.%20Halstead&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B33" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">34<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="34"><li>D. Gubler, “Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem,” in <i>Dengue and Dengue Hemorrhagic Fever</i>, D. Gubler and G. Kuno, Eds., pp. 1–22, CAB International, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20hemorrhagic%20fever:%20its%20history%20and%20resurgence%20as%20a%20global%20public%20health%20problem&amp;author=D.%20Gubler&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B34" class="seeRef">See in References</a>
          </div></a>]. Subsequently, the gradual decline of mosquito control measures and increasing introduction and dispersal of mosquitoes via transportation for commercial and military purposes led to the reemergence of dengue as a major health problem during the mid and later parts of the 20th Century. The incidence of dengue fever increased dramatically in Southeast Asia during World War II and continued to intensify with increased geographic spread of the viruses and the principal mosquito vector, <i>St. aegypti</i>. In addition to the major influence of increased shipping and air-traffic globally, other major factors for the reemergence of dengue fever include ecological and demographic changes in the tropical zones [<a class="refAnchor">2<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="2"><li>D. J. Gubler, “The global emergence/resurgence of arboviral diseases as public health problems,” <i>Archives of Medical Research</i>, vol. 33, no. 4, pp. 330–342, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0188-4409(02)00378-8" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20global%20emergence/resurgence%20of%20arboviral%20diseases%20as%20public%20health%20problems&amp;author=D.%20J.%20Gubler&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B2" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">34<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="34"><li>D. Gubler, “Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem,” in <i>Dengue and Dengue Hemorrhagic Fever</i>, D. Gubler and G. Kuno, Eds., pp. 1–22, CAB International, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20hemorrhagic%20fever:%20its%20history%20and%20resurgence%20as%20a%20global%20public%20health%20problem&amp;author=D.%20Gubler&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B34" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">39<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="39"><li>S. B. Halstead, “Dengue virus-mosquito interactions,” <i>Annual Review of Entomology</i>, vol. 53, pp. 273–291, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.ento.53.103106.093326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus-mosquito%20interactions&amp;author=S.%20B.%20Halstead&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B39" class="seeRef">See in References</a>
          </div></a>]. </p><p>During the 1980s and 1990s, rapidly expanding populations of <i>St. aegypti</i> in Brazil resulted in successive epidemics due to DENV-1, DENV-2, and DENV-3. In Brazil, these infections presented mostly as DF, with surprisingly few cases of DHF. This contrasts with Asia where the proportion of DHF cases was significantly higher during DF epidemics. These differences have been partly attributed to the widespread presence of dengue virus resistance genes in Latin Americans with African ancestry [<a class="refAnchor">33<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="33"><li>S. B. Halstead, “Dengue in the Americas and Southeast Asia: do they differ?” <i>Revista Panamericana de Salud Publica</i>, vol. 20, no. 6, pp. 407–415, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20in%20the%20Americas%20and%20Southeast%20Asia:%20do%20they%20differ?&amp;author=S.%20B.%20Halstead&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B33" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">40<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="40"><li>R. E. Blanton, L. K. Silva, V. G. Morato et al., “Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population,” <i>European Journal of Human Genetics</i>, vol. 16, no. 6, pp. 762–765, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1038/ejhg.2008.4" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genetic%20ancestry%20and%20income%20are%20associated%20with%20dengue%20hemorrhagic%20fever%20in%20a%20highly%20admixed%20population&amp;author=R.%20E.%20Blanton&amp;author=L.%20K.%20Silva&amp;author=V.%20G.%20Morato%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B40" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">41<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="41"><li>B. D. L. C. Sierra, G. Kourí, and M. G. Guzmán, “Race: a risk factor for dengue hemorrhagic fever,” <i>Archives of Virology</i>, vol. 152, no. 3, pp. 533–542, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-006-0869-x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Race:%20a%20risk%20factor%20for%20dengue%20hemorrhagic%20fever&amp;author=B.%20D.%20L.%20C.%20Sierra&amp;author=G.%20Kour%C3%AD&amp;author=&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B41" class="seeRef">See in References</a>
          </div></a>]. The differences may also be partly explained by the high levels of antibody against the American DENV-2 genotype and antigenically cross-reactive DENV-1, both of which had been endemic in Latin America for many years. </p><p>Today, all four DENV serotypes circulate in Africa, South and Southeast Asia, the Western Pacific region, the Caribbean basin, and Central and South America [<a class="refAnchor">39<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="39"><li>S. B. Halstead, “Dengue virus-mosquito interactions,” <i>Annual Review of Entomology</i>, vol. 53, pp. 273–291, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.ento.53.103106.093326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus-mosquito%20interactions&amp;author=S.%20B.%20Halstead&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B39" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">42<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="42"><li>M. G. Guzman and G. Kouri, “Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges,” <i>Journal of Clinical Virology</i>, vol. 27, no. 1, pp. 1–13, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S1386-6532(03)00010-6" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20hemorrhagic%20fever%20in%20the%20Americas:%20lessons%20and%20challenges&amp;author=M.%20G.%20Guzman%20&amp;author=G.%20Kouri&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B42" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">44<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="44"><li>A. Wilder-Smith and D. J. Gubler, “Geographic expansion of dengue: the impact of international travel,” <i>Medical Clinics of North America</i>, vol. 92, no. 6, pp. 1377–1390, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.mcna.2008.07.002" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Geographic%20expansion%20of%20dengue:%20the%20impact%20of%20international%20travel&amp;author=A.%20Wilder-Smith%20&amp;author=D.%20J.%20Gubler&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B44" class="seeRef">See in References</a>
          </div></a>]. Frequent introductions into the Southern states of North America are also regularly recorded although to date they have not resulted in epidemic outbreaks in the USA; DF has the potential to become reestablished as an endemic disease in this country. In fact, sustained transmission of dengue has occurred in Florida during recent years. Conditions exist that could facilitate sustained dengue transmission, including environmental factors, competent mosquito vectors, limited vector and dengue surveillance, increased domestic outdoor daytime activities in warmer months, and low public awareness of the disease [<a class="refAnchor">45<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="45"><li>C. Franco, N. A. Hynes, N. Bouri, and D. A. Henderson, “The dengue threat to the United States,” <i>Biosecurity and Bioterrorism</i>, vol. 8, no. 3, pp. 273–276, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1089/bsp.2010.0032" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20dengue%20threat%20to%20the%20United%20States&amp;author=C.%20Franco&amp;author=N.%20A.%20Hynes&amp;author=N.%20Bouri&amp;author=&amp;author=D.%20A.%20Henderson&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B45" class="seeRef">See in References</a>
          </div></a>]. Indeed, dengue continues to spread more widely as demonstrated in 2010 by the first recorded cases of autochthonous dengue fever in southern France [<a class="refAnchor">46<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="46"><li>E. A. Gould, P. Gallian, X. De Lamballerie, and R. N. Charrel, “First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!,” <i>Clinical Microbiology and Infection</i>, vol. 16, no. 12, pp. 1702–1704, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1469-0691.2010.03386.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=First%20cases%20of%20autochthonous%20dengue%20fever%20and%20chikungunya%20fever%20in%20France:%20from%20bad%20dream%20to%20reality!&amp;author=E.%20A.%20Gould&amp;author=P.%20Gallian&amp;author=X.%20De%20Lamballerie&amp;author=&amp;author=R.%20N.%20Charrel&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B46" class="seeRef">See in References</a>
          </div></a>] and Croatia [<a class="refAnchor">47<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="47"><li>I. C. Kurolt, L. Betica-Radic, O. Dakovic-Rode et al., “Molecular characterization of dengue virus 1 from autochthonous dengue fever cases in Croatia,” <i>Clinical Microbiology and Infection</i>, vol. 19, no. 3, pp. 163–165, 2013. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Molecular%20characterization%20of%20dengue%20virus%201%20from%20autochthonous%20dengue%20fever%20cases%20in%20Croatia&amp;author=I.%20C.%20Kurolt&amp;author=L.%20Betica-Radic&amp;author=O.%20Dakovic-Rode%20et%20al.&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B47" class="seeRef">See in References</a>
          </div></a>].</p><p>Many countries in the tropics and subtropical regions show cocirculation of at least two DENV serotypes [<a class="refAnchor">36<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="36"><li>D. J. Gubler, “Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century,” <i>Trends in Microbiology</i>, vol. 10, no. 2, pp. 100–103, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0966-842X(01)02288-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemic%20dengue/dengue%20hemorrhagic%20fever%20as%20a%20public%20health,%20social%20and%20economic%20problem%20in%20the%2021st%20century&amp;author=D.%20J.%20Gubler&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B36" class="seeRef">See in References</a>
          </div></a>], and increasingly, cocirculation of all 4 serotypes is being recorded in individual countries. Taken together with the ecological and demographic changes, this partly explains why the pattern of epidemics is gradually increasing from a frequency of outbreaks every 3–5 years to approximately every 2 years [<a class="refAnchor">48<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="48"><li>M. G. Guzman and G. Kouri, “Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987–2007,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 102, no. 6, pp. 522–523, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.trstmh.2008.03.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20haemorrhagic%20fever%20integral%20hypothesis:%20confirming%20observations,%201987%E2%80%932007&amp;author=M.%20G.%20Guzman%20&amp;author=G.%20Kouri&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B48" class="seeRef">See in References</a>
          </div></a>]. Additional explanations for this increased incidence include the possibility that more highly pathogenic strains of DENV are also emerging [<a class="refAnchor">44<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="44"><li>A. Wilder-Smith and D. J. Gubler, “Geographic expansion of dengue: the impact of international travel,” <i>Medical Clinics of North America</i>, vol. 92, no. 6, pp. 1377–1390, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.mcna.2008.07.002" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Geographic%20expansion%20of%20dengue:%20the%20impact%20of%20international%20travel&amp;author=A.%20Wilder-Smith%20&amp;author=D.%20J.%20Gubler&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B44" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">49<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="49"><li>M. G. Guzman, S. Vazquez, E. Martinez et al., “Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas,” <i>Boletin de la Oficina Sanitaria Panamericana</i>, vol. 121, no. 2, pp. 102–110, 1996. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20in%20Nicaragua,%201994:%20reintroduction%20of%20serotype%203%20in%20the%20Americas&amp;author=M.%20G.%20Guzman&amp;author=S.%20Vazquez&amp;author=E.%20Martinez%20et%20al.&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B49" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">51<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="51"><li>R. Rico-Hesse, “Microevolution and virulence of dengue viruses,” <i>Advances in Virus Research</i>, vol. 59, pp. 315–341, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0065-3527(03)59009-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Microevolution%20and%20virulence%20of%20dengue%20viruses&amp;author=R.%20Rico-Hesse&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B51" class="seeRef">See in References</a>
          </div></a>]. Greater awareness of this disease, as the result of more extensive monitoring, is also impacting on our understanding of and the apparent increased periodicity of dengue virus epidemiology. </p><p>Comparison of disease incidence in Asia and Latin America reveals a distinct difference in the age distribution of DF and DHF. In Asia, hospitalizations principally involve children, whereas in the Americas, they tend to involve a greater proportion of adults [<a class="refAnchor">33<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="33"><li>S. B. Halstead, “Dengue in the Americas and Southeast Asia: do they differ?” <i>Revista Panamericana de Salud Publica</i>, vol. 20, no. 6, pp. 407–415, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20in%20the%20Americas%20and%20Southeast%20Asia:%20do%20they%20differ?&amp;author=S.%20B.%20Halstead&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B33" class="seeRef">See in References</a>
          </div></a>]. The reasons for this apparent difference have not been adequately defined. However, to complicate this issue, a recent epidemic in the State of Rio de Janeiro revealed that the incidence of DHF in children was significantly higher than in previous epidemics in Brazil [<a class="refAnchor">52<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="52"><li>M. G. Teixeira, M. C. N. Costa, G. Coelho, and M. L. Barreto, “Recent shift in age pattern of dengue hemorrhagic fever, Brazil,” <i>Emerging Infectious Diseases</i>, vol. 14, no. 10, p. 1663, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1410.071164" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Recent%20shift%20in%20age%20pattern%20of%20dengue%20hemorrhagic%20fever,%20Brazil&amp;author=M.%20G.%20Teixeira&amp;author=M.%20C.%20N.%20Costa&amp;author=G.%20Coelho&amp;author=&amp;author=M.%20L.%20Barreto&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B52" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">53<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="53"><li>L. P. Cavalcanti, D. Vilar, R. Souza-Santos, and M. G. Teixeira, “Change in age pattern of persons with dengue, Northeastern Brazil,” <i>Emerging Infectious Diseases</i>, vol. 17, no. 1, pp. 132–134, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1701.100321" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Change%20in%20age%20pattern%20of%20persons%20with%20dengue,%20Northeastern%20Brazil&amp;author=L.%20P.%20Cavalcanti&amp;author=D.%20Vilar&amp;author=R.%20Souza-Santos&amp;author=&amp;author=M.%20G.%20Teixeira&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B53" class="seeRef">See in References</a>
          </div></a>]. </p><h5 id="sec2.3">2.3. Risk Factors Associated with the Development of Severe Dengue</h5><p>The principal vector associated with all 4 DENV serotypes is the African mosquito <i>St. aegypti </i>an urban-dwelling anthropophilic mosquito. However, <i>St. albopicta </i>the Asian “Tiger” mosquito is also competent to reproduce and transmit DENV between humans. In contrast with <i>St. aegypti, St. albopicta </i>is peridomestic, with a preference for the rural environment. In some parts of Asia and Africa, <i>St. albopicta </i>has displaced <i>St. aegypti </i>[<a class="refAnchor">54<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="54"><li>M. Q. Benedict, R. S. Levine, W. A. Hawley, and L. P. Lounibos, “Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus,” <i>Vector-Borne and Zoonotic Diseases</i>, vol. 7, no. 1, pp. 76–85, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1089/vbz.2006.0562" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Spread%20of%20the%20tiger:%20global%20risk%20of%20invasion%20by%20the%20mosquito%20Aedes%20albopictus&amp;author=M.%20Q.%20Benedict&amp;author=R.%20S.%20Levine&amp;author=W.%20A.%20Hawley&amp;author=&amp;author=L.%20P.%20Lounibos&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B54" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">55<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="55"><li>R. N. Charrel, X. De Lamballerie, and D. Raoult, “Chikungunya outbreaks—the globalization of vectorborne diseases,” <i>The New England Journal of Medicine</i>, vol. 356, no. 8, pp. 769–771, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1056/NEJMp078013" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Chikungunya%20outbreaks%E2%80%94the%20globalization%20of%20vectorborne%20diseases&amp;author=R.%20N.%20Charrel&amp;author=X.%20De%20Lamballerie&amp;author=&amp;author=D.%20Raoult&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B55" class="seeRef">See in References</a>
          </div></a>]. A possible scenario of this changing pattern of mosquito distribution and the continuing dispersal of <i>St. albopicta</i> is that the dengue viruses will disperse even more widely, gradually establishing in the warmer regions of the temperate zones, including Europe [<a class="refAnchor">46<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="46"><li>E. A. Gould, P. Gallian, X. De Lamballerie, and R. N. Charrel, “First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!,” <i>Clinical Microbiology and Infection</i>, vol. 16, no. 12, pp. 1702–1704, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1469-0691.2010.03386.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=First%20cases%20of%20autochthonous%20dengue%20fever%20and%20chikungunya%20fever%20in%20France:%20from%20bad%20dream%20to%20reality!&amp;author=E.%20A.%20Gould&amp;author=P.%20Gallian&amp;author=X.%20De%20Lamballerie&amp;author=&amp;author=R.%20N.%20Charrel&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B46" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">47<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="47"><li>I. C. Kurolt, L. Betica-Radic, O. Dakovic-Rode et al., “Molecular characterization of dengue virus 1 from autochthonous dengue fever cases in Croatia,” <i>Clinical Microbiology and Infection</i>, vol. 19, no. 3, pp. 163–165, 2013. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Molecular%20characterization%20of%20dengue%20virus%201%20from%20autochthonous%20dengue%20fever%20cases%20in%20Croatia&amp;author=I.%20C.%20Kurolt&amp;author=L.%20Betica-Radic&amp;author=O.%20Dakovic-Rode%20et%20al.&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B47" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">56<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="56"><li>C. Sousa, M. Clairouin, G. Seixas et al., “Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report,” <i>Eurosurveillance</i>, vol. 17, no. 49, article 3, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Ongoing%20outbreak%20of%20dengue%20type%201%20in%20the%20Autonomous%20Region%20of%20Madeira,%20Portugal:%20preliminary%20report&amp;author=C.%20Sousa&amp;author=M.%20Clairouin&amp;author=G.%20Seixas%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B56" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">57<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="57"><li>C. Caminade, J. M. Medlock, E. Ducheyne et al., “Suitability of European climate for the Asian tiger mosquito <i>Aedes albopictus</i>: recent trends and future scenarios,” <i>Journal of the Royal Society Interface</i>, vol. 9, no. 75, pp. 2708–2717, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1098/rsif.2012.0138" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Suitability%20of%20European%20climate%20for%20the%20Asian%20tiger%20mosquito%20%3Ci%3EAedes%20albopictus%3C/i%3E:%20recent%20trends%20and%20future%20scenarios&amp;author=C.%20Caminade&amp;author=J.%20M.%20Medlock&amp;author=E.%20Ducheyne%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B57" class="seeRef">See in References</a>
          </div></a>], the southern regions of North America [<a class="refAnchor">58<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="58"><li>W. F. Wright and B. S. Pritt, “Update: the diagnosis and management of dengue virus infection in North America,” <i>Diagnostic Microbiology and Infectious Disease</i>, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.diagmicrobio.2012.03.021" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Update:%20the%20diagnosis%20and%20management%20of%20dengue%20virus%20infection%20in%20North%20America&amp;author=W.%20F.%20Wright%20&amp;author=B.%20S.%20Pritt&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B58" class="seeRef">See in References</a>
          </div></a>], and more northern regions of Asia [<a class="refAnchor">59<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="59"><li>F. Wu, Q. Liu, L. Lu, J. Wang, X. Song, and D. Ren, “Distribution of Aedes albopictus (Diptera: Culicidae) in northwestern China,” <i>Vector-Borne and Zoonotic Diseases</i>, vol. 11, no. 8, pp. 1181–1186, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1089/vbz.2010.0032" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Distribution%20of%20Aedes%20albopictus%20(Diptera:%20Culicidae)%20in%20northwestern%20China&amp;author=F.%20Wu&amp;author=Q.%20Liu&amp;author=L.%20Lu&amp;author=J.%20Wang&amp;author=X.%20Song&amp;author=&amp;author=D.%20Ren&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B59" class="seeRef">See in References</a>
          </div></a>]. </p><p>The pathogenetic basis for DHF has been a subject of study for decades, and whilst significant progress has been made in understanding the most important risk factors involved, the precise biochemical and immunological pathways have not yet been defined [<a class="refAnchor">60<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="60"><li>M. G. Guzmán, “Deciphering dengue: the Cuban experience,” <i>Science</i>, vol. 309, no. 5740, pp. 1495–1497, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.1115177" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Deciphering%20dengue:%20the%20Cuban%20experience&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B60" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">62<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="62"><li>A. Mathew and A. L. Rothman, “Understanding the contribution of cellular immunity to dengue disease pathogenesis,” <i>Immunological Reviews</i>, vol. 225, no. 1, pp. 300–313, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1600-065X.2008.00678.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Understanding%20the%20contribution%20of%20cellular%20immunity%20to%20dengue%20disease%20pathogenesis&amp;author=A.%20Mathew%20&amp;author=A.%20L.%20Rothman&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B62" class="seeRef">See in References</a>
          </div></a>]. Amongst the several possibilities that have been identified, there is compelling evidence that secondary infection with a heterologous DENV serotype, or primary infection in infants born to dengue-immune mothers, is an important individual risk factor for DHF/DSS [<a class="refAnchor">63<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="63"><li>M. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1–3 virus infections over a long time interval: Havana epidemic, 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1113–1117, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20caused%20by%20sequential%20dengue%201%E2%80%933%20virus%20infections%20over%20a%20long%20time%20interval:%20Havana%20epidemic,%202001-2002&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche&amp;author=L.%20Bernardo%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B63" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">70<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="70"><li>S. B. Halstead, S. Nimmannitya, and M. R. Margiotta, “Dengue d chikungunya virus infection in man in Thailand, 1962–1964. II. Observations on disease in outpatients,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 18, no. 6, pp. 972–983, 1969. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20d%20chikungunya%20virus%20infection%20in%20man%20in%20Thailand,%201962%E2%80%931964.%20II.%20Observations%20on%20disease%20in%20outpatients&amp;author=S.%20B.%20Halstead&amp;author=S.%20Nimmannitya&amp;author=&amp;author=M.%20R.%20Margiotta&amp;publication_year=1969" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B70" class="seeRef">See in References</a>
          </div></a>]. During secondary infection with a different serotype, the presence of low levels of heterotypic neutralizing antibodies may reduce disease severity. Alternatively, in the absence of such neutralizing antibodies, heterotypic cross-reactive antibodies may form complexes with the virus and the Fc-receptors on these complexed antibodies may attach to mononuclear phagocytes, thus enhancing the efficiency of infection and thereby increasing the number of infected mononuclear phagocytes [<a class="refAnchor">71<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="71"><li>S. B. Halstead, “The pathogenesis of dengue. Molecular epidemiology in infectious disease,” <i>American Journal of Epidemiology</i>, vol. 114, no. 5, pp. 632–648, 1981. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue.%20Molecular%20epidemiology%20in%20infectious%20disease&amp;author=S.%20B.%20Halstead&amp;publication_year=1981" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B71" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">74<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="74"><li>I. Kurane, B. J. Mady, and F. A. Ennis, “Antibody-dependent enhancement of dengue virus infection,” <i>Reviews in Medical Virology</i>, vol. 1, no. 4, pp. 211–221, 1991. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Antibody-dependent%20enhancement%20of%20dengue%20virus%20infection&amp;author=I.%20Kurane&amp;author=B.%20J.%20Mady&amp;author=&amp;author=F.%20A.%20Ennis&amp;publication_year=1991" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B74" class="seeRef">See in References</a>
          </div></a>]. This phenomenon is known as antibody dependent enhancement (ADE) [<a class="refAnchor">75<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="75"><li>S. Halstead, <i>Antibody-Dependent Enhancement of Infection: a mechanism for Indirect Virus Entry into Cells. Cellular Receptors for Animal Viruses</i>, Harbor Laboraty Press, Cold Spring Harbor, NY, USA, 1994. <span class="reflinks"></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B75" class="seeRef">See in References</a>
          </div></a>]. Humans infected with one serotype maintain a life-long protective immunity to infection by the homologous virus, but protective immunity to infection with heterologous serotypes is relatively short-lived [<a class="refAnchor">76<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="76"><li>A. B. Sabin and R. Walter Schlesinger, “Production of immunity to dengue with virus modified by propagation in mice1,” <i>Science</i>, vol. 101, no. 2634, pp. 640–642, 1945. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Production%20of%20immunity%20to%20dengue%20with%20virus%20modified%20by%20propagation%20in%20mice1&amp;author=A.%20B.%20Sabin%20&amp;author=R.%20Walter%20Schlesinger&amp;publication_year=1945" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B76" class="seeRef">See in References</a>
          </div></a>]. The precise mechanism by which DENV replication is amplified in the infected cells remains unclear. One possibility is that there is a relationship between DENV-ADE infection, suppression of nitric oxide during the innate immune response, and the corresponding cytokine-expression pattern in THP-1 cells [<a class="refAnchor">77<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="77"><li>T. Chareonsirisuthigul, S. Kalayanarooj, and S. Ubol, “Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells,” <i>Journal of General Virology</i>, vol. 88, no. 2, pp. 365–375, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1099/vir.0.82537-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20(DENV)%20antibody-dependent%20enhancement%20of%20infection%20upregulates%20the%20production%20of%20anti-inflammatory%20cytokines,%20but%20suppresses%20anti-DENV%20free%20radical%20and%20pro-inflammatory%20cytokine%20production,%20in%20THP-1%20cells&amp;author=T.%20Chareonsirisuthigul&amp;author=S.%20Kalayanarooj&amp;author=&amp;author=S.%20Ubol&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B77" class="seeRef">See in References</a>
          </div></a>]. Recent evidence suggests that viral susceptibility or resistance to nitric oxide may be regulated by the viral NS5 protein [<a class="refAnchor">78<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="78"><li>S. Ubol, T. Chareonsirisuthigul, J. Kasisith, and C. Klungthong, “Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells,” <i>Virology</i>, vol. 376, no. 2, pp. 290–296, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2008.03.030" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Clinical%20isolates%20of%20dengue%20virus%20with%20distinctive%20susceptibility%20to%20nitric%20oxide%20radical%20induce%20differential%20gene%20responses%20in%20THP-1%20cells&amp;author=S.%20Ubol&amp;author=T.%20Chareonsirisuthigul&amp;author=J.%20Kasisith&amp;author=&amp;author=C.%20Klungthong&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B78" class="seeRef">See in References</a>
          </div></a>].</p><p> It has also been argued that strain differences in virulence may contribute to disease severity [<a class="refAnchor">51<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="51"><li>R. Rico-Hesse, “Microevolution and virulence of dengue viruses,” <i>Advances in Virus Research</i>, vol. 59, pp. 315–341, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0065-3527(03)59009-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Microevolution%20and%20virulence%20of%20dengue%20viruses&amp;author=R.%20Rico-Hesse&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B51" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">79<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="79"><li>R. Cologna, P. M. Armstrong, and R. Rico-Hesse, “Selection for virulent dengue viruses occurs in humans and mosquitoes,” <i>Journal of Virology</i>, vol. 79, no. 2, pp. 853–859, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.79.2.853-859.2005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Selection%20for%20virulent%20dengue%20viruses%20occurs%20in%20humans%20and%20mosquitoes&amp;author=R.%20Cologna&amp;author=P.%20M.%20Armstrong&amp;author=&amp;author=R.%20Rico-Hesse&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B79" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">84<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="84"><li>K. C. Leitmeyer, D. W. Vaughn, D. M. Watts et al., “Dengue virus structural differences that correlate with pathogenesis,” <i>Journal of Virology</i>, vol. 73, no. 6, pp. 4738–4747, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20structural%20differences%20that%20correlate%20with%20pathogenesis&amp;author=K.%20C.%20Leitmeyer&amp;author=D.%20W.%20Vaughn&amp;author=D.%20M.%20Watts%20et%20al.&amp;publication_year=1999" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B84" class="seeRef">See in References</a>
          </div></a>]. However, the fact that severe dengue disease is identified most consistently following secondary dengue infections supports the view that virulence must be defined in a two-infection context [<a class="refAnchor">39<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="39"><li>S. B. Halstead, “Dengue virus-mosquito interactions,” <i>Annual Review of Entomology</i>, vol. 53, pp. 273–291, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.ento.53.103106.093326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus-mosquito%20interactions&amp;author=S.%20B.%20Halstead&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B39" class="seeRef">See in References</a>
          </div></a>]. Host risk factors such as gender, ethnicity, the presence of chronic disease (bronchial asthma, diabetes mellitus, and sickle cell anaemia) [<a class="refAnchor">85<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="85"><li>D. González, O. E. Castro, G. Kourí et al., “Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002,” <i>International Journal of Infectious Diseases</i>, vol. 9, no. 5, pp. 280–285, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2004.07.012" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Classical%20dengue%20hemorrhagic%20fever%20resulting%20from%20two%20dengue%20infections%20spaced%2020%20years%20or%20more%20apart:%20Havana,%20Dengue%203%20epidemic,%202001-2002&amp;author=D.%20Gonz%C3%A1lez&amp;author=O.%20E.%20Castro&amp;author=G.%20Kour%C3%AD%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B85" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">87<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="87"><li>M.-S. Lee, K.-P. Hwang, T.-C. Chen, P.-L. Lu, and T.-P. Chen, “Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic,” <i>Journal of Microbiology, Immunology and Infection</i>, vol. 39, no. 2, pp. 121–129, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Clinical%20characteristics%20of%20dengue%20and%20dengue%20hemorrhagic%20fever%20in%20a%20medical%20center%20of%20southern%20Taiwan%20during%20the%202002%20epidemic&amp;author=M.-S.%20Lee&amp;author=K.-P.%20Hwang&amp;author=T.-C.%20Chen&amp;author=P.-L.%20Lu&amp;author=&amp;author=T.-P.%20Chen&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B87" class="seeRef">See in References</a>
          </div></a>] and also the genetic characteristics of the individual are also likely predisposing factors for severe illness. Human leukocyte antigen (HLA), Fc<i>γ</i>R, tumor necrosis factor- (TNF-) <i>α</i>, and dendritic cell-specific intracellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), among other genes, have been associated with the pathogenesis of dengue [<a class="refAnchor">41<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="41"><li>B. D. L. C. Sierra, G. Kourí, and M. G. Guzmán, “Race: a risk factor for dengue hemorrhagic fever,” <i>Archives of Virology</i>, vol. 152, no. 3, pp. 533–542, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-006-0869-x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Race:%20a%20risk%20factor%20for%20dengue%20hemorrhagic%20fever&amp;author=B.%20D.%20L.%20C.%20Sierra&amp;author=G.%20Kour%C3%AD&amp;author=&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B41" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">66<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="66"><li>M. G. Guzman, G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier, “Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 42, no. 2, pp. 179–184, 1990. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20in%20Cuba,%201981:%20a%20retrospective%20seroepidemiologic%20study&amp;author=M.%20G.%20Guzman&amp;author=G.%20P.%20Kouri&amp;author=J.%20Bravo&amp;author=M.%20Soler&amp;author=S.%20Vazquez&amp;author=&amp;author=L.%20Morier&amp;publication_year=1990" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B66" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">86<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="86"><li>D. Limonta, D. González, V. Capó et al., “Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic,” <i>International Journal of Infectious Diseases</i>, vol. 13, no. 2, pp. e77–e78, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2008.06.028" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Fatal%20severe%20dengue%20and%20cell%20death%20in%20sickle%20cell%20disease%20during%20the%202001-2002%20Havana%20dengue%20epidemic&amp;author=D.%20Limonta&amp;author=D.%20Gonz%C3%A1lez&amp;author=V.%20Cap%C3%B3%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B86" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">88<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="88"><li>B. Sierra, R. Alegre, A. B. Pérez et al., “HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection,” <i>Human Immunology</i>, vol. 68, no. 6, pp. 531–540, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.humimm.2007.03.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=HLA-A,%20-B,%20-C,%20and%20-DRB1%20allele%20frequencies%20in%20Cuban%20individuals%20with%20antecedents%20of%20dengue%202%20disease:%20advantages%20of%20the%20Cuban%20population%20for%20HLA%20studies%20of%20dengue%20virus%20infection&amp;author=B.%20Sierra&amp;author=R.%20Alegre&amp;author=A.%20B.%20P%C3%A9rez%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B88" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">93<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="93"><li>G. García, B. Sierra, A. B. Pérez et al., “Asymptomatic dengue infection in a cuban population confirms the protective role of the RR variant of the Fc<i>γ</i>RIIa polymorphism,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 82, no. 6, pp. 1153–1156, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.4269/ajtmh.2010.09-0353" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Asymptomatic%20dengue%20infection%20in%20a%20cuban%20population%20confirms%20the%20protective%20role%20of%20the%20RR%20variant%20of%20the%20Fc%3Ci%3E%CE%B3%3C/i%3ERIIa%20polymorphism&amp;author=G.%20Garc%C3%ADa&amp;author=B.%20Sierra&amp;author=A.%20B.%20P%C3%A9rez%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B93" class="seeRef">See in References</a>
          </div></a>]. In addition, T-cell mediated immune mechanisms, involving skewed cytokine responses resulting in plasma leakage, are also risk factors for DHF [<a class="refAnchor">62<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="62"><li>A. Mathew and A. L. Rothman, “Understanding the contribution of cellular immunity to dengue disease pathogenesis,” <i>Immunological Reviews</i>, vol. 225, no. 1, pp. 300–313, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1600-065X.2008.00678.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Understanding%20the%20contribution%20of%20cellular%20immunity%20to%20dengue%20disease%20pathogenesis&amp;author=A.%20Mathew%20&amp;author=A.%20L.%20Rothman&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B62" class="seeRef">See in References</a>
          </div></a>]. It has been proposed that an inappropriate immune response to the secondary virus infection, that in turn induces reactivation of cross-memory T cells specific for the first rather than the secondary DENV infection, results in delayed viral clearance [<a class="refAnchor">94<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="94"><li>J. Mongkolsapaya, T. Duangchinda, W. Dejnirattisai et al., “T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?” <i>Journal of Immunology</i>, vol. 176, no. 6, pp. 3821–3829, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=T%20cell%20responses%20in%20dengue%20hemorrhagic%20fever:%20are%20cross-reactive%20T%20cells%20suboptimal?&amp;author=J.%20Mongkolsapaya&amp;author=T.%20Duangchinda&amp;author=W.%20Dejnirattisai%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B94" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">95<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="95"><li>K. Clyde, J. L. Kyle, and E. Harris, “Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis,” <i>Journal of Virology</i>, vol. 80, no. 23, pp. 11418–11431, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.01257-06" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20deciphering%20viral%20and%20host%20determinants%20of%20dengue%20virus%20replication%20and%20pathogenesis&amp;author=K.%20Clyde&amp;author=J.%20L.%20Kyle&amp;author=&amp;author=E.%20Harris&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B95" class="seeRef">See in References</a>
          </div></a>]. More recently, it was suggested that the presence of an effective antiviral inflammatory response in the presence of adequate immune regulation could be associated with protection during dengue secondary infection [<a class="refAnchor">96<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="96"><li>B. Sierra, A. B. Perez, K. Vogt et al., “Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation?” <i>Cellular Immunology</i>, vol. 262, no. 2, pp. 134–140, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cellimm.2010.02.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Secondary%20heterologous%20dengue%20infection%20risk:%20disequilibrium%20between%20immune%20regulation%20and%20inflammation?&amp;author=B.%20Sierra&amp;author=A.%20B.%20Perez&amp;author=K.%20Vogt%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B96" class="seeRef">See in References</a>
          </div></a>]. However, as highlighted in a recent review on dengue pathogenesis, it is worth noting that other infectious diseases and inflammatory disorders result in elevated cytokines without the attendant increased vascular permeability seen in severe dengue [<a class="refAnchor">97<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="97"><li>J. Whitehorn and C. P. Simmons, “The pathogenesis of dengue,” <i>Vaccine</i>, vol. 29, no. 42, pp. 7221–7228, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.07.022" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue&amp;author=J.%20Whitehorn%20&amp;author=C.%20P.%20Simmons&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B97" class="seeRef">See in References</a>
          </div></a>]. Indeed, one of the major challenges in dengue, magnified due to absence of good animal models of disease, is to dissect those elements of the host immune response that are causally linked to capillary permeability from those that simply reflect the normal host immune response to a pathogen [<a class="refAnchor">97<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="97"><li>J. Whitehorn and C. P. Simmons, “The pathogenesis of dengue,” <i>Vaccine</i>, vol. 29, no. 42, pp. 7221–7228, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.07.022" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue&amp;author=J.%20Whitehorn%20&amp;author=C.%20P.%20Simmons&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B97" class="seeRef">See in References</a>
          </div></a>].</p><p>Independent of this, antibodies specific for the NS1 viral protein may form immune complexes with the NS1 protein in the circulation and on the surface of infected cells leading to complement activation [<a class="refAnchor">98<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="98"><li>P. Avirutnan, N. Punyadee, S. Noisakran et al., “Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement,” <i>Journal of Infectious Diseases</i>, vol. 193, no. 8, pp. 1078–1088, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1086/500949" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Vascular%20leakage%20in%20severe%20dengue%20virus%20infections:%20a%20potential%20role%20for%20the%20nonstructural%20viral%20protein%20NS1%20and%20complement&amp;author=P.%20Avirutnan&amp;author=N.%20Punyadee&amp;author=S.%20Noisakran%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B98" class="seeRef">See in References</a>
          </div></a>]. An additional risk factor for DHF is believed to be dependent on autoimmune responses against cross-reactive viral components. For example, antibodies specific for dengue virus NS1 protein may induce platelet lysis and/or nitric oxide-mediated apoptosis of endothelial cells, contributing to thrombocytopenia and vascular damage [<a class="refAnchor">99<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="99"><li>C.-F. Lin, S.-W. Wan, M.-C. Chen et al., “Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model,” <i>Laboratory Investigation</i>, vol. 88, no. 10, pp. 1079–1089, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1038/labinvest.2008.70" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Liver%20injury%20caused%20by%20antibodies%20against%20dengue%20virus%20nonstructural%20protein%201%20in%20a%20murine%20model&amp;author=C.-F.%20Lin&amp;author=S.-W.%20Wan&amp;author=M.-C.%20Chen%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B99" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">104<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="104"><li>A. K. I. Falconar, “The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis,” <i>Archives of Virology</i>, vol. 142, no. 5, pp. 897–916, 1997. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s007050050127" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20dengue%20virus%20nonstructural-1%20protein%20(NS1)%20generates%20antibodies%20to%20common%20epitopes%20on%20human%20blood%20clotting,%20integrin/adhesin%20proteins%20and%20binds%20to%20human%20endothelial%20cells:%20potential%20implications%20in%20haemorrhagic%20fever%20pathogenesis&amp;author=A.%20K.%20I.%20Falconar&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B104" class="seeRef">See in References</a>
          </div></a>]. </p><p>The serious complications observed during dengue infection occur as plasma viremia is resolving. This is thought to be immunologically mediated. Tam et al. performed a randomised trial to verify the effects of short-course oral corticosteroid therapy in early dengue infection. No association between treatment allocation and any of the predefined clinical, hematological, or virological endpoints was found [<a class="refAnchor">105<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="105"><li>D. T. Tam, T. V. Ngoc, N. T. Tien et al., “Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial,” <i>Clinical Infectious Diseases</i>, vol. 55, no. 9, pp. 1216–1224, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cis655" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effects%20of%20short-course%20oral%20corticosteroid%20therapy%20in%20early%20dengue%20infection%20in%20Vietnamese%20patients:%20a%20randomized,%20placebo-controlled%20trial&amp;author=D.%20T.%20Tam&amp;author=T.%20V.%20Ngoc&amp;author=N.%20T.%20Tien%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B105" class="seeRef">See in References</a>
          </div></a>]. Unexpectedly, the steroid doses administered were not immunosuppressive. Based on these observations it was suggested that rather than dengue-mediated vascular permeability being T-cell mediated, an alternative pathogenetic mechanism could involve the dengue soluble complement fixing antigen or the viral NS1 protein. Indeed, it was recently proposed that during the late stages of clinically apparent dengue infection, secreted DENV NS1 protein may bind to prothrombin and inhibit its activation, which in turn could contribute to the prolongation of activated partial thromboplastin time and haemorrhage in DHF patients [<a class="refAnchor">106<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="106"><li>S.-W. Lin, Y.-C. Chuang, Y.-S. Lin, H.-Y. Lei, H.-S. Liu, and T.-M. Yeh, “Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation,” <i>Journal of Infection</i>, vol. 64, no. 3, pp. 325–334, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jinf.2011.11.023" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20nonstructural%20protein%20NS1%20binds%20to%20prothrombin/thrombin%20and%20inhibits%20prothrombin%20activation&amp;author=S.-W.%20Lin&amp;author=Y.-C.%20Chuang&amp;author=Y.-S.%20Lin&amp;author=H.-Y.%20Lei&amp;author=H.-S.%20Liu&amp;author=&amp;author=T.-M.%20Yeh&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B106" class="seeRef">See in References</a>
          </div></a>]. Also, previous studies on the virological course of dengue infections in monkeys have shown that the peak of cellular infection occurs at the end of the viremic phase. Accordingly, it was proposed that dengue vascular permeability syndrome could be the equivalent of a viral toxicosis induced by circulating NS1 protein [<a class="refAnchor">107<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="107"><li>S. B. Halstead, “Dengue vascular permeability syndrome: what, no T cells?” <i>Clinical Infectious Diseases</i>, vol. 56, no. 6, pp. 900–901, 2013. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cis1047" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vascular%20permeability%20syndrome:%20what,%20no%20T%20cells?&amp;author=S.%20B.%20Halstead&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B107" class="seeRef">See in References</a>
          </div></a>]. </p><p>Whilst higher levels of viremia and circulating NS1 protein have been associated with dengue disease severity [<a class="refAnchor">108<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="108"><li>D. H. Libraty, P. R. Young, D. Pickering et al., “High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever,” <i>Journal of Infectious Diseases</i>, vol. 186, no. 8, pp. 1165–1168, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1086/343813" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=High%20circulating%20levels%20of%20the%20dengue%20virus%20nonstructural%20protein%20NS1%20early%20in%20dengue%20illness%20correlate%20with%20the%20development%20of%20dengue%20hemorrhagic%20fever&amp;author=D.%20H.%20Libraty&amp;author=P.%20R.%20Young&amp;author=D.%20Pickering%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B108" class="seeRef">See in References</a>
          </div></a>], collective results arising from different epidemiological settings are inconclusive, showing variations depending on the infecting serotype and patient immune status [<a class="refAnchor">109<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="109"><li>H. T. L. Duyen, T. V. Ngoc, D. T. Ha et al., “Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status,” <i>Journal of Infectious Diseases</i>, vol. 203, no. 9, pp. 1292–1300, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1093/infdis/jir014" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Kinetics%20of%20plasma%20viremia%20and%20soluble%20nonstructural%20protein%201%20concentrations%20in%20dengue:%20differential%20effects%20according%20to%20serotype%20and%20immune%20status&amp;author=H.%20T.%20L.%20Duyen&amp;author=T.%20V.%20Ngoc&amp;author=D.%20T.%20Ha%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B109" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">112<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="112"><li>A. Fox, L. N. M. Hoa, C. P. Simmons et al., “Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam,” <i>PLoS Neglected Tropical Diseases</i>, vol. 5, no. 3, article e967, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000967" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Immunological%20and%20viral%20determinants%20of%20dengue%20severity%20in%20hospitalized%20adults%20in%20Ha%20Noi,%20Viet%20Nam&amp;author=A.%20Fox&amp;author=L.%20N.%20M.%20Hoa&amp;author=C.%20P.%20Simmons%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B112" class="seeRef">See in References</a>
          </div></a>]. Therefore, the usefulness of these markers for the recognition of patients with increased risk of progression towards the more severe forms of dengue is still limited.</p><h5 id="sec2.4">2.4. Underlying Basis for the Emergence of DHF in Particular Epidemiological Settings</h5><p>Taking into account many of the factors described earlier and based on observations made during the 1981 Cuban epidemic of DF/DHF, Kouri and coworkers presented an integral hypothesis in which the association of different factors, such as immunological status, genetic background, host condition, viral strain, and epidemiological and ecological conditions, determines whether or not and to what extent, DHF will be involved in any particular epidemic [<a class="refAnchor">113<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="113"><li>G. P. Kouri, M. G. Guzmán, and J. R. Bravo, “Why dengue haemorrhagic fever in Cuba? 2. An integral analysis,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 81, no. 5, pp. 821–823, 1987. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Why%20dengue%20haemorrhagic%20fever%20in%20Cuba?%202.%20An%20integral%20analysis&amp;author=G.%20P.%20Kouri&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=&amp;author=J.%20R.%20Bravo&amp;publication_year=1987" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B113" class="seeRef">See in References</a>
          </div></a>]. Research conducted during the past 20 years strongly supports this unifying view of the situation [<a class="refAnchor">3<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="3"><li>S. B. Halstead, “Dengue,” <i>The Lancet</i>, vol. 370, no. 9599, pp. 1644–1652, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(07)61687-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue&amp;author=S.%20B.%20Halstead&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B3" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">39<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="39"><li>S. B. Halstead, “Dengue virus-mosquito interactions,” <i>Annual Review of Entomology</i>, vol. 53, pp. 273–291, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.ento.53.103106.093326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus-mosquito%20interactions&amp;author=S.%20B.%20Halstead&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B39" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">48<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="48"><li>M. G. Guzman and G. Kouri, “Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987–2007,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 102, no. 6, pp. 522–523, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.trstmh.2008.03.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20haemorrhagic%20fever%20integral%20hypothesis:%20confirming%20observations,%201987%E2%80%932007&amp;author=M.%20G.%20Guzman%20&amp;author=G.%20Kouri&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B48" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">114<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="114"><li>J. L. Kyle and E. Harris, “Global spread and persistence of dengue,” <i>Annual Review of Microbiology</i>, vol. 62, pp. 71–92, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.micro.62.081307.163005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Global%20spread%20and%20persistence%20of%20dengue&amp;author=J.%20L.%20Kyle%20&amp;author=E.%20Harris&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B114" class="seeRef">See in References</a>
          </div></a>].</p><p>With the exception of Chile, Uruguay, and Cuba, that experience occasional epidemics, resulting from introduced virus, DF is endemic in Latin America and the Caribbean region. Cuba is a relatively small island with a well-integrated medical health and research infrastructure. When combined with the epidemiological history of DF in Cuba, this situation has provided a unique opportunity to investigate the specific risk factors for severe illness in detail [<a class="refAnchor">48<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="48"><li>M. G. Guzman and G. Kouri, “Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987–2007,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 102, no. 6, pp. 522–523, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.trstmh.2008.03.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20haemorrhagic%20fever%20integral%20hypothesis:%20confirming%20observations,%201987%E2%80%932007&amp;author=M.%20G.%20Guzman%20&amp;author=G.%20Kouri&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B48" class="seeRef">See in References</a>
          </div></a>]. Firstly, it is important to realise that from the end of World War II until 1977, dengue virus was not evident in Cuba. This was supported by a national seroepidemiological survey in 1975, which identified only 2.6% of the population with DENV hemagglutination-inhibition (HI) antibodies. Importantly, most of the positives were individuals older than 45 years [<a class="refAnchor">115<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="115"><li>P. Mas Lago, “Dengue fever in Cuba in 1977: some laboratory aspects,” <i>PAHO Scientific Publication</i>, vol. 375, pp. 40–43, 1979. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20fever%20in%20Cuba%20in%201977:%20some%20laboratory%20aspects&amp;author=P.%20Mas%20Lago&amp;publication_year=1979" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B115" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">116<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="116"><li>P. Mas Lago, R. Palomera, and M. Jacobo, “Dengue: some epidemiologic aspects,” <i>Revista Cubana de Medicina Tropical</i>, vol. 22, no. 6, 1983. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue:%20some%20epidemiologic%20aspects&amp;author=P.%20Mas%20Lago&amp;author=R.%20Palomera&amp;author=&amp;author=M.%20Jacobo&amp;publication_year=1983" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B116" class="seeRef">See in References</a>
          </div></a>]. However, in 1977, based on serological evidence [<a class="refAnchor">117<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="117"><li>N. Cantelar de Francisco, A. Fernández, L. Albert Molina, and E. Pérez Balbis, “Survey of dengue in Cuba. 1978-1979,” <i>Revista Cubana de Medicina Tropical</i>, vol. 33, no. 1, pp. 72–78, 1981. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Survey%20of%20dengue%20in%20Cuba.%201978-1979&amp;author=N.%20Cantelar%20de%20Francisco&amp;author=A.%20Fern%C3%A1ndez&amp;author=L.%20Albert%20Molina&amp;author=&amp;author=E.%20P%C3%A9rez%20Balbis&amp;publication_year=1981" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B117" class="seeRef">See in References</a>
          </div></a>] it was estimated that up to 44.5% of all Cubans became infected by an introduced Asian strain of DENV-1. Nevertheless, no cases of DHF were recorded. These results demonstrate that in the absence of heterologous immunity, primary DENV-1 infections did not result in cases of DHF and, bearing in mind that subsequent DHF epidemics in Cuba all involved secondary infections (see later), the results strongly support the contention that secondary infections by heterologous serotypes are a very important risk factor for DHF as proposed previously [<a class="refAnchor">118<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="118"><li>S. B. Halstead, S. Nimmannitya, and S. N. Cohen, “Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered,” <i>Yale Journal of Biology and Medicine</i>, vol. 42, no. 5, pp. 311–328, 1970. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Observations%20related%20to%20pathogenesis%20of%20dengue%20hemorrhagic%20fever.%20IV.%20Relation%20of%20disease%20severity%20to%20antibody%20response%20and%20virus%20recovered&amp;author=S.%20B.%20Halstead&amp;author=S.%20Nimmannitya&amp;author=&amp;author=S.%20N.%20Cohen&amp;publication_year=1970" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B118" class="seeRef">See in References</a>
          </div></a>].</p><p>During the past 28 years, three DENV-epidemics involving DHF have occurred in Cuba. The first epidemic started in 1981 [<a class="refAnchor">113<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="113"><li>G. P. Kouri, M. G. Guzmán, and J. R. Bravo, “Why dengue haemorrhagic fever in Cuba? 2. An integral analysis,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 81, no. 5, pp. 821–823, 1987. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Why%20dengue%20haemorrhagic%20fever%20in%20Cuba?%202.%20An%20integral%20analysis&amp;author=G.%20P.%20Kouri&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=&amp;author=J.%20R.%20Bravo&amp;publication_year=1987" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B113" class="seeRef">See in References</a>
          </div></a>], the second was seen in 1997 [<a class="refAnchor">65<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="65"><li>M. G. Guzman, M. Alvarez, R. Rodriguez et al., “Fatal dengue hemorrhagic fever in Cuba,” <i>International Journal of Infectious Diseases</i>, vol. 3, no. 3, pp. 130–135, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Fatal%20dengue%20hemorrhagic%20fever%20in%20Cuba&amp;author=M.%20G.%20Guzman&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez%20et%20al.&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B65" class="seeRef">See in References</a>
          </div></a>], and the third occurred in 2001 [<a class="refAnchor">63<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="63"><li>M. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1–3 virus infections over a long time interval: Havana epidemic, 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1113–1117, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20caused%20by%20sequential%20dengue%201%E2%80%933%20virus%20infections%20over%20a%20long%20time%20interval:%20Havana%20epidemic,%202001-2002&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche&amp;author=L.%20Bernardo%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B63" class="seeRef">See in References</a>
          </div></a>]. During each epidemic, secondary infection was demonstrated as the most important host risk factor for DHF. Additionally, specific sequential virus serotypes were associated with severe disease, independent of the time-gap between the primary and secondary infection. For example, in Cuba, two epidemics of DHF have been associated with primary infections due to an Asian strain of DENV-1 and secondary infections due to DENV-2 (i.e., DENV-1/DENV-2) [<a class="refAnchor">119<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="119"><li>M. G. Guzmán, G. Kouri, J. Bravo, M. Soler, and E. Martínez, “Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic,” <i>Memorias do Instituto Oswaldo Cruz</i>, vol. 86, no. 3, p. 367, 1991. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Sequential%20infection%20as%20risk%20factor%20for%20dengue%20hemorrhagic%20fever/dengue%20shock%20syndrome%20(DHF/DSS)%20during%20the%201981%20dengue%20hemorrhagic%20Cuban%20epidemic&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri&amp;author=J.%20Bravo&amp;author=M.%20Soler&amp;author=&amp;author=E.%20Mart%C3%ADnez&amp;publication_year=1991" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B119" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">120<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="120"><li>G. Kourí, M. G. Guzmán, L. Valdés et al., “Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba,” <i>Emerging Infectious Diseases</i>, vol. 4, no. 1, pp. 89–92, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Reemergence%20of%20dengue%20in%20Cuba:%20a%201997%20epidemic%20in%20Santiago%20de%20Cuba&amp;author=G.%20Kour%C3%AD&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=L.%20Vald%C3%A9s%20et%20al.&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B120" class="seeRef">See in References</a>
          </div></a>]. Significantly, during the 1997 Cuban epidemic, it was demonstrated for the first time that there was a higher risk of DHF in DENV-1/DENV-2 individuals when the average time gap between primary and secondary infections was about 20 years as opposed to 4 years, a more commonly reported timespan [<a class="refAnchor">64<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="64"><li>M. G. Guzmán, G. Kouri, L. Valdes et al., “Epidemiologic studies on dengue in Santiago de Cuba, 1997,” <i>American Journal of Epidemiology</i>, vol. 152, no. 9, pp. 793–799, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1093/aje/152.9.793" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemiologic%20studies%20on%20dengue%20in%20Santiago%20de%20Cuba,%201997&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri&amp;author=L.%20Valdes%20et%20al.&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B64" class="seeRef">See in References</a>
          </div></a>]. Moreover, comparison of attack rates and case fatality rates, in the same age groups, revealed that during the 1997 epidemic the rate in patients older than 15 years of age was 40 times higher than during the 1981 epidemic [<a class="refAnchor">121<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="121"><li>M. G. Guzmán, G. Kourí, L. Valdés, J. Bravo, S. Vázquez, and S. B. Halstead, “Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks,” <i>Revista Panamericana de Salud Publica</i>, vol. 11, no. 4, pp. 223–227, 2002. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Enhanced%20severity%20of%20secondary%20dengue-2%20infections:%20death%20rates%20in%201981%20and%201997%20Cuban%20outbreaks&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kour%C3%AD&amp;author=L.%20Vald%C3%A9s&amp;author=J.%20Bravo&amp;author=S.%20V%C3%A1zquez&amp;author=&amp;author=S.%20B.%20Halstead&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B121" class="seeRef">See in References</a>
          </div></a>]. </p><p>Subsequently, another Cuban epidemic, caused by DENV-3 and involving cases of DHF, occurred in 2001. Thus, DHF occurred in DENV-3-infected Cubans 24 years after primary exposure to DENV-1 infection [<a class="refAnchor">122<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="122"><li>O. Peláez, M. G. Guzmán, G. Kouri et al., “Dengue 3 epidemic, Havana, 2001,” <i>Emerging Infectious Diseases</i>, vol. 10, no. 4, pp. 719–722, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1004.030271" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%203%20epidemic,%20Havana,%202001&amp;author=O.%20Pel%C3%A1ez&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri%20et%20al.&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B122" class="seeRef">See in References</a>
          </div></a>]. Interestingly, Cubans infected sequentially with DENV-1/DENV-3 were associated with severe disease whilst those infected sequentially with DENV-2/DENV-3 were associated with milder disease or asymptomatic infections [<a class="refAnchor">63<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="63"><li>M. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1–3 virus infections over a long time interval: Havana epidemic, 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1113–1117, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20caused%20by%20sequential%20dengue%201%E2%80%933%20virus%20infections%20over%20a%20long%20time%20interval:%20Havana%20epidemic,%202001-2002&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche&amp;author=L.%20Bernardo%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B63" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">123<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="123"><li>M. Álvarez, A. Pavón-Oro, S. Vázquez, L. Morier, Á. M. Álvarez, and M. G. Guzmán, “Viral infection sequences related to dengue fever in dengue 3 epidemics occurred in the City of Havana, 2001-2002,” <i>Revista Cubana de Medicina Tropical</i>, vol. 60, no. 1, pp. 18–23, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Viral%20infection%20sequences%20related%20to%20dengue%20fever%20in%20dengue%203%20epidemics%20occurred%20in%20the%20City%20of%20Havana,%202001-2002&amp;author=M.%20%C3%81lvarez&amp;author=A.%20Pav%C3%B3n-Oro&amp;author=S.%20V%C3%A1zquez&amp;author=L.%20Morier&amp;author=%C3%81.%20M.%20%C3%81lvarez&amp;author=&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B123" class="seeRef">See in References</a>
          </div></a>]. Additionally, the DENV-3 immune individuals, infected during the 2001 Cuban epidemic, revealed differences in the neutralization capability of their sera to different DENV-3 strains belonging to different genotypes [<a class="refAnchor">124<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="124"><li>M. Alvarez, A. Pavon-Oro, R. Rodriguez-Roche et al., “Neutralizing antibody response variation against dengue 3 strains,” <i>Journal of Medical Virology</i>, vol. 80, no. 10, pp. 1783–1789, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1002/jmv.21234" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibody%20response%20variation%20against%20dengue%203%20strains&amp;author=M.%20Alvarez&amp;author=A.%20Pavon-Oro&amp;author=R.%20Rodriguez-Roche%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B124" class="seeRef">See in References</a>
          </div></a>]. This observation might be anticipated taking into account that differences in neutralisation capability have been found using different genotypes of DENV-2. However, it was highly significant to find differences in neutralisation against strains belonging to the same genotype [<a class="refAnchor">125<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="125"><li>R. Rodriguez-Roche, M. Alvarez, E. C. Holmes et al., “Dengue virus type 3, Cuba, 2000–2002,” <i>Emerging Infectious Diseases</i>, vol. 11, no. 5, pp. 773–774, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%203,%20Cuba,%202000%E2%80%932002&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=E.%20C.%20Holmes%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B125" class="seeRef">See in References</a>
          </div></a>]. Moreover, the strains involved in the Cuban 1981, 1997, and 2001 epidemics [<a class="refAnchor">80<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="80"><li>M. G. Guzman, V. Deubel, J. L. Pelegrino et al., “Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 52, no. 3, pp. 241–246, 1995. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Partial%20nucleotide%20and%20amino%20acid%20sequences%20of%20the%20envelope%20and%20the%20envelope/nonstructural%20protein-1%20gene%20junction%20of%20four%20dengue-2%20virus%20strains%20isolated%20during%20the%201981%20Cuban%20epidemic&amp;author=M.%20G.%20Guzman&amp;author=V.%20Deubel&amp;author=J.%20L.%20Pelegrino%20et%20al.&amp;publication_year=1995" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B80" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">125<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="125"><li>R. Rodriguez-Roche, M. Alvarez, E. C. Holmes et al., “Dengue virus type 3, Cuba, 2000–2002,” <i>Emerging Infectious Diseases</i>, vol. 11, no. 5, pp. 773–774, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%203,%20Cuba,%202000%E2%80%932002&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=E.%20C.%20Holmes%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B125" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">126<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="126"><li>R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic,” <i>Archives of Virology</i>, vol. 150, no. 3, pp. 415–425, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-004-0445-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%202%20in%20Cuba,%201997:%20conservation%20of%20E%20gene%20sequence%20in%20isolates%20obtained%20at%20different%20times%20during%20the%20epidemic&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=T.%20Gritsun%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B126" class="seeRef">See in References</a>
          </div></a>] had previously been associated with severe epidemics and therefore had the potential to produce DHF. Nevertheless, in all of these epidemics, an extremely high number of primarily infected individuals were asymptomatic [<a class="refAnchor">64<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="64"><li>M. G. Guzmán, G. Kouri, L. Valdes et al., “Epidemiologic studies on dengue in Santiago de Cuba, 1997,” <i>American Journal of Epidemiology</i>, vol. 152, no. 9, pp. 793–799, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1093/aje/152.9.793" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemiologic%20studies%20on%20dengue%20in%20Santiago%20de%20Cuba,%201997&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri&amp;author=L.%20Valdes%20et%20al.&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B64" class="seeRef">See in References</a>
          </div></a>]. </p><p>Using human volunteers, Dr. Albert Sabin was the first scientist to demonstrate that heterotypic immunity can prevent disease induced by a different dengue virus serotype [<a class="refAnchor">127<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="127"><li>A. B. Sabin, “Research on dengue during World War II,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 1, no. 1, pp. 30–50, 1952. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Research%20on%20dengue%20during%20World%20War%20II&amp;author=A.%20B.%20Sabin&amp;publication_year=1952" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B127" class="seeRef">See in References</a>
          </div></a>]. Whilst DENV-1 immunity did not appear to prevent DENV-2 infections, partial immunity may have downregulated infections, thus reducing severity to mild disease during secondary dengue infections. It has been postulated that if virological factors are involved in determining disease severity, they may reflect common antigenic determinants shared between the first and second infecting viruses [<a class="refAnchor">39<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="39"><li>S. B. Halstead, “Dengue virus-mosquito interactions,” <i>Annual Review of Entomology</i>, vol. 53, pp. 273–291, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.ento.53.103106.093326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus-mosquito%20interactions&amp;author=S.%20B.%20Halstead&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B39" class="seeRef">See in References</a>
          </div></a>]. An exceptional illustration of this phenomenon is the neutralization of American genotype DENV-2 by human antibodies to DENV-1 [<a class="refAnchor">81<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="81"><li>T. J. Kochel, D. M. Watts, S. B. Halstead et al., “Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever,” <i>The Lancet</i>, vol. 360, no. 9329, pp. 310–312, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(02)09522-3" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20dengue-1%20antibodies%20on%20American%20dengue-2%20viral%20infection%20and%20dengue%20haemorrhagic%20fever&amp;author=T.%20J.%20Kochel&amp;author=D.%20M.%20Watts&amp;author=S.%20B.%20Halstead%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B81" class="seeRef">See in References</a>
          </div></a>]. These results suggest that the apparent lower virulence of American genotype DENV-2 results from a DENV-1 like surface epitope on the DENV-2 that permits partial neutralization (and downregulation of disease) by DENV-1 antibodies [<a class="refAnchor">81<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="81"><li>T. J. Kochel, D. M. Watts, S. B. Halstead et al., “Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever,” <i>The Lancet</i>, vol. 360, no. 9329, pp. 310–312, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(02)09522-3" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20dengue-1%20antibodies%20on%20American%20dengue-2%20viral%20infection%20and%20dengue%20haemorrhagic%20fever&amp;author=T.%20J.%20Kochel&amp;author=D.%20M.%20Watts&amp;author=S.%20B.%20Halstead%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B81" class="seeRef">See in References</a>
          </div></a>]. In contrast, Asian genotypes DENV-2 are poorly neutralised by human antibodies to DENV-1 [<a class="refAnchor">128<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="128"><li>M. G. Guzman, M. Alvarez, R. Rodriguez-Roche et al., “Neutralizing antibodies after infection with dengue 1 virus,” <i>Emerging Infectious Diseases</i>, vol. 13, no. 2, pp. 282–286, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibodies%20after%20infection%20with%20dengue%201%20virus&amp;author=M.%20G.%20Guzman&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B128" class="seeRef">See in References</a>
          </div></a>]. Furthermore, a significant increase in the mean titre of homologous DENV-1 neutralizing antibodies and a significant decrease in heterologous antibodies to DENV-2 American genotype were reported in a long-term study in Cuba [<a class="refAnchor">128<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="128"><li>M. G. Guzman, M. Alvarez, R. Rodriguez-Roche et al., “Neutralizing antibodies after infection with dengue 1 virus,” <i>Emerging Infectious Diseases</i>, vol. 13, no. 2, pp. 282–286, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibodies%20after%20infection%20with%20dengue%201%20virus&amp;author=M.%20G.%20Guzman&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B128" class="seeRef">See in References</a>
          </div></a>]. This finding may reflect time-dependent changes in severity of disease observed following secondary dengue infection.</p><p>On the other hand, case fatality rates were observed to increase month by month during epidemics that were studied in Cuba. Taking into account that DENV-2 epidemics occurred in 1981 and 1997, Guzmán and coworkers proposed a neutralisation escape mutant hypothesis based on the association of severe disease with dengue secondary infection [<a class="refAnchor">129<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="129"><li>M. G. Guzmán, G. Kourí, and S. B. Halstead, “Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?” <i>The Lancet</i>, vol. 355, no. 9218, pp. 1902–1903, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Do%20escape%20mutants%20explain%20rapid%20increases%20in%20dengue%20case-fatality%20rates%20within%20epidemics?&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kour%C3%AD&amp;author=&amp;author=S.%20B.%20Halstead&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B129" class="seeRef">See in References</a>
          </div></a>]. Furthermore, during the DENV-3 epidemic that occurred in Havana in 2001, the same sequential increase in case fatality rates was observed [<a class="refAnchor">48<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="48"><li>M. G. Guzman and G. Kouri, “Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987–2007,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 102, no. 6, pp. 522–523, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.trstmh.2008.03.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20haemorrhagic%20fever%20integral%20hypothesis:%20confirming%20observations,%201987%E2%80%932007&amp;author=M.%20G.%20Guzman%20&amp;author=G.%20Kouri&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B48" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">85<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="85"><li>D. González, O. E. Castro, G. Kourí et al., “Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002,” <i>International Journal of Infectious Diseases</i>, vol. 9, no. 5, pp. 280–285, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2004.07.012" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Classical%20dengue%20hemorrhagic%20fever%20resulting%20from%20two%20dengue%20infections%20spaced%2020%20years%20or%20more%20apart:%20Havana,%20Dengue%203%20epidemic,%202001-2002&amp;author=D.%20Gonz%C3%A1lez&amp;author=O.%20E.%20Castro&amp;author=G.%20Kour%C3%AD%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B85" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">122<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="122"><li>O. Peláez, M. G. Guzmán, G. Kouri et al., “Dengue 3 epidemic, Havana, 2001,” <i>Emerging Infectious Diseases</i>, vol. 10, no. 4, pp. 719–722, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1004.030271" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%203%20epidemic,%20Havana,%202001&amp;author=O.%20Pel%C3%A1ez&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri%20et%20al.&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B122" class="seeRef">See in References</a>
          </div></a>].</p><p> Although specific viral factors alone probably do not determine the severity of dengue infection in individual cases, the demonstrated increasing severity of infection with time during a single epidemic strongly argues that significant changes occur in the virus causing the epidemic. Indeed, host factors do not appear to explain this observation of increasing severity with time, because it is not logical to assume that the most susceptible individuals would all be infected towards the end of the epidemic. </p><p> The 1997 Cuban epidemic was the most severe reported in Cuba to date. Nevertheless, a search for evidence of the appearance of neutralisation-escape mutants proved negative. The structural gene sequences were highly conserved in viruses isolated at different times during the epidemic [<a class="refAnchor">126<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="126"><li>R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic,” <i>Archives of Virology</i>, vol. 150, no. 3, pp. 415–425, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-004-0445-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%202%20in%20Cuba,%201997:%20conservation%20of%20E%20gene%20sequence%20in%20isolates%20obtained%20at%20different%20times%20during%20the%20epidemic&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=T.%20Gritsun%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B126" class="seeRef">See in References</a>
          </div></a>]. However, nucleotide substitutions were found in the nonstructural genes and in general they correlated with the time of sampling, showing a clear pattern of virus evolution during the epidemic [<a class="refAnchor">130<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="130"><li>R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Virus evolution during a severe dengue epidemic in Cuba, 1997,” <i>Virology</i>, vol. 334, no. 2, pp. 154–159, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2005.01.037" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Virus%20evolution%20during%20a%20severe%20dengue%20epidemic%20in%20Cuba,%201997&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=T.%20Gritsun%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B130" class="seeRef">See in References</a>
          </div></a>]. Therefore, at least in this study, antibody-driven selection of escape mutants in the structural genes was not the key selective force. On the other hand, cytotoxic T-lymphocytes (CTLs) play a crucial role in controlling infection in RNA viruses, including dengue viruses [<a class="refAnchor">62<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="62"><li>A. Mathew and A. L. Rothman, “Understanding the contribution of cellular immunity to dengue disease pathogenesis,” <i>Immunological Reviews</i>, vol. 225, no. 1, pp. 300–313, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1600-065X.2008.00678.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Understanding%20the%20contribution%20of%20cellular%20immunity%20to%20dengue%20disease%20pathogenesis&amp;author=A.%20Mathew%20&amp;author=A.%20L.%20Rothman&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B62" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">131<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="131"><li>J. Mongkolsapaya, W. Dejnirattisai, X.-N. Xu et al., “Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever,” <i>Nature Medicine</i>, vol. 9, no. 7, pp. 921–927, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nm887" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Original%20antigenic%20sin%20and%20apoptosis%20in%20the%20pathogenesis%20of%20dengue%20hemorrhagic%20fever&amp;author=J.%20Mongkolsapaya&amp;author=W.%20Dejnirattisai&amp;author=X.-N.%20Xu%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B131" class="seeRef">See in References</a>
          </div></a>]. Variation in the epitopes recognized by CTL is common and frequently offers potential escape routes for mutant virus. Forthcoming studies will assess whether or not the reported mutations in NS1 and NS5 proteins [<a class="refAnchor">130<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="130"><li>R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Virus evolution during a severe dengue epidemic in Cuba, 1997,” <i>Virology</i>, vol. 334, no. 2, pp. 154–159, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2005.01.037" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Virus%20evolution%20during%20a%20severe%20dengue%20epidemic%20in%20Cuba,%201997&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=T.%20Gritsun%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B130" class="seeRef">See in References</a>
          </div></a>] are represented in antibody inducing or CTL epitopes.</p><p>Regardless of which mechanism, that is, natural selection or genetic drift, is operating, it is likely that a fitter virus could be selected during the period of high transmission in individuals that have experienced secondary infections. However, it is a very difficult task to study dengue epidemiology because it is not only endemic in most tropical countries but there are four serotypes and many different genotypes often cocirculating. Nevertheless, Cuba represents a unique epidemiological setting for this kind of research because epidemics caused by only one serotype have occurred providing the opportunity for carefully defined epidemiological studies. </p><p>Mutations in the nonstructural genes of DENV-2, isolated during the Santiago de Cuba epidemic, may correlate with increased efficiency of virus replication. Variation in nonstructural proteins has been also associated with increasing severity in epidemiological settings corresponding to endemic/epidemic transmission [<a class="refAnchor">132<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="132"><li>S. N. Bennett, E. C. Holmes, M. Chirivella et al., “Selection-driven evolution of emergent dengue virus,” <i>Molecular Biology and Evolution</i>, vol. 20, no. 10, pp. 1650–1658, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1093/molbev/msg182" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Selection-driven%20evolution%20of%20emergent%20dengue%20virus&amp;author=S.%20N.%20Bennett&amp;author=E.%20C.%20Holmes&amp;author=M.%20Chirivella%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B132" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">136<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="136"><li>R. Zhao, P. Chinnawirotpisan, C. Klungthong, C. Zhang, and R. Putnak, “Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001,” <i>Virus Genes</i>, vol. 41, no. 1, pp. 5–13, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s11262-010-0473-8" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Evidence%20for%20inter-%20and%20intra-genotypic%20variations%20in%20dengue%20serotype%204%20viruses%20representing%20predominant%20and%20non-predominant%20genotypes%20co-circulating%20in%20Thailand%20from%201977%20to%202001&amp;author=R.%20Zhao&amp;author=P.%20Chinnawirotpisan&amp;author=C.%20Klungthong&amp;author=C.%20Zhang&amp;author=&amp;author=R.%20Putnak&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B136" class="seeRef">See in References</a>
          </div></a>]. However, the specific relevance of these types of mutation has not yet been investigated thoroughly. This is in large part due to the lack of suitable animal models with which to study dengue virus “virulence” [<a class="refAnchor">51<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="51"><li>R. Rico-Hesse, “Microevolution and virulence of dengue viruses,” <i>Advances in Virus Research</i>, vol. 59, pp. 315–341, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0065-3527(03)59009-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Microevolution%20and%20virulence%20of%20dengue%20viruses&amp;author=R.%20Rico-Hesse&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B51" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">137<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="137"><li>R. Rico-Hesse, “Dengue virus evolution and virulence models,” <i>Clinical Infectious Diseases</i>, vol. 44, no. 11, pp. 1462–1466, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1086/517587" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20evolution%20and%20virulence%20models&amp;author=R.%20Rico-Hesse&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B137" class="seeRef">See in References</a>
          </div></a>]. </p><p>During the most recent and severe DENV-4 epidemic in Puerto Rico in 1998, viruses were distinguished by three amino acid replacements in the NS2A protein (I14V, V54T, and P101T), which were fixed more rapidly than would have been expected by drift alone. This study demonstrates the significance of viral genetic turnover within a focal population and the potential importance of adaptive evolution during viral epidemic expansion [<a class="refAnchor">132<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="132"><li>S. N. Bennett, E. C. Holmes, M. Chirivella et al., “Selection-driven evolution of emergent dengue virus,” <i>Molecular Biology and Evolution</i>, vol. 20, no. 10, pp. 1650–1658, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1093/molbev/msg182" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Selection-driven%20evolution%20of%20emergent%20dengue%20virus&amp;author=S.%20N.%20Bennett&amp;author=E.%20C.%20Holmes&amp;author=M.%20Chirivella%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B132" class="seeRef">See in References</a>
          </div></a>]. In contrast, a retrospective phylogenetic study of events on the Southern Pacific islands three decades ago, where severe dengue was described in patients infected with the DENV-2 American genotype, recorded attenuation of this virus following a series of outbreaks involving nonsynonymous mutations, also in the NS2A gene [<a class="refAnchor">138<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="138"><li>A. Steel, D. J. Gubler, and S. N. Bennett, “Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago,” <i>Virology</i>, vol. 405, no. 2, pp. 505–512, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2010.05.033" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Natural%20attenuation%20of%20dengue%20virus%20type-2%20after%20a%20series%20of%20island%20outbreaks:%20a%20retrospective%20phylogenetic%20study%20of%20events%20in%20the%20South%20Pacific%20three%20decades%20ago&amp;author=A.%20Steel&amp;author=D.%20J.%20Gubler&amp;author=&amp;author=S.%20N.%20Bennett&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B138" class="seeRef">See in References</a>
          </div></a>]. </p><p>Similarly, study of the population structure of dengue viruses transmitted in Aragua, Venezuela, during the period 2006-2007, under hyperendemic conditions also suggested that the nonstructural proteins could play an important role in DENV evolution. According to this particular epidemiological setting, changes in NS1, NS2A, and NS4B proteins were either favourable or adverse in terms of viral fitness. The authors argued that specific mutations could be associated with severe disease but some could be associated with mild disease due to the appearance of naturally attenuated strains [<a class="refAnchor">139<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="139"><li>R. Rodriguez-Roche, E. Villegas, S. Cook et al., “Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission,” <i>Infection, Genetics and Evolution</i>, vol. 12, no. 2, pp. 332–344, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.meegid.2011.12.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Population%20structure%20of%20the%20dengue%20viruses,%20Aragua,%20Venezuela,%202006-2007.%20Insights%20into%20dengue%20evolution%20under%20hyperendemic%20transmission&amp;author=R.%20Rodriguez-Roche&amp;author=E.%20Villegas&amp;author=S.%20Cook%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B139" class="seeRef">See in References</a>
          </div></a>]. </p><p>The flavivirus NS2A protein is a small, hydrophobic, multifunctional membrane-associated protein involved in RNA replication [<a class="refAnchor">140<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="140"><li>T. J. Chambers, D. W. McCourt, and C. M. Rice, “Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis,” <i>Virology</i>, vol. 169, no. 1, pp. 100–109, 1989. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Yellow%20fever%20virus%20proteins%20NS2A,%20NS2B,%20and%20NS4B:%20identification%20and%20partial%20N-terminal%20amino%20acid%20sequence%20analysis&amp;author=T.%20J.%20Chambers&amp;author=D.%20W.%20McCourt&amp;author=&amp;author=C.%20M.%20Rice&amp;publication_year=1989" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B140" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">141<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="141"><li>J. M. MacKenzie, A. A. Khromykh, M. K. Jones, and E. G. Westaway, “Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A,” <i>Virology</i>, vol. 245, no. 2, pp. 203–215, 1998. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.1998.9156" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Subcellular%20localization%20and%20some%20biochemical%20properties%20of%20the%20flavivirus%20Kunjin%20nonstructural%20proteins%20NS2A%20and%20NS4A&amp;author=J.%20M.%20MacKenzie&amp;author=A.%20A.%20Khromykh&amp;author=M.%20K.%20Jones&amp;author=&amp;author=E.%20G.%20Westaway&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B141" class="seeRef">See in References</a>
          </div></a>], host-antiviral interferon response [<a class="refAnchor">142<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="142"><li>J. L. Wen, B. C. Hua, J. W. Xiang, H. Huang, and A. A. Khromykh, “Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription,” <i>Journal of Virology</i>, vol. 78, no. 22, pp. 12225–12235, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.78.22.12225-12235.2004" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Analysis%20of%20adaptive%20mutations%20in%20Kunjin%20virus%20replicon%20RNA%20reveals%20a%20novel%20role%20for%20the%20flavivirus%20nonstructural%20protein%20NS2A%20in%20inhibition%20of%20beta%20interferon%20promoter-driven%20transcription&amp;author=J.%20L.%20Wen&amp;author=B.%20C.%20Hua&amp;author=J.%20W.%20Xiang&amp;author=H.%20Huang&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B142" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">145<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="145"><li>W. J. Liu, X. J. Wang, V. V. Mokhonov, P.-Y. Shi, R. Randall, and A. A. Khromykh, “Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins,” <i>Journal of Virology</i>, vol. 79, no. 3, pp. 1934–1942, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.79.3.1934-1942.2005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20interferon%20signaling%20by%20the%20New%20York%2099%20strain%20and%20Kunjin%20subtype%20of%20West%20Nile%20virus%20involves%20blockage%20of%20STAT1%20and%20STAT2%20activation%20by%20nonstructural%20proteins&amp;author=W.%20J.%20Liu&amp;author=X.%20J.%20Wang&amp;author=V.%20V.%20Mokhonov&amp;author=P.-Y.%20Shi&amp;author=R.%20Randall&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B145" class="seeRef">See in References</a>
          </div></a>], and assembly/secretion of virus particles [<a class="refAnchor">146<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="146"><li>B. M. Kümmerer and C. M. Rice, “Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles,” <i>Journal of Virology</i>, vol. 76, no. 10, pp. 4773–4784, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.76.10.4773-4784.2002" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mutations%20in%20the%20yellow%20fever%20virus%20nonstructural%20protein%20NS2A%20selectively%20block%20production%20of%20infectious%20particles&amp;author=B.%20M.%20K%C3%BCmmerer%20&amp;author=C.%20M.%20Rice&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B146" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">148<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="148"><li>J. Y. Leung, G. P. Pijlman, N. Kondratieva, J. Hyde, J. M. Mackenzie, and A. A. Khromykh, “Role of nonstructural protein NS2A in flavivirus assembly,” <i>Journal of Virology</i>, vol. 82, no. 10, pp. 4731–4741, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.00002-08" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Role%20of%20nonstructural%20protein%20NS2A%20in%20flavivirus%20assembly&amp;author=J.%20Y.%20Leung&amp;author=G.%20P.%20Pijlman&amp;author=N.%20Kondratieva&amp;author=J.%20Hyde&amp;author=J.%20M.%20Mackenzie&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B148" class="seeRef">See in References</a>
          </div></a>]. In addition, the NS2A and the NS4B proteins may participate in the modulation of vector competence [<a class="refAnchor">149<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="149"><li>K. L. McElroy, K. A. Tsetsarkin, D. L. Vanlandingham, and S. Higgs, “Manipulation of the yellow fever virus non-structural genes 2A and 4B and the <math id="M1" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math> non-coding region to evaluate genetic determinants of viral dissemination from the <i>Aedes aegypti</i> midgut,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1158–1164, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Manipulation%20of%20the%20yellow%20fever%20virus%20non-structural%20genes%202A%20and%204B%20and%20the%20%3Cinline-formula%3E%3Cmml:math%20id=" m1"%20xmlns:mml="http://www.w3.org/1998/Math/MathML" target="_blank"><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow>%20non-coding%20region%20to%20evaluate%20genetic%20determinants%20of%20viral%20dissemination%20from%20the%20<i>Aedes%20aegypti</i>%20midgut&amp;author=K. L. McElroy&amp;author=K. A. Tsetsarkin&amp;author=D. L. Vanlandingham&amp;author=&amp;author=S. Higgs&amp;publication_year=2006" target="_blank"&gt;Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B149" class="seeRef">See in References</a>
          </div></a>]. According to previous reports, changes in NS1 and NS4 proteins could be involved in viral attenuation [<a class="refAnchor">150<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="150"><li>K. A. Hanley, L. R. Manlucu, L. E. Gilmore et al., “A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4,” <i>Virology</i>, vol. 312, no. 1, pp. 222–232, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0042-6822(03)00197-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20trade-off%20in%20replication%20in%20mosquito%20versus%20mammalian%20systems%20conferred%20by%20a%20point%20mutation%20in%20the%20NS4B%20protein%20of%20dengue%20virus%20type%204&amp;author=K.%20A.%20Hanley&amp;author=L.%20R.%20Manlucu&amp;author=L.%20E.%20Gilmore%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B150" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">151<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="151"><li>E. P. Kelly, B. Puri, W. Sun, and B. Falgout, “Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate,” <i>Vaccine</i>, vol. 28, no. 17, pp. 3030–3037, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2009.10.084" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Identification%20of%20mutations%20in%20a%20candidate%20dengue%204%20vaccine%20strain%20341750%20PDK20%20and%20construction%20of%20a%20full-length%20cDNA%20clone%20of%20the%20PDK20%20vaccine%20candidate&amp;author=E.%20P.%20Kelly&amp;author=B.%20Puri&amp;author=W.%20Sun&amp;author=&amp;author=B.%20Falgout&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B151" class="seeRef">See in References</a>
          </div></a>]. On the contrary, recent studies have demonstrated that mutations in the NS4B protein may increase the efficiency of DENV replication. In addition, it has been suggested that mutations in this protein may also be involved in species tropism of DENV and may even modulate the balance of efficient replication in mosquito and mammalian cells [<a class="refAnchor">152<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="152"><li>S. Tajima, T. Takasaki, and I. Kurane, “Restoration of replication-defective dengue type 1 virus bearing mutations in the N-terminal cytoplasmic portion of NS4A by additional mutations in NS4B,” <i>Archives of Virology</i>, vol. 156, no. 1, pp. 63–69, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-010-0816-8" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Restoration%20of%20replication-defective%20dengue%20type%201%20virus%20bearing%20mutations%20in%20the%20N-terminal%20cytoplasmic%20portion%20of%20NS4A%20by%20additional%20mutations%20in%20NS4B&amp;author=S.%20Tajima&amp;author=T.%20Takasaki&amp;author=&amp;author=I.%20Kurane&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B152" class="seeRef">See in References</a>
          </div></a>]. Moreover, it has been shown that a single amino acid in the nonstructural NS4B protein namely, L52F, confers virulence on DENV-2 in AG129 mice through enhancement of viral RNA synthesis [<a class="refAnchor">153<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="153"><li>D. Grant, G. K. Tan, M. Qing et al., “A single amino acid in nonstructural protein NS4B Confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis,” <i>Journal of Virology</i>, vol. 85, no. 15, pp. 7775–7787, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.00665-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20single%20amino%20acid%20in%20nonstructural%20protein%20NS4B%20Confers%20virulence%20to%20dengue%20virus%20in%20AG129%20mice%20through%20enhancement%20of%20viral%20RNA%20synthesis&amp;author=D.%20Grant&amp;author=G.%20K.%20Tan&amp;author=M.%20Qing%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B153" class="seeRef">See in References</a>
          </div></a>]. </p><p>Whilst these results suggest a possible role for the NS genes in determining viral fitness, the importance of the structural genes should not be overlooked. The sequences compared in the cited studies represent a consensus of those observed within each patient and may not necessarily represent the dominant variant present in the original clinical sample. For example, virus isolation using mosquito cell lines [<a class="refAnchor">154<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="154"><li>R. R. Roche, M. Alvarez, M. G. Guzman, L. Morier, and G. Kouri, “Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells,” <i>Journal of Clinical Microbiology</i>, vol. 38, no. 9, pp. 3508–3510, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Comparison%20of%20rapid%20centrifugation%20assay%20with%20conventional%20tissue%20culture%20method%20for%20isolation%20of%20dengue%202%20virus%20in%20C6/36-HT%20cells&amp;author=R.%20R.%20Roche&amp;author=M.%20Alvarez&amp;author=M.%20G.%20Guzman&amp;author=L.%20Morier&amp;author=&amp;author=G.%20Kouri&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B154" class="seeRef">See in References</a>
          </div></a>] is known to perturb the distribution of variants in the original clinical sample. This is particularly important given that studies of dengue virus populations sampled from individual humans or mosquitoes have revealed significant sequence variation [<a class="refAnchor">155<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="155"><li>W.-K. Wang, S.-R. Lin, C.-M. Lee, C.-C. King, and S.-C. Chang, “Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies,” <i>Journal of Virology</i>, vol. 76, no. 9, pp. 4662–4665, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.76.9.4662-4665.2002" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20type%203%20virus%20in%20plasma%20is%20a%20population%20of%20closely%20related%20genomes:%20quasispecies&amp;author=W.-K.%20Wang&amp;author=S.-R.%20Lin&amp;author=C.-M.%20Lee&amp;author=C.-C.%20King&amp;author=&amp;author=S.-C.%20Chang&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B155" class="seeRef">See in References</a>
          </div></a>]. Consequently, a greater focus on studies of viral population variation during epidemics is needed and the data should be obtained directly from clinical samples. </p><p>The demonstration of long-term transmission of defective dengue virus in humans and mosquitoes has added a new dimension to the study of dengue evolution. The increased frequency of the “stop-codon” strain was concomitant with a major reduction in DENV-1 prevalence in Myanmar. The authors suggested that complementation between defective variants might provide a mechanism for the survival of “hyperparasites,” and this process of viral complementation could impact on pathogen transmission and virulence [<a class="refAnchor">156<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="156"><li>J. Aaskov, K. Buzacott, H. M. Thu, K. Lowry, and E. C. Holmes, “Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes,” <i>Science</i>, vol. 311, no. 5758, pp. 236–238, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.1115030" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Long-term%20transmission%20of%20defective%20RNA%20viruses%20in%20humans%20and%20Aedes%20mosquitoes&amp;author=J.%20Aaskov&amp;author=K.%20Buzacott&amp;author=H.%20M.%20Thu&amp;author=K.%20Lowry&amp;author=&amp;author=E.%20C.%20Holmes&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B156" class="seeRef">See in References</a>
          </div></a>].</p><p>Obviously, more comprehensive approaches, including sequencing of larger numbers of viral genomes obtained directly from diverse clinical samples corresponding to longitudinal studies, are needed to examine how the genetic structure of dengue virus is influenced by heterotypic antibodies. </p><p>Data obtained in two carefully planned clinical studies of dengue in Nicaragua demonstrate that the complex interplay between viral genetics and serotype-specific immunity determines the risk of severe dengue disease. Indeed, these data provide insights into viral evolution and the interaction between viral and immunological determinants of fitness and virulence. The abrupt increase in disease severity across several epidemic seasons of DENV-2 transmission coincided with clade replacement events. Interestingly, DENV-2 strains corresponding to NI-1 clade caused severe disease specifically in children who were immune to DENV-1, whereas DENV-3 immunity was associated with more severe disease among NI-2B infections, signifying that mutations altering the neutralization profile of some DENV strains can lead to increased viral fitness [<a class="refAnchor">157<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="157"><li>M. OhAinle, A. Balmaseda, A. R. Macalalad et al., “Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity,” <i>Science Translational Medicine</i>, vol. 3, no. 114, Article ID 114ra128, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1126/scitranslmed.3003084" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dynamics%20of%20dengue%20disease%20severity%20determined%20by%20the%20interplay%20between%20viral%20genetics%20and%20serotype-specific%20immunity&amp;author=M.%20OhAinle&amp;author=A.%20Balmaseda&amp;author=A.%20R.%20Macalalad%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B157" class="seeRef">See in References</a>
          </div></a>]. </p><p>  Most dengue virus genomic studies have been directed at identifying the origin and genetic relatedness of the viruses causing epidemics. Other studies have focussed on identifying genetic markers associated with severe disease and comparing viruses isolated from DF and DHF/DSS cases within the same epidemiological setting. However, genetic variations have not been consistently associated with differences in clinical outcome. Conversely, introduction of new genotypes/serotypes with replacement/displacement of the existing viruses or changes in viral populations during an interepidemic period, extinction events, and sustained transmission of dengue virus due to repeated introductions have all been related to changes in the severity pattern of local epidemics [<a class="refAnchor">134<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="134"><li>H.-L. Chen, S.-R. Lin, H.-F. Liu, C.-C. King, S.-C. Hsieh, and W.-K. Wang, “Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in Southern Taiwan in 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 79, no. 4, pp. 495–504, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Evolution%20of%20dengue%20virus%20type%202%20during%20two%20consecutive%20outbreaks%20with%20an%20increase%20in%20severity%20in%20Southern%20Taiwan%20in%202001-2002&amp;author=H.-L.%20Chen&amp;author=S.-R.%20Lin&amp;author=H.-F.%20Liu&amp;author=C.-C.%20King&amp;author=S.-C.%20Hsieh&amp;author=&amp;author=W.-K.%20Wang&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B134" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">158<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="158"><li>J. E. Foster, S. N. Bennett, C. V. F. Carrington, H. Vaughan, and W. O. McMillan, “Phylogeography and molecular evolution of dengue 2 in the Caribbean basin, 1981–2000,” <i>Virology</i>, vol. 324, no. 1, pp. 48–59, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2004.03.020" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phylogeography%20and%20molecular%20evolution%20of%20dengue%202%20in%20the%20Caribbean%20basin,%201981%E2%80%932000&amp;author=J.%20E.%20Foster&amp;author=S.%20N.%20Bennett&amp;author=C.%20V.%20F.%20Carrington&amp;author=H.%20Vaughan&amp;author=&amp;author=W.%20O.%20McMillan&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B158" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">161<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="161"><li>L. T. D. Salda, M. D. C. Parquet, R. R. Matias, F. F. Natividad, N. Kobayashi, and K. Morita, “Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 73, no. 4, pp. 796–802, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Molecular%20epidemiology%20of%20dengue%202%20viruses%20in%20the%20Philippines:%20genotype%20shift%20and%20local%20evolution&amp;author=L.%20T.%20D.%20Salda&amp;author=M.%20D.%20C.%20Parquet&amp;author=R.%20R.%20Matias&amp;author=F.%20F.%20Natividad&amp;author=N.%20Kobayashi&amp;author=&amp;author=K.%20Morita&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B161" class="seeRef">See in References</a>
          </div></a>]. </p><p>Recently, in Vietnam, the introduction of the Asian 1 genotype of DENV-2 led to the complete replacement of the resident Asian/American genotype of DENV-2. The transmission fitness advantage of Asian 1 viruses was attributed to this virus attaining higher viremia levels in humans [<a class="refAnchor">162<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="162"><li>T. T. H. Vu, E. C. Holmes, V. Duong et al., “Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia,” <i>PLoS Neglected Tropical Diseases</i>, vol. 4, no. 7, p. e757, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000757" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Emergence%20of%20the%20Asian%201%20genotype%20of%20dengue%20virus%20serotype%202%20in%20viet%20nam:%20in%20vivo%20fitness%20advantage%20and%20lineage%20replacement%20in%20South-East%20Asia&amp;author=T.%20T.%20H.%20Vu&amp;author=E.%20C.%20Holmes&amp;author=V.%20Duong%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B162" class="seeRef">See in References</a>
          </div></a>]. However, there are multiple factors implicated in the transmission dynamic of DENVs that remain unclear. Epidemiological data have suggested that fitness is always context dependent and that as the immunological landscape changes, viral lineages that evade cross-immunity will be at a selective advantage [<a class="refAnchor">163<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="163"><li>E. C. Holmes, “RNA virus genomics: a world of possibilities,” <i>Journal of Clinical Investigation</i>, vol. 119, no. 9, pp. 2488–2495, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1172/JCI38050" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=RNA%20virus%20genomics:%20a%20world%20of%20possibilities&amp;author=E.%20C.%20Holmes&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B163" class="seeRef">See in References</a>
          </div></a>]. </p><p> Clearly, there is still wide scope for research on the molecular basis of dengue virus epidemiology and pathogenesis. We need to know whether or not a circulating dengue virus that produces an asymptomatic infection in one host differs in sequence from the same virus that causes a fatal infection in another host. We also need to know if different tissues [<a class="refAnchor">164<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="164"><li>D. Limonta, V. Capó, G. Torres, A. B. Pérez, and M. G. Guzmán, “Apoptosis in tissues from fatal dengue shock syndrome,” <i>Journal of Clinical Virology</i>, vol. 40, no. 1, pp. 50–54, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jcv.2007.04.024" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Apoptosis%20in%20tissues%20from%20fatal%20dengue%20shock%20syndrome&amp;author=D.%20Limonta&amp;author=V.%20Cap%C3%B3&amp;author=G.%20Torres&amp;author=A.%20B.%20P%C3%A9rez&amp;author=&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B164" class="seeRef">See in References</a>
          </div></a>] within a single host house the same dominant dengue virus strain. Similarly, does the virus that circulates in a single epidemic have the same sequence in individuals with different histories of dengue infection?</p><h5 id="sec2.5">2.5. Intrahost Genetic Variation</h5><p>The population genetics and evolutionary epidemiology of RNA viruses have been reviewed [<a class="refAnchor">165<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="165"><li>A. Moya, E. C. Holmes, and F. González-Candelas, “The population genetics and evolutionary epidemiology of RNA viruses,” <i>Nature Reviews Microbiology</i>, vol. 2, no. 4, pp. 279–288, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nrmicro863" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20population%20genetics%20and%20evolutionary%20epidemiology%20of%20RNA%20viruses&amp;author=A.%20Moya&amp;author=E.%20C.%20Holmes&amp;author=&amp;author=F.%20Gonz%C3%A1lez-Candelas&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B165" class="seeRef">See in References</a>
          </div></a>]. The authors describe migration or gene flow as a factor to consider during RNA virus evolution. Accordingly, they advocate that migration must not only be understood at a macroscopic level (i.e., among hosts within a population, among populations, or between host species), but also within a single infected individual. From the site of inoculation, viruses can be transported to several tissues, generating intrahost spatial variation. This has been studied in Hepatitis C virus, family<i> Flaviviridae</i> [<a class="refAnchor">166<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="166"><li>S. Navas, J. Martín, J. A. Quiroga, I. Castillo, and V. Carreño, “Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients,” <i>Journal of Virology</i>, vol. 72, no. 2, pp. 1640–1646, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Genetic%20diversity%20and%20tissue%20compartmentalization%20of%20the%20hepatitis%20C%20virus%20genome%20in%20blood%20mononuclear%20cells,%20liver,%20and%20serum%20from%20chronic%20hepatitis%20C%20patients&amp;author=S.%20Navas&amp;author=J.%20Mart%C3%ADn&amp;author=J.%20A.%20Quiroga&amp;author=I.%20Castillo&amp;author=&amp;author=V.%20Carre%C3%B1o&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B166" class="seeRef">See in References</a>
          </div></a>]. However, the effect of a nonhomogeneous population distribution on the spread, fitness, and variability of virus populations has not been studied extensively. Nevertheless, a positive correlation between migration rate and average fitness of the population has been observed [<a class="refAnchor">167<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="167"><li>R. Miralles, A. Moya, and S. F. Elena, “Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations,” <i>Journal of General Virology</i>, vol. 80, no. 8, pp. 2051–2059, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20population%20patchiness%20and%20migration%20rates%20on%20the%20adaptation%20and%20divergence%20of%20vesicular%20stomatitis%20virus%20quasispecies%20populations&amp;author=R.%20Miralles&amp;author=A.%20Moya&amp;author=&amp;author=S.%20F.%20Elena&amp;publication_year=1999" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B167" class="seeRef">See in References</a>
          </div></a>]. The outcome of acute Hepatitis C infection has been attributed to the evolution of viral quasispecies [<a class="refAnchor">168<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="168"><li>P. Farci, A. Shimoda, A. Coiana et al., “The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies,” <i>Science</i>, vol. 288, no. 5464, pp. 339–344, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.288.5464.339" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20outcome%20of%20acute%20hepatitis%20C%20predicted%20by%20the%20evolution%20of%20the%20viral%20quasispecies&amp;author=P.%20Farci&amp;author=A.%20Shimoda&amp;author=A.%20Coiana%20et%20al.&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B168" class="seeRef">See in References</a>
          </div></a>]. Large-scale sequencing of complete viral RNA genomes obtained directly from clinical samples is needed to investigate the role of variation in viral populations on dengue pathogenesis. The purifying selection that phylogenies have revealed [<a class="refAnchor">169<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="169"><li>E. C. Holmes, “Patterns of intra- and interhost nonsynonymous variation reveal strong purifying selection in dengue virus,” <i>Journal of Virology</i>, vol. 77, no. 20, pp. 11296–11298, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.77.20.11296-11298.2003" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Patterns%20of%20intra-%20and%20interhost%20nonsynonymous%20variation%20reveal%20strong%20purifying%20selection%20in%20dengue%20virus&amp;author=E.%20C.%20Holmes&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B169" class="seeRef">See in References</a>
          </div></a>] thus far may be misleading because most of the sequences analysed over the years were obtained from tissue culture viral isolates. Additionally, an intrinsic inadequacy of utilising consensus sequences to make inferences concerning the fitness of viral populations is that consensus sequences only reflect the majority nucleotide at any given position of the viral genome. Consequently, low frequency variants will remain undetected.</p><p>Examination of the viral population structure in mosquitoes and patients has revealed that the sequences of the major variants are the same but the extent of sequence variation seen with the mosquitoes is generally lower than that seen with the patients, suggesting that the mosquito contributes to the evolutionary conservation of dengue virus by maintaining a more homogenous viral population and a dominant variant during transmission [<a class="refAnchor">170<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="170"><li>S.-R. Lin, S.-C. Hsieh, Y.-Y. Yueh et al., “Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution,” <i>Journal of Virology</i>, vol. 78, no. 22, pp. 12717–12721, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.78.22.12717-12721.2004" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Study%20of%20sequence%20variation%20of%20dengue%20type%203%20virus%20in%20naturally%20infected%20mosquitoes%20and%20human%20hosts:%20implications%20for%20transmission%20and%20evolution&amp;author=S.-R.%20Lin&amp;author=S.-C.%20Hsieh&amp;author=Y.-Y.%20Yueh%20et%20al.&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B170" class="seeRef">See in References</a>
          </div></a>]. In addition, by studying the evolutionary relationships of DENV-1 viruses that have circulated in French Polynesia and the viral intrahost genetic diversity according to clinical presentation, Descloux and coworkers suggested for the first time that clinical outcome may correlate with intrahost genetic diversity [<a class="refAnchor">171<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="171"><li>E. Descloux, V.-M. Cao-Lormeau, C. Roche, and X. De Lamballerie, “Dengue 1 diversity and microevolution, French Polynesia 2001–2006: connection with epidemiology and clinics,” <i>PLoS Neglected Tropical Diseases</i>, vol. 3, no. 8, article e493, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000493" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%201%20diversity%20and%20microevolution,%20French%20Polynesia%202001%E2%80%932006:%20connection%20with%20epidemiology%20and%20clinics&amp;author=E.%20Descloux&amp;author=V.-M.%20Cao-Lormeau&amp;author=C.%20Roche&amp;author=&amp;author=X.%20De%20Lamballerie&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B171" class="seeRef">See in References</a>
          </div></a>]. On the other hand, a recent study in Vietnam showed no relationship between the extent and pattern of DENV-1 genetic diversity and disease severity, immune status, or level of viremia. Interestingly, despite the high sequence conservation observed, clear evidence for mixed infection with the presence of multiple phylogenetically distinct lineages present within the same host was demonstrated [<a class="refAnchor">172<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="172"><li>K. T. D. Thai, M. R. Henn, M. C. Zody et al., “High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections,” <i>Journal of Virology</i>, vol. 86, no. 2, pp. 835–843, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.05985-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=High-resolution%20analysis%20of%20intrahost%20genetic%20diversity%20in%20dengue%20virus%20serotype%201%20infection%20identifies%20mixed%20infections&amp;author=K.%20T.%20D.%20Thai&amp;author=M.%20R.%20Henn&amp;author=M.%20C.%20Zody%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B172" class="seeRef">See in References</a>
          </div></a>]. </p><p>Indeed, most attempts to investigate intrahost genetic variation in DENV characterised only a few viral genes or a limited number of full-length genomes. A new study in Nicaragua using a whole-genome amplification approach coupled with deep sequencing to capture intrahost diversity across the entire coding region of DENV-2 showed significant genetic diversity among genes [<a class="refAnchor">173<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="173"><li>P. Parameswaran, P. Charlebois, Y. Tellez et al., “Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity,” <i>Journal of Virology</i>, vol. 86, no. 16, pp. 8546–8558, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.00736-12" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genome-wide%20patterns%20of%20intrahuman%20dengue%20virus%20diversity%20reveal%20associations%20with%20viral%20phylogenetic%20clade%20and%20interhost%20diversity&amp;author=P.%20Parameswaran&amp;author=P.%20Charlebois&amp;author=Y.%20Tellez%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B173" class="seeRef">See in References</a>
          </div></a>]. However, the extension of that diversity was less than expected, suggesting strong purifying selection across transmission events as have been proposed previously [<a class="refAnchor">174<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="174"><li>R. L. Costa, C. M. Voloch, and C. G. Schrago, “Comparative evolutionary epidemiology of dengue virus serotypes,” <i>Infection, Genetics and Evolution</i>, vol. 12, no. 2, pp. 309–314, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.meegid.2011.12.011" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Comparative%20evolutionary%20epidemiology%20of%20dengue%20virus%20serotypes&amp;author=R.%20L.%20Costa&amp;author=C.%20M.%20Voloch&amp;author=&amp;author=C.%20G.%20Schrago&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B174" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">176<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="176"><li>V. Wittke, T. E. Robb, H. M. Thu et al., “Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period,” <i>Virology</i>, vol. 301, no. 1, pp. 148–156, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.2002.1549" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Extinction%20and%20rapid%20emergence%20of%20strains%20of%20dengue%203%20virus%20during%20an%20interepidemic%20period&amp;author=V.%20Wittke&amp;author=T.%20E.%20Robb&amp;author=H.%20M.%20Thu%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B176" class="seeRef">See in References</a>
          </div></a>]. </p><p>Another point of view is that there is no reason to ignore vector-driven selection [<a class="refAnchor">177<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="177"><li>C. Chevillon and A.-B. Failloux, “Questions on viral population biology to complete dengue puzzle,” <i>Trends in Microbiology</i>, vol. 11, no. 9, pp. 415–421, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0966-842X(03)00206-3" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Questions%20on%20viral%20population%20biology%20to%20complete%20dengue%20puzzle&amp;author=C.%20Chevillon%20&amp;author=A.-B.%20Failloux&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B177" class="seeRef">See in References</a>
          </div></a>]. However, the interaction between virus and vector has been less extensively explored. By comparing the ability of DENV-1 isolates from Thailand, spanning a 24-year period, to infect and be transmitted by <i>St. aegypti</i>, Lambrechts et al. found that a major clade replacement event in the mid-1990s was associated with a higher transmission potential of the isolates belonging to the new clade. Higher transmissibility was mainly due to a higher infectious titre of virus in the vector’s  haemocoel, which is predicted to result in a higher probability of transmission. This finding supports the hypothesis that major clade replacement events can be driven by natural selection and emphasizes the potentially important role of vector-virus interactions in DENV evolution [<a class="refAnchor">178<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="178"><li>L. Lambrechts, T. Fansiri, A. Pongsiri et al., “Dengue-1 virus clade replacement in Thailand associated with enhanced mosquito transmission,” <i>Journal of Virology</i>, vol. 86, no. 3, pp. 1853–1861, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.06458-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue-1%20virus%20clade%20replacement%20in%20Thailand%20associated%20with%20enhanced%20mosquito%20transmission&amp;author=L.%20Lambrechts&amp;author=T.%20Fansiri&amp;author=A.%20Pongsiri%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B178" class="seeRef">See in References</a>
          </div></a>]. </p><p>Since the 1900s, the extrinsic incubation period (EIP), that is the time taken for the viremic bloodmeal to be amplified in the mosquito and then transmitted to a new host, had been recognized as an important component of DENV transmission dynamics. The DENV EIP is generally considered to be between 8 and 12 days [<a class="refAnchor">17<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="17"><li> WHO/TDR, <i>Dengue Guidelines for Diagnosis, Treatment, Prevention and Control</i>, WHO Press, Geneva, Switzerland, 2009. <span class="reflinks"></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B17" class="seeRef">See in References</a>
          </div></a>]. Nonetheless, different factors can induce variations in EIP. For example, considerable degrees of variation in EIP have been shown to vary depending on the specific DENV strain studied. Mosquitoes feeding on humans infected with an unadapted strain of DENV-1 had shorter EIPs (14 days) than mosquitoes feeding on humans infected with strains at low mouse passage levels, where the EIP was 22 days [<a class="refAnchor">127<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="127"><li>A. B. Sabin, “Research on dengue during World War II,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 1, no. 1, pp. 30–50, 1952. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Research%20on%20dengue%20during%20World%20War%20II&amp;author=A.%20B.%20Sabin&amp;publication_year=1952" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B127" class="seeRef">See in References</a>
          </div></a>]. In addition, long EIPs have been observed with dengue virus attenuated strains [<a class="refAnchor">179<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="179"><li>W. H. Bancroft, R. M. Scott, and W. E. Brandt, “Dengue-2 vaccine: infection of <i>Aedes aegypti</i> mosquitoes by feeding on viremic recipients,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 31, no. 6, pp. 1229–1231, 1982. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue-2%20vaccine:%20infection%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20mosquitoes%20by%20feeding%20on%20viremic%20recipients&amp;author=W.%20H.%20Bancroft&amp;author=R.%20M.%20Scott&amp;author=&amp;author=W.%20E.%20Brandt&amp;publication_year=1982" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B179" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">180<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="180"><li>B. R. Miller, B. J. Beaty, and T. H. G. Aitken, “Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, <i>Aedes aegypti</i>,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 31, no. 6, pp. 1232–1237, 1982. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue-2%20vaccine:%20oral%20infection,%20transmission,%20and%20lack%20of%20evidence%20for%20reversion%20in%20the%20mosquito,%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=B.%20R.%20Miller&amp;author=B.%20J.%20Beaty&amp;author=&amp;author=T.%20H.%20G.%20Aitken&amp;publication_year=1982" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B180" class="seeRef">See in References</a>
          </div></a>]. Likewise, highly controlled laboratory studies have demonstrated the effect of distinct genotypes, serotypes, and mosquito population on the EIP [<a class="refAnchor">181<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="181"><li>D. J. Gubler, S. Nalim, and R. Tan, “Variation in susceptibility to oral infection with dengue viruses among geographic strains of <i>Aedes aegypti</i>,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 28, no. 6, pp. 1045–1052, 1979. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Variation%20in%20susceptibility%20to%20oral%20infection%20with%20dengue%20viruses%20among%20geographic%20strains%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=D.%20J.%20Gubler&amp;author=S.%20Nalim&amp;author=&amp;author=R.%20Tan&amp;publication_year=1979" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B181" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">182<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="182"><li>P. M. Armstrong and R. Rico-Hesse, “Differential susceptibility of <i>Aedes aegypti</i> to infection by the American and Southeast Asian genotypes of dengue type 2 virus,” <i>Vector Borne Zoonotic Dis</i>, vol. 1, no. 2, pp. 159–168, 2001. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Differential%20susceptibility%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20to%20infection%20by%20the%20American%20and%20Southeast%20Asian%20genotypes%20of%20dengue%20type%202%20virus&amp;author=P.%20M.%20Armstrong%20&amp;author=R.%20Rico-Hesse&amp;publication_year=2001" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B182" class="seeRef">See in References</a>
          </div></a>]. Taking into account the advanced technologies available in molecular biology, new avenues for the study of virus-vector interactions should reveal new mechanisms involved in dengue virus transmission dynamics.</p><h4 id="disease-control-strategies">3. Disease Control Strategies</h4><p>Increasing human and associated mosquito population densities and mobility of humans and commercial goods are the main factors that have determined the very successful reemergence of DF and DHF during recent decades. In contrast with YFV, which exploits the same mosquito species (<i>St. aegypti</i>) to infect humans, the dengue viruses have evolved to become independent of the need for a reservoir sylvatic environment with which to sustain their epidemicity. Thus, in the absence of effective control strategies we are faced with the prospect of further increases in morbidity and mortality due to the dengue viruses. Currently, several different approaches (reviewed after) are being developed in the future hope of alleviating this “scourge” of modern times.</p><h5 id="sec3.1">3.1. Vector Control</h5><p>History has shown that vector control measures can be effective in reducing arthropod-borne virus diseases [<a class="refAnchor">120<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="120"><li>G. Kourí, M. G. Guzmán, L. Valdés et al., “Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba,” <i>Emerging Infectious Diseases</i>, vol. 4, no. 1, pp. 89–92, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Reemergence%20of%20dengue%20in%20Cuba:%20a%201997%20epidemic%20in%20Santiago%20de%20Cuba&amp;author=G.%20Kour%C3%AD&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=L.%20Vald%C3%A9s%20et%20al.&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B120" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">183<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="183"><li>F. L. Soper, “<i>Aedes aegypti</i> and yellow fever,” <i>Bulletin of the World Health Organization</i>, vol. 36, no. 4, pp. 521–527, 1967. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=%3Ci%3EAedes%20aegypti%3C/i%3E%20and%20yellow%20fever&amp;author=F.%20L.%20Soper&amp;publication_year=1967" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B183" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">186<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="186"><li>M. G. Guzman, O. Pelaez, G. Kouri et al., “Final characterization of and lessons learned from the dengue 3 epidemic in Cuba, 2001-2002,” <i>Revista Panamericana de Salud Pública</i>, vol. 19, no. 4, pp. 282–289, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Final%20characterization%20of%20and%20lessons%20learned%20from%20the%20dengue%203%20epidemic%20in%20Cuba,%202001-2002&amp;author=M.%20G.%20Guzman&amp;author=O.%20Pelaez&amp;author=G.%20Kouri%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B186" class="seeRef">See in References</a>
          </div></a>]. However, many developing countries do not have the necessary resources and infrastructure for successful eradication measures to be implemented and sustainable in the manner that has been achieved in Singapore and Cuba [<a class="refAnchor">187<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="187"><li>M. Bonet, J. M. Spiegel, A. M. Ibarra, G. Kouri, A. Pintre Lic, and A. Yassi, “An integrated ecosystem approach for sustainable prevention and control of dengue in Central Havana,” <i>International Journal of Occupational and Environmental Health</i>, vol. 13, no. 2, pp. 188–194, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=An%20integrated%20ecosystem%20approach%20for%20sustainable%20prevention%20and%20control%20of%20dengue%20in%20Central%20Havana&amp;author=M.%20Bonet&amp;author=J.%20M.%20Spiegel&amp;author=A.%20M.%20Ibarra&amp;author=G.%20Kouri&amp;author=A.%20Pintre%20Lic&amp;author=&amp;author=A.%20Yassi&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B187" class="seeRef">See in References</a>
          </div></a>]. This situation is exacerbated by the emergence of resistance to insecticides and the environmental issues arising from the use of potentially toxic chemicals [<a class="refAnchor">188<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="188"><li>J. A. Bisset, M. M. Rodríguez, Y. Ricardo et al., “Temephos resistance and esterase activity in the mosquito <i>Aedes aegypti</i> in Havana, Cuba increased dramatically between 2006 and 2008,” <i>Medical and Veterinary Entomology</i>, vol. 25, no. 3, pp. 233–239, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-2915.2011.00959.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Temephos%20resistance%20and%20esterase%20activity%20in%20the%20mosquito%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20Havana,%20Cuba%20increased%20dramatically%20between%202006%20and%202008&amp;author=J.%20A.%20Bisset&amp;author=M.%20M.%20Rodr%C3%ADguez&amp;author=Y.%20Ricardo%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B188" class="seeRef">See in References</a>
          </div></a>]. Today, dissemination of insecticide resistance throughout vector populations is much faster than the rate of development of new insecticides. In addition, the existence of cross-resistance, based on the activation of general detoxifying mechanisms in the vector, can shorten the useful lifespan of alternative insecticides or even prevent their implementation [<a class="refAnchor">189<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="189"><li>R. Maciel-de-Freitas, R. Aguiar, R. V. Bruno et al., “Why do we need alternative tools to control mosquito-borne diseases in Latin America?” <i>Memórias do Instituto Oswaldo Cruz</i>, vol. 107, no. 6, pp. 828–829, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Why%20do%20we%20need%20alternative%20tools%20to%20control%20mosquito-borne%20diseases%20in%20Latin%20America?&amp;author=R.%20Maciel-de-Freitas&amp;author=R.%20Aguiar&amp;author=R.%20V.%20Bruno%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B189" class="seeRef">See in References</a>
          </div></a>]. </p><p>New approaches to vector eradication including the use of naturally occurring plant insecticides/larvicides [<a class="refAnchor">190<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="190"><li>R. A. Sá, N. D. D. L. Santos, C. S. B. D. Silva et al., “Larvicidal activity of lectins from Myracrodruon urundeuva on <i>Aedes aegypti</i>,” <i>Comparative Biochemistry and Physiology Part C</i>, vol. 149, no. 3, pp. 300–306, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cbpc.2008.08.004" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Larvicidal%20activity%20of%20lectins%20from%20Myracrodruon%20urundeuva%20on%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=R.%20A.%20S%C3%A1&amp;author=N.%20D.%20D.%20L.%20Santos&amp;author=C.%20S.%20B.%20D.%20Silva%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B190" class="seeRef">See in References</a>
          </div></a>] and vaccines that induce antibodies to impair vital functions in mosquitoes [<a class="refAnchor">191<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="191"><li>P. F. Billingsley, B. Foy, and J. L. Rasgon, “Mosquitocidal vaccines: a neglected addition to malaria and dengue control strategies,” <i>Trends in Parasitology</i>, vol. 24, no. 9, pp. 396–400, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.pt.2008.06.003" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mosquitocidal%20vaccines:%20a%20neglected%20addition%20to%20malaria%20and%20dengue%20control%20strategies&amp;author=P.%20F.%20Billingsley&amp;author=B.%20Foy&amp;author=&amp;author=J.%20L.%20Rasgon&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B191" class="seeRef">See in References</a>
          </div></a>] are being considered but such approaches are unlikely to provide effective vector control measures in the near future. </p><p>Primary prevention of dengue is largely dependent on larval and adult mosquito control. <i>St. aegypti</i> surveillance has relied heavily upon larval indices. However, this has been strongly criticised as they provide little information to determine the risk of DENV transmission. The studies of Bisset Lazcano and colleagues used pupal surveillance for the <i>St. aegypti </i>control programme in Cuba and focused on the most productive mosquito water containers [<a class="refAnchor">192<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="192"><li>J. A. Bisset Lazcano, M. C. Marquetti, A. Garcia et al., “Pupal surveillance of <i>Aedes aegypti</i> as a tool for control of the vector in a municipality with low density of La Habana City, Cuba,” <i>Revista Biomédica</i>, vol. 19, pp. 92–103, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Pupal%20surveillance%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20as%20a%20tool%20for%20control%20of%20the%20vector%20in%20a%20municipality%20with%20low%20density%20of%20La%20Habana%20City,%20Cuba&amp;author=J.%20A.%20Bisset%20Lazcano&amp;author=M.%20C.%20Marquetti&amp;author=A.%20Garcia%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B192" class="seeRef">See in References</a>
          </div></a>]. In urban areas, <i>St. aegypti</i> breed on water that collects in artificial containers such as plastic cups, used tyres, broken bottles, flowerpots, and other water traps. Elimination of these containers is the most effective way of reducing the mosquito breeding grounds. The use of insect repellents, mosquito traps, and mosquito nets in the home can also be moderately effective in reducing the number of bites due to mosquitoes.</p><p>Novel alternative approaches have also been investigated. In Vietnam, trials were conducted in which children and local communities were encouraged to place, a known mosquito predator, the crustacean <i>Mesocyclops</i> [<a class="refAnchor">193<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="193"><li>T. T. Tuyet Hanh, P. S. Hill, B. H. Kay, and M. Q. Tran, “Development of a framework for evaluating the sustainability of community-based dengue control projects,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 80, no. 2, pp. 312–318, 2009. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Development%20of%20a%20framework%20for%20evaluating%20the%20sustainability%20of%20community-based%20dengue%20control%20projects&amp;author=T.%20T.%20Tuyet%20Hanh&amp;author=P.%20S.%20Hill&amp;author=B.%20H.%20Kay&amp;author=&amp;author=M.%20Q.%20Tran&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B193" class="seeRef">See in References</a>
          </div></a>], in water tanks and discarded containers where <i>St. aegypti</i> are known to thrive [<a class="refAnchor">194<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="194"><li>S. N. Vu, T. Y. Nguyen, B. H. Kay, G. G. Marten, and J. W. Reid, “Eradication of <i>Aedes aegypti</i> from a village in Vietnam, using copepods and community participation,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 59, no. 4, pp. 657–660, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Eradication%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20from%20a%20village%20in%20Vietnam,%20using%20copepods%20and%20community%20participation&amp;author=S.%20N.%20Vu&amp;author=T.%20Y.%20Nguyen&amp;author=B.%20H.%20Kay&amp;author=G.%20G.%20Marten&amp;author=&amp;author=J.%20W.%20Reid&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B194" class="seeRef">See in References</a>
          </div></a>]. The concept exploited the principle that this procedure might be more cost-effective and environmentally friendly than the use of pesticides. Over a period of years and in defined rural provinces of Viet Nam a reduction in mosquitoes and dengue fever was observed [<a class="refAnchor">195<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="195"><li>V. S. Nam, N. T. Yen, T. V. Phong et al., “Elimination of dengue by community programs using Mesocyclops (copepoda) against <i>Aedes aegypti</i> in central Vietnam,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 72, no. 1, pp. 67–73, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Elimination%20of%20dengue%20by%20community%20programs%20using%20Mesocyclops%20(copepoda)%20against%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20central%20Vietnam&amp;author=V.%20S.%20Nam&amp;author=N.%20T.%20Yen&amp;author=T.%20V.%20Phong%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B195" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">196<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="196"><li>B. Kay and V. S. Nam, “New strategy against <i>Aedes aegypti</i> in Vietnam,” <i>The Lancet</i>, vol. 365, no. 9459, pp. 613–617, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(05)17913-6" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=New%20strategy%20against%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20Vietnam&amp;author=B.%20Kay%20&amp;author=V.%20S.%20Nam&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B196" class="seeRef">See in References</a>
          </div></a>]. However, such approaches are only likely to be successful in regions of countries with the organisational infrastructure and appropriate community attitudes. A community education strategy is utilised to promote participation in dengue prevention in Cuba, resulting in reduced mosquito vector infestation levels. The main principle has been to increase community participation in decision-making and strengthening the competence of the medical teams and community working groups [<a class="refAnchor">197<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="197"><li>L. Sánchez, D. Pérez, L. Alfonso et al., “A community education strategy to promote participation in dengue prevention in Cuba,” <i>Revista Panamericana de Salud Publica</i>, vol. 24, no. 1, pp. 61–69, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=A%20community%20education%20strategy%20to%20promote%20participation%20in%20dengue%20prevention%20in%20Cuba&amp;author=L.%20S%C3%A1nchez&amp;author=D.%20P%C3%A9rez&amp;author=L.%20Alfonso%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B197" class="seeRef">See in References</a>
          </div></a>]. Whether or not a similar approach could be successfully applied to major cities and urban areas in other countries remains to be seen. </p><p>An alternative approach involves infecting <i>St. aegypti</i> with the bacterium Wolbachia [<a class="refAnchor">189<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="189"><li>R. Maciel-de-Freitas, R. Aguiar, R. V. Bruno et al., “Why do we need alternative tools to control mosquito-borne diseases in Latin America?” <i>Memórias do Instituto Oswaldo Cruz</i>, vol. 107, no. 6, pp. 828–829, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Why%20do%20we%20need%20alternative%20tools%20to%20control%20mosquito-borne%20diseases%20in%20Latin%20America?&amp;author=R.%20Maciel-de-Freitas&amp;author=R.%20Aguiar&amp;author=R.%20V.%20Bruno%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B189" class="seeRef">See in References</a>
          </div></a>]. Early studies suggest that this reduces the adult lifespan of the mosquito by 50% [<a class="refAnchor">198<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="198"><li>C. J. McMeniman, R. V. Lane, B. N. Cass et al., “Stable introduction of a life-shortening Wolbachia infection into the mosquito <i>Aedes aegypti</i>,” <i>Science</i>, vol. 323, no. 5910, pp. 141–144, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.1165326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Stable%20introduction%20of%20a%20life-shortening%20Wolbachia%20infection%20into%20the%20mosquito%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=C.%20J.%20McMeniman&amp;author=R.%20V.%20Lane&amp;author=B.%20N.%20Cass%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B198" class="seeRef">See in References</a>
          </div></a>]. This is important because the adult female mosquito is the primary vector of the virus. Insects infected by Wolbachia transmit them transovarially to the next generation. Thus, by reducing the lifespan of the mosquito, virus-vector competence, and virus transmission efficiency, a significant reduction of <i>St. aegypti </i>should be observed. Another important feature of Wolbachia is its ability to induce resistance to a variety of pathogens, including DENV, in its insect hosts [<a class="refAnchor">199<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="199"><li>P. Lu, G. Bian, X. Pan, and Z. Xi, “Wolbachia induces density-dependent inhibition to dengue virus in mosquito cells,” <i>PLOS Neglected Tropical Diseases</i>, vol. 6, no. 7, Article ID e1754, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Wolbachia%20induces%20density-dependent%20inhibition%20to%20dengue%20virus%20in%20mosquito%20cells&amp;author=P.%20Lu&amp;author=G.%20Bian&amp;author=X.%20Pan&amp;author=&amp;author=Z.%20Xi&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B199" class="seeRef">See in References</a>
          </div></a>]. In the transinfected <i>St. aegypti</i>, all the three different types of Wolbachia, wAlbB, wMelPop-CLA, and wMel, induce significant inhibition of DENV replication and dissemination, resulting in either complete or partial block of virus transmission [<a class="refAnchor">200<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="200"><li>T. Walker, P. H. Johnson, L. A. Moreira et al., “The wMel Wolbachia strain blocks dengue and invades caged <i>Aedes aegypti</i> populations,” <i>Nature</i>, vol. 476, no. 7361, pp. 450–455, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nature10355" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20wMel%20Wolbachia%20strain%20blocks%20dengue%20and%20invades%20caged%20%3Ci%3EAedes%20aegypti%3C/i%3E%20populations&amp;author=T.%20Walker&amp;author=P.%20H.%20Johnson&amp;author=L.%20A.%20Moreira%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B200" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">202<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="202"><li>L. A. Moreira, I. Iturbe-Ormaetxe, J. A. Jeffery et al., “A Wolbachia Symbiont in <i>Aedes aegypti</i> Limits Infection with Dengue, Chikungunya, and Plasmodium,” <i>Cell</i>, vol. 139, no. 7, pp. 1268–1278, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cell.2009.11.042" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20Wolbachia%20Symbiont%20in%20%3Ci%3EAedes%20aegypti%3C/i%3E%20Limits%20Infection%20with%20Dengue,%20Chikungunya,%20and%20Plasmodium&amp;author=L.%20A.%20Moreira&amp;author=I.%20Iturbe-Ormaetxe&amp;author=J.%20A.%20Jeffery%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B202" class="seeRef">See in References</a>
          </div></a>]. Recent studies also show that Wolbachia induces production of reactive-oxygen species which then activate the Toll-pathway to induce expression of antiviral effectors [<a class="refAnchor">203<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="203"><li>X. Pan, G. Zhou, J. Wu et al., “Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito <i>Aedes aegypti</i>,” <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 109, no. 1, pp. E23–E31, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.1116932108" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Wolbachia%20induces%20reactive%20oxygen%20species%20(ROS)-dependent%20activation%20of%20the%20Toll%20pathway%20to%20control%20dengue%20virus%20in%20the%20mosquito%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=X.%20Pan&amp;author=G.%20Zhou&amp;author=J.%20Wu%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B203" class="seeRef">See in References</a>
          </div></a>]. Interestingly, it was recently demonstrated that native Wolbachia symbionts limit transmission of DENV in <i>St. albopictus</i> by restricting the delivery of infectious viral particles from the mosquito saliva when biting. These results might therefore explain the low vector competence of <i>St. albopictus</i> for dengue and thus its relatively weak contribution as an epidemic dengue vector [<a class="refAnchor">204<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="204"><li>L. Mousson, K. Zouache, C. Arias-Goeta, V. Raquin, P. Mavingui, and A. B. Failloux, “The native wolbachia symbionts limit transmission of dengue virus in <i>Aedes albopictus</i>,” <i>PLOS Neglected Tropical Diseases</i>, vol. 6, no. 12, Article ID e1989, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20native%20wolbachia%20symbionts%20limit%20transmission%20of%20dengue%20virus%20in%20%3Ci%3EAedes%20albopictus%3C/i%3E&amp;author=L.%20Mousson&amp;author=K.%20Zouache&amp;author=C.%20Arias-Goeta&amp;author=V.%20Raquin&amp;author=P.%20Mavingui&amp;author=&amp;author=A.%20B.%20Failloux&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B204" class="seeRef">See in References</a>
          </div></a>]. </p><p>Understanding how Wolbachia density is regulated by mosquito hosts and how the Wolbachia machinery controls its replication will facilitate the current effort to eliminate dengue through Wolbachia-based population replacement [<a class="refAnchor">205<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="205"><li>P. E. Cook, C. J. McMeniman, and S. L. O'Neill, “Modifying insect population age structure to control vector-borne disease,” <i>Advances in Experimental Medicine and Biology</i>, vol. 627, pp. 126–140, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1007/978-0-387-78225-6-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Modifying%20insect%20population%20age%20structure%20to%20control%20vector-borne%20disease&amp;author=P.%20E.%20Cook&amp;author=C.%20J.%20McMeniman&amp;author=&amp;author=S.%20L.%20O%27Neill&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B205" class="seeRef">See in References</a>
          </div></a>].</p><p>The genetic structure of <i>St. aegypti </i>populations and its implications for potential mosquito releases have been studied in Queensland, Australia [<a class="refAnchor">206<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="206"><li>N. M. Endersby, A. A. Hoffmann, V. L. White, S. A. Ritchie, P. H. Johnson, and A. R. Weeks, “Changes in the genetic structure of <i>Aedes aegypti</i> (Diptera: Culicidae) populations in Queensland, Australia, across two seasons: implications for potential mosquito releases,” <i>Journal of Medical Entomology</i>, vol. 48, no. 5, pp. 999–1007, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1603/ME10264" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Changes%20in%20the%20genetic%20structure%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20(Diptera:%20Culicidae)%20populations%20in%20Queensland,%20Australia,%20across%20two%20seasons:%20implications%20for%20potential%20mosquito%20releases&amp;author=N.%20M.%20Endersby&amp;author=A.%20A.%20Hoffmann&amp;author=V.%20L.%20White&amp;author=S.%20A.%20Ritchie&amp;author=P.%20H.%20Johnson&amp;author=&amp;author=A.%20R.%20Weeks&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B206" class="seeRef">See in References</a>
          </div></a>], and Tri Nguyen village, Vietnam [<a class="refAnchor">207<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="207"><li>N. M. Endersby, A. A. Hoffmann, V. L. White et al., “Genetic structure of <i>Aedes aegypti</i> in Australia and Vietnam revealed by microsatellite and exon primed intron crossing markers suggests feasibility of local control options,” <i>Journal of Medical Entomology</i>, vol. 46, no. 5, pp. 1074–1083, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1603/033.046.0514" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genetic%20structure%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20Australia%20and%20Vietnam%20revealed%20by%20microsatellite%20and%20exon%20primed%20intron%20crossing%20markers%20suggests%20feasibility%20of%20local%20control%20options&amp;author=N.%20M.%20Endersby&amp;author=A.%20A.%20Hoffmann&amp;author=V.%20L.%20White%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B207" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">208<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="208"><li>J. A. L. Jeffery, N. T. Yen, V. S. Nam et al., “Characterizing the <i>Aedes aegypti</i> population in a Vietnamese village in preparation for a Wolbachia-based mosquito control strategy to eliminate dengue,” <i>PLoS Neglected Tropical Diseases</i>, vol. 3, no. 11, Article ID e0000552, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000552" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Characterizing%20the%20%3Ci%3EAedes%20aegypti%3C/i%3E%20population%20in%20a%20Vietnamese%20village%20in%20preparation%20for%20a%20Wolbachia-based%20mosquito%20control%20strategy%20to%20eliminate%20dengue&amp;author=J.%20A.%20L.%20Jeffery&amp;author=N.%20T.%20Yen&amp;author=V.%20S.%20Nam%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B208" class="seeRef">See in References</a>
          </div></a>]. Populations of <i>St</i>. <i>aegypti</i> artificially infected with strains of <i>Wolbachia pipientis</i> that interfere with its vector competence are being backcrossed into wild mosquito genetic backgrounds from north Queensland and assessed as potential candidates for release [<a class="refAnchor">209<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="209"><li>H. L. Yeap, P. Mee, T. Walker et al., “Dynamics of the “popcorn” Wolbachia infection in outbred <i>Aedes aegypti</i> informs prospects for mosquito vector control,” <i>Genetics</i>, vol. 187, no. 2, pp. 583–595, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1534/genetics.110.122390" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dynamics%20of%20the%20%E2%80%9Cpopcorn%E2%80%9D%20Wolbachia%20infection%20in%20outbred%20%3Ci%3EAedes%20aegypti%3C/i%3E%20informs%20prospects%20for%20mosquito%20vector%20control&amp;author=H.%20L.%20Yeap&amp;author=P.%20Mee&amp;author=T.%20Walker%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B209" class="seeRef">See in References</a>
          </div></a>]. In addition, a pilot release—<a href="http://www.eliminatedengue.com/project/vietnem/progress" target="_blank">http://www.eliminatedengue.com/project/vietnem/progress</a>—of infected mosquitoes has been authorised to take place from April 2013 on Tri Nguyen village (611 households) on Hon Mieu Island in central Vietnam. Subject to satisfactory results larger scale studies could be launched within five years [<a class="refAnchor">210<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="210"><li>R. Macey, “Dengue fever breakthrough,” Sydney Morning Herald, 2009, <a target="_blank" href="http://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/02/1230681699070.html">http://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/02/1230681699070.html</a>. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20fever%20breakthrough&amp;author=R.%20Macey" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B210" class="seeRef">See in References</a>
          </div></a>].</p><p>Promisingly, studies related with the effect of Wolbachia on insecticide susceptibility in lines of <i>St. aegypti</i> have demonstrated that spreading Wolbachia infections are unlikely to affect the efficacy of traditional chemical methods of controlling mosquito outbreaks [<a class="refAnchor">211<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="211"><li>N. M. Endersby and A. A. Hoffmann, “Effect of Wolbachia on insecticide susceptibility in lines of <i>Aedes aegypti</i>,” <i>Bulletin of Entomological Research</i>, pp. 1–9, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20Wolbachia%20on%20insecticide%20susceptibility%20in%20lines%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=N.%20M.%20Endersby%20&amp;author=A.%20A.%20Hoffmann&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B211" class="seeRef">See in References</a>
          </div></a>].</p><h5 id="sec3.2">3.2. Development of Vaccines against Dengue Viruses</h5><p> It is generally agreed that vaccination can provide an effective method with which to control virus diseases. In the case of the dengue viruses, the four serotypes are sufficiently antigenically different that it is considered necessary to produce four monovalent vaccines, which will then be mixed to produce a tetravalent immunological response. This is a logical approach that has previously been employed successfully with the three monovalent poliovirus vaccines. However, as discussed earlier, the dengue viruses also present the problem of antibody mediated enhancement of disease severity [<a class="refAnchor">75<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="75"><li>S. Halstead, <i>Antibody-Dependent Enhancement of Infection: a mechanism for Indirect Virus Entry into Cells. Cellular Receptors for Animal Viruses</i>, Harbor Laboraty Press, Cold Spring Harbor, NY, USA, 1994. <span class="reflinks"></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B75" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">118<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="118"><li>S. B. Halstead, S. Nimmannitya, and S. N. Cohen, “Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered,” <i>Yale Journal of Biology and Medicine</i>, vol. 42, no. 5, pp. 311–328, 1970. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Observations%20related%20to%20pathogenesis%20of%20dengue%20hemorrhagic%20fever.%20IV.%20Relation%20of%20disease%20severity%20to%20antibody%20response%20and%20virus%20recovered&amp;author=S.%20B.%20Halstead&amp;author=S.%20Nimmannitya&amp;author=&amp;author=S.%20N.%20Cohen&amp;publication_year=1970" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B118" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">212<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="212"><li>S. B. Halstead, “Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade,” <i>Reviews of Infectious Diseases</i>, vol. 11, pp. S830–839, 1989. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Antibody,%20macrophages,%20dengue%20virus%20infection,%20shock,%20and%20hemorrhage:%20a%20pathogenetic%20cascade&amp;author=S.%20B.%20Halstead&amp;publication_year=1989" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B212" class="seeRef">See in References</a>
          </div></a>]. Long-term protection is essential as severe dengue has been observed in individuals secondarily infected more than 20 years after the primary infection [<a class="refAnchor">63<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="63"><li>M. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1–3 virus infections over a long time interval: Havana epidemic, 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1113–1117, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20caused%20by%20sequential%20dengue%201%E2%80%933%20virus%20infections%20over%20a%20long%20time%20interval:%20Havana%20epidemic,%202001-2002&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche&amp;author=L.%20Bernardo%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B63" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">85<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="85"><li>D. González, O. E. Castro, G. Kourí et al., “Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002,” <i>International Journal of Infectious Diseases</i>, vol. 9, no. 5, pp. 280–285, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2004.07.012" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Classical%20dengue%20hemorrhagic%20fever%20resulting%20from%20two%20dengue%20infections%20spaced%2020%20years%20or%20more%20apart:%20Havana,%20Dengue%203%20epidemic,%202001-2002&amp;author=D.%20Gonz%C3%A1lez&amp;author=O.%20E.%20Castro&amp;author=G.%20Kour%C3%AD%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B85" class="seeRef">See in References</a>
          </div></a>]. As it is virtually impossible to test whether or not the tetravalent formula would overcome this potential problem, an element of uncertainty might prevail following the introduction of the vaccines in Asia and/or Latin America where dengue viruses are most prevalent. In addition, although the protective role of neutralizing antibodies is recognised, correlates of protection need to be defined [<a class="refAnchor">213<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="213"><li>J. Hombach, M. Jane Cardosa, A. Sabchareon, D. W. Vaughn, and A. D. T. Barrett, “Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005,” <i>Vaccine</i>, vol. 25, no. 21, pp. 4130–4139, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2007.02.079" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Scientific%20consultation%20on%20immunological%20correlates%20of%20protection%20induced%20by%20dengue%20vaccines.%20Report%20from%20a%20meeting%20held%20at%20the%20World%20Health%20Organization%2017-18%20November%202005&amp;author=J.%20Hombach&amp;author=M.%20Jane%20Cardosa&amp;author=A.%20Sabchareon&amp;author=D.%20W.%20Vaughn&amp;author=&amp;author=A.%20D.%20T.%20Barrett&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B213" class="seeRef">See in References</a>
          </div></a>]. </p><p>Several different approaches are being employed to develop dengue virus vaccines. The vaccine pipeline includes live empirically attenuated vaccines, newer live attenuated vaccines developed using infectious clone technology, genetic vaccines using virus and plasmid vectors, and many recombinant subunit vaccine candidates [<a class="refAnchor">214<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="214"><li>S. Swaminathan, G. Batra, and N. Khanna, “Dengue vaccines: state of the art,” <i>Expert Opinion on Therapeutic Patents</i>, vol. 20, no. 6, pp. 819–835, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1517/13543771003767476" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vaccines:%20state%20of%20the%20art&amp;author=S.%20Swaminathan&amp;author=G.%20Batra&amp;author=&amp;author=N.%20Khanna&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B214" class="seeRef">See in References</a>
          </div></a>].</p><p> Potential vaccines already progressing through clinical trials include a live attenuated tetravalent vaccine, produced via serial subculture in primary dog kidney cells [<a class="refAnchor">215<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="215"><li>R. Edelman, S. S. Wasserman, S. A. Bodison et al., “Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 69, no. 6, pp. 48–60, 2003. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Phase%20I%20trial%20of%2016%20formulations%20of%20a%20tetravalent%20live-attenuated%20dengue%20vaccine&amp;author=R.%20Edelman&amp;author=S.%20S.%20Wasserman&amp;author=S.%20A.%20Bodison%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B215" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">217<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="217"><li>W. Sun, D. Cunningham, S. S. Wasserman et al., “Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults,” <i>Human Vaccines</i>, vol. 5, no. 1, pp. 33–40, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.4161/hv.5.1.6348" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phase%202%20clinical%20trial%20of%20three%20formulations%20of%20tetravalent%20live-attenuated%20dengue%20vaccine%20in%20flavivirus-na%C3%AFve%20adults&amp;author=W.%20Sun&amp;author=D.%20Cunningham&amp;author=S.%20S.%20Wasserman%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B217" class="seeRef">See in References</a>
          </div></a>]. Another approach involves the use of genetic modification of dengue viruses to attenuate their virulence [<a class="refAnchor">218<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="218"><li>A. P. Durbin, S. S. Whitehead, J. McArthur et al., “rDEN4<i>σ</i>30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers,” <i>Journal of Infectious Diseases</i>, vol. 191, no. 5, pp. 710–718, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1086/427780" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=rDEN4%3Ci%3E%CF%83%3C/i%3E30,%20a%20live%20attenuated%20dengue%20virus%20type%204%20vaccine%20candidate,%20is%20safe,%20immunogenic,%20and%20highly%20infectious%20in%20healthy%20adult%20volunteers&amp;author=A.%20P.%20Durbin&amp;author=S.%20S.%20Whitehead&amp;author=J.%20McArthur%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B218" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">222<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="222"><li>J. E. Blaney Jr., N. S. Sathe, L. Goddard et al., “Dengue virus type 3 vaccine candidates generated by introduction of deletions in the <math id="M2" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math> untranslated region (<math id="M3" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math>-UTR) or by exchange of the DENV-3 <math id="M4" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math>-UTR with that of DENV-4,” <i>Vaccine</i>, vol. 26, no. 6, pp. 817–828, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2007.11.082" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%203%20vaccine%20candidates%20generated%20by%20introduction%20of%20deletions%20in%20the%20%3Cinline-formula%3E%3Cmml:math%20id=" m2"%20xmlns:mml="http://www.w3.org/1998/Math/MathML" target="_blank"><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow>%20untranslated%20region%20(<inline-formula><mml:math%20id="m3"%20xmlns:mml="http: www.w3.org="" 1998="" math="" mathml"=""><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math%20id="m3"%20xmlns:mml="http:></inline-formula>-UTR)%20or%20by%20exchange%20of%20the%20DENV-3%20<inline-formula><mml:math%20id="m4"%20xmlns:mml="http: www.w3.org="" 1998="" math="" mathml"=""><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math%20id="m4"%20xmlns:mml="http:></inline-formula>-UTR%20with%20that%20of%20DENV-4&amp;author=J. E. Blaney Jr.&amp;author=N. S. Sathe&amp;author=L. Goddard et al.&amp;publication_year=2008" target="_blank"&gt;Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B222" class="seeRef">See in References</a>
          </div></a>]. Although vaccine candidates based on infectious virus have shown the greatest progress amongst different dengue vaccine approaches, there are safety concerns associated with their use based on potential reactogenicity, interference amongst the viruses, possible reversion to native virus, and possible increase of virus infectivity and/or virulence via antibody dependent enhancement [<a class="refAnchor">223<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="223"><li>M. G. Guzman, L. Hermida, L. Bernardo, R. Ramirez, and G. Guillén, “Domain III of the envelope protein as a dengue vaccine target,” <i>Expert Review of Vaccines</i>, vol. 9, no. 2, pp. 137–147, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1586/erv.09.139" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Domain%20III%20of%20the%20envelope%20protein%20as%20a%20dengue%20vaccine%20target&amp;author=M.%20G.%20Guzman&amp;author=L.%20Hermida&amp;author=L.%20Bernardo&amp;author=R.%20Ramirez&amp;author=&amp;author=G.%20Guill%C3%A9n&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B223" class="seeRef">See in References</a>
          </div></a>].</p><p>  An alternative approach is based on the use of the live attenuated YFV 17D vaccine as a backbone for the production of four chimaeric live attenuated viruses in which the prM and E genes of the 17D vaccine virus are replaced by the corresponding genes of the four dengue virus serotypes [<a class="refAnchor">224<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="224"><li>F. Guirakhoo, S. Kitckener, D. Morrison et al., “Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity—effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes,” <i>Human Vaccines</i>, vol. 2, no. 2, pp. 60–67, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Live%20attenuated%20chimeric%20yellow%20fever%20dengue%20type%202%20(ChimeriVax-DEN2)%20vaccine:%20phase%20I%20clinical%20trial%20for%20safety%20and%20immunogenicity%E2%80%94effect%20of%20yellow%20fever%20pre-immunity%20in%20induction%20of%20cross%20neutralizing%20antibody%20responses%20to%20all%204%20dengue%20serotypes&amp;author=F.%20Guirakhoo&amp;author=S.%20Kitckener&amp;author=D.%20Morrison%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B224" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">226<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="226"><li>B. Guy, F. Guirakhoo, V. Barban, S. Higgs, T. P. Monath, and J. Lang, “Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses,” <i>Vaccine</i>, vol. 28, no. 3, pp. 632–649, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2009.09.098" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Preclinical%20and%20clinical%20development%20of%20YFV%2017D-based%20chimeric%20vaccines%20against%20dengue,%20West%20Nile%20and%20Japanese%20encephalitis%20viruses&amp;author=B.%20Guy&amp;author=F.%20Guirakhoo&amp;author=V.%20Barban&amp;author=S.%20Higgs&amp;author=T.%20P.%20Monath&amp;author=&amp;author=J.%20Lang&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B226" class="seeRef">See in References</a>
          </div></a>]. Preclinical studies demonstrated that the tetravalent vaccine is genetically and phenotypically stable, nonhepatotropic, less neurovirulent than the tried and tested YFV 17D vaccine, and does not infect mosquitoes by the oral route. Vaccine reactogenicity, viremia induction, and antibody responses have been investigated in phase 1 trials in the USA, the Philippines, and Mexico. Preclinical and clinical trials showed favourable immunogenicity and short-term safety of this vaccine [<a class="refAnchor">227<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="227"><li>B. Guy, M. Saville, and J. Lang, “Development of Sanofi Pasteur tetravalent dengue vaccine,” <i>Human Vaccines</i>, vol. 6, no. 9, pp. 696–705, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.4161.hv.6.9.12739" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Development%20of%20Sanofi%20Pasteur%20tetravalent%20dengue%20vaccine&amp;author=B.%20Guy&amp;author=M.%20Saville&amp;author=&amp;author=J.%20Lang&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B227" class="seeRef">See in References</a>
          </div></a>]. Relatively favourable results of phase 2 trials were published recently. A surprising lack of efficacy against DENV2 was observed, and the fact that DENV2 was the prevalent serotype during the study diminished the overall vaccine efficacy in this setting [<a class="refAnchor">228<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="228"><li>A. Sabchareon, D. Wallace, C. Sirivichayakul et al., “Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial,” <i>The Lancet</i>, vol. 380, no. 9853, pp. 1559–1567, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Protective%20efficacy%20of%20the%20recombinant,%20live-attenuated,%20CYD%20tetravalent%20dengue%20vaccine%20in%20Thai%20schoolchildren:%20a%20randomised,%20controlled%20phase%202b%20trial&amp;author=A.%20Sabchareon&amp;author=D.%20Wallace&amp;author=C.%20Sirivichayakul%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B228" class="seeRef">See in References</a>
          </div></a>].</p><p> Several possible causes of this apparent failure have been proposed including significant genetic differences between the circulating DENV-2 genotype and the strain incorporated in the yellow fever chimaeric vaccine, imbalanced viraemias, or immune responses due to interference. Nevertheless, Sanofi’s CYD dengue vaccine has been discussed as a potential “75% solution” referring to the vaccine’s efficacy towards three of the four DENVs in the context of potential antibody-dependent enhancement. The general view seems to be that this approach would be inappropriate [<a class="refAnchor">229<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="229"><li>S. Swaminathan, N. Khanna, B. Herring, and S. Mahalingam, “Dengue vaccine efficacy trial: does interference cause failure?” <i>The Lancet Infectious Diseases</i>, vol. 13, no. 3, pp. 191–192, 2013. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vaccine%20efficacy%20trial:%20does%20interference%20cause%20failure?&amp;author=S.%20Swaminathan&amp;author=N.%20Khanna&amp;author=B.%20Herring&amp;author=&amp;author=S.%20Mahalingam&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B229" class="seeRef">See in References</a>
          </div></a>]. Probably, the most relevant issue is related to the long-term safety of such vaccines. DENV-2 has been associated with severe disease in several epidemiological settings. In fact, studies in Cuba demonstrated that disease severity increased notably when infection with DENV-2 follows infection with DENV-1 at an interval of 20 years [<a class="refAnchor">64<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="64"><li>M. G. Guzmán, G. Kouri, L. Valdes et al., “Epidemiologic studies on dengue in Santiago de Cuba, 1997,” <i>American Journal of Epidemiology</i>, vol. 152, no. 9, pp. 793–799, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1093/aje/152.9.793" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemiologic%20studies%20on%20dengue%20in%20Santiago%20de%20Cuba,%201997&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri&amp;author=L.%20Valdes%20et%20al.&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B64" class="seeRef">See in References</a>
          </div></a>], probably due to a significant decrease in mean titre of heterologous neutralizing antibodies [<a class="refAnchor">128<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="128"><li>M. G. Guzman, M. Alvarez, R. Rodriguez-Roche et al., “Neutralizing antibodies after infection with dengue 1 virus,” <i>Emerging Infectious Diseases</i>, vol. 13, no. 2, pp. 282–286, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibodies%20after%20infection%20with%20dengue%201%20virus&amp;author=M.%20G.%20Guzman&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B128" class="seeRef">See in References</a>
          </div></a>]. Thus, there is justified concern that CYD vaccinated individuals could develop severe disease if infection with DENV-2 occurs after a relatively long interval of time. On the other hand, depending on the DENV-2 genotype that might subsequently circulate, it cannot be ruled out that heterologous neutralisation might lead to a satisfactory immune outcome, as occurred in Cuba during the 2001-2002 epidemic caused by DENV-3, where most DENV-2 immune individuals (infected in 1981) developed asymptomatic DENV-3 infections whilst a high proportion of the DENV-1 immune cases suffered overt disease [<a class="refAnchor">63<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="63"><li>M. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1–3 virus infections over a long time interval: Havana epidemic, 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1113–1117, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20caused%20by%20sequential%20dengue%201%E2%80%933%20virus%20infections%20over%20a%20long%20time%20interval:%20Havana%20epidemic,%202001-2002&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche&amp;author=L.%20Bernardo%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B63" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">230<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="230"><li>M. G. Guzman, A. Alvarez, S. Vazquez et al., “Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002,” <i>International Journal of Infectious Diseases</i>, vol. 16, no. 3, pp. e198–e203, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2011.09.026" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemiological%20studies%20on%20dengue%20virus%20type%203%20in%20Playa%20municipality,%20Havana,%20Cuba,%202001-2002&amp;author=M.%20G.%20Guzman&amp;author=A.%20Alvarez&amp;author=S.%20Vazquez%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B230" class="seeRef">See in References</a>
          </div></a>]. In summary our limited understanding of the underlying processes of the immunopathological response to primary and successive infections with the four DENV largely determines our inability to predict the clinical outcome [<a class="refAnchor">231<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="231"><li>S. B. Halstead, “Dengue vaccine development: a 75% solution?” <i>The Lancet</i>, vol. 380, no. 9853, pp. 1535–1536, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vaccine%20development:%20a%2075%%20solution?&amp;author=S.%20B.%20Halstead&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B231" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">232<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="232"><li>W. M. P. B. Wahala and A. M. de Silva, “The human antibody response to dengue virus infection,” <i>Viruses</i>, vol. 3, no. 12, pp. 2374–2395, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.3390/v3122374" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20human%20antibody%20response%20to%20dengue%20virus%20infection&amp;author=W.%20M.%20P.%20B.%20Wahala%20&amp;author=A.%20M.%20de%20Silva&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B232" class="seeRef">See in References</a>
          </div></a>]. Nevertheless, ongoing large-scale phase 3 studies in more than 30,000 volunteers in ten countries in Latin America and Asia should provide critical data with which to overcome initial problems identified with the CYD dengue vaccine candidate.</p><p>A similar approach is being developed based on the attenuated DENV-2 virus, DENV-2 PDK-53, and three chimaeric viruses containing the prM and E genes of DENV-1, DENV-3, and DENV-4 virus in the genetic backbone of the DENV-2 PDK-53 virus (termed DENVax). Based on the safety, immunogenicity, and efficacy in preclinical studies in animal models, phase 1 clinical testing of tetravalent DENVax has been initiated [<a class="refAnchor">233<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="233"><li>J. E. Osorio, C. Y.-H. Huang, R. M. Kinney, and D. T. Stinchcomb, “Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever,” <i>Vaccine</i>, vol. 29, no. 42, pp. 7251–7260, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.07.020" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Development%20of%20DENVax:%20a%20chimeric%20dengue-2%20PDK-53-based%20tetravalent%20vaccine%20for%20protection%20against%20dengue%20fever&amp;author=J.%20E.%20Osorio&amp;author=C.%20Y.-H.%20Huang&amp;author=R.%20M.%20Kinney&amp;author=&amp;author=D.%20T.%20Stinchcomb&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B233" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">235<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="235"><li>J. N. Brewoo, R. M. Kinney, T. D. Powell et al., “Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice,” <i>Vaccine</i>, vol. 30, no. 8, pp. 1513–1520, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.11.072" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity%20and%20efficacy%20of%20chimeric%20dengue%20vaccine%20(DENVax)%20formulations%20in%20interferon-deficient%20AG129%20mice&amp;author=J.%20N.%20Brewoo&amp;author=R.%20M.%20Kinney&amp;author=T.%20D.%20Powell%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B235" class="seeRef">See in References</a>
          </div></a>]. This candidate might have advantages as the DENV backbone could reduce the risk of unanticipated effects due to the YFV NS proteins present in the Sanofi vaccine candidate [<a class="refAnchor">228<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="228"><li>A. Sabchareon, D. Wallace, C. Sirivichayakul et al., “Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial,” <i>The Lancet</i>, vol. 380, no. 9853, pp. 1559–1567, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Protective%20efficacy%20of%20the%20recombinant,%20live-attenuated,%20CYD%20tetravalent%20dengue%20vaccine%20in%20Thai%20schoolchildren:%20a%20randomised,%20controlled%20phase%202b%20trial&amp;author=A.%20Sabchareon&amp;author=D.%20Wallace&amp;author=C.%20Sirivichayakul%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B228" class="seeRef">See in References</a>
          </div></a>].</p><p>Potential vaccines not yet progressing through clinical trials include the development of subunit vaccines based on domain III of the dengue virus envelope protein. Recombinant fusion proteins formed by domain III and P64k protein from Neisseria meningitides expressed in <i>E. coli</i> induce functional and protective immunity in mice and nonhuman primate models inducing highly serotype specific immune responses [<a class="refAnchor">236<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="236"><li>L. Hermida, L. Bernardo, J. Martín et al., “A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates,” <i>Vaccine</i>, vol. 24, no. 16, pp. 3165–3171, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2006.01.036" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20recombinant%20fusion%20protein%20containing%20the%20domain%20III%20of%20the%20dengue-2%20envelope%20protein%20is%20immunogenic%20and%20protective%20in%20nonhuman%20primates&amp;author=L.%20Hermida&amp;author=L.%20Bernardo&amp;author=J.%20Mart%C3%ADn%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B236" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">238<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="238"><li>A. Izquierdo, L. Bernardo, J. Martin et al., “Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus,” <i>Virus Research</i>, vol. 138, no. 1-2, pp. 135–138, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virusres.2008.08.008" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Serotype-specificity%20of%20recombinant%20fusion%20proteins%20containing%20domain%20III%20of%20dengue%20virus&amp;author=A.%20Izquierdo&amp;author=L.%20Bernardo&amp;author=J.%20Martin%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B238" class="seeRef">See in References</a>
          </div></a>]. Additionally, the domains of each serotype have been engineered in tandem in a yeast expression system [<a class="refAnchor">239<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="239"><li>B. Etemad, G. Batra, R. Raut et al., “An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 79, no. 3, pp. 353–363, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=An%20envelope%20domain%20III-based%20chimeric%20antigen%20produced%20in%20Pichia%20pastoris%20elicits%20neutralizing%20antibodies%20against%20all%20four%20dengue%20virus%20serotypes&amp;author=B.%20Etemad&amp;author=G.%20Batra&amp;author=R.%20Raut%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B239" class="seeRef">See in References</a>
          </div></a>]. A recombinant adenovirus system has been utilised to express the DENV NS1 proteins [<a class="refAnchor">240<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="240"><li>G. Gao, Q. Wang, Z. Dai et al., “Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes,” <i>Human Gene Therapy</i>, vol. 19, no. 9, pp. 927–936, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1089/hum.2008.011" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Adenovirus-based%20vaccines%20generate%20cytotoxic%20T%20lymphocytes%20to%20epitopes%20of%20NS1%20from%20dengue%20virus%20that%20are%20present%20in%20all%20major%20serotypes&amp;author=G.%20Gao&amp;author=Q.%20Wang&amp;author=Z.%20Dai%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B240" class="seeRef">See in References</a>
          </div></a>].  The paediatric measles vaccine has been modified to express a fragment of the DENV-1 M protein together with domain III of the envelope protein [<a class="refAnchor">241<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="241"><li>S. Brandler, M. Lucas-Hourani, A. Moris et al., “Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus,” <i>PLoS Neglected Tropical Diseases</i>, vol. 1, no. 3, article e96, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000096" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Pediatric%20measles%20vaccine%20expressing%20a%20dengue%20antigen%20induces%20durable%20serotype-specific%20neutralizing%20antibodies%20to%20dengue%20virus&amp;author=S.%20Brandler&amp;author=M.%20Lucas-Hourani&amp;author=A.%20Moris%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B241" class="seeRef">See in References</a>
          </div></a>]. More recently, the evaluation in mice of a novel domain III-capsid chimaeric protein expressed in <i>E. coli</i> provides additional evidence for a crucial role of cell-mediated immunity in protection against dengue virus [<a class="refAnchor">242<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="242"><li>I. Valdés, L. Bernardo, L. Gil et al., “A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice,” <i>Virology</i>, vol. 394, no. 2, pp. 249–258, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2009.08.029" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20novel%20fusion%20protein%20domain%20III-capsid%20from%20dengue-2,%20in%20a%20highly%20aggregated%20form,%20induces%20a%20functional%20immune%20response%20and%20protection%20in%20mice&amp;author=I.%20Vald%C3%A9s&amp;author=L.%20Bernardo&amp;author=L.%20Gil%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B242" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">245<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="245"><li>L. Gil, L. Bernardo, A. Pavon et al., “Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice,” <i>Journal of General Virology</i>, vol. 93, part 6, pp. 1204–1214, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Recombinant%20nucleocapsid-like%20particles%20from%20dengue-2%20induce%20functional%20serotype-specific%20cell-mediated%20immunity%20in%20mice&amp;author=L.%20Gil&amp;author=L.%20Bernardo&amp;author=A.%20Pavon%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B245" class="seeRef">See in References</a>
          </div></a>]. Finally, a  novel single-dose lipidated consensus dengue virus envelope protein domain III (LcEDIII) subunit vaccine was shown to induce humoral and cellular immune responses in mice [<a class="refAnchor">246<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="246"><li>C.-Y. Chiang, S.-J. Liu, J.-P. Tsai et al., “A novel single-dose dengue subunit vaccine induces memory immune responses,” <i>PLoS ONE</i>, vol. 6, no. 8, Article ID e23319, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pone.0023319" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20novel%20single-dose%20dengue%20subunit%20vaccine%20induces%20memory%20immune%20responses&amp;author=C.-Y.%20Chiang&amp;author=S.-J.%20Liu&amp;author=J.-P.%20Tsai%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B246" class="seeRef">See in References</a>
          </div></a>]. This group also evaluated the efficacy of the newly developed water-in-oil-in-water multiphase emulsion system, termed PELC plus CpG oligodeoxynucleotides, in potentiating the protective capacity of dengue-1 envelope protein domain III concluding that it could be a promising adjuvant for recombinant protein candidates [<a class="refAnchor">247<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="247"><li>C. Y. Chiang, M. H. Huang, C. H. Hsieh et al., “Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses,” <i>PLOS Neglected Tropical Diseases</i>, vol. 6, no. 5, Article ID e1645, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0001645" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue-1%20envelope%20protein%20domain%20III%20along%20with%20PELC%20and%20CpG%20oligodeoxynucleotides%20synergistically%20enhances%20immune%20responses&amp;author=C.%20Y.%20Chiang&amp;author=M.%20H.%20Huang&amp;author=C.%20H.%20Hsieh%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B247" class="seeRef">See in References</a>
          </div></a>].</p><p> Whilst subunit vaccines may have some advantages in terms of type-specific neutralisation with a low potential for inducing ADE via cross-reactive antibodies and low reactogenicity, multiple doses are usually needed to ensure long-term immune protection. However, it has been suggested that recombinant domain III vaccine could function as a booster if used in combination with live vaccine [<a class="refAnchor">223<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="223"><li>M. G. Guzman, L. Hermida, L. Bernardo, R. Ramirez, and G. Guillén, “Domain III of the envelope protein as a dengue vaccine target,” <i>Expert Review of Vaccines</i>, vol. 9, no. 2, pp. 137–147, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1586/erv.09.139" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Domain%20III%20of%20the%20envelope%20protein%20as%20a%20dengue%20vaccine%20target&amp;author=M.%20G.%20Guzman&amp;author=L.%20Hermida&amp;author=L.%20Bernardo&amp;author=R.%20Ramirez&amp;author=&amp;author=G.%20Guill%C3%A9n&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B223" class="seeRef">See in References</a>
          </div></a>].</p><p>It is anticipated that within the next five years, increased understanding of the basis for dengue pathogenesis [<a class="refAnchor">248<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="248"><li>S. B. Halstead, “Controversies in dengue pathogenesis,” <i>Paediatrics and International Child Health</i>, vol. 32, supplement 1, pp. 5–9, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1179/2046904712Z.00000000045" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Controversies%20in%20dengue%20pathogenesis&amp;author=S.%20B.%20Halstead&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B248" class="seeRef">See in References</a>
          </div></a>] and the protective immune response to DENV will improve our ability to develop safer and more effective vaccines [<a class="refAnchor">223<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="223"><li>M. G. Guzman, L. Hermida, L. Bernardo, R. Ramirez, and G. Guillén, “Domain III of the envelope protein as a dengue vaccine target,” <i>Expert Review of Vaccines</i>, vol. 9, no. 2, pp. 137–147, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1586/erv.09.139" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Domain%20III%20of%20the%20envelope%20protein%20as%20a%20dengue%20vaccine%20target&amp;author=M.%20G.%20Guzman&amp;author=L.%20Hermida&amp;author=L.%20Bernardo&amp;author=R.%20Ramirez&amp;author=&amp;author=G.%20Guill%C3%A9n&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B223" class="seeRef">See in References</a>
          </div></a>]. </p><p>Critical issues in dengue vaccine development have been reviewed [<a class="refAnchor">249<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="249"><li>S. J. Thomas and T. P. Endy, “Critical issues in dengue vaccine development,” <i>Current Opinion in Infectious Diseases</i>, vol. 24, no. 5, pp. 442–450, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1097/QCO.0b013e32834a1b0b" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Critical%20issues%20in%20dengue%20vaccine%20development&amp;author=S.%20J.%20Thomas%20&amp;author=T.%20P.%20Endy&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B249" class="seeRef">See in References</a>
          </div></a>]. Of relevance is the potential impact of vaccination on the evolution of naturally occurring DENVs. Vaccination could ultimately produce an environment where relatively low transmission of natural DENV occurs. This is especially relevant if vaccination is focused on a selected portion of the population, thereby increasing stochastic events that will allow new DENV genotypes to emerge possibly with greater virulence. Furthermore, dengue vaccination may produce a background of low titres of enhancing antibody to specific DENV serotypes, resulting in the emergence of specific serotypes in a population. Recent studies suggest that strain diversity may limit the efficacy of monoclonal antibody therapy or tetravalent vaccines against DENV as neutralization potency generally correlates with a narrowed genotype specificity [<a class="refAnchor">250<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="250"><li>J. D. Brien, S. K. Austin, S. Sukupolvi-Petty et al., “Genotype-specific neutralization and protection by antibodies against dengue virus type 3,” <i>Journal of Virology</i>, vol. 84, no. 20, pp. 10630–10643, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.01190-10" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genotype-specific%20neutralization%20and%20protection%20by%20antibodies%20against%20dengue%20virus%20type%203&amp;author=J.%20D.%20Brien&amp;author=S.%20K.%20Austin&amp;author=S.%20Sukupolvi-Petty%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B250" class="seeRef">See in References</a>
          </div></a>]. Consequently, a better understanding of dengue immunopathogenesis will assist not only development of therapeutic interventions but also the understanding of dengue vaccine efficacy or vaccine adverse events [<a class="refAnchor">97<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="97"><li>J. Whitehorn and C. P. Simmons, “The pathogenesis of dengue,” <i>Vaccine</i>, vol. 29, no. 42, pp. 7221–7228, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.07.022" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue&amp;author=J.%20Whitehorn%20&amp;author=C.%20P.%20Simmons&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B97" class="seeRef">See in References</a>
          </div></a>]. Therefore, laboratory surveillance of dengue needs to be improved considerably to increase our knowledge of the circulating viruses at the molecular level, preferably before the introduction of a vaccine on a large-scale.</p><h5 id="sec3.3">3.3. Development of Antivirals against Dengue Viruses</h5><p>Whilst no approved antiviral therapeutic agents are available to treat individuals presenting with symptoms of DF/DHF, several potential virus inhibitors are under consideration for further development. The dengue viruses provide a variety of potential targets for inhibitors of infection/replication. As Hepatitis C virus (HCV) is also a member of the <i>Flaviviridae</i>, antivirals under development to control disease due to HCV may also prove to be effective against the dengue viruses. One of the major problems likely to be encountered is drug resistance. Consequently, the discovery and development of at least two antivirals that attack different viral targets should be a minimum goal. Another major hurdle for dengue viruses is the lack of availability of a validated animal model that faithfully reflects DHF and DSS observed in patients. </p><p>The NS5 viral RNA dependent RNA polymerase (RdRp) and the methyl transferase, as well as the NS3 protease and helicase, are considered good targets for inhibitors of dengue infection, because they are all major components of the replicative viral complex [<a class="refAnchor">251<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="251"><li>M. Bollati, K. Alvarez, R. Assenberg et al., “Structure and functionality in flavivirus NS-proteins: perspectives for drug design,” <i>Antiviral Research</i>, vol. 87, no. 2, pp. 125–148, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2009.11.009" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Structure%20and%20functionality%20in%20flavivirus%20NS-proteins:%20perspectives%20for%20drug%20design&amp;author=M.%20Bollati&amp;author=K.%20Alvarez&amp;author=R.%20Assenberg%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B251" class="seeRef">See in References</a>
          </div></a>]. The viral envelope (E) protein is also a good target for antivirals. The use of E protein-specific monoclonal antibodies has been shown to have some potential in this context [<a class="refAnchor">252<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="252"><li>E. A. Gould, T. Solomon, and J. S. Mackenzie, “Does antiviral therapy have a role in the control of Japanese encephalitis?” <i>Antiviral Research</i>, vol. 78, no. 1, pp. 140–149, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2007.10.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Does%20antiviral%20therapy%20have%20a%20role%20in%20the%20control%20of%20Japanese%20encephalitis?&amp;author=E.%20A.%20Gould&amp;author=T.%20Solomon&amp;author=&amp;author=J.%20S.%20Mackenzie&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B252" class="seeRef">See in References</a>
          </div></a>]. The NS1, prM, and capsid protein of the dengue viruses have not been studied at the same level of intensity, and thus there are few if any potential antivirals against these targets. </p><p>One approach that appears quite successful both <i>in vitro </i>and <i>in vivo</i> has been the demonstration that specific antisense morpholino oligomers can inhibit dengue virus replication [<a class="refAnchor">253<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="253"><li>R. M. Kinney, C. Y.-H. Huang, B. C. Rose et al., “Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers,” <i>Journal of Virology</i>, vol. 79, no. 8, pp. 5116–5128, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.79.8.5116-5128.2005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20dengue%20virus%20serotypes%201%20to%204%20in%20vero%20cell%20cultures%20with%20morpholino%20oligomers&amp;author=R.%20M.%20Kinney&amp;author=C.%20Y.-H.%20Huang&amp;author=B.%20C.%20Rose%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B253" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">254<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="254"><li>D. A. Stein, C. Y.-H. Huang, S. Silengo et al., “Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus,” <i>Journal of Antimicrobial Chemotherapy</i>, vol. 62, no. 3, pp. 555–565, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1093/jac/dkn221" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Treatment%20of%20AG129%20mice%20with%20antisense%20morpholino%20oligomers%20increases%20survival%20time%20following%20challenge%20with%20dengue%202%20virus&amp;author=D.%20A.%20Stein&amp;author=C.%20Y.-H.%20Huang&amp;author=S.%20Silengo%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B254" class="seeRef">See in References</a>
          </div></a>]. However, major efforts are required to reduce the risk of toxicity and to provide safe and effective delivery systems for these oligomers [<a class="refAnchor">252<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="252"><li>E. A. Gould, T. Solomon, and J. S. Mackenzie, “Does antiviral therapy have a role in the control of Japanese encephalitis?” <i>Antiviral Research</i>, vol. 78, no. 1, pp. 140–149, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2007.10.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Does%20antiviral%20therapy%20have%20a%20role%20in%20the%20control%20of%20Japanese%20encephalitis?&amp;author=E.%20A.%20Gould&amp;author=T.%20Solomon&amp;author=&amp;author=J.%20S.%20Mackenzie&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B252" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">255<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="255"><li>P. Kumar, H. Wu, J. L. McBride et al., “Transvascular delivery of small interfering RNA to the central nervous system,” <i>Nature</i>, vol. 448, no. 7149, pp. 39–43, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nature05901" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Transvascular%20delivery%20of%20small%20interfering%20RNA%20to%20the%20central%20nervous%20system&amp;author=P.%20Kumar&amp;author=H.%20Wu&amp;author=J.%20L.%20McBride%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B255" class="seeRef">See in References</a>
          </div></a>]. </p><p>Other approaches are being utilised to identify flavivirus chemotherapeutic agents, including screening known inhibitors of other viruses, rational design based on protein crystal structures or secondary viral RNA structures, optimization of known viral inhibitors, use of humanized antibodies, use of immunoglobulins, and nucleic acid-based therapy [<a class="refAnchor">256<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="256"><li>D. Ray and P.-Y. Shi, “Recent advances in flavivirus antiviral drug discovery and vaccine development,” <i>Recent Patents on Anti-Infective Drug Discovery</i>, vol. 1, no. 1, pp. 45–55, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.2174/157489106775244055" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20flavivirus%20antiviral%20drug%20discovery%20and%20vaccine%20development&amp;author=D.%20Ray%20&amp;author=P.-Y.%20Shi&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B256" class="seeRef">See in References</a>
          </div></a>].</p><p>Polyoxotungstates and sulphated polysaccharides show some potential as viral inhibitors. They impair flavivirus adsorption and entry into host cells <i>in vitro</i>, apparently by binding to the cell surface [<a class="refAnchor">257<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="257"><li>S. Shigeta, S. Mori, E. Kodama, J. Kodama, K. Takahashi, and T. Yamase, “Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates,” <i>Antiviral Research</i>, vol. 58, no. 3, pp. 265–271, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0166-3542(03)00009-3" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Broad%20spectrum%20anti-RNA%20virus%20activities%20of%20titanium%20and%20vanadium%20substituted%20polyoxotungstates&amp;author=S.%20Shigeta&amp;author=S.%20Mori&amp;author=E.%20Kodama&amp;author=J.%20Kodama&amp;author=K.%20Takahashi&amp;author=&amp;author=T.%20Yamase&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B257" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">258<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="258"><li>L. B. Talarico, C. A. Pujol, R. G. M. Zibetti et al., “The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell,” <i>Antiviral Research</i>, vol. 66, no. 2-3, pp. 103–110, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2005.02.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20antiviral%20activity%20of%20sulfated%20polysaccharides%20against%20dengue%20virus%20is%20dependent%20on%20virus%20serotype%20and%20host%20cell&amp;author=L.%20B.%20Talarico&amp;author=C.%20A.%20Pujol&amp;author=R.%20G.%20M.%20Zibetti%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B258" class="seeRef">See in References</a>
          </div></a>]. Sulphated galactomannans protected mice from lethal YFV infection when inoculated simultaneously with the virus [<a class="refAnchor">259<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="259"><li>L. Ono, W. Wollinger, I. M. Rocco, T. L. M. Coimbra, P. A. J. Gorin, and M.-R. Sierakowski, “In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain),” <i>Antiviral Research</i>, vol. 60, no. 3, pp. 201–208, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0166-3542(03)00175-X" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=In%20vitro%20and%20in%20vivo%20antiviral%20properties%20of%20sulfated%20galactomannans%20against%20yellow%20fever%20virus%20(BeH111%20strain)%20and%20dengue%201%20virus%20(Hawaii%20strain)&amp;author=L.%20Ono&amp;author=W.%20Wollinger&amp;author=I.%20M.%20Rocco&amp;author=T.%20L.%20M.%20Coimbra&amp;author=P.%20A.%20J.%20Gorin&amp;author=&amp;author=M.-R.%20Sierakowski&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B259" class="seeRef">See in References</a>
          </div></a>].</p><p>The licensed drug Ribavirin has been used to treat a number of RNA viral infections. It functions as an RNA cap analogue and mutagen, causing errors in synthetic pathways [<a class="refAnchor">260<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="260"><li>P. Leyssen, A. Van Lommel, C. Drosten, H. Schmitz, E. De Clercq, and J. Neyts, “A novel model for the study of the therapy of flavivirus infections using the Modoc virus,” <i>Virology</i>, vol. 279, no. 1, pp. 27–37, 2001. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.2000.0723" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20novel%20model%20for%20the%20study%20of%20the%20therapy%20of%20flavivirus%20infections%20using%20the%20Modoc%20virus&amp;author=P.%20Leyssen&amp;author=A.%20Van%20Lommel&amp;author=C.%20Drosten&amp;author=H.%20Schmitz&amp;author=E.%20De%20Clercq&amp;author=&amp;author=J.%20Neyts&amp;publication_year=2001" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B260" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">262<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="262"><li>J. D. Morrey, D. F. Smee, R. W. Sidwell, and C. Tseng, “Identification of active antiviral compounds against a New York isolate of West Nile virus,” <i>Antiviral Research</i>, vol. 55, no. 1, pp. 107–116, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0166-3542(02)00013-X" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Identification%20of%20active%20antiviral%20compounds%20against%20a%20New%20York%20isolate%20of%20West%20Nile%20virus&amp;author=J.%20D.%20Morrey&amp;author=D.%20F.%20Smee&amp;author=R.%20W.%20Sidwell&amp;author=&amp;author=C.%20Tseng&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B262" class="seeRef">See in References</a>
          </div></a>]. However, the <i>in vitro</i> and <i>in vivo </i>activity of Ribavirin against YFV and DENV was poor [<a class="refAnchor">263<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="263"><li>J. W. Huggins, “Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug,” <i>Reviews of Infectious Diseases</i>, vol. 11, pp. S750–761, 1989. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Prospects%20for%20treatment%20of%20viral%20hemorrhagic%20fevers%20with%20ribavirin,%20a%20broad-spectrum%20antiviral%20drug&amp;author=J.%20W.%20Huggins&amp;publication_year=1989" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B263" class="seeRef">See in References</a>
          </div></a>–<a class="refAnchor">265<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="265"><li>J. Neyts, A. Meerbach, P. McKenna, and E. De Clercq, “Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections,” <i>Antiviral Research</i>, vol. 30, no. 2-3, pp. 125–132, 1996. <span class="reflinks">View at: <a href="https://doi.org/10.1016/0166-3542(96)89697-5" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Use%20of%20the%20yellow%20fever%20virus%20vaccine%20strain%2017D%20for%20the%20study%20of%20strategies%20for%20the%20treatment%20of%20yellow%20fever%20virus%20infections&amp;author=J.%20Neyts&amp;author=A.%20Meerbach&amp;author=P.%20McKenna&amp;author=&amp;author=E.%20De%20Clercq&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B265" class="seeRef">See in References</a>
          </div></a>]. Prophylactic Ribavirin treatment of rhesus monkeys infected with DENV had little effect on viremia [<a class="refAnchor">266<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="266"><li>F. J. Malinoski, S. E. Hasty, M. A. Ussery, and J. M. Dalrymple, “Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys,” <i>Antiviral Research</i>, vol. 13, no. 3, pp. 139–150, 1990. <span class="reflinks">View at: <a href="https://doi.org/10.1016/0166-3542(90)90029-7" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Prophylactic%20ribavirin%20treatment%20of%20dengue%20type%201%20infection%20in%20rhesus%20monkeys&amp;author=F.%20J.%20Malinoski&amp;author=S.%20E.%20Hasty&amp;author=M.%20A.%20Ussery&amp;author=&amp;author=J.%20M.%20Dalrymple&amp;publication_year=1990" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B266" class="seeRef">See in References</a>
          </div></a>] and in mice, intraperitoneal administration of Ribavirin had no effect on survival following intracerebral inoculation with DENV. However, treatment with Ribavirin-2′,3′,5′-triacetate, a prodrug of Ribavirin, resulted in a significantly increased survival time and rate, possibly due to its higher ability to cross the blood-brain barrier [<a class="refAnchor">267<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="267"><li>W. C. Koff, R. D. Pratt, J. L. Elm Jr., C. N. Venkateshan, and S. B. Halstead, “Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin,” <i>Antimicrobial Agents and Chemotherapy</i>, vol. 24, no. 1, pp. 134–136, 1983. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Treatment%20of%20intracranial%20dengue%20virus%20infections%20in%20mice%20with%20a%20lipophilic%20derivative%20of%20ribavirin&amp;author=W.%20C.%20Koff&amp;author=R.%20D.%20Pratt&amp;author=J.%20L.%20Elm%20Jr.&amp;author=C.%20N.%20Venkateshan&amp;author=&amp;author=S.%20B.%20Halstead&amp;publication_year=1983" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B267" class="seeRef">See in References</a>
          </div></a>]. </p><p>Nucleoside analogues, characterized for chemotherapeutic use against HIV and Hepatitis B virus, show inhibitory activity in cell culture against YFV, DENV, and West Nile virus (WNV) [<a class="refAnchor">268<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="268"><li>P. LaColla and J. P. Sommadossi, “Methods and compositions for treating flaviviruses and pestiviruses,” US6812219, 2004. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Methods%20and%20compositions%20for%20treating%20flaviviruses%20and%20pestiviruses&amp;author=P.%20LaColla%20&amp;author=J.%20P.%20Sommadossi" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B268" class="seeRef">See in References</a>
          </div></a>]. Rather than blocking RNA replication, some analogues inhibit flaviviruses by inhibiting nucleoside triphosphate synthesis in host cells. For example, 6-azauridine acetate, pyrazofurin, and 2 thio-azauridine inhibit orotidine monophosphate decarboxylase (OMPDC). In contrast, mycophenolic acid and Ribavirin-2′,3′,5′-triacetate inhibit inosine monophosphate dehydrogenase (IMPDH) and block viral RNA synthesis [<a class="refAnchor">269<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="269"><li>M. S. Diamond, M. Zachariah, and E. Harris, “Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA,” <i>Virology</i>, vol. 304, no. 2, pp. 211–221, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.2002.1685" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mycophenolic%20acid%20inhibits%20dengue%20virus%20infection%20by%20preventing%20replication%20of%20viral%20RNA&amp;author=M.%20S.%20Diamond&amp;author=M.%20Zachariah&amp;author=&amp;author=E.%20Harris&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B269" class="seeRef">See in References</a>
          </div></a>, <a class="refAnchor">270<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="270"><li>M. D. Sintchak, M. A. Fleming, O. Futer et al., “Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid,” <i>Cell</i>, vol. 85, no. 6, pp. 921–930, 1996. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0092-8674(00)81275-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Structure%20and%20mechanism%20of%20inosine%20monophosphate%20dehydrogenase%20in%20complex%20with%20the%20immunosuppressant%20mycophenolic%20acid&amp;author=M.%20D.%20Sintchak&amp;author=M.%20A.%20Fleming&amp;author=O.%20Futer%20et%20al.&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B270" class="seeRef">See in References</a>
          </div></a>]. Carbamate prodrugs have also been recommended as IMPDH inhibitors since they show <i>in vivo </i>activity [<a class="refAnchor">271<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="271"><li>D. P. Stamos and R. S. Bethiel, “Prodrugs of carbamate inhibitors of IMPDH,” US6825224, 2004. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Prodrugs%20of%20carbamate%20inhibitors%20of%20IMPDH&amp;author=D.%20P.%20Stamos%20&amp;author=R.%20S.%20Bethiel" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B271" class="seeRef">See in References</a>
          </div></a>]. Recently a uracil-based multifunctional compound was shown to have strong activity against dengue virus. It is likely that the mechanism of action of the antiviral activity of this compound is through inhibition of the enzyme, IMPDH [<a class="refAnchor">272<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="272"><li>V. Nair, G. Chi, Q. Shu, J. Julander, and D. F. Smee, “A heterocyclic molecule with significant activity against dengue virus,” <i>Bioorganic and Medicinal Chemistry Letters</i>, vol. 19, no. 5, pp. 1425–1427, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.bmcl.2009.01.031" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20heterocyclic%20molecule%20with%20significant%20activity%20against%20dengue%20virus&amp;author=V.%20Nair&amp;author=G.%20Chi&amp;author=Q.%20Shu&amp;author=J.%20Julander&amp;author=&amp;author=D.%20F.%20Smee&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B272" class="seeRef">See in References</a>
          </div></a>].  </p><p>An alternative strategy in the search for effective antivirals that potentially reduces the lead-time for their development is to identify drugs already licensed for use to control diseases other than those caused by the target virus. For example, the aminoglycoside, Geneticin (G418), was recently shown to have antiviral activity against bovine viral diarrhea virus (BVDV). Since BVDV, DENV, and YFV all belong to the virus family <i>Flaviviridae</i>, it seems possible that a common step in their life cycle might be affected by this aminoglycoside. Geneticin prevented the cytopathic effect resulting from DENV-2 infection of BHK cells, in a dose-dependent manner [<a class="refAnchor">273<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="273"><li>X. G. Zhang, P. W. Mason, E. J. Dubovi et al., “Antiviral activity of geneticin against dengue virus,” <i>Antiviral Research</i>, vol. 83, no. 1, pp. 21–27, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2009.02.204" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Antiviral%20activity%20of%20geneticin%20against%20dengue%20virus&amp;author=X.%20G.%20Zhang&amp;author=P.%20W.%20Mason&amp;author=E.%20J.%20Dubovi%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B273" class="seeRef">See in References</a>
          </div></a>]. However, Geneticin had no detectable effect on YFV in BHK cells. </p><p>Ivermectin, a broadly used antihelmintic drug, displays specific inhibitory unwinding activity against helicases from several flaviviruses, including YFV, DENV, and WNV with the half maximal inhibitory concentration (IC<sub>50</sub>) values in the submicromolar range [<a class="refAnchor">274<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="274"><li>E. Mastrangelo, M. Pezzullo, T. De Burghgraeve et al., “Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug,” <i>Journal of Antimicrobial Chemotherapy</i>, vol. 67, no. 8, pp. 1884–1894, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1093/jac/dks147" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Ivermectin%20is%20a%20potent%20inhibitor%20of%20flavivirus%20replication%20specifically%20targeting%20NS3%20helicase%20activity:%20new%20prospects%20for%20an%20old%20drug&amp;author=E.%20Mastrangelo&amp;author=M.%20Pezzullo&amp;author=T.%20De%20Burghgraeve%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B274" class="seeRef">See in References</a>
          </div></a>]. Preliminary studies indicate higher binding efficiency with YFV than with DENV. Nevertheless, disappointingly, Ivermectin did not protect hamsters against infection with YFV. Structure-based optimization may result in analogues exerting potent activity against flaviviruses both <i>in vitro </i>and <i>in vivo</i>.</p><p>Doxorubicin is an antineoplastic antibiotic obtained from <i>Streptomyces peucetius</i>. This antibiotic exhibits <i>in vitro </i>antiviral activity against the YFV17D vaccine strain and the DENV-2 NGC strain. Doxorubicin proved to be cytotoxic in uninfected host cells. However, a novel derivative of doxorubicin, SA-17, showed excellent antiviral activity against DENV and markedly reduced cytopathogenicity [<a class="refAnchor">275<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="275"><li>S. J. F. Kaptein, T. De Burghgraeve, M. Froeyen et al., “A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro,” <i>Antimicrobial Agents and Chemotherapy</i>, vol. 54, no. 12, pp. 5269–5280, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1128/AAC.00686-10" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20derivate%20of%20the%20antibiotic%20doxorubicin%20is%20a%20selective%20inhibitor%20of%20dengue%20and%20yellow%20fever%20virus%20replication%20in%20vitro&amp;author=S.%20J.%20F.%20Kaptein&amp;author=T.%20De%20Burghgraeve&amp;author=M.%20Froeyen%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B275" class="seeRef">See in References</a>
          </div></a>]. Dose-dependent anti-DENV activity was confirmed using a dengue reporter virus. Time-of-drug addition studies indicated that SA-17 acts at an early stage of the replication cycle. It does not inhibit the replication of the replicon and thus does not work at the level of the viral replication machinery. Further studies revealed that SA-17 exerts it activity <i>via </i>a virucidal effect, even when using very high titres of the virus as the inoculum. </p><p>A large number of small molecules derived by computer modelling of known enzyme domains were screened for inhibitory activity against DENV-2 virus. Two of these molecules, ARDP0006 and ARDP0009, inhibited DENV-2 with high efficiency. ARDP0009 had no apparent toxicity at the concentrations tested. Selectivity indices calculated for ARDP0006 and ARDP0009 were comparable to those calculated for Ribavirin which has demonstrated inhibition of the DENV-2-O-methyltransferase NS5 [<a class="refAnchor">276<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="276"><li>D. Benarroch, M.-P. Egloff, L. Mulard, C. Guerreiro, J.-L. Romette, and B. Canard, “A structural basis for the inhibition of the NS5 dengue virus mRNA <math id="M5" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>2</mn><mo>′</mo></msup></mrow></math>-O-methyltransferase domain by ribavirin <math id="M6" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>5</mn><mo>′</mo></msup></mrow></math>-triphosphate,” <i>Journal of Biological Chemistry</i>, vol. 279, no. 34, pp. 35638–35643, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M400460200" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20structural%20basis%20for%20the%20inhibition%20of%20the%20NS5%20dengue%20virus%20mRNA%20%3Cinline-formula%3E%3Cmml:math%20id=" m5"%20xmlns:mml="http://www.w3.org/1998/Math/MathML" target="_blank"><mml:mrow><mml:msup><mml:mn>2</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow>-O-methyltransferase%20domain%20by%20ribavirin%20<inline-formula><mml:math%20id="m6"%20xmlns:mml="http: www.w3.org="" 1998="" math="" mathml"=""><mml:mrow><mml:msup><mml:mn>5</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math%20id="m6"%20xmlns:mml="http:></inline-formula>-triphosphate&amp;author=D. Benarroch&amp;author=M.-P. Egloff&amp;author=L. Mulard&amp;author=C. Guerreiro&amp;author=J.-L. Romette&amp;author=&amp;author=B. Canard&amp;publication_year=2004" target="_blank"&gt;Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B276" class="seeRef">See in References</a>
          </div></a>] and HCV replication when used in combination with interferon. Antiviral activity, <i>in vitro,</i> of 3′,5′ di-<i>O</i>-trityluridine has also been identified. The compound inhibits DENV and YFV replication by targeting the elongation process of the viral NS5 RNA-dependent RNA polymerase. A nucleoside analogue (T-705) which is a substituted pyrazine compound that has been used in clinical trials for the treatment of human influenza virus infection is an analogue of T-1106, a known HCV polymerase inhibitor [<a class="refAnchor">277<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="277"><li>J. G. Julander, K. Shafer, D. F. Smee, J. D. Morrey, and Y. Furuta, “Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106,” <i>Antimicrobial Agents and Chemotherapy</i>, vol. 53, no. 1, pp. 202–209, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1128/AAC.01074-08" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Activity%20of%20T-705%20in%20a%20hamster%20model%20of%20yellow%20fever%20virus%20infection%20in%20comparison%20with%20that%20of%20a%20chemically%20related%20compound,%20T-1106&amp;author=J.%20G.%20Julander&amp;author=K.%20Shafer&amp;author=D.%20F.%20Smee&amp;author=J.%20D.%20Morrey&amp;author=&amp;author=Y.%20Furuta&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B277" class="seeRef">See in References</a>
          </div></a>]. T-705 significantly improved survival and disease parameters in YFV-infected hamsters despite the lack of good <i>in vitro </i>antiviral activity. These studies highlight the possibility that nucleoside analogues could potentially be developed for flavivirus therapy although more potent compounds with reduced toxic effects on the host cells will need to be generated.</p><p>Flaviviral inhibitory activity has also been observed with plant extracts. Boesenbergia rotunda (L.) Mansf. Kulturpfl. (BR) is a common spice belonging to a member of the ginger family (Zingiberaceae). Some of the BR compounds, such as flavanoids and chalcones, have been shown to be pharmaceutically active. The chalcone, cardamonin, isolated from BR, was recently reported to exhibit appreciable anti-HIV-1 protease inhibition [<a class="refAnchor">278<div class="tooltip" style="display: none;">
          <img class="cross" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/cross.svg">
          <ol start="278"><li>S. Cheenpracha, C. Karalai, C. Ponglimanont, S. Subhadhirasakul, and S. Tewtrakul, “Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata,” <i>Bioorganic and Medicinal Chemistry</i>, vol. 14, no. 6, pp. 1710–1714, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.bmc.2005.10.019" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Anti-HIV-1%20protease%20activity%20of%20compounds%20from%20Boesenbergia%20pandurata&amp;author=S.%20Cheenpracha&amp;author=C.%20Karalai&amp;author=C.%20Ponglimanont&amp;author=S.%20Subhadhirasakul&amp;author=&amp;author=S.%20Tewtrakul&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol>
          <a href="https://www.hindawi.com/journals/bmri/2013/690835/#B278" class="seeRef">See in References</a>
          </div></a>]. Moreover, inhibitory activity by six compounds isolated from BR has also been demonstrated on DENV-2 virus NS3 protease activity.</p><p>In conclusion, whilst mosquito control strategies have been shown to be successful in reducing the incidence of dengue infections, such methods are most effective in those tropical/subtropical countries that have well-developed human and environmental health infrastructures. Clearly, there is a real need for more effort to understand the complex epidemiology and pathogenesis of the dengue viruses to expedite the development of suitable vaccines and/or antiviral therapies. Although some vaccine candidates appear promising, as yet none has been licensed. Due to the presence of the four DENV serotypes, these viruses present a different situation from YFV, tick-borne encephalitis virus, and Japanese encephalitis virus. The question of whether or not deteriorating antibody levels will leave vaccinated people liable to the development of DHF via ADE will need to be addressed. Moreover, the relationships between the presence of neutralizing antibodies, the level of protection afforded and the duration of protection by each of the four serotypes will need to be critically assessed. There is a pressing need for global collective efforts to develop antiviral therapeutics with which to combat dengue viruses. The current trend of expanding our efforts on antiviral drug discovery is encouraging in this respect.</p><h4 id="acknowledgments">Acknowledgments</h4><p>The authors wish to thank Dr. Maria G Guzman for helpful advice and criticism in the preparation of this review. Professor Gould is supported under the EU 7th Framework-Health Programmes (Grant Agreement no. 260644 - SILVER and Grant Agreement no. 278433 - PREDEMICS), and Dr. Rodriguez-Roche is supported by the Cuban Ministry of Public Health and under the EU 7th Framework-Health Programme (Grant Agreement no. 282378 - DENFREE).</p></div><div class="xml-content"><h4 class="references" id="references">References</h4><ol><li id="B1">F. P. Pinheiro and S. J. Corber, “Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas,” <i>World Health Statistics Quarterly</i>, vol. 50, no. 3-4, pp. 161–169, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Global%20situation%20of%20dengue%20and%20dengue%20haemorrhagic%20fever,%20and%20its%20emergence%20in%20the%20Americas&amp;author=F.%20P.%20Pinheiro%20&amp;author=S.%20J.%20Corber&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li><li id="B2">D. J. Gubler, “The global emergence/resurgence of arboviral diseases as public health problems,” <i>Archives of Medical Research</i>, vol. 33, no. 4, pp. 330–342, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0188-4409(02)00378-8" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20global%20emergence/resurgence%20of%20arboviral%20diseases%20as%20public%20health%20problems&amp;author=D.%20J.%20Gubler&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B3">S. B. Halstead, “Dengue,” <i>The Lancet</i>, vol. 370, no. 9599, pp. 1644–1652, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(07)61687-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue&amp;author=S.%20B.%20Halstead&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B4">P. M. De A. Zanotto, E. A. Gould, G. F. Gao, P. H. Harvey, and E. C. Holmes, “Population dynamics of flaviviruses revealed by molecular phylogenies,” <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 93, no. 2, pp. 548–553, 1996. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.93.2.548" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Population%20dynamics%20of%20flaviviruses%20revealed%20by%20molecular%20phylogenies&amp;author=P.%20M.%20De%20A.%20Zanotto&amp;author=E.%20A.%20Gould&amp;author=G.%20F.%20Gao&amp;author=P.%20H.%20Harvey&amp;author=&amp;author=E.%20C.%20Holmes&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li><li id="B5"> WHO, <i>Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control</i>, WHO, Geneva, Switzerland, 2nd edition, 1997. <span class="reflinks"></span></li><li id="B6">L. M. Ling, A. Wilder-Smith, and Y. S. Leo, “Fulminant hepatitis in dengue haemorrhagic fever,” <i>Journal of Clinical Virology</i>, vol. 38, no. 3, pp. 265–268, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jcv.2006.12.011" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Fulminant%20hepatitis%20in%20dengue%20haemorrhagic%20fever&amp;author=L.%20M.%20Ling&amp;author=A.%20Wilder-Smith&amp;author=&amp;author=Y.%20S.%20Leo&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B7">S. Gulati and A. Maheshwari, “Atypical manifestations of dengue,” <i>Tropical Medicine and International Health</i>, vol. 12, no. 9, pp. 1087–1095, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-3156.2007.01891.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Atypical%20manifestations%20of%20dengue&amp;author=S.%20Gulati%20&amp;author=A.%20Maheshwari&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B8">R. Kumar, S. Tripathi, J. J. Tambe, V. Arora, A. Srivastava, and V. L. Nag, “Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue,” <i>Journal of the Neurological Sciences</i>, vol. 269, no. 1-2, pp. 41–48, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jns.2007.12.018" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20encephalopathy%20in%20children%20in%20Northern%20India:%20clinical%20features%20and%20comparison%20with%20non%20dengue&amp;author=R.%20Kumar&amp;author=S.%20Tripathi&amp;author=J.%20J.%20Tambe&amp;author=V.%20Arora&amp;author=A.%20Srivastava&amp;author=&amp;author=V.%20L.%20Nag&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B9">M. Wasay, R. Channa, M. Jumani, G. Shabbir, M. Azeemuddin, and A. Zafar, “Encephalitis and myelitis associated with dengue viral infection. Clinical and neuroimaging features,” <i>Clinical Neurology and Neurosurgery</i>, vol. 110, no. 6, pp. 635–640, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.clineuro.2008.03.011" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Encephalitis%20and%20myelitis%20associated%20with%20dengue%20viral%20infection.%20Clinical%20and%20neuroimaging%20features&amp;author=M.%20Wasay&amp;author=R.%20Channa&amp;author=M.%20Jumani&amp;author=G.%20Shabbir&amp;author=M.%20Azeemuddin&amp;author=&amp;author=A.%20Zafar&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B10">T. Solomon, N. M. Dung, D. W. Vaughn et al., “Neurological manifestations of dengue infection,” <i>The Lancet</i>, vol. 355, no. 9209, pp. 1053–1059, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Neurological%20manifestations%20of%20dengue%20infection&amp;author=T.%20Solomon&amp;author=N.%20M.%20Dung&amp;author=D.%20W.%20Vaughn%20et%20al.&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li><li id="B11">S. B. Park, S. Y. Ryu, K. B. Jin et al., “Acute colitis associated with dengue fever in a renal transplant recipient,” <i>Transplantation Proceedings</i>, vol. 40, no. 7, pp. 2431–2432, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.transproceed.2008.07.037" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Acute%20colitis%20associated%20with%20dengue%20fever%20in%20a%20renal%20transplant%20recipient&amp;author=S.%20B.%20Park&amp;author=S.%20Y.%20Ryu&amp;author=K.%20B.%20Jin%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B12">A. Balmaseda, S. N. Hammond, M. A. Pérez et al., “Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 73, no. 6, pp. 1059–1062, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Short%20report:%20assessment%20of%20the%20World%20Health%20Organization%20scheme%20for%20classification%20of%20dengue%20severity%20in%20Nicaragua&amp;author=A.%20Balmaseda&amp;author=S.%20N.%20Hammond&amp;author=M.%20A.%20P%C3%A9rez%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B13">S. Bandyopadhyay, L. C. S. Lum, and A. Kroeger, “Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever,” <i>Tropical Medicine and International Health</i>, vol. 11, no. 8, pp. 1238–1255, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-3156.2006.01678.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Classifying%20dengue:%20a%20review%20of%20the%20difficulties%20in%20using%20the%20WHO%20case%20classification%20for%20dengue%20haemorrhagic%20fever&amp;author=S.%20Bandyopadhyay&amp;author=L.%20C.%20S.%20Lum&amp;author=&amp;author=A.%20Kroeger&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B14">J. G. Rigau-Pérez, “Severe dengue: the need for new case definitions,” <i>Lancet Infectious Diseases</i>, vol. 6, no. 5, pp. 297–302, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S1473-3099(06)70465-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Severe%20dengue:%20the%20need%20for%20new%20case%20definitions&amp;author=J.%20G.%20Rigau-P%C3%A9rez&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B15">J. L. Deen, E. Harris, B. Wills et al., “The WHO dengue classification and case definitions: time for a reassessment,” <i>The Lancet</i>, vol. 368, no. 9530, pp. 170–173, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(06)69006-5" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20WHO%20dengue%20classification%20and%20case%20definitions:%20time%20for%20a%20reassessment&amp;author=J.%20L.%20Deen&amp;author=E.%20Harris&amp;author=B.%20Wills%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B16">N. Alexander, A. Balmaseda, I. C. B. Coelho et al., “Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries,” <i>Tropical Medicine and International Health</i>, vol. 16, no. 8, pp. 936–948, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-3156.2011.02793.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Multicentre%20prospective%20study%20on%20dengue%20classification%20in%20four%20South-east%20Asian%20and%20three%20Latin%20American%20countries&amp;author=N.%20Alexander&amp;author=A.%20Balmaseda&amp;author=I.%20C.%20B.%20Coelho%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B17"> WHO/TDR, <i>Dengue Guidelines for Diagnosis, Treatment, Prevention and Control</i>, WHO Press, Geneva, Switzerland, 2009. <span class="reflinks"></span></li><li id="B18">N. A. Akbar, I. Allende, A. Balmaseda et al., “Regarding “Dengue—how best to classify it”,” <i>Clinical Infectious Diseases</i>, vol. 54, no. 12, pp. 1820–1821, 2012, author reply 1821-1822. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cis328" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Regarding%20%E2%80%9CDengue%E2%80%94how%20best%20to%20classify%20it%E2%80%9D&amp;author=N.%20A.%20Akbar&amp;author=I.%20Allende&amp;author=A.%20Balmaseda%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B19">A. Srikiatkhachorn, A. L. Rothman, R. V. Gibbons et al., “Dengue-how best to classify it,” <i>Clinical Infectious Diseases</i>, vol. 53, no. 6, pp. 563–567, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cir451" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue-how%20best%20to%20classify%20it&amp;author=A.%20Srikiatkhachorn&amp;author=A.%20L.%20Rothman&amp;author=R.%20V.%20Gibbons%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B20">S. Kalayanarooj, “Dengue classification: current WHO vs. the newly suggested classification for better clinical application?” <i>Journal of the Medical Association of Thailand</i>, vol. 94, pp. S74–84, 2011. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20classification:%20current%20WHO%20vs.%20the%20newly%20suggested%20classification%20for%20better%20clinical%20application?&amp;author=S.%20Kalayanarooj&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B21">S. B. Halstead, “Dengue: the syndromic basis to pathogenesis research. Inutility of the 2009 WHO case definition,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 88, no. 2, pp. 212–215, 2013. <span class="reflinks">View at: <a href="https://doi.org/10.4269/ajtmh.12-0197" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue:%20the%20syndromic%20basis%20to%20pathogenesis%20research.%20Inutility%20of%20the%202009%20WHO%20case%20definition&amp;author=S.%20B.%20Halstead&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li><li id="B22">J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Ochlerotatus and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” <i>Zoological Journal of the Linnean Society</i>, vol. 153, no. 1, pp. 29–114, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1096-3642.2008.00382.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Ochlerotatus%20and%20allied%20taxa%20(Diptera:%20Culicidae:%20Aedini)%20based%20on%20morphological%20data%20from%20all%20life%20stages&amp;author=J.%20F.%20Reinert&amp;author=R.%20E.%20Harbach&amp;author=&amp;author=I.%20J.%20Kitching&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B23">J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Aedini (Diptera: Culicidae), based on morphological characters of all life stages,” <i>Zoological Journal of the Linnean Society</i>, vol. 142, no. 3, pp. 289–368, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1096-3642.2004.00144.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Aedini%20(Diptera:%20Culicidae),%20based%20on%20morphological%20characters%20of%20all%20life%20stages&amp;author=J.%20F.%20Reinert&amp;author=R.%20E.%20Harbach&amp;author=&amp;author=I.%20J.%20Kitching&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li><li id="B24">J. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Finlaya and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” <i>Zoological Journal of the Linnean Society</i>, vol. 148, no. 1, pp. 1–101, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1096-3642.2006.00254.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Finlaya%20and%20allied%20taxa%20(Diptera:%20Culicidae:%20Aedini)%20based%20on%20morphological%20data%20from%20all%20life%20stages&amp;author=J.%20F.%20Reinert&amp;author=R.%20E.%20Harbach&amp;author=&amp;author=I.%20J.%20Kitching&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B25">E. A. Gould, X. de Lamballerie, P. M. D. A. Zanotto, and E. C. Holmes, “Origins, evolution, and vector{plus 45 degree rule}host coadaptations within the Genus Flavivirus,” <i>Advances in Virus Research</i>, vol. 59, pp. 277–314, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0065-3527(03)59008-X" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Origins,%20evolution,%20and%20vector{plus%2045%20degree%20rule}host%20coadaptations%20within%20the%20Genus%20Flavivirus&amp;author=E.%20A.%20Gould&amp;author=X.%20de%20Lamballerie&amp;author=P.%20M.%20D.%20A.%20Zanotto&amp;author=&amp;author=E.%20C.%20Holmes&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B26">G. K. Strode, <i>Yellow Fever</i>, McGraw-Hill, New York, NY, USA, 1951. <span class="reflinks"></span></li><li id="B27">W. J. Tabachnick, “Evolutionary genetics and arthropod-borne diseases. The yellow fever mosquito, <i>Aedes aegypti</i>,” <i>American Journal of Entomology</i>, vol. 37, pp. 14–24, 1991. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Evolutionary%20genetics%20and%20arthropod-borne%20diseases.%20The%20yellow%20fever%20mosquito,%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=W.%20J.%20Tabachnick&amp;publication_year=1991" target="_blank">Google Scholar</a></span></li><li id="B28">L. P. Lounibos, “Invasions by insect vectors of human disease,” <i>Annual Review of Entomology</i>, vol. 47, pp. 233–266, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.ento.47.091201.145206" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Invasions%20by%20insect%20vectors%20of%20human%20disease&amp;author=L.%20P.%20Lounibos&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B29">X. De Lamballerie, E. Leroy, R. N. Charrel, K. Ttsetsarkin, S. Higgs, and E. A. Gould, “Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?” <i>Virology Journal</i>, vol. 5, article 33, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1186/1743-422X-5-33" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Chikungunya%20virus%20adapts%20to%20tiger%20mosquito%20via%20evolutionary%20convergence:%20a%20sign%20of%20things%20to%20come?&amp;author=X.%20De%20Lamballerie&amp;author=E.%20Leroy&amp;author=R.%20N.%20Charrel&amp;author=K.%20Ttsetsarkin&amp;author=S.%20Higgs&amp;author=&amp;author=E.%20A.%20Gould&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B30">A. J. Tatem, R. W. Snow, and S. I. Hay, “Mapping the environmental coverage of the INDEPTH demographic surveillance system network in rural Africa,” <i>Tropical Medicine and International Health</i>, vol. 11, no. 8, pp. 1318–1326, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-3156.2006.01681.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mapping%20the%20environmental%20coverage%20of%20the%20INDEPTH%20demographic%20surveillance%20system%20network%20in%20rural%20Africa&amp;author=A.%20J.%20Tatem&amp;author=R.%20W.%20Snow&amp;author=&amp;author=S.%20I.%20Hay&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B31">K. J. Bloom, <i>The Mississippi Valley's Great Yellow Fever Epidemic of 1978</i>, Louisiana State University Press, Baton Rouge, Lo, USA, 1993. <span class="reflinks"></span></li><li id="B32">B. Rush, “An account of the bilious remitting fever. As it appeared in philadelphia, in the summer and autumn of the year 1780,” <i>The American Journal of Medicine</i>, vol. 11, no. 5, pp. 546–550, 1951. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=An%20account%20of%20the%20bilious%20remitting%20fever.%20As%20it%20appeared%20in%20philadelphia,%20in%20the%20summer%20and%20autumn%20of%20the%20year%201780&amp;author=B.%20Rush&amp;publication_year=1951" target="_blank">Google Scholar</a></span></li><li id="B33">S. B. Halstead, “Dengue in the Americas and Southeast Asia: do they differ?” <i>Revista Panamericana de Salud Publica</i>, vol. 20, no. 6, pp. 407–415, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20in%20the%20Americas%20and%20Southeast%20Asia:%20do%20they%20differ?&amp;author=S.%20B.%20Halstead&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B34">D. Gubler, “Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem,” in <i>Dengue and Dengue Hemorrhagic Fever</i>, D. Gubler and G. Kuno, Eds., pp. 1–22, CAB International, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20hemorrhagic%20fever:%20its%20history%20and%20resurgence%20as%20a%20global%20public%20health%20problem&amp;author=D.%20Gubler&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li><li id="B35">D. J. Gubler, “The emergence of dengue/dengue haemorrhagic fever as a global public health problem,” in <i>Factors in the Emergence of Arbovirus Diseases</i>, J. F. Saluzzo and B. Dodet, Eds., pp. 83–92, Elsevier, Paris, France, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20emergence%20of%20dengue/dengue%20haemorrhagic%20fever%20as%20a%20global%20public%20health%20problem&amp;author=D.%20J.%20Gubler&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li><li id="B36">D. J. Gubler, “Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century,” <i>Trends in Microbiology</i>, vol. 10, no. 2, pp. 100–103, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0966-842X(01)02288-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemic%20dengue/dengue%20hemorrhagic%20fever%20as%20a%20public%20health,%20social%20and%20economic%20problem%20in%20the%2021st%20century&amp;author=D.%20J.%20Gubler&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B37">D. J. Gubler, “Dengue/dengue haemorrhagic fever: history and current status,” <i>Novartis Foundation Symposium</i>, vol. 277, pp. 3–16, 2006, discussion 16–22, 71–13, 251–253. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue/dengue%20haemorrhagic%20fever:%20history%20and%20current%20status&amp;author=D.%20J.%20Gubler&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B38">S. B. Halstead, “Dengue hemorrhagic fever: two infections and antibody dependent enhancement, a brief history and personal memoir,” <i>Revista Cubana de Medicina Tropical</i>, vol. 54, no. 3, pp. 171–179, 2002. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever:%20two%20infections%20and%20antibody%20dependent%20enhancement,%20a%20brief%20history%20and%20personal%20memoir&amp;author=S.%20B.%20Halstead&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B39">S. B. Halstead, “Dengue virus-mosquito interactions,” <i>Annual Review of Entomology</i>, vol. 53, pp. 273–291, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.ento.53.103106.093326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus-mosquito%20interactions&amp;author=S.%20B.%20Halstead&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B40">R. E. Blanton, L. K. Silva, V. G. Morato et al., “Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population,” <i>European Journal of Human Genetics</i>, vol. 16, no. 6, pp. 762–765, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1038/ejhg.2008.4" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genetic%20ancestry%20and%20income%20are%20associated%20with%20dengue%20hemorrhagic%20fever%20in%20a%20highly%20admixed%20population&amp;author=R.%20E.%20Blanton&amp;author=L.%20K.%20Silva&amp;author=V.%20G.%20Morato%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B41">B. D. L. C. Sierra, G. Kourí, and M. G. Guzmán, “Race: a risk factor for dengue hemorrhagic fever,” <i>Archives of Virology</i>, vol. 152, no. 3, pp. 533–542, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-006-0869-x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Race:%20a%20risk%20factor%20for%20dengue%20hemorrhagic%20fever&amp;author=B.%20D.%20L.%20C.%20Sierra&amp;author=G.%20Kour%C3%AD&amp;author=&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B42">M. G. Guzman and G. Kouri, “Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges,” <i>Journal of Clinical Virology</i>, vol. 27, no. 1, pp. 1–13, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S1386-6532(03)00010-6" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20hemorrhagic%20fever%20in%20the%20Americas:%20lessons%20and%20challenges&amp;author=M.%20G.%20Guzman%20&amp;author=G.%20Kouri&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B43">N. Singh, T. Kiedrzynski, C. Lepers, and E. K. Benyon, “Dengue in the Pacific—an update of the current situation,” <i>Pacific Health Dialog</i>, vol. 12, no. 2, pp. 111–119, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20in%20the%20Pacific%E2%80%94an%20update%20of%20the%20current%20situation&amp;author=N.%20Singh&amp;author=T.%20Kiedrzynski&amp;author=C.%20Lepers&amp;author=&amp;author=E.%20K.%20Benyon&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B44">A. Wilder-Smith and D. J. Gubler, “Geographic expansion of dengue: the impact of international travel,” <i>Medical Clinics of North America</i>, vol. 92, no. 6, pp. 1377–1390, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.mcna.2008.07.002" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Geographic%20expansion%20of%20dengue:%20the%20impact%20of%20international%20travel&amp;author=A.%20Wilder-Smith%20&amp;author=D.%20J.%20Gubler&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B45">C. Franco, N. A. Hynes, N. Bouri, and D. A. Henderson, “The dengue threat to the United States,” <i>Biosecurity and Bioterrorism</i>, vol. 8, no. 3, pp. 273–276, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1089/bsp.2010.0032" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20dengue%20threat%20to%20the%20United%20States&amp;author=C.%20Franco&amp;author=N.%20A.%20Hynes&amp;author=N.%20Bouri&amp;author=&amp;author=D.%20A.%20Henderson&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B46">E. A. Gould, P. Gallian, X. De Lamballerie, and R. N. Charrel, “First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!,” <i>Clinical Microbiology and Infection</i>, vol. 16, no. 12, pp. 1702–1704, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1469-0691.2010.03386.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=First%20cases%20of%20autochthonous%20dengue%20fever%20and%20chikungunya%20fever%20in%20France:%20from%20bad%20dream%20to%20reality!&amp;author=E.%20A.%20Gould&amp;author=P.%20Gallian&amp;author=X.%20De%20Lamballerie&amp;author=&amp;author=R.%20N.%20Charrel&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B47">I. C. Kurolt, L. Betica-Radic, O. Dakovic-Rode et al., “Molecular characterization of dengue virus 1 from autochthonous dengue fever cases in Croatia,” <i>Clinical Microbiology and Infection</i>, vol. 19, no. 3, pp. 163–165, 2013. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Molecular%20characterization%20of%20dengue%20virus%201%20from%20autochthonous%20dengue%20fever%20cases%20in%20Croatia&amp;author=I.%20C.%20Kurolt&amp;author=L.%20Betica-Radic&amp;author=O.%20Dakovic-Rode%20et%20al.&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li><li id="B48">M. G. Guzman and G. Kouri, “Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987–2007,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 102, no. 6, pp. 522–523, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.trstmh.2008.03.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20haemorrhagic%20fever%20integral%20hypothesis:%20confirming%20observations,%201987%E2%80%932007&amp;author=M.%20G.%20Guzman%20&amp;author=G.%20Kouri&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B49">M. G. Guzman, S. Vazquez, E. Martinez et al., “Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas,” <i>Boletin de la Oficina Sanitaria Panamericana</i>, vol. 121, no. 2, pp. 102–110, 1996. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20in%20Nicaragua,%201994:%20reintroduction%20of%20serotype%203%20in%20the%20Americas&amp;author=M.%20G.%20Guzman&amp;author=S.%20Vazquez&amp;author=E.%20Martinez%20et%20al.&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li><li id="B50">M. G. Guzmán, D. Rosario, M. Muné, M. Alvarez, R. Rodríguez, and G. Kourí, “Genetic relatedness of the dengue 3 virus isolated in the outbreak of dengue hemorrhagic fever in Nicaragua, 1994,” <i>Revista Cubana de Medicina Tropical</i>, vol. 48, no. 2, pp. 114–117, 1996. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Genetic%20relatedness%20of%20the%20dengue%203%20virus%20isolated%20in%20the%20outbreak%20of%20dengue%20hemorrhagic%20fever%20in%20Nicaragua,%201994&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=D.%20Rosario&amp;author=M.%20Mun%C3%A9&amp;author=M.%20Alvarez&amp;author=R.%20Rodr%C3%ADguez&amp;author=&amp;author=G.%20Kour%C3%AD&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li><li id="B51">R. Rico-Hesse, “Microevolution and virulence of dengue viruses,” <i>Advances in Virus Research</i>, vol. 59, pp. 315–341, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0065-3527(03)59009-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Microevolution%20and%20virulence%20of%20dengue%20viruses&amp;author=R.%20Rico-Hesse&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B52">M. G. Teixeira, M. C. N. Costa, G. Coelho, and M. L. Barreto, “Recent shift in age pattern of dengue hemorrhagic fever, Brazil,” <i>Emerging Infectious Diseases</i>, vol. 14, no. 10, p. 1663, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1410.071164" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Recent%20shift%20in%20age%20pattern%20of%20dengue%20hemorrhagic%20fever,%20Brazil&amp;author=M.%20G.%20Teixeira&amp;author=M.%20C.%20N.%20Costa&amp;author=G.%20Coelho&amp;author=&amp;author=M.%20L.%20Barreto&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B53">L. P. Cavalcanti, D. Vilar, R. Souza-Santos, and M. G. Teixeira, “Change in age pattern of persons with dengue, Northeastern Brazil,” <i>Emerging Infectious Diseases</i>, vol. 17, no. 1, pp. 132–134, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1701.100321" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Change%20in%20age%20pattern%20of%20persons%20with%20dengue,%20Northeastern%20Brazil&amp;author=L.%20P.%20Cavalcanti&amp;author=D.%20Vilar&amp;author=R.%20Souza-Santos&amp;author=&amp;author=M.%20G.%20Teixeira&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B54">M. Q. Benedict, R. S. Levine, W. A. Hawley, and L. P. Lounibos, “Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus,” <i>Vector-Borne and Zoonotic Diseases</i>, vol. 7, no. 1, pp. 76–85, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1089/vbz.2006.0562" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Spread%20of%20the%20tiger:%20global%20risk%20of%20invasion%20by%20the%20mosquito%20Aedes%20albopictus&amp;author=M.%20Q.%20Benedict&amp;author=R.%20S.%20Levine&amp;author=W.%20A.%20Hawley&amp;author=&amp;author=L.%20P.%20Lounibos&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B55">R. N. Charrel, X. De Lamballerie, and D. Raoult, “Chikungunya outbreaks—the globalization of vectorborne diseases,” <i>The New England Journal of Medicine</i>, vol. 356, no. 8, pp. 769–771, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1056/NEJMp078013" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Chikungunya%20outbreaks%E2%80%94the%20globalization%20of%20vectorborne%20diseases&amp;author=R.%20N.%20Charrel&amp;author=X.%20De%20Lamballerie&amp;author=&amp;author=D.%20Raoult&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B56">C. Sousa, M. Clairouin, G. Seixas et al., “Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report,” <i>Eurosurveillance</i>, vol. 17, no. 49, article 3, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Ongoing%20outbreak%20of%20dengue%20type%201%20in%20the%20Autonomous%20Region%20of%20Madeira,%20Portugal:%20preliminary%20report&amp;author=C.%20Sousa&amp;author=M.%20Clairouin&amp;author=G.%20Seixas%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B57">C. Caminade, J. M. Medlock, E. Ducheyne et al., “Suitability of European climate for the Asian tiger mosquito <i>Aedes albopictus</i>: recent trends and future scenarios,” <i>Journal of the Royal Society Interface</i>, vol. 9, no. 75, pp. 2708–2717, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1098/rsif.2012.0138" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Suitability%20of%20European%20climate%20for%20the%20Asian%20tiger%20mosquito%20%3Ci%3EAedes%20albopictus%3C/i%3E:%20recent%20trends%20and%20future%20scenarios&amp;author=C.%20Caminade&amp;author=J.%20M.%20Medlock&amp;author=E.%20Ducheyne%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B58">W. F. Wright and B. S. Pritt, “Update: the diagnosis and management of dengue virus infection in North America,” <i>Diagnostic Microbiology and Infectious Disease</i>, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.diagmicrobio.2012.03.021" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Update:%20the%20diagnosis%20and%20management%20of%20dengue%20virus%20infection%20in%20North%20America&amp;author=W.%20F.%20Wright%20&amp;author=B.%20S.%20Pritt&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B59">F. Wu, Q. Liu, L. Lu, J. Wang, X. Song, and D. Ren, “Distribution of Aedes albopictus (Diptera: Culicidae) in northwestern China,” <i>Vector-Borne and Zoonotic Diseases</i>, vol. 11, no. 8, pp. 1181–1186, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1089/vbz.2010.0032" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Distribution%20of%20Aedes%20albopictus%20(Diptera:%20Culicidae)%20in%20northwestern%20China&amp;author=F.%20Wu&amp;author=Q.%20Liu&amp;author=L.%20Lu&amp;author=J.%20Wang&amp;author=X.%20Song&amp;author=&amp;author=D.%20Ren&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B60">M. G. Guzmán, “Deciphering dengue: the Cuban experience,” <i>Science</i>, vol. 309, no. 5740, pp. 1495–1497, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.1115177" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Deciphering%20dengue:%20the%20Cuban%20experience&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B61">G. K. Tan and S. Alonso, “Pathogenesis and prevention of dengue virus infection: state-of-the-art,” <i>Current Opinion in Infectious Diseases</i>, vol. 22, no. 3, pp. 302–308, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1097/QCO.0b013e328329ae32" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Pathogenesis%20and%20prevention%20of%20dengue%20virus%20infection:%20state-of-the-art&amp;author=G.%20K.%20Tan%20&amp;author=S.%20Alonso&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B62">A. Mathew and A. L. Rothman, “Understanding the contribution of cellular immunity to dengue disease pathogenesis,” <i>Immunological Reviews</i>, vol. 225, no. 1, pp. 300–313, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1600-065X.2008.00678.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Understanding%20the%20contribution%20of%20cellular%20immunity%20to%20dengue%20disease%20pathogenesis&amp;author=A.%20Mathew%20&amp;author=A.%20L.%20Rothman&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B63">M. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1–3 virus infections over a long time interval: Havana epidemic, 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1113–1117, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20caused%20by%20sequential%20dengue%201%E2%80%933%20virus%20infections%20over%20a%20long%20time%20interval:%20Havana%20epidemic,%202001-2002&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche&amp;author=L.%20Bernardo%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B64">M. G. Guzmán, G. Kouri, L. Valdes et al., “Epidemiologic studies on dengue in Santiago de Cuba, 1997,” <i>American Journal of Epidemiology</i>, vol. 152, no. 9, pp. 793–799, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1093/aje/152.9.793" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemiologic%20studies%20on%20dengue%20in%20Santiago%20de%20Cuba,%201997&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri&amp;author=L.%20Valdes%20et%20al.&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li><li id="B65">M. G. Guzman, M. Alvarez, R. Rodriguez et al., “Fatal dengue hemorrhagic fever in Cuba,” <i>International Journal of Infectious Diseases</i>, vol. 3, no. 3, pp. 130–135, 1997. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Fatal%20dengue%20hemorrhagic%20fever%20in%20Cuba&amp;author=M.%20G.%20Guzman&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez%20et%20al.&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li><li id="B66">M. G. Guzman, G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier, “Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 42, no. 2, pp. 179–184, 1990. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20in%20Cuba,%201981:%20a%20retrospective%20seroepidemiologic%20study&amp;author=M.%20G.%20Guzman&amp;author=G.%20P.%20Kouri&amp;author=J.%20Bravo&amp;author=M.%20Soler&amp;author=S.%20Vazquez&amp;author=&amp;author=L.%20Morier&amp;publication_year=1990" target="_blank">Google Scholar</a></span></li><li id="B67">J. R. Bravo, M. G. Guzmán, and G. P. Kouri, “Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS),” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 81, no. 5, pp. 816–820, 1987. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Why%20dengue%20haemorrhagic%20fever%20in%20Cuba?%20I.%20Individual%20risk%20factors%20for%20dengue%20haemorrhagic%20fever/dengue%20shock%20syndrome%20(DHF/DSS)&amp;author=J.%20R.%20Bravo&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=&amp;author=G.%20P.%20Kouri&amp;publication_year=1987" target="_blank">Google Scholar</a></span></li><li id="B68">L. Valdés, M. G. Guzmán, G. Kourí et al., “The epidemiology of dengue and dengue hemorrhagic fever in Santiago de Cuba, 1997,” <i>Revista Panamericana de Salud Publica</i>, vol. 6, no. 1, pp. 16–25, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20epidemiology%20of%20dengue%20and%20dengue%20hemorrhagic%20fever%20in%20Santiago%20de%20Cuba,%201997&amp;author=L.%20Vald%C3%A9s&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kour%C3%AD%20et%20al.&amp;publication_year=1999" target="_blank">Google Scholar</a></span></li><li id="B69">N. Sangkawibha, S. Rojanasuphot, and S. Ahandrik, “Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak,” <i>American Journal of Epidemiology</i>, vol. 120, no. 5, pp. 653–669, 1984. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Risk%20factors%20in%20dengue%20shock%20syndrome:%20a%20prospective%20epidemiologic%20study%20in%20Rayong,%20Thailand.%20I.%20The%201980%20outbreak&amp;author=N.%20Sangkawibha&amp;author=S.%20Rojanasuphot&amp;author=&amp;author=S.%20Ahandrik&amp;publication_year=1984" target="_blank">Google Scholar</a></span></li><li id="B70">S. B. Halstead, S. Nimmannitya, and M. R. Margiotta, “Dengue d chikungunya virus infection in man in Thailand, 1962–1964. II. Observations on disease in outpatients,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 18, no. 6, pp. 972–983, 1969. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20d%20chikungunya%20virus%20infection%20in%20man%20in%20Thailand,%201962%E2%80%931964.%20II.%20Observations%20on%20disease%20in%20outpatients&amp;author=S.%20B.%20Halstead&amp;author=S.%20Nimmannitya&amp;author=&amp;author=M.%20R.%20Margiotta&amp;publication_year=1969" target="_blank">Google Scholar</a></span></li><li id="B71">S. B. Halstead, “The pathogenesis of dengue. Molecular epidemiology in infectious disease,” <i>American Journal of Epidemiology</i>, vol. 114, no. 5, pp. 632–648, 1981. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue.%20Molecular%20epidemiology%20in%20infectious%20disease&amp;author=S.%20B.%20Halstead&amp;publication_year=1981" target="_blank">Google Scholar</a></span></li><li id="B72">D. M. Morens, “Antibody-dependent enhancement of infection and the pathogenesis of viral disease,” <i>Clinical Infectious Diseases</i>, vol. 19, no. 3, pp. 500–512, 1994. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Antibody-dependent%20enhancement%20of%20infection%20and%20the%20pathogenesis%20of%20viral%20disease&amp;author=D.%20M.%20Morens&amp;publication_year=1994" target="_blank">Google Scholar</a></span></li><li id="B73">B. J. Mady, D. V. Erbe, I. Kurane, M. W. Fanger, and F. A. Ennis, “Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc<i>γ</i> receptors,” <i>Journal of Immunology</i>, vol. 147, no. 9, pp. 3139–3144, 1991. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Antibody-dependent%20enhancement%20of%20dengue%20virus%20infection%20mediated%20by%20bispecific%20antibodies%20against%20cell%20surface%20molecules%20other%20than%20Fc%3Ci%3E%CE%B3%3C/i%3E%20receptors&amp;author=B.%20J.%20Mady&amp;author=D.%20V.%20Erbe&amp;author=I.%20Kurane&amp;author=M.%20W.%20Fanger&amp;author=&amp;author=F.%20A.%20Ennis&amp;publication_year=1991" target="_blank">Google Scholar</a></span></li><li id="B74">I. Kurane, B. J. Mady, and F. A. Ennis, “Antibody-dependent enhancement of dengue virus infection,” <i>Reviews in Medical Virology</i>, vol. 1, no. 4, pp. 211–221, 1991. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Antibody-dependent%20enhancement%20of%20dengue%20virus%20infection&amp;author=I.%20Kurane&amp;author=B.%20J.%20Mady&amp;author=&amp;author=F.%20A.%20Ennis&amp;publication_year=1991" target="_blank">Google Scholar</a></span></li><li id="B75">S. Halstead, <i>Antibody-Dependent Enhancement of Infection: a mechanism for Indirect Virus Entry into Cells. Cellular Receptors for Animal Viruses</i>, Harbor Laboraty Press, Cold Spring Harbor, NY, USA, 1994. <span class="reflinks"></span></li><li id="B76">A. B. Sabin and R. Walter Schlesinger, “Production of immunity to dengue with virus modified by propagation in mice1,” <i>Science</i>, vol. 101, no. 2634, pp. 640–642, 1945. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Production%20of%20immunity%20to%20dengue%20with%20virus%20modified%20by%20propagation%20in%20mice1&amp;author=A.%20B.%20Sabin%20&amp;author=R.%20Walter%20Schlesinger&amp;publication_year=1945" target="_blank">Google Scholar</a></span></li><li id="B77">T. Chareonsirisuthigul, S. Kalayanarooj, and S. Ubol, “Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells,” <i>Journal of General Virology</i>, vol. 88, no. 2, pp. 365–375, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1099/vir.0.82537-0" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20(DENV)%20antibody-dependent%20enhancement%20of%20infection%20upregulates%20the%20production%20of%20anti-inflammatory%20cytokines,%20but%20suppresses%20anti-DENV%20free%20radical%20and%20pro-inflammatory%20cytokine%20production,%20in%20THP-1%20cells&amp;author=T.%20Chareonsirisuthigul&amp;author=S.%20Kalayanarooj&amp;author=&amp;author=S.%20Ubol&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B78">S. Ubol, T. Chareonsirisuthigul, J. Kasisith, and C. Klungthong, “Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells,” <i>Virology</i>, vol. 376, no. 2, pp. 290–296, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2008.03.030" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Clinical%20isolates%20of%20dengue%20virus%20with%20distinctive%20susceptibility%20to%20nitric%20oxide%20radical%20induce%20differential%20gene%20responses%20in%20THP-1%20cells&amp;author=S.%20Ubol&amp;author=T.%20Chareonsirisuthigul&amp;author=J.%20Kasisith&amp;author=&amp;author=C.%20Klungthong&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B79">R. Cologna, P. M. Armstrong, and R. Rico-Hesse, “Selection for virulent dengue viruses occurs in humans and mosquitoes,” <i>Journal of Virology</i>, vol. 79, no. 2, pp. 853–859, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.79.2.853-859.2005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Selection%20for%20virulent%20dengue%20viruses%20occurs%20in%20humans%20and%20mosquitoes&amp;author=R.%20Cologna&amp;author=P.%20M.%20Armstrong&amp;author=&amp;author=R.%20Rico-Hesse&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B80">M. G. Guzman, V. Deubel, J. L. Pelegrino et al., “Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 52, no. 3, pp. 241–246, 1995. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Partial%20nucleotide%20and%20amino%20acid%20sequences%20of%20the%20envelope%20and%20the%20envelope/nonstructural%20protein-1%20gene%20junction%20of%20four%20dengue-2%20virus%20strains%20isolated%20during%20the%201981%20Cuban%20epidemic&amp;author=M.%20G.%20Guzman&amp;author=V.%20Deubel&amp;author=J.%20L.%20Pelegrino%20et%20al.&amp;publication_year=1995" target="_blank">Google Scholar</a></span></li><li id="B81">T. J. Kochel, D. M. Watts, S. B. Halstead et al., “Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever,” <i>The Lancet</i>, vol. 360, no. 9329, pp. 310–312, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(02)09522-3" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20dengue-1%20antibodies%20on%20American%20dengue-2%20viral%20infection%20and%20dengue%20haemorrhagic%20fever&amp;author=T.%20J.%20Kochel&amp;author=D.%20M.%20Watts&amp;author=S.%20B.%20Halstead%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B82">D. M. Watts, K. R. Porter, P. Putvatana et al., “Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever,” <i>The Lancet</i>, vol. 354, no. 9188, pp. 1431–1434, 1999. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(99)04015-5" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Failure%20of%20secondary%20infection%20with%20American%20genotype%20dengue%202%20to%20cause%20dengue%20haemorrhagic%20fever&amp;author=D.%20M.%20Watts&amp;author=K.%20R.%20Porter&amp;author=P.%20Putvatana%20et%20al.&amp;publication_year=1999" target="_blank">Google Scholar</a></span></li><li id="B83">R. Rico-Hesse, L. M. Harrison, R. A. Salas et al., “Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas,” <i>Virology</i>, vol. 230, no. 2, pp. 244–251, 1997. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.1997.8504" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Origins%20of%20dengue%20type%202%20viruses%20associated%20with%20increased%20pathogenicity%20in%20the%20Americas&amp;author=R.%20Rico-Hesse&amp;author=L.%20M.%20Harrison&amp;author=R.%20A.%20Salas%20et%20al.&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li><li id="B84">K. C. Leitmeyer, D. W. Vaughn, D. M. Watts et al., “Dengue virus structural differences that correlate with pathogenesis,” <i>Journal of Virology</i>, vol. 73, no. 6, pp. 4738–4747, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20structural%20differences%20that%20correlate%20with%20pathogenesis&amp;author=K.%20C.%20Leitmeyer&amp;author=D.%20W.%20Vaughn&amp;author=D.%20M.%20Watts%20et%20al.&amp;publication_year=1999" target="_blank">Google Scholar</a></span></li><li id="B85">D. González, O. E. Castro, G. Kourí et al., “Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002,” <i>International Journal of Infectious Diseases</i>, vol. 9, no. 5, pp. 280–285, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2004.07.012" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Classical%20dengue%20hemorrhagic%20fever%20resulting%20from%20two%20dengue%20infections%20spaced%2020%20years%20or%20more%20apart:%20Havana,%20Dengue%203%20epidemic,%202001-2002&amp;author=D.%20Gonz%C3%A1lez&amp;author=O.%20E.%20Castro&amp;author=G.%20Kour%C3%AD%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B86">D. Limonta, D. González, V. Capó et al., “Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic,” <i>International Journal of Infectious Diseases</i>, vol. 13, no. 2, pp. e77–e78, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2008.06.028" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Fatal%20severe%20dengue%20and%20cell%20death%20in%20sickle%20cell%20disease%20during%20the%202001-2002%20Havana%20dengue%20epidemic&amp;author=D.%20Limonta&amp;author=D.%20Gonz%C3%A1lez&amp;author=V.%20Cap%C3%B3%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B87">M.-S. Lee, K.-P. Hwang, T.-C. Chen, P.-L. Lu, and T.-P. Chen, “Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic,” <i>Journal of Microbiology, Immunology and Infection</i>, vol. 39, no. 2, pp. 121–129, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Clinical%20characteristics%20of%20dengue%20and%20dengue%20hemorrhagic%20fever%20in%20a%20medical%20center%20of%20southern%20Taiwan%20during%20the%202002%20epidemic&amp;author=M.-S.%20Lee&amp;author=K.-P.%20Hwang&amp;author=T.-C.%20Chen&amp;author=P.-L.%20Lu&amp;author=&amp;author=T.-P.%20Chen&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B88">B. Sierra, R. Alegre, A. B. Pérez et al., “HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection,” <i>Human Immunology</i>, vol. 68, no. 6, pp. 531–540, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.humimm.2007.03.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=HLA-A,%20-B,%20-C,%20and%20-DRB1%20allele%20frequencies%20in%20Cuban%20individuals%20with%20antecedents%20of%20dengue%202%20disease:%20advantages%20of%20the%20Cuban%20population%20for%20HLA%20studies%20of%20dengue%20virus%20infection&amp;author=B.%20Sierra&amp;author=R.%20Alegre&amp;author=A.%20B.%20P%C3%A9rez%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B89">C. LaFleur, J. Granados, G. Vargas-Alarcon et al., “HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever,” <i>Human Immunology</i>, vol. 63, no. 11, pp. 1039–1044, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0198-8859(02)00682-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=HLA-DR%20antigen%20frequencies%20in%20Mexican%20patients%20with%20dengue%20virus%20infection:%20HLA-DR4%20as%20a%20possible%20genetic%20resistance%20factor%20for%20dengue%20hemorrhagic%20fever&amp;author=C.%20LaFleur&amp;author=J.%20Granados&amp;author=G.%20Vargas-Alarcon%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B90">H. A. F. Stephens, R. Klaythong, M. Sirikong et al., “HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais,” <i>Tissue Antigens</i>, vol. 60, no. 4, pp. 309–318, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1034/j.1399-0039.2002.600405.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=HLA-A%20and%20-B%20allele%20associations%20with%20secondary%20dengue%20virus%20infections%20correlate%20with%20disease%20severity%20and%20the%20infecting%20viral%20serotype%20in%20ethnic%20Thais&amp;author=H.%20A.%20F.%20Stephens&amp;author=R.%20Klaythong&amp;author=M.%20Sirikong%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B91">M. L. Paradoa Pérez, Y. Trujillo, and P. Basanta, “Association of dengue hemorrhagic fever with the HLA system,” <i>Haematologia</i>, vol. 20, no. 2, pp. 83–87, 1987. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Association%20of%20dengue%20hemorrhagic%20fever%20with%20the%20HLA%20system&amp;author=M.%20L.%20Paradoa%20P%C3%A9rez&amp;author=Y.%20Trujillo&amp;author=&amp;author=P.%20Basanta&amp;publication_year=1987" target="_blank">Google Scholar</a></span></li><li id="B92">U. C. Chaturvedi, R. Nagar, and R. Shrivastava, “Dengue and dengue haemorrhagic fever: implications of host genetics,” <i>FEMS Immunology and Medical Microbiology</i>, vol. 47, no. 2, pp. 155–166, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1574-695X.2006.00058.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20haemorrhagic%20fever:%20implications%20of%20host%20genetics&amp;author=U.%20C.%20Chaturvedi&amp;author=R.%20Nagar&amp;author=&amp;author=R.%20Shrivastava&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B93">G. García, B. Sierra, A. B. Pérez et al., “Asymptomatic dengue infection in a cuban population confirms the protective role of the RR variant of the Fc<i>γ</i>RIIa polymorphism,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 82, no. 6, pp. 1153–1156, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.4269/ajtmh.2010.09-0353" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Asymptomatic%20dengue%20infection%20in%20a%20cuban%20population%20confirms%20the%20protective%20role%20of%20the%20RR%20variant%20of%20the%20Fc%3Ci%3E%CE%B3%3C/i%3ERIIa%20polymorphism&amp;author=G.%20Garc%C3%ADa&amp;author=B.%20Sierra&amp;author=A.%20B.%20P%C3%A9rez%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B94">J. Mongkolsapaya, T. Duangchinda, W. Dejnirattisai et al., “T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?” <i>Journal of Immunology</i>, vol. 176, no. 6, pp. 3821–3829, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=T%20cell%20responses%20in%20dengue%20hemorrhagic%20fever:%20are%20cross-reactive%20T%20cells%20suboptimal?&amp;author=J.%20Mongkolsapaya&amp;author=T.%20Duangchinda&amp;author=W.%20Dejnirattisai%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B95">K. Clyde, J. L. Kyle, and E. Harris, “Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis,” <i>Journal of Virology</i>, vol. 80, no. 23, pp. 11418–11431, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.01257-06" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20deciphering%20viral%20and%20host%20determinants%20of%20dengue%20virus%20replication%20and%20pathogenesis&amp;author=K.%20Clyde&amp;author=J.%20L.%20Kyle&amp;author=&amp;author=E.%20Harris&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B96">B. Sierra, A. B. Perez, K. Vogt et al., “Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation?” <i>Cellular Immunology</i>, vol. 262, no. 2, pp. 134–140, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cellimm.2010.02.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Secondary%20heterologous%20dengue%20infection%20risk:%20disequilibrium%20between%20immune%20regulation%20and%20inflammation?&amp;author=B.%20Sierra&amp;author=A.%20B.%20Perez&amp;author=K.%20Vogt%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B97">J. Whitehorn and C. P. Simmons, “The pathogenesis of dengue,” <i>Vaccine</i>, vol. 29, no. 42, pp. 7221–7228, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.07.022" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue&amp;author=J.%20Whitehorn%20&amp;author=C.%20P.%20Simmons&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B98">P. Avirutnan, N. Punyadee, S. Noisakran et al., “Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement,” <i>Journal of Infectious Diseases</i>, vol. 193, no. 8, pp. 1078–1088, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1086/500949" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Vascular%20leakage%20in%20severe%20dengue%20virus%20infections:%20a%20potential%20role%20for%20the%20nonstructural%20viral%20protein%20NS1%20and%20complement&amp;author=P.%20Avirutnan&amp;author=N.%20Punyadee&amp;author=S.%20Noisakran%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B99">C.-F. Lin, S.-W. Wan, M.-C. Chen et al., “Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model,” <i>Laboratory Investigation</i>, vol. 88, no. 10, pp. 1079–1089, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1038/labinvest.2008.70" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Liver%20injury%20caused%20by%20antibodies%20against%20dengue%20virus%20nonstructural%20protein%201%20in%20a%20murine%20model&amp;author=C.-F.%20Lin&amp;author=S.-W.%20Wan&amp;author=M.-C.%20Chen%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B100">H.-J. Cheng, C.-F. Lin, H.-Y. Lei et al., “Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies,” <i>Experimental Biology and Medicine</i>, vol. 234, no. 1, pp. 63–73, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.3181/0805-RM-147" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Proteomic%20analysis%20of%20endothelial%20cell%20autoantigens%20recognized%20by%20anti-dengue%20virus%20nonstructural%20protein%201%20antibodies&amp;author=H.-J.%20Cheng&amp;author=C.-F.%20Lin&amp;author=H.-Y.%20Lei%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B101">C.-F. Lin, S.-W. Wan, H.-J. Cheng, H.-Y. Lei, and Y.-S. Lin, “Autoimmune pathogenesis in dengue virus infection,” <i>Viral Immunology</i>, vol. 19, no. 2, pp. 127–132, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1089/vim.2006.19.127" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Autoimmune%20pathogenesis%20in%20dengue%20virus%20infection&amp;author=C.-F.%20Lin&amp;author=S.-W.%20Wan&amp;author=H.-J.%20Cheng&amp;author=H.-Y.%20Lei&amp;author=&amp;author=Y.-S.%20Lin&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B102">M. G. Brown, Y. Y. Huang, J. S. Marshall, C. A. King, D. W. Hoskin, and R. Anderson, “Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells,” <i>Journal of Leukocyte Biology</i>, vol. 85, no. 1, pp. 71–80, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1189/jlb.0308167" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dramatic%20caspase-dependent%20apoptosis%20in%20antibody-enhanced%20dengue%20virus%20infection%20of%20human%20mast%20cells&amp;author=M.%20G.%20Brown&amp;author=Y.%20Y.%20Huang&amp;author=J.%20S.%20Marshall&amp;author=C.%20A.%20King&amp;author=D.%20W.%20Hoskin&amp;author=&amp;author=R.%20Anderson&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B103">M. G. Brown, C. A. King, C. Sherren, J. S. Marshall, and R. Anderson, “A dominant role for Fc<i>γ</i>RII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release,” <i>Journal of Leukocyte Biology</i>, vol. 80, no. 6, pp. 1242–1250, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1189/jlb.0805441" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20dominant%20role%20for%20Fc%3Ci%3E%CE%B3%3C/i%3ERII%20in%20antibody-enhanced%20dengue%20virus%20infection%20of%20human%20mast%20cells%20and%20associated%20CCL5%20release&amp;author=M.%20G.%20Brown&amp;author=C.%20A.%20King&amp;author=C.%20Sherren&amp;author=J.%20S.%20Marshall&amp;author=&amp;author=R.%20Anderson&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B104">A. K. I. Falconar, “The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis,” <i>Archives of Virology</i>, vol. 142, no. 5, pp. 897–916, 1997. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s007050050127" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20dengue%20virus%20nonstructural-1%20protein%20(NS1)%20generates%20antibodies%20to%20common%20epitopes%20on%20human%20blood%20clotting,%20integrin/adhesin%20proteins%20and%20binds%20to%20human%20endothelial%20cells:%20potential%20implications%20in%20haemorrhagic%20fever%20pathogenesis&amp;author=A.%20K.%20I.%20Falconar&amp;publication_year=1997" target="_blank">Google Scholar</a></span></li><li id="B105">D. T. Tam, T. V. Ngoc, N. T. Tien et al., “Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial,” <i>Clinical Infectious Diseases</i>, vol. 55, no. 9, pp. 1216–1224, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cis655" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Effects%20of%20short-course%20oral%20corticosteroid%20therapy%20in%20early%20dengue%20infection%20in%20Vietnamese%20patients:%20a%20randomized,%20placebo-controlled%20trial&amp;author=D.%20T.%20Tam&amp;author=T.%20V.%20Ngoc&amp;author=N.%20T.%20Tien%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B106">S.-W. Lin, Y.-C. Chuang, Y.-S. Lin, H.-Y. Lei, H.-S. Liu, and T.-M. Yeh, “Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation,” <i>Journal of Infection</i>, vol. 64, no. 3, pp. 325–334, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jinf.2011.11.023" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20nonstructural%20protein%20NS1%20binds%20to%20prothrombin/thrombin%20and%20inhibits%20prothrombin%20activation&amp;author=S.-W.%20Lin&amp;author=Y.-C.%20Chuang&amp;author=Y.-S.%20Lin&amp;author=H.-Y.%20Lei&amp;author=H.-S.%20Liu&amp;author=&amp;author=T.-M.%20Yeh&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B107">S. B. Halstead, “Dengue vascular permeability syndrome: what, no T cells?” <i>Clinical Infectious Diseases</i>, vol. 56, no. 6, pp. 900–901, 2013. <span class="reflinks">View at: <a href="https://doi.org/10.1093/cid/cis1047" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vascular%20permeability%20syndrome:%20what,%20no%20T%20cells?&amp;author=S.%20B.%20Halstead&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li><li id="B108">D. H. Libraty, P. R. Young, D. Pickering et al., “High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever,” <i>Journal of Infectious Diseases</i>, vol. 186, no. 8, pp. 1165–1168, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1086/343813" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=High%20circulating%20levels%20of%20the%20dengue%20virus%20nonstructural%20protein%20NS1%20early%20in%20dengue%20illness%20correlate%20with%20the%20development%20of%20dengue%20hemorrhagic%20fever&amp;author=D.%20H.%20Libraty&amp;author=P.%20R.%20Young&amp;author=D.%20Pickering%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B109">H. T. L. Duyen, T. V. Ngoc, D. T. Ha et al., “Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status,” <i>Journal of Infectious Diseases</i>, vol. 203, no. 9, pp. 1292–1300, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1093/infdis/jir014" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Kinetics%20of%20plasma%20viremia%20and%20soluble%20nonstructural%20protein%201%20concentrations%20in%20dengue:%20differential%20effects%20according%20to%20serotype%20and%20immune%20status&amp;author=H.%20T.%20L.%20Duyen&amp;author=T.%20V.%20Ngoc&amp;author=D.%20T.%20Ha%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B110">V. Tricou, N. N. Minh, J. Farrar, H. T. Tran, and C. P. Simmons, “Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue,” <i>PLoS Neglected Tropical Diseases</i>, vol. 5, no. 9, Article ID e1309, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0001309" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Kinetics%20of%20viremia%20and%20NS1%20antigenemia%20are%20shaped%20by%20immune%20status%20and%20virus%20serotype%20in%20adults%20with%20dengue&amp;author=V.%20Tricou&amp;author=N.%20N.%20Minh&amp;author=J.%20Farrar&amp;author=H.%20T.%20Tran&amp;author=&amp;author=C.%20P.%20Simmons&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B111">S. I. de la Cruz-Hernandez, H. Flores-Aguilar, S. Gonzalez-Mateos et al., “Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 88, no. 3, pp. 446–454, 2013. <span class="reflinks">View at: <a href="https://doi.org/10.4269/ajtmh.12-0023" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Determination%20of%20viremia%20and%20concentration%20of%20circulating%20nonstructural%20protein%201%20in%20patients%20infected%20with%20dengue%20virus%20in%20Mexico&amp;author=S.%20I.%20de%20la%20Cruz-Hernandez&amp;author=H.%20Flores-Aguilar&amp;author=S.%20Gonzalez-Mateos%20et%20al.&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li><li id="B112">A. Fox, L. N. M. Hoa, C. P. Simmons et al., “Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam,” <i>PLoS Neglected Tropical Diseases</i>, vol. 5, no. 3, article e967, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000967" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Immunological%20and%20viral%20determinants%20of%20dengue%20severity%20in%20hospitalized%20adults%20in%20Ha%20Noi,%20Viet%20Nam&amp;author=A.%20Fox&amp;author=L.%20N.%20M.%20Hoa&amp;author=C.%20P.%20Simmons%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B113">G. P. Kouri, M. G. Guzmán, and J. R. Bravo, “Why dengue haemorrhagic fever in Cuba? 2. An integral analysis,” <i>Transactions of the Royal Society of Tropical Medicine and Hygiene</i>, vol. 81, no. 5, pp. 821–823, 1987. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Why%20dengue%20haemorrhagic%20fever%20in%20Cuba?%202.%20An%20integral%20analysis&amp;author=G.%20P.%20Kouri&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=&amp;author=J.%20R.%20Bravo&amp;publication_year=1987" target="_blank">Google Scholar</a></span></li><li id="B114">J. L. Kyle and E. Harris, “Global spread and persistence of dengue,” <i>Annual Review of Microbiology</i>, vol. 62, pp. 71–92, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1146/annurev.micro.62.081307.163005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Global%20spread%20and%20persistence%20of%20dengue&amp;author=J.%20L.%20Kyle%20&amp;author=E.%20Harris&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B115">P. Mas Lago, “Dengue fever in Cuba in 1977: some laboratory aspects,” <i>PAHO Scientific Publication</i>, vol. 375, pp. 40–43, 1979. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20fever%20in%20Cuba%20in%201977:%20some%20laboratory%20aspects&amp;author=P.%20Mas%20Lago&amp;publication_year=1979" target="_blank">Google Scholar</a></span></li><li id="B116">P. Mas Lago, R. Palomera, and M. Jacobo, “Dengue: some epidemiologic aspects,” <i>Revista Cubana de Medicina Tropical</i>, vol. 22, no. 6, 1983. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue:%20some%20epidemiologic%20aspects&amp;author=P.%20Mas%20Lago&amp;author=R.%20Palomera&amp;author=&amp;author=M.%20Jacobo&amp;publication_year=1983" target="_blank">Google Scholar</a></span></li><li id="B117">N. Cantelar de Francisco, A. Fernández, L. Albert Molina, and E. Pérez Balbis, “Survey of dengue in Cuba. 1978-1979,” <i>Revista Cubana de Medicina Tropical</i>, vol. 33, no. 1, pp. 72–78, 1981. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Survey%20of%20dengue%20in%20Cuba.%201978-1979&amp;author=N.%20Cantelar%20de%20Francisco&amp;author=A.%20Fern%C3%A1ndez&amp;author=L.%20Albert%20Molina&amp;author=&amp;author=E.%20P%C3%A9rez%20Balbis&amp;publication_year=1981" target="_blank">Google Scholar</a></span></li><li id="B118">S. B. Halstead, S. Nimmannitya, and S. N. Cohen, “Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered,” <i>Yale Journal of Biology and Medicine</i>, vol. 42, no. 5, pp. 311–328, 1970. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Observations%20related%20to%20pathogenesis%20of%20dengue%20hemorrhagic%20fever.%20IV.%20Relation%20of%20disease%20severity%20to%20antibody%20response%20and%20virus%20recovered&amp;author=S.%20B.%20Halstead&amp;author=S.%20Nimmannitya&amp;author=&amp;author=S.%20N.%20Cohen&amp;publication_year=1970" target="_blank">Google Scholar</a></span></li><li id="B119">M. G. Guzmán, G. Kouri, J. Bravo, M. Soler, and E. Martínez, “Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic,” <i>Memorias do Instituto Oswaldo Cruz</i>, vol. 86, no. 3, p. 367, 1991. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Sequential%20infection%20as%20risk%20factor%20for%20dengue%20hemorrhagic%20fever/dengue%20shock%20syndrome%20(DHF/DSS)%20during%20the%201981%20dengue%20hemorrhagic%20Cuban%20epidemic&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri&amp;author=J.%20Bravo&amp;author=M.%20Soler&amp;author=&amp;author=E.%20Mart%C3%ADnez&amp;publication_year=1991" target="_blank">Google Scholar</a></span></li><li id="B120">G. Kourí, M. G. Guzmán, L. Valdés et al., “Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba,” <i>Emerging Infectious Diseases</i>, vol. 4, no. 1, pp. 89–92, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Reemergence%20of%20dengue%20in%20Cuba:%20a%201997%20epidemic%20in%20Santiago%20de%20Cuba&amp;author=G.%20Kour%C3%AD&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=L.%20Vald%C3%A9s%20et%20al.&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li><li id="B121">M. G. Guzmán, G. Kourí, L. Valdés, J. Bravo, S. Vázquez, and S. B. Halstead, “Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks,” <i>Revista Panamericana de Salud Publica</i>, vol. 11, no. 4, pp. 223–227, 2002. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Enhanced%20severity%20of%20secondary%20dengue-2%20infections:%20death%20rates%20in%201981%20and%201997%20Cuban%20outbreaks&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kour%C3%AD&amp;author=L.%20Vald%C3%A9s&amp;author=J.%20Bravo&amp;author=S.%20V%C3%A1zquez&amp;author=&amp;author=S.%20B.%20Halstead&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B122">O. Peláez, M. G. Guzmán, G. Kouri et al., “Dengue 3 epidemic, Havana, 2001,” <i>Emerging Infectious Diseases</i>, vol. 10, no. 4, pp. 719–722, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.3201/eid1004.030271" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%203%20epidemic,%20Havana,%202001&amp;author=O.%20Pel%C3%A1ez&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kouri%20et%20al.&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li><li id="B123">M. Álvarez, A. Pavón-Oro, S. Vázquez, L. Morier, Á. M. Álvarez, and M. G. Guzmán, “Viral infection sequences related to dengue fever in dengue 3 epidemics occurred in the City of Havana, 2001-2002,” <i>Revista Cubana de Medicina Tropical</i>, vol. 60, no. 1, pp. 18–23, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Viral%20infection%20sequences%20related%20to%20dengue%20fever%20in%20dengue%203%20epidemics%20occurred%20in%20the%20City%20of%20Havana,%202001-2002&amp;author=M.%20%C3%81lvarez&amp;author=A.%20Pav%C3%B3n-Oro&amp;author=S.%20V%C3%A1zquez&amp;author=L.%20Morier&amp;author=%C3%81.%20M.%20%C3%81lvarez&amp;author=&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B124">M. Alvarez, A. Pavon-Oro, R. Rodriguez-Roche et al., “Neutralizing antibody response variation against dengue 3 strains,” <i>Journal of Medical Virology</i>, vol. 80, no. 10, pp. 1783–1789, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1002/jmv.21234" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibody%20response%20variation%20against%20dengue%203%20strains&amp;author=M.%20Alvarez&amp;author=A.%20Pavon-Oro&amp;author=R.%20Rodriguez-Roche%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B125">R. Rodriguez-Roche, M. Alvarez, E. C. Holmes et al., “Dengue virus type 3, Cuba, 2000–2002,” <i>Emerging Infectious Diseases</i>, vol. 11, no. 5, pp. 773–774, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%203,%20Cuba,%202000%E2%80%932002&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=E.%20C.%20Holmes%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B126">R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic,” <i>Archives of Virology</i>, vol. 150, no. 3, pp. 415–425, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-004-0445-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%202%20in%20Cuba,%201997:%20conservation%20of%20E%20gene%20sequence%20in%20isolates%20obtained%20at%20different%20times%20during%20the%20epidemic&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=T.%20Gritsun%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B127">A. B. Sabin, “Research on dengue during World War II,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 1, no. 1, pp. 30–50, 1952. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Research%20on%20dengue%20during%20World%20War%20II&amp;author=A.%20B.%20Sabin&amp;publication_year=1952" target="_blank">Google Scholar</a></span></li><li id="B128">M. G. Guzman, M. Alvarez, R. Rodriguez-Roche et al., “Neutralizing antibodies after infection with dengue 1 virus,” <i>Emerging Infectious Diseases</i>, vol. 13, no. 2, pp. 282–286, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibodies%20after%20infection%20with%20dengue%201%20virus&amp;author=M.%20G.%20Guzman&amp;author=M.%20Alvarez&amp;author=R.%20Rodriguez-Roche%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B129">M. G. Guzmán, G. Kourí, and S. B. Halstead, “Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?” <i>The Lancet</i>, vol. 355, no. 9218, pp. 1902–1903, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Do%20escape%20mutants%20explain%20rapid%20increases%20in%20dengue%20case-fatality%20rates%20within%20epidemics?&amp;author=M.%20G.%20Guzm%C3%A1n&amp;author=G.%20Kour%C3%AD&amp;author=&amp;author=S.%20B.%20Halstead&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li><li id="B130">R. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Virus evolution during a severe dengue epidemic in Cuba, 1997,” <i>Virology</i>, vol. 334, no. 2, pp. 154–159, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2005.01.037" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Virus%20evolution%20during%20a%20severe%20dengue%20epidemic%20in%20Cuba,%201997&amp;author=R.%20Rodriguez-Roche&amp;author=M.%20Alvarez&amp;author=T.%20Gritsun%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B131">J. Mongkolsapaya, W. Dejnirattisai, X.-N. Xu et al., “Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever,” <i>Nature Medicine</i>, vol. 9, no. 7, pp. 921–927, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nm887" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Original%20antigenic%20sin%20and%20apoptosis%20in%20the%20pathogenesis%20of%20dengue%20hemorrhagic%20fever&amp;author=J.%20Mongkolsapaya&amp;author=W.%20Dejnirattisai&amp;author=X.-N.%20Xu%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B132">S. N. Bennett, E. C. Holmes, M. Chirivella et al., “Selection-driven evolution of emergent dengue virus,” <i>Molecular Biology and Evolution</i>, vol. 20, no. 10, pp. 1650–1658, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1093/molbev/msg182" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Selection-driven%20evolution%20of%20emergent%20dengue%20virus&amp;author=S.%20N.%20Bennett&amp;author=E.%20C.%20Holmes&amp;author=M.%20Chirivella%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B133">C. Klungthong, C. Zhang, M. P. Mammen Jr., S. Ubol, and E. C. Holmes, “The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand,” <i>Virology</i>, vol. 329, no. 1, pp. 168–179, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2004.08.003" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20molecular%20epidemiology%20of%20dengue%20virus%20serotype%204%20in%20Bangkok,%20Thailand&amp;author=C.%20Klungthong&amp;author=C.%20Zhang&amp;author=M.%20P.%20Mammen%20Jr.&amp;author=S.%20Ubol&amp;author=&amp;author=E.%20C.%20Holmes&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li><li id="B134">H.-L. Chen, S.-R. Lin, H.-F. Liu, C.-C. King, S.-C. Hsieh, and W.-K. Wang, “Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in Southern Taiwan in 2001-2002,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 79, no. 4, pp. 495–504, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Evolution%20of%20dengue%20virus%20type%202%20during%20two%20consecutive%20outbreaks%20with%20an%20increase%20in%20severity%20in%20Southern%20Taiwan%20in%202001-2002&amp;author=H.-L.%20Chen&amp;author=S.-R.%20Lin&amp;author=H.-F.%20Liu&amp;author=C.-C.%20King&amp;author=S.-C.%20Hsieh&amp;author=&amp;author=W.-K.%20Wang&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B135">Y. Tang, P. Rodpradit, P. Chinnawirotpisan et al., “Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 years,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 83, no. 5, pp. 1156–1165, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.4269/ajtmh.2010.10-0052" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Comparative%20analysis%20of%20full-length%20genomic%20sequences%20of%2010%20dengue%20serotype%201%20viruses%20associated%20with%20different%20genotypes,%20epidemics,%20and%20disease%20severity%20isolated%20in%20Thailand%20over%2022%20years&amp;author=Y.%20Tang&amp;author=P.%20Rodpradit&amp;author=P.%20Chinnawirotpisan%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B136">R. Zhao, P. Chinnawirotpisan, C. Klungthong, C. Zhang, and R. Putnak, “Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001,” <i>Virus Genes</i>, vol. 41, no. 1, pp. 5–13, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s11262-010-0473-8" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Evidence%20for%20inter-%20and%20intra-genotypic%20variations%20in%20dengue%20serotype%204%20viruses%20representing%20predominant%20and%20non-predominant%20genotypes%20co-circulating%20in%20Thailand%20from%201977%20to%202001&amp;author=R.%20Zhao&amp;author=P.%20Chinnawirotpisan&amp;author=C.%20Klungthong&amp;author=C.%20Zhang&amp;author=&amp;author=R.%20Putnak&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B137">R. Rico-Hesse, “Dengue virus evolution and virulence models,” <i>Clinical Infectious Diseases</i>, vol. 44, no. 11, pp. 1462–1466, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1086/517587" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20evolution%20and%20virulence%20models&amp;author=R.%20Rico-Hesse&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B138">A. Steel, D. J. Gubler, and S. N. Bennett, “Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago,” <i>Virology</i>, vol. 405, no. 2, pp. 505–512, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2010.05.033" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Natural%20attenuation%20of%20dengue%20virus%20type-2%20after%20a%20series%20of%20island%20outbreaks:%20a%20retrospective%20phylogenetic%20study%20of%20events%20in%20the%20South%20Pacific%20three%20decades%20ago&amp;author=A.%20Steel&amp;author=D.%20J.%20Gubler&amp;author=&amp;author=S.%20N.%20Bennett&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B139">R. Rodriguez-Roche, E. Villegas, S. Cook et al., “Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission,” <i>Infection, Genetics and Evolution</i>, vol. 12, no. 2, pp. 332–344, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.meegid.2011.12.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Population%20structure%20of%20the%20dengue%20viruses,%20Aragua,%20Venezuela,%202006-2007.%20Insights%20into%20dengue%20evolution%20under%20hyperendemic%20transmission&amp;author=R.%20Rodriguez-Roche&amp;author=E.%20Villegas&amp;author=S.%20Cook%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B140">T. J. Chambers, D. W. McCourt, and C. M. Rice, “Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis,” <i>Virology</i>, vol. 169, no. 1, pp. 100–109, 1989. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Yellow%20fever%20virus%20proteins%20NS2A,%20NS2B,%20and%20NS4B:%20identification%20and%20partial%20N-terminal%20amino%20acid%20sequence%20analysis&amp;author=T.%20J.%20Chambers&amp;author=D.%20W.%20McCourt&amp;author=&amp;author=C.%20M.%20Rice&amp;publication_year=1989" target="_blank">Google Scholar</a></span></li><li id="B141">J. M. MacKenzie, A. A. Khromykh, M. K. Jones, and E. G. Westaway, “Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A,” <i>Virology</i>, vol. 245, no. 2, pp. 203–215, 1998. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.1998.9156" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Subcellular%20localization%20and%20some%20biochemical%20properties%20of%20the%20flavivirus%20Kunjin%20nonstructural%20proteins%20NS2A%20and%20NS4A&amp;author=J.%20M.%20MacKenzie&amp;author=A.%20A.%20Khromykh&amp;author=M.%20K.%20Jones&amp;author=&amp;author=E.%20G.%20Westaway&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li><li id="B142">J. L. Wen, B. C. Hua, J. W. Xiang, H. Huang, and A. A. Khromykh, “Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription,” <i>Journal of Virology</i>, vol. 78, no. 22, pp. 12225–12235, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.78.22.12225-12235.2004" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Analysis%20of%20adaptive%20mutations%20in%20Kunjin%20virus%20replicon%20RNA%20reveals%20a%20novel%20role%20for%20the%20flavivirus%20nonstructural%20protein%20NS2A%20in%20inhibition%20of%20beta%20interferon%20promoter-driven%20transcription&amp;author=J.%20L.%20Wen&amp;author=B.%20C.%20Hua&amp;author=J.%20W.%20Xiang&amp;author=H.%20Huang&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li><li id="B143">W. J. Liu, X. J. Wang, D. C. Clark, M. Lobigs, R. A. Hall, and A. A. Khromykh, “A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice,” <i>Journal of Virology</i>, vol. 80, no. 5, pp. 2396–2404, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.80.5.2396-2404.2006" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20single%20amino%20acid%20substitution%20in%20the%20West%20Nile%20virus%20nonstructural%20protein%20NS2A%20disables%20its%20ability%20to%20inhibit%20alpha/beta%20interferon%20induction%20and%20attenuates%20virus%20virulence%20in%20mice&amp;author=W.%20J.%20Liu&amp;author=X.%20J.%20Wang&amp;author=D.%20C.%20Clark&amp;author=M.%20Lobigs&amp;author=R.%20A.%20Hall&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B144">J. L. Muñoz-Jordán, G. G. Sánchez-Burgos, M. Laurent-Rolle, and A. García-Sastre, “Inhibition of interferon signaling by dengue virus,” <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 100, no. 2, pp. 14333–14338, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.2335168100" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20interferon%20signaling%20by%20dengue%20virus&amp;author=J.%20L.%20Mu%C3%B1oz-Jord%C3%A1n&amp;author=G.%20G.%20S%C3%A1nchez-Burgos&amp;author=M.%20Laurent-Rolle&amp;author=&amp;author=A.%20Garc%C3%ADa-Sastre&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B145">W. J. Liu, X. J. Wang, V. V. Mokhonov, P.-Y. Shi, R. Randall, and A. A. Khromykh, “Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins,” <i>Journal of Virology</i>, vol. 79, no. 3, pp. 1934–1942, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.79.3.1934-1942.2005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20interferon%20signaling%20by%20the%20New%20York%2099%20strain%20and%20Kunjin%20subtype%20of%20West%20Nile%20virus%20involves%20blockage%20of%20STAT1%20and%20STAT2%20activation%20by%20nonstructural%20proteins&amp;author=W.%20J.%20Liu&amp;author=X.%20J.%20Wang&amp;author=V.%20V.%20Mokhonov&amp;author=P.-Y.%20Shi&amp;author=R.%20Randall&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B146">B. M. Kümmerer and C. M. Rice, “Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles,” <i>Journal of Virology</i>, vol. 76, no. 10, pp. 4773–4784, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.76.10.4773-4784.2002" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mutations%20in%20the%20yellow%20fever%20virus%20nonstructural%20protein%20NS2A%20selectively%20block%20production%20of%20infectious%20particles&amp;author=B.%20M.%20K%C3%BCmmerer%20&amp;author=C.%20M.%20Rice&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B147">W. J. Liu, H. B. Chen, and A. A. Khromykh, “Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication,” <i>Journal of Virology</i>, vol. 77, no. 14, pp. 7804–7813, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.77.14.7804-7813.2003" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Molecular%20and%20functional%20analyses%20of%20Kunjin%20virus%20infectious%20cDNA%20clones%20demonstrate%20the%20essential%20roles%20for%20NS2A%20in%20virus%20assembly%20and%20for%20a%20nonconservative%20residue%20in%20NS3%20in%20RNA%20replication&amp;author=W.%20J.%20Liu&amp;author=H.%20B.%20Chen&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B148">J. Y. Leung, G. P. Pijlman, N. Kondratieva, J. Hyde, J. M. Mackenzie, and A. A. Khromykh, “Role of nonstructural protein NS2A in flavivirus assembly,” <i>Journal of Virology</i>, vol. 82, no. 10, pp. 4731–4741, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.00002-08" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Role%20of%20nonstructural%20protein%20NS2A%20in%20flavivirus%20assembly&amp;author=J.%20Y.%20Leung&amp;author=G.%20P.%20Pijlman&amp;author=N.%20Kondratieva&amp;author=J.%20Hyde&amp;author=J.%20M.%20Mackenzie&amp;author=&amp;author=A.%20A.%20Khromykh&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B149">K. L. McElroy, K. A. Tsetsarkin, D. L. Vanlandingham, and S. Higgs, “Manipulation of the yellow fever virus non-structural genes 2A and 4B and the <math id="M1" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math> non-coding region to evaluate genetic determinants of viral dissemination from the <i>Aedes aegypti</i> midgut,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 75, no. 6, pp. 1158–1164, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Manipulation%20of%20the%20yellow%20fever%20virus%20non-structural%20genes%202A%20and%204B%20and%20the%20%3Cinline-formula%3E%3Cmml:math%20id=" m1"%20xmlns:mml="http://www.w3.org/1998/Math/MathML" target="_blank"><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow>%20non-coding%20region%20to%20evaluate%20genetic%20determinants%20of%20viral%20dissemination%20from%20the%20<i>Aedes%20aegypti</i>%20midgut&amp;author=K. L. McElroy&amp;author=K. A. Tsetsarkin&amp;author=D. L. Vanlandingham&amp;author=&amp;author=S. Higgs&amp;publication_year=2006" target="_blank"&gt;Google Scholar</a></span></li><li id="B150">K. A. Hanley, L. R. Manlucu, L. E. Gilmore et al., “A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4,” <i>Virology</i>, vol. 312, no. 1, pp. 222–232, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0042-6822(03)00197-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20trade-off%20in%20replication%20in%20mosquito%20versus%20mammalian%20systems%20conferred%20by%20a%20point%20mutation%20in%20the%20NS4B%20protein%20of%20dengue%20virus%20type%204&amp;author=K.%20A.%20Hanley&amp;author=L.%20R.%20Manlucu&amp;author=L.%20E.%20Gilmore%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B151">E. P. Kelly, B. Puri, W. Sun, and B. Falgout, “Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate,” <i>Vaccine</i>, vol. 28, no. 17, pp. 3030–3037, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2009.10.084" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Identification%20of%20mutations%20in%20a%20candidate%20dengue%204%20vaccine%20strain%20341750%20PDK20%20and%20construction%20of%20a%20full-length%20cDNA%20clone%20of%20the%20PDK20%20vaccine%20candidate&amp;author=E.%20P.%20Kelly&amp;author=B.%20Puri&amp;author=W.%20Sun&amp;author=&amp;author=B.%20Falgout&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B152">S. Tajima, T. Takasaki, and I. Kurane, “Restoration of replication-defective dengue type 1 virus bearing mutations in the N-terminal cytoplasmic portion of NS4A by additional mutations in NS4B,” <i>Archives of Virology</i>, vol. 156, no. 1, pp. 63–69, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1007/s00705-010-0816-8" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Restoration%20of%20replication-defective%20dengue%20type%201%20virus%20bearing%20mutations%20in%20the%20N-terminal%20cytoplasmic%20portion%20of%20NS4A%20by%20additional%20mutations%20in%20NS4B&amp;author=S.%20Tajima&amp;author=T.%20Takasaki&amp;author=&amp;author=I.%20Kurane&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B153">D. Grant, G. K. Tan, M. Qing et al., “A single amino acid in nonstructural protein NS4B Confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis,” <i>Journal of Virology</i>, vol. 85, no. 15, pp. 7775–7787, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.00665-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20single%20amino%20acid%20in%20nonstructural%20protein%20NS4B%20Confers%20virulence%20to%20dengue%20virus%20in%20AG129%20mice%20through%20enhancement%20of%20viral%20RNA%20synthesis&amp;author=D.%20Grant&amp;author=G.%20K.%20Tan&amp;author=M.%20Qing%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B154">R. R. Roche, M. Alvarez, M. G. Guzman, L. Morier, and G. Kouri, “Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells,” <i>Journal of Clinical Microbiology</i>, vol. 38, no. 9, pp. 3508–3510, 2000. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Comparison%20of%20rapid%20centrifugation%20assay%20with%20conventional%20tissue%20culture%20method%20for%20isolation%20of%20dengue%202%20virus%20in%20C6/36-HT%20cells&amp;author=R.%20R.%20Roche&amp;author=M.%20Alvarez&amp;author=M.%20G.%20Guzman&amp;author=L.%20Morier&amp;author=&amp;author=G.%20Kouri&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li><li id="B155">W.-K. Wang, S.-R. Lin, C.-M. Lee, C.-C. King, and S.-C. Chang, “Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies,” <i>Journal of Virology</i>, vol. 76, no. 9, pp. 4662–4665, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.76.9.4662-4665.2002" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20type%203%20virus%20in%20plasma%20is%20a%20population%20of%20closely%20related%20genomes:%20quasispecies&amp;author=W.-K.%20Wang&amp;author=S.-R.%20Lin&amp;author=C.-M.%20Lee&amp;author=C.-C.%20King&amp;author=&amp;author=S.-C.%20Chang&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B156">J. Aaskov, K. Buzacott, H. M. Thu, K. Lowry, and E. C. Holmes, “Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes,” <i>Science</i>, vol. 311, no. 5758, pp. 236–238, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.1115030" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Long-term%20transmission%20of%20defective%20RNA%20viruses%20in%20humans%20and%20Aedes%20mosquitoes&amp;author=J.%20Aaskov&amp;author=K.%20Buzacott&amp;author=H.%20M.%20Thu&amp;author=K.%20Lowry&amp;author=&amp;author=E.%20C.%20Holmes&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B157">M. OhAinle, A. Balmaseda, A. R. Macalalad et al., “Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity,” <i>Science Translational Medicine</i>, vol. 3, no. 114, Article ID 114ra128, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1126/scitranslmed.3003084" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dynamics%20of%20dengue%20disease%20severity%20determined%20by%20the%20interplay%20between%20viral%20genetics%20and%20serotype-specific%20immunity&amp;author=M.%20OhAinle&amp;author=A.%20Balmaseda&amp;author=A.%20R.%20Macalalad%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B158">J. E. Foster, S. N. Bennett, C. V. F. Carrington, H. Vaughan, and W. O. McMillan, “Phylogeography and molecular evolution of dengue 2 in the Caribbean basin, 1981–2000,” <i>Virology</i>, vol. 324, no. 1, pp. 48–59, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2004.03.020" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phylogeography%20and%20molecular%20evolution%20of%20dengue%202%20in%20the%20Caribbean%20basin,%201981%E2%80%932000&amp;author=J.%20E.%20Foster&amp;author=S.%20N.%20Bennett&amp;author=C.%20V.%20F.%20Carrington&amp;author=H.%20Vaughan&amp;author=&amp;author=W.%20O.%20McMillan&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li><li id="B159">W. B. Messer, U. T. Vitarana, K. Sivananthan et al., “Epidemiology of dengue in Sri lanka before and after the emergence of epidemic dengue hemorrhagic fever,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 66, no. 6, pp. 765–773, 2002. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Epidemiology%20of%20dengue%20in%20Sri%20lanka%20before%20and%20after%20the%20emergence%20of%20epidemic%20dengue%20hemorrhagic%20fever&amp;author=W.%20B.%20Messer&amp;author=U.%20T.%20Vitarana&amp;author=K.%20Sivananthan%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B160">H. M. Thu, K. Lowry, L. Jiang, T. Hlaing, E. C. Holmes, and J. Aaskov, “Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection,” <i>Virology</i>, vol. 336, no. 2, pp. 163–172, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2005.03.018" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Lineage%20extinction%20and%20replacement%20in%20dengue%20type%201%20virus%20populations%20are%20due%20to%20stochastic%20events%20rather%20than%20to%20natural%20selection&amp;author=H.%20M.%20Thu&amp;author=K.%20Lowry&amp;author=L.%20Jiang&amp;author=T.%20Hlaing&amp;author=E.%20C.%20Holmes&amp;author=&amp;author=J.%20Aaskov&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B161">L. T. D. Salda, M. D. C. Parquet, R. R. Matias, F. F. Natividad, N. Kobayashi, and K. Morita, “Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 73, no. 4, pp. 796–802, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Molecular%20epidemiology%20of%20dengue%202%20viruses%20in%20the%20Philippines:%20genotype%20shift%20and%20local%20evolution&amp;author=L.%20T.%20D.%20Salda&amp;author=M.%20D.%20C.%20Parquet&amp;author=R.%20R.%20Matias&amp;author=F.%20F.%20Natividad&amp;author=N.%20Kobayashi&amp;author=&amp;author=K.%20Morita&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B162">T. T. H. Vu, E. C. Holmes, V. Duong et al., “Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia,” <i>PLoS Neglected Tropical Diseases</i>, vol. 4, no. 7, p. e757, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000757" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Emergence%20of%20the%20Asian%201%20genotype%20of%20dengue%20virus%20serotype%202%20in%20viet%20nam:%20in%20vivo%20fitness%20advantage%20and%20lineage%20replacement%20in%20South-East%20Asia&amp;author=T.%20T.%20H.%20Vu&amp;author=E.%20C.%20Holmes&amp;author=V.%20Duong%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B163">E. C. Holmes, “RNA virus genomics: a world of possibilities,” <i>Journal of Clinical Investigation</i>, vol. 119, no. 9, pp. 2488–2495, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1172/JCI38050" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=RNA%20virus%20genomics:%20a%20world%20of%20possibilities&amp;author=E.%20C.%20Holmes&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B164">D. Limonta, V. Capó, G. Torres, A. B. Pérez, and M. G. Guzmán, “Apoptosis in tissues from fatal dengue shock syndrome,” <i>Journal of Clinical Virology</i>, vol. 40, no. 1, pp. 50–54, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.jcv.2007.04.024" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Apoptosis%20in%20tissues%20from%20fatal%20dengue%20shock%20syndrome&amp;author=D.%20Limonta&amp;author=V.%20Cap%C3%B3&amp;author=G.%20Torres&amp;author=A.%20B.%20P%C3%A9rez&amp;author=&amp;author=M.%20G.%20Guzm%C3%A1n&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B165">A. Moya, E. C. Holmes, and F. González-Candelas, “The population genetics and evolutionary epidemiology of RNA viruses,” <i>Nature Reviews Microbiology</i>, vol. 2, no. 4, pp. 279–288, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nrmicro863" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20population%20genetics%20and%20evolutionary%20epidemiology%20of%20RNA%20viruses&amp;author=A.%20Moya&amp;author=E.%20C.%20Holmes&amp;author=&amp;author=F.%20Gonz%C3%A1lez-Candelas&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li><li id="B166">S. Navas, J. Martín, J. A. Quiroga, I. Castillo, and V. Carreño, “Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients,” <i>Journal of Virology</i>, vol. 72, no. 2, pp. 1640–1646, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Genetic%20diversity%20and%20tissue%20compartmentalization%20of%20the%20hepatitis%20C%20virus%20genome%20in%20blood%20mononuclear%20cells,%20liver,%20and%20serum%20from%20chronic%20hepatitis%20C%20patients&amp;author=S.%20Navas&amp;author=J.%20Mart%C3%ADn&amp;author=J.%20A.%20Quiroga&amp;author=I.%20Castillo&amp;author=&amp;author=V.%20Carre%C3%B1o&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li><li id="B167">R. Miralles, A. Moya, and S. F. Elena, “Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations,” <i>Journal of General Virology</i>, vol. 80, no. 8, pp. 2051–2059, 1999. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20population%20patchiness%20and%20migration%20rates%20on%20the%20adaptation%20and%20divergence%20of%20vesicular%20stomatitis%20virus%20quasispecies%20populations&amp;author=R.%20Miralles&amp;author=A.%20Moya&amp;author=&amp;author=S.%20F.%20Elena&amp;publication_year=1999" target="_blank">Google Scholar</a></span></li><li id="B168">P. Farci, A. Shimoda, A. Coiana et al., “The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies,” <i>Science</i>, vol. 288, no. 5464, pp. 339–344, 2000. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.288.5464.339" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20outcome%20of%20acute%20hepatitis%20C%20predicted%20by%20the%20evolution%20of%20the%20viral%20quasispecies&amp;author=P.%20Farci&amp;author=A.%20Shimoda&amp;author=A.%20Coiana%20et%20al.&amp;publication_year=2000" target="_blank">Google Scholar</a></span></li><li id="B169">E. C. Holmes, “Patterns of intra- and interhost nonsynonymous variation reveal strong purifying selection in dengue virus,” <i>Journal of Virology</i>, vol. 77, no. 20, pp. 11296–11298, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.77.20.11296-11298.2003" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Patterns%20of%20intra-%20and%20interhost%20nonsynonymous%20variation%20reveal%20strong%20purifying%20selection%20in%20dengue%20virus&amp;author=E.%20C.%20Holmes&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B170">S.-R. Lin, S.-C. Hsieh, Y.-Y. Yueh et al., “Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution,” <i>Journal of Virology</i>, vol. 78, no. 22, pp. 12717–12721, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.78.22.12717-12721.2004" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Study%20of%20sequence%20variation%20of%20dengue%20type%203%20virus%20in%20naturally%20infected%20mosquitoes%20and%20human%20hosts:%20implications%20for%20transmission%20and%20evolution&amp;author=S.-R.%20Lin&amp;author=S.-C.%20Hsieh&amp;author=Y.-Y.%20Yueh%20et%20al.&amp;publication_year=2004" target="_blank">Google Scholar</a></span></li><li id="B171">E. Descloux, V.-M. Cao-Lormeau, C. Roche, and X. De Lamballerie, “Dengue 1 diversity and microevolution, French Polynesia 2001–2006: connection with epidemiology and clinics,” <i>PLoS Neglected Tropical Diseases</i>, vol. 3, no. 8, article e493, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000493" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%201%20diversity%20and%20microevolution,%20French%20Polynesia%202001%E2%80%932006:%20connection%20with%20epidemiology%20and%20clinics&amp;author=E.%20Descloux&amp;author=V.-M.%20Cao-Lormeau&amp;author=C.%20Roche&amp;author=&amp;author=X.%20De%20Lamballerie&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B172">K. T. D. Thai, M. R. Henn, M. C. Zody et al., “High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections,” <i>Journal of Virology</i>, vol. 86, no. 2, pp. 835–843, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.05985-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=High-resolution%20analysis%20of%20intrahost%20genetic%20diversity%20in%20dengue%20virus%20serotype%201%20infection%20identifies%20mixed%20infections&amp;author=K.%20T.%20D.%20Thai&amp;author=M.%20R.%20Henn&amp;author=M.%20C.%20Zody%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B173">P. Parameswaran, P. Charlebois, Y. Tellez et al., “Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity,” <i>Journal of Virology</i>, vol. 86, no. 16, pp. 8546–8558, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.00736-12" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genome-wide%20patterns%20of%20intrahuman%20dengue%20virus%20diversity%20reveal%20associations%20with%20viral%20phylogenetic%20clade%20and%20interhost%20diversity&amp;author=P.%20Parameswaran&amp;author=P.%20Charlebois&amp;author=Y.%20Tellez%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B174">R. L. Costa, C. M. Voloch, and C. G. Schrago, “Comparative evolutionary epidemiology of dengue virus serotypes,” <i>Infection, Genetics and Evolution</i>, vol. 12, no. 2, pp. 309–314, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.meegid.2011.12.011" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Comparative%20evolutionary%20epidemiology%20of%20dengue%20virus%20serotypes&amp;author=R.%20L.%20Costa&amp;author=C.%20M.%20Voloch&amp;author=&amp;author=C.%20G.%20Schrago&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B175">J. Lourenço and M. Recker, “Viral and epidemiological determinants of the invasion dynamics of Novel Dengue Genotypes,” <i>PLoS Neglected Tropical Diseases</i>, vol. 4, no. 11, article e894, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000894" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Viral%20and%20epidemiological%20determinants%20of%20the%20invasion%20dynamics%20of%20Novel%20Dengue%20Genotypes&amp;author=J.%20Louren%C3%A7o%20&amp;author=M.%20Recker&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B176">V. Wittke, T. E. Robb, H. M. Thu et al., “Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period,” <i>Virology</i>, vol. 301, no. 1, pp. 148–156, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.2002.1549" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Extinction%20and%20rapid%20emergence%20of%20strains%20of%20dengue%203%20virus%20during%20an%20interepidemic%20period&amp;author=V.%20Wittke&amp;author=T.%20E.%20Robb&amp;author=H.%20M.%20Thu%20et%20al.&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B177">C. Chevillon and A.-B. Failloux, “Questions on viral population biology to complete dengue puzzle,” <i>Trends in Microbiology</i>, vol. 11, no. 9, pp. 415–421, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0966-842X(03)00206-3" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Questions%20on%20viral%20population%20biology%20to%20complete%20dengue%20puzzle&amp;author=C.%20Chevillon%20&amp;author=A.-B.%20Failloux&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B178">L. Lambrechts, T. Fansiri, A. Pongsiri et al., “Dengue-1 virus clade replacement in Thailand associated with enhanced mosquito transmission,” <i>Journal of Virology</i>, vol. 86, no. 3, pp. 1853–1861, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.06458-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue-1%20virus%20clade%20replacement%20in%20Thailand%20associated%20with%20enhanced%20mosquito%20transmission&amp;author=L.%20Lambrechts&amp;author=T.%20Fansiri&amp;author=A.%20Pongsiri%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B179">W. H. Bancroft, R. M. Scott, and W. E. Brandt, “Dengue-2 vaccine: infection of <i>Aedes aegypti</i> mosquitoes by feeding on viremic recipients,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 31, no. 6, pp. 1229–1231, 1982. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue-2%20vaccine:%20infection%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20mosquitoes%20by%20feeding%20on%20viremic%20recipients&amp;author=W.%20H.%20Bancroft&amp;author=R.%20M.%20Scott&amp;author=&amp;author=W.%20E.%20Brandt&amp;publication_year=1982" target="_blank">Google Scholar</a></span></li><li id="B180">B. R. Miller, B. J. Beaty, and T. H. G. Aitken, “Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, <i>Aedes aegypti</i>,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 31, no. 6, pp. 1232–1237, 1982. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue-2%20vaccine:%20oral%20infection,%20transmission,%20and%20lack%20of%20evidence%20for%20reversion%20in%20the%20mosquito,%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=B.%20R.%20Miller&amp;author=B.%20J.%20Beaty&amp;author=&amp;author=T.%20H.%20G.%20Aitken&amp;publication_year=1982" target="_blank">Google Scholar</a></span></li><li id="B181">D. J. Gubler, S. Nalim, and R. Tan, “Variation in susceptibility to oral infection with dengue viruses among geographic strains of <i>Aedes aegypti</i>,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 28, no. 6, pp. 1045–1052, 1979. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Variation%20in%20susceptibility%20to%20oral%20infection%20with%20dengue%20viruses%20among%20geographic%20strains%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=D.%20J.%20Gubler&amp;author=S.%20Nalim&amp;author=&amp;author=R.%20Tan&amp;publication_year=1979" target="_blank">Google Scholar</a></span></li><li id="B182">P. M. Armstrong and R. Rico-Hesse, “Differential susceptibility of <i>Aedes aegypti</i> to infection by the American and Southeast Asian genotypes of dengue type 2 virus,” <i>Vector Borne Zoonotic Dis</i>, vol. 1, no. 2, pp. 159–168, 2001. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Differential%20susceptibility%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20to%20infection%20by%20the%20American%20and%20Southeast%20Asian%20genotypes%20of%20dengue%20type%202%20virus&amp;author=P.%20M.%20Armstrong%20&amp;author=R.%20Rico-Hesse&amp;publication_year=2001" target="_blank">Google Scholar</a></span></li><li id="B183">F. L. Soper, “<i>Aedes aegypti</i> and yellow fever,” <i>Bulletin of the World Health Organization</i>, vol. 36, no. 4, pp. 521–527, 1967. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=%3Ci%3EAedes%20aegypti%3C/i%3E%20and%20yellow%20fever&amp;author=F.%20L.%20Soper&amp;publication_year=1967" target="_blank">Google Scholar</a></span></li><li id="B184">D. J. Gubler, “<i>Aedes aegypti</i> and <i>Aedes aegypti</i>-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 40, no. 6, pp. 571–578, 1989. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=%3Ci%3EAedes%20aegypti%3C/i%3E%20and%20%3Ci%3EAedes%20aegypti%3C/i%3E-borne%20disease%20control%20in%20the%201990s:%20top%20down%20or%20bottom%20up.%20Charles%20Franklin%20Craig%20Lecture&amp;author=D.%20J.%20Gubler&amp;publication_year=1989" target="_blank">Google Scholar</a></span></li><li id="B185">E.-E. Ooi, K.-T. Goh, and D. J. Gubler, “Dengue prevention and 35 years of vector control in Singapore,” <i>Emerging Infectious Diseases</i>, vol. 12, no. 6, pp. 887–893, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20prevention%20and%2035%20years%20of%20vector%20control%20in%20Singapore&amp;author=E.-E.%20Ooi&amp;author=K.-T.%20Goh&amp;author=&amp;author=D.%20J.%20Gubler&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B186">M. G. Guzman, O. Pelaez, G. Kouri et al., “Final characterization of and lessons learned from the dengue 3 epidemic in Cuba, 2001-2002,” <i>Revista Panamericana de Salud Pública</i>, vol. 19, no. 4, pp. 282–289, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Final%20characterization%20of%20and%20lessons%20learned%20from%20the%20dengue%203%20epidemic%20in%20Cuba,%202001-2002&amp;author=M.%20G.%20Guzman&amp;author=O.%20Pelaez&amp;author=G.%20Kouri%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B187">M. Bonet, J. M. Spiegel, A. M. Ibarra, G. Kouri, A. Pintre Lic, and A. Yassi, “An integrated ecosystem approach for sustainable prevention and control of dengue in Central Havana,” <i>International Journal of Occupational and Environmental Health</i>, vol. 13, no. 2, pp. 188–194, 2007. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=An%20integrated%20ecosystem%20approach%20for%20sustainable%20prevention%20and%20control%20of%20dengue%20in%20Central%20Havana&amp;author=M.%20Bonet&amp;author=J.%20M.%20Spiegel&amp;author=A.%20M.%20Ibarra&amp;author=G.%20Kouri&amp;author=A.%20Pintre%20Lic&amp;author=&amp;author=A.%20Yassi&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B188">J. A. Bisset, M. M. Rodríguez, Y. Ricardo et al., “Temephos resistance and esterase activity in the mosquito <i>Aedes aegypti</i> in Havana, Cuba increased dramatically between 2006 and 2008,” <i>Medical and Veterinary Entomology</i>, vol. 25, no. 3, pp. 233–239, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1111/j.1365-2915.2011.00959.x" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Temephos%20resistance%20and%20esterase%20activity%20in%20the%20mosquito%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20Havana,%20Cuba%20increased%20dramatically%20between%202006%20and%202008&amp;author=J.%20A.%20Bisset&amp;author=M.%20M.%20Rodr%C3%ADguez&amp;author=Y.%20Ricardo%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B189">R. Maciel-de-Freitas, R. Aguiar, R. V. Bruno et al., “Why do we need alternative tools to control mosquito-borne diseases in Latin America?” <i>Memórias do Instituto Oswaldo Cruz</i>, vol. 107, no. 6, pp. 828–829, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Why%20do%20we%20need%20alternative%20tools%20to%20control%20mosquito-borne%20diseases%20in%20Latin%20America?&amp;author=R.%20Maciel-de-Freitas&amp;author=R.%20Aguiar&amp;author=R.%20V.%20Bruno%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B190">R. A. Sá, N. D. D. L. Santos, C. S. B. D. Silva et al., “Larvicidal activity of lectins from Myracrodruon urundeuva on <i>Aedes aegypti</i>,” <i>Comparative Biochemistry and Physiology Part C</i>, vol. 149, no. 3, pp. 300–306, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cbpc.2008.08.004" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Larvicidal%20activity%20of%20lectins%20from%20Myracrodruon%20urundeuva%20on%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=R.%20A.%20S%C3%A1&amp;author=N.%20D.%20D.%20L.%20Santos&amp;author=C.%20S.%20B.%20D.%20Silva%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B191">P. F. Billingsley, B. Foy, and J. L. Rasgon, “Mosquitocidal vaccines: a neglected addition to malaria and dengue control strategies,” <i>Trends in Parasitology</i>, vol. 24, no. 9, pp. 396–400, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.pt.2008.06.003" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mosquitocidal%20vaccines:%20a%20neglected%20addition%20to%20malaria%20and%20dengue%20control%20strategies&amp;author=P.%20F.%20Billingsley&amp;author=B.%20Foy&amp;author=&amp;author=J.%20L.%20Rasgon&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B192">J. A. Bisset Lazcano, M. C. Marquetti, A. Garcia et al., “Pupal surveillance of <i>Aedes aegypti</i> as a tool for control of the vector in a municipality with low density of La Habana City, Cuba,” <i>Revista Biomédica</i>, vol. 19, pp. 92–103, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Pupal%20surveillance%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20as%20a%20tool%20for%20control%20of%20the%20vector%20in%20a%20municipality%20with%20low%20density%20of%20La%20Habana%20City,%20Cuba&amp;author=J.%20A.%20Bisset%20Lazcano&amp;author=M.%20C.%20Marquetti&amp;author=A.%20Garcia%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B193">T. T. Tuyet Hanh, P. S. Hill, B. H. Kay, and M. Q. Tran, “Development of a framework for evaluating the sustainability of community-based dengue control projects,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 80, no. 2, pp. 312–318, 2009. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Development%20of%20a%20framework%20for%20evaluating%20the%20sustainability%20of%20community-based%20dengue%20control%20projects&amp;author=T.%20T.%20Tuyet%20Hanh&amp;author=P.%20S.%20Hill&amp;author=B.%20H.%20Kay&amp;author=&amp;author=M.%20Q.%20Tran&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B194">S. N. Vu, T. Y. Nguyen, B. H. Kay, G. G. Marten, and J. W. Reid, “Eradication of <i>Aedes aegypti</i> from a village in Vietnam, using copepods and community participation,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 59, no. 4, pp. 657–660, 1998. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Eradication%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20from%20a%20village%20in%20Vietnam,%20using%20copepods%20and%20community%20participation&amp;author=S.%20N.%20Vu&amp;author=T.%20Y.%20Nguyen&amp;author=B.%20H.%20Kay&amp;author=G.%20G.%20Marten&amp;author=&amp;author=J.%20W.%20Reid&amp;publication_year=1998" target="_blank">Google Scholar</a></span></li><li id="B195">V. S. Nam, N. T. Yen, T. V. Phong et al., “Elimination of dengue by community programs using Mesocyclops (copepoda) against <i>Aedes aegypti</i> in central Vietnam,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 72, no. 1, pp. 67–73, 2005. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Elimination%20of%20dengue%20by%20community%20programs%20using%20Mesocyclops%20(copepoda)%20against%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20central%20Vietnam&amp;author=V.%20S.%20Nam&amp;author=N.%20T.%20Yen&amp;author=T.%20V.%20Phong%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B196">B. Kay and V. S. Nam, “New strategy against <i>Aedes aegypti</i> in Vietnam,” <i>The Lancet</i>, vol. 365, no. 9459, pp. 613–617, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0140-6736(05)17913-6" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=New%20strategy%20against%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20Vietnam&amp;author=B.%20Kay%20&amp;author=V.%20S.%20Nam&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B197">L. Sánchez, D. Pérez, L. Alfonso et al., “A community education strategy to promote participation in dengue prevention in Cuba,” <i>Revista Panamericana de Salud Publica</i>, vol. 24, no. 1, pp. 61–69, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=A%20community%20education%20strategy%20to%20promote%20participation%20in%20dengue%20prevention%20in%20Cuba&amp;author=L.%20S%C3%A1nchez&amp;author=D.%20P%C3%A9rez&amp;author=L.%20Alfonso%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B198">C. J. McMeniman, R. V. Lane, B. N. Cass et al., “Stable introduction of a life-shortening Wolbachia infection into the mosquito <i>Aedes aegypti</i>,” <i>Science</i>, vol. 323, no. 5910, pp. 141–144, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1126/science.1165326" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Stable%20introduction%20of%20a%20life-shortening%20Wolbachia%20infection%20into%20the%20mosquito%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=C.%20J.%20McMeniman&amp;author=R.%20V.%20Lane&amp;author=B.%20N.%20Cass%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B199">P. Lu, G. Bian, X. Pan, and Z. Xi, “Wolbachia induces density-dependent inhibition to dengue virus in mosquito cells,” <i>PLOS Neglected Tropical Diseases</i>, vol. 6, no. 7, Article ID e1754, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Wolbachia%20induces%20density-dependent%20inhibition%20to%20dengue%20virus%20in%20mosquito%20cells&amp;author=P.%20Lu&amp;author=G.%20Bian&amp;author=X.%20Pan&amp;author=&amp;author=Z.%20Xi&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B200">T. Walker, P. H. Johnson, L. A. Moreira et al., “The wMel Wolbachia strain blocks dengue and invades caged <i>Aedes aegypti</i> populations,” <i>Nature</i>, vol. 476, no. 7361, pp. 450–455, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nature10355" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20wMel%20Wolbachia%20strain%20blocks%20dengue%20and%20invades%20caged%20%3Ci%3EAedes%20aegypti%3C/i%3E%20populations&amp;author=T.%20Walker&amp;author=P.%20H.%20Johnson&amp;author=L.%20A.%20Moreira%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B201">G. Bian, Y. Xu, P. Lu, Y. Xie, and Z. Xi, “The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in <i>Aedes aegypti</i>,” <i>PLoS Pathogens</i>, vol. 6, no. 4, Article ID e1000833, 2010. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20endosymbiotic%20bacterium%20Wolbachia%20induces%20resistance%20to%20dengue%20virus%20in%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=G.%20Bian&amp;author=Y.%20Xu&amp;author=P.%20Lu&amp;author=Y.%20Xie&amp;author=&amp;author=Z.%20Xi&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B202">L. A. Moreira, I. Iturbe-Ormaetxe, J. A. Jeffery et al., “A Wolbachia Symbiont in <i>Aedes aegypti</i> Limits Infection with Dengue, Chikungunya, and Plasmodium,” <i>Cell</i>, vol. 139, no. 7, pp. 1268–1278, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.cell.2009.11.042" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20Wolbachia%20Symbiont%20in%20%3Ci%3EAedes%20aegypti%3C/i%3E%20Limits%20Infection%20with%20Dengue,%20Chikungunya,%20and%20Plasmodium&amp;author=L.%20A.%20Moreira&amp;author=I.%20Iturbe-Ormaetxe&amp;author=J.%20A.%20Jeffery%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B203">X. Pan, G. Zhou, J. Wu et al., “Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito <i>Aedes aegypti</i>,” <i>Proceedings of the National Academy of Sciences of the United States of America</i>, vol. 109, no. 1, pp. E23–E31, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1073/pnas.1116932108" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Wolbachia%20induces%20reactive%20oxygen%20species%20(ROS)-dependent%20activation%20of%20the%20Toll%20pathway%20to%20control%20dengue%20virus%20in%20the%20mosquito%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=X.%20Pan&amp;author=G.%20Zhou&amp;author=J.%20Wu%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B204">L. Mousson, K. Zouache, C. Arias-Goeta, V. Raquin, P. Mavingui, and A. B. Failloux, “The native wolbachia symbionts limit transmission of dengue virus in <i>Aedes albopictus</i>,” <i>PLOS Neglected Tropical Diseases</i>, vol. 6, no. 12, Article ID e1989, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20native%20wolbachia%20symbionts%20limit%20transmission%20of%20dengue%20virus%20in%20%3Ci%3EAedes%20albopictus%3C/i%3E&amp;author=L.%20Mousson&amp;author=K.%20Zouache&amp;author=C.%20Arias-Goeta&amp;author=V.%20Raquin&amp;author=P.%20Mavingui&amp;author=&amp;author=A.%20B.%20Failloux&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B205">P. E. Cook, C. J. McMeniman, and S. L. O'Neill, “Modifying insect population age structure to control vector-borne disease,” <i>Advances in Experimental Medicine and Biology</i>, vol. 627, pp. 126–140, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1007/978-0-387-78225-6-11" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Modifying%20insect%20population%20age%20structure%20to%20control%20vector-borne%20disease&amp;author=P.%20E.%20Cook&amp;author=C.%20J.%20McMeniman&amp;author=&amp;author=S.%20L.%20O%27Neill&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B206">N. M. Endersby, A. A. Hoffmann, V. L. White, S. A. Ritchie, P. H. Johnson, and A. R. Weeks, “Changes in the genetic structure of <i>Aedes aegypti</i> (Diptera: Culicidae) populations in Queensland, Australia, across two seasons: implications for potential mosquito releases,” <i>Journal of Medical Entomology</i>, vol. 48, no. 5, pp. 999–1007, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1603/ME10264" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Changes%20in%20the%20genetic%20structure%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20(Diptera:%20Culicidae)%20populations%20in%20Queensland,%20Australia,%20across%20two%20seasons:%20implications%20for%20potential%20mosquito%20releases&amp;author=N.%20M.%20Endersby&amp;author=A.%20A.%20Hoffmann&amp;author=V.%20L.%20White&amp;author=S.%20A.%20Ritchie&amp;author=P.%20H.%20Johnson&amp;author=&amp;author=A.%20R.%20Weeks&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B207">N. M. Endersby, A. A. Hoffmann, V. L. White et al., “Genetic structure of <i>Aedes aegypti</i> in Australia and Vietnam revealed by microsatellite and exon primed intron crossing markers suggests feasibility of local control options,” <i>Journal of Medical Entomology</i>, vol. 46, no. 5, pp. 1074–1083, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1603/033.046.0514" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genetic%20structure%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E%20in%20Australia%20and%20Vietnam%20revealed%20by%20microsatellite%20and%20exon%20primed%20intron%20crossing%20markers%20suggests%20feasibility%20of%20local%20control%20options&amp;author=N.%20M.%20Endersby&amp;author=A.%20A.%20Hoffmann&amp;author=V.%20L.%20White%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B208">J. A. L. Jeffery, N. T. Yen, V. S. Nam et al., “Characterizing the <i>Aedes aegypti</i> population in a Vietnamese village in preparation for a Wolbachia-based mosquito control strategy to eliminate dengue,” <i>PLoS Neglected Tropical Diseases</i>, vol. 3, no. 11, Article ID e0000552, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000552" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Characterizing%20the%20%3Ci%3EAedes%20aegypti%3C/i%3E%20population%20in%20a%20Vietnamese%20village%20in%20preparation%20for%20a%20Wolbachia-based%20mosquito%20control%20strategy%20to%20eliminate%20dengue&amp;author=J.%20A.%20L.%20Jeffery&amp;author=N.%20T.%20Yen&amp;author=V.%20S.%20Nam%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B209">H. L. Yeap, P. Mee, T. Walker et al., “Dynamics of the “popcorn” Wolbachia infection in outbred <i>Aedes aegypti</i> informs prospects for mosquito vector control,” <i>Genetics</i>, vol. 187, no. 2, pp. 583–595, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1534/genetics.110.122390" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dynamics%20of%20the%20%E2%80%9Cpopcorn%E2%80%9D%20Wolbachia%20infection%20in%20outbred%20%3Ci%3EAedes%20aegypti%3C/i%3E%20informs%20prospects%20for%20mosquito%20vector%20control&amp;author=H.%20L.%20Yeap&amp;author=P.%20Mee&amp;author=T.%20Walker%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B210">R. Macey, “Dengue fever breakthrough,” Sydney Morning Herald, 2009, <a target="_blank" href="http://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/02/1230681699070.html">http://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/02/1230681699070.html</a>. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20fever%20breakthrough&amp;author=R.%20Macey" target="_blank">Google Scholar</a></span></li><li id="B211">N. M. Endersby and A. A. Hoffmann, “Effect of Wolbachia on insecticide susceptibility in lines of <i>Aedes aegypti</i>,” <i>Bulletin of Entomological Research</i>, pp. 1–9, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Effect%20of%20Wolbachia%20on%20insecticide%20susceptibility%20in%20lines%20of%20%3Ci%3EAedes%20aegypti%3C/i%3E&amp;author=N.%20M.%20Endersby%20&amp;author=A.%20A.%20Hoffmann&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B212">S. B. Halstead, “Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade,” <i>Reviews of Infectious Diseases</i>, vol. 11, pp. S830–839, 1989. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Antibody,%20macrophages,%20dengue%20virus%20infection,%20shock,%20and%20hemorrhage:%20a%20pathogenetic%20cascade&amp;author=S.%20B.%20Halstead&amp;publication_year=1989" target="_blank">Google Scholar</a></span></li><li id="B213">J. Hombach, M. Jane Cardosa, A. Sabchareon, D. W. Vaughn, and A. D. T. Barrett, “Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005,” <i>Vaccine</i>, vol. 25, no. 21, pp. 4130–4139, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2007.02.079" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Scientific%20consultation%20on%20immunological%20correlates%20of%20protection%20induced%20by%20dengue%20vaccines.%20Report%20from%20a%20meeting%20held%20at%20the%20World%20Health%20Organization%2017-18%20November%202005&amp;author=J.%20Hombach&amp;author=M.%20Jane%20Cardosa&amp;author=A.%20Sabchareon&amp;author=D.%20W.%20Vaughn&amp;author=&amp;author=A.%20D.%20T.%20Barrett&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B214">S. Swaminathan, G. Batra, and N. Khanna, “Dengue vaccines: state of the art,” <i>Expert Opinion on Therapeutic Patents</i>, vol. 20, no. 6, pp. 819–835, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1517/13543771003767476" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vaccines:%20state%20of%20the%20art&amp;author=S.%20Swaminathan&amp;author=G.%20Batra&amp;author=&amp;author=N.%20Khanna&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B215">R. Edelman, S. S. Wasserman, S. A. Bodison et al., “Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 69, no. 6, pp. 48–60, 2003. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Phase%20I%20trial%20of%2016%20formulations%20of%20a%20tetravalent%20live-attenuated%20dengue%20vaccine&amp;author=R.%20Edelman&amp;author=S.%20S.%20Wasserman&amp;author=S.%20A.%20Bodison%20et%20al.&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B216">S. Simasathien, S. J. Thomas, V. Watanaveeradej et al., “Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 78, no. 3, pp. 426–433, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Safety%20and%20immunogenicity%20of%20a%20tetravalent%20live-attenuated%20dengue%20vaccine%20in%20flavivirus%20naive%20children&amp;author=S.%20Simasathien&amp;author=S.%20J.%20Thomas&amp;author=V.%20Watanaveeradej%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B217">W. Sun, D. Cunningham, S. S. Wasserman et al., “Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults,” <i>Human Vaccines</i>, vol. 5, no. 1, pp. 33–40, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.4161/hv.5.1.6348" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Phase%202%20clinical%20trial%20of%20three%20formulations%20of%20tetravalent%20live-attenuated%20dengue%20vaccine%20in%20flavivirus-na%C3%AFve%20adults&amp;author=W.%20Sun&amp;author=D.%20Cunningham&amp;author=S.%20S.%20Wasserman%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B218">A. P. Durbin, S. S. Whitehead, J. McArthur et al., “rDEN4<i>σ</i>30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers,” <i>Journal of Infectious Diseases</i>, vol. 191, no. 5, pp. 710–718, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1086/427780" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=rDEN4%3Ci%3E%CF%83%3C/i%3E30,%20a%20live%20attenuated%20dengue%20virus%20type%204%20vaccine%20candidate,%20is%20safe,%20immunogenic,%20and%20highly%20infectious%20in%20healthy%20adult%20volunteers&amp;author=A.%20P.%20Durbin&amp;author=S.%20S.%20Whitehead&amp;author=J.%20McArthur%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B219">A. P. Durbin, J. McArthur, J. A. Marron et al., “The live attenuated dengue serotype 1 vaccine rDEN1Δ30 is safe and highly immunogenic in healthy adult volunteers,” <i>Human Vaccines</i>, vol. 2, no. 4, pp. 167–173, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=The%20live%20attenuated%20dengue%20serotype%201%20vaccine%20rDEN1%CE%9430%20is%20safe%20and%20highly%20immunogenic%20in%20healthy%20adult%20volunteers&amp;author=A.%20P.%20Durbin&amp;author=J.%20McArthur&amp;author=J.%20A.%20Marron%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B220">A. P. Durbin, J. H. McArthur, J. A. Marron et al., “rDEN2/4Δ30(ME), a live attenuated chimeric dengue serotype 2 vaccine, is safe and highly immunogenic in healthy dengue-naïve adults,” <i>Human Vaccines</i>, vol. 2, no. 6, pp. 255–260, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=rDEN2/4%CE%9430(ME),%20a%20live%20attenuated%20chimeric%20dengue%20serotype%202%20vaccine,%20is%20safe%20and%20highly%20immunogenic%20in%20healthy%20dengue-na%C3%AFve%20adults&amp;author=A.%20P.%20Durbin&amp;author=J.%20H.%20McArthur&amp;author=J.%20A.%20Marron%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B221">J. H. McArthur, A. P. Durbin, J. A. Marron et al., “Phase I clinical evaluation of rDEN4Δ30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 79, no. 5, pp. 678–684, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Phase%20I%20clinical%20evaluation%20of%20rDEN4%CE%9430-200,201:%20a%20live%20attenuated%20dengue%204%20vaccine%20candidate%20designed%20for%20decreased%20hepatotoxicity&amp;author=J.%20H.%20McArthur&amp;author=A.%20P.%20Durbin&amp;author=J.%20A.%20Marron%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B222">J. E. Blaney Jr., N. S. Sathe, L. Goddard et al., “Dengue virus type 3 vaccine candidates generated by introduction of deletions in the <math id="M2" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math> untranslated region (<math id="M3" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math>-UTR) or by exchange of the DENV-3 <math id="M4" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>3</mn><mo>′</mo></msup></mrow></math>-UTR with that of DENV-4,” <i>Vaccine</i>, vol. 26, no. 6, pp. 817–828, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2007.11.082" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%203%20vaccine%20candidates%20generated%20by%20introduction%20of%20deletions%20in%20the%20%3Cinline-formula%3E%3Cmml:math%20id=" m2"%20xmlns:mml="http://www.w3.org/1998/Math/MathML" target="_blank"><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow>%20untranslated%20region%20(<inline-formula><mml:math%20id="m3"%20xmlns:mml="http: www.w3.org="" 1998="" math="" mathml"=""><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math%20id="m3"%20xmlns:mml="http:></inline-formula>-UTR)%20or%20by%20exchange%20of%20the%20DENV-3%20<inline-formula><mml:math%20id="m4"%20xmlns:mml="http: www.w3.org="" 1998="" math="" mathml"=""><mml:mrow><mml:msup><mml:mn>3</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math%20id="m4"%20xmlns:mml="http:></inline-formula>-UTR%20with%20that%20of%20DENV-4&amp;author=J. E. Blaney Jr.&amp;author=N. S. Sathe&amp;author=L. Goddard et al.&amp;publication_year=2008" target="_blank"&gt;Google Scholar</a></span></li><li id="B223">M. G. Guzman, L. Hermida, L. Bernardo, R. Ramirez, and G. Guillén, “Domain III of the envelope protein as a dengue vaccine target,” <i>Expert Review of Vaccines</i>, vol. 9, no. 2, pp. 137–147, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1586/erv.09.139" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Domain%20III%20of%20the%20envelope%20protein%20as%20a%20dengue%20vaccine%20target&amp;author=M.%20G.%20Guzman&amp;author=L.%20Hermida&amp;author=L.%20Bernardo&amp;author=R.%20Ramirez&amp;author=&amp;author=G.%20Guill%C3%A9n&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B224">F. Guirakhoo, S. Kitckener, D. Morrison et al., “Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity—effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes,” <i>Human Vaccines</i>, vol. 2, no. 2, pp. 60–67, 2006. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Live%20attenuated%20chimeric%20yellow%20fever%20dengue%20type%202%20(ChimeriVax-DEN2)%20vaccine:%20phase%20I%20clinical%20trial%20for%20safety%20and%20immunogenicity%E2%80%94effect%20of%20yellow%20fever%20pre-immunity%20in%20induction%20of%20cross%20neutralizing%20antibody%20responses%20to%20all%204%20dengue%20serotypes&amp;author=F.%20Guirakhoo&amp;author=S.%20Kitckener&amp;author=D.%20Morrison%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B225">B. Guy, N. Nougarede, S. Begue et al., “Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects,” <i>Vaccine</i>, vol. 26, no. 45, pp. 5712–5721, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2008.08.019" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Cell-mediated%20immunity%20induced%20by%20chimeric%20tetravalent%20dengue%20vaccine%20in%20naive%20or%20flavivirus-primed%20subjects&amp;author=B.%20Guy&amp;author=N.%20Nougarede&amp;author=S.%20Begue%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B226">B. Guy, F. Guirakhoo, V. Barban, S. Higgs, T. P. Monath, and J. Lang, “Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses,” <i>Vaccine</i>, vol. 28, no. 3, pp. 632–649, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2009.09.098" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Preclinical%20and%20clinical%20development%20of%20YFV%2017D-based%20chimeric%20vaccines%20against%20dengue,%20West%20Nile%20and%20Japanese%20encephalitis%20viruses&amp;author=B.%20Guy&amp;author=F.%20Guirakhoo&amp;author=V.%20Barban&amp;author=S.%20Higgs&amp;author=T.%20P.%20Monath&amp;author=&amp;author=J.%20Lang&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B227">B. Guy, M. Saville, and J. Lang, “Development of Sanofi Pasteur tetravalent dengue vaccine,” <i>Human Vaccines</i>, vol. 6, no. 9, pp. 696–705, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.4161.hv.6.9.12739" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Development%20of%20Sanofi%20Pasteur%20tetravalent%20dengue%20vaccine&amp;author=B.%20Guy&amp;author=M.%20Saville&amp;author=&amp;author=J.%20Lang&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B228">A. Sabchareon, D. Wallace, C. Sirivichayakul et al., “Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial,” <i>The Lancet</i>, vol. 380, no. 9853, pp. 1559–1567, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Protective%20efficacy%20of%20the%20recombinant,%20live-attenuated,%20CYD%20tetravalent%20dengue%20vaccine%20in%20Thai%20schoolchildren:%20a%20randomised,%20controlled%20phase%202b%20trial&amp;author=A.%20Sabchareon&amp;author=D.%20Wallace&amp;author=C.%20Sirivichayakul%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B229">S. Swaminathan, N. Khanna, B. Herring, and S. Mahalingam, “Dengue vaccine efficacy trial: does interference cause failure?” <i>The Lancet Infectious Diseases</i>, vol. 13, no. 3, pp. 191–192, 2013. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vaccine%20efficacy%20trial:%20does%20interference%20cause%20failure?&amp;author=S.%20Swaminathan&amp;author=N.%20Khanna&amp;author=B.%20Herring&amp;author=&amp;author=S.%20Mahalingam&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li><li id="B230">M. G. Guzman, A. Alvarez, S. Vazquez et al., “Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002,” <i>International Journal of Infectious Diseases</i>, vol. 16, no. 3, pp. e198–e203, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.ijid.2011.09.026" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Epidemiological%20studies%20on%20dengue%20virus%20type%203%20in%20Playa%20municipality,%20Havana,%20Cuba,%202001-2002&amp;author=M.%20G.%20Guzman&amp;author=A.%20Alvarez&amp;author=S.%20Vazquez%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B231">S. B. Halstead, “Dengue vaccine development: a 75% solution?” <i>The Lancet</i>, vol. 380, no. 9853, pp. 1535–1536, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Dengue%20vaccine%20development:%20a%2075%%20solution?&amp;author=S.%20B.%20Halstead&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B232">W. M. P. B. Wahala and A. M. de Silva, “The human antibody response to dengue virus infection,” <i>Viruses</i>, vol. 3, no. 12, pp. 2374–2395, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.3390/v3122374" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20human%20antibody%20response%20to%20dengue%20virus%20infection&amp;author=W.%20M.%20P.%20B.%20Wahala%20&amp;author=A.%20M.%20de%20Silva&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B233">J. E. Osorio, C. Y.-H. Huang, R. M. Kinney, and D. T. Stinchcomb, “Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever,” <i>Vaccine</i>, vol. 29, no. 42, pp. 7251–7260, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.07.020" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Development%20of%20DENVax:%20a%20chimeric%20dengue-2%20PDK-53-based%20tetravalent%20vaccine%20for%20protection%20against%20dengue%20fever&amp;author=J.%20E.%20Osorio&amp;author=C.%20Y.-H.%20Huang&amp;author=R.%20M.%20Kinney&amp;author=&amp;author=D.%20T.%20Stinchcomb&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B234">J. E. Osorio, J. N. Brewoo, S. J. Silengo et al., “Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in cynomolgus macaques,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 84, no. 6, pp. 978–987, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.4269/ajtmh.2011.10-0592" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Efficacy%20of%20a%20tetravalent%20chimeric%20dengue%20vaccine%20(DENVax)%20in%20cynomolgus%20macaques&amp;author=J.%20E.%20Osorio&amp;author=J.%20N.%20Brewoo&amp;author=S.%20J.%20Silengo%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B235">J. N. Brewoo, R. M. Kinney, T. D. Powell et al., “Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice,” <i>Vaccine</i>, vol. 30, no. 8, pp. 1513–1520, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2011.11.072" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity%20and%20efficacy%20of%20chimeric%20dengue%20vaccine%20(DENVax)%20formulations%20in%20interferon-deficient%20AG129%20mice&amp;author=J.%20N.%20Brewoo&amp;author=R.%20M.%20Kinney&amp;author=T.%20D.%20Powell%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B236">L. Hermida, L. Bernardo, J. Martín et al., “A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates,” <i>Vaccine</i>, vol. 24, no. 16, pp. 3165–3171, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.vaccine.2006.01.036" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20recombinant%20fusion%20protein%20containing%20the%20domain%20III%20of%20the%20dengue-2%20envelope%20protein%20is%20immunogenic%20and%20protective%20in%20nonhuman%20primates&amp;author=L.%20Hermida&amp;author=L.%20Bernardo&amp;author=J.%20Mart%C3%ADn%20et%20al.&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B237">L. Bernardo, A. Izquierdo, M. Alvarez et al., “Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates,” <i>Antiviral Research</i>, vol. 80, no. 2, pp. 194–199, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2008.06.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Immunogenicity%20and%20protective%20efficacy%20of%20a%20recombinant%20fusion%20protein%20containing%20the%20domain%20III%20of%20the%20dengue%201%20envelope%20protein%20in%20non-human%20primates&amp;author=L.%20Bernardo&amp;author=A.%20Izquierdo&amp;author=M.%20Alvarez%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B238">A. Izquierdo, L. Bernardo, J. Martin et al., “Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus,” <i>Virus Research</i>, vol. 138, no. 1-2, pp. 135–138, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virusres.2008.08.008" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Serotype-specificity%20of%20recombinant%20fusion%20proteins%20containing%20domain%20III%20of%20dengue%20virus&amp;author=A.%20Izquierdo&amp;author=L.%20Bernardo&amp;author=J.%20Martin%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B239">B. Etemad, G. Batra, R. Raut et al., “An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes,” <i>The American Journal of Tropical Medicine and Hygiene</i>, vol. 79, no. 3, pp. 353–363, 2008. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=An%20envelope%20domain%20III-based%20chimeric%20antigen%20produced%20in%20Pichia%20pastoris%20elicits%20neutralizing%20antibodies%20against%20all%20four%20dengue%20virus%20serotypes&amp;author=B.%20Etemad&amp;author=G.%20Batra&amp;author=R.%20Raut%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B240">G. Gao, Q. Wang, Z. Dai et al., “Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes,” <i>Human Gene Therapy</i>, vol. 19, no. 9, pp. 927–936, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1089/hum.2008.011" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Adenovirus-based%20vaccines%20generate%20cytotoxic%20T%20lymphocytes%20to%20epitopes%20of%20NS1%20from%20dengue%20virus%20that%20are%20present%20in%20all%20major%20serotypes&amp;author=G.%20Gao&amp;author=Q.%20Wang&amp;author=Z.%20Dai%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B241">S. Brandler, M. Lucas-Hourani, A. Moris et al., “Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus,” <i>PLoS Neglected Tropical Diseases</i>, vol. 1, no. 3, article e96, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0000096" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Pediatric%20measles%20vaccine%20expressing%20a%20dengue%20antigen%20induces%20durable%20serotype-specific%20neutralizing%20antibodies%20to%20dengue%20virus&amp;author=S.%20Brandler&amp;author=M.%20Lucas-Hourani&amp;author=A.%20Moris%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B242">I. Valdés, L. Bernardo, L. Gil et al., “A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice,” <i>Virology</i>, vol. 394, no. 2, pp. 249–258, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.virol.2009.08.029" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20novel%20fusion%20protein%20domain%20III-capsid%20from%20dengue-2,%20in%20a%20highly%20aggregated%20form,%20induces%20a%20functional%20immune%20response%20and%20protection%20in%20mice&amp;author=I.%20Vald%C3%A9s&amp;author=L.%20Bernardo&amp;author=L.%20Gil%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B243">E. Marcos, L. Gil, L. Lazo et al., “Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus,” <i>Archives of Virology</i>, vol. 158, no. 1, pp. 225–230, 2013. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Purified%20and%20highly%20aggregated%20chimeric%20protein%20DIIIC-2%20induces%20a%20functional%20immune%20response%20in%20mice%20against%20dengue%202%20virus&amp;author=E.%20Marcos&amp;author=L.%20Gil&amp;author=L.%20Lazo%20et%20al.&amp;publication_year=2013" target="_blank">Google Scholar</a></span></li><li id="B244">L. Lazo, L. Gil, C. Lopez et al., “A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice,” <i>Acta Tropica</i>, vol. 124, no. 2, pp. 107–112, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.actatropica.2012.06.006" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20vaccine%20formulation%20consisting%20of%20nucleocapsid-like%20particles%20from%20Dengue-2%20and%20the%20fusion%20protein%20P64k-domain%20III%20from%20Dengue-1%20induces%20a%20protective%20immune%20response%20against%20the%20homologous%20serotypes%20in%20mice&amp;author=L.%20Lazo&amp;author=L.%20Gil&amp;author=C.%20Lopez%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B245">L. Gil, L. Bernardo, A. Pavon et al., “Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice,” <i>Journal of General Virology</i>, vol. 93, part 6, pp. 1204–1214, 2012. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Recombinant%20nucleocapsid-like%20particles%20from%20dengue-2%20induce%20functional%20serotype-specific%20cell-mediated%20immunity%20in%20mice&amp;author=L.%20Gil&amp;author=L.%20Bernardo&amp;author=A.%20Pavon%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B246">C.-Y. Chiang, S.-J. Liu, J.-P. Tsai et al., “A novel single-dose dengue subunit vaccine induces memory immune responses,” <i>PLoS ONE</i>, vol. 6, no. 8, Article ID e23319, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pone.0023319" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20novel%20single-dose%20dengue%20subunit%20vaccine%20induces%20memory%20immune%20responses&amp;author=C.-Y.%20Chiang&amp;author=S.-J.%20Liu&amp;author=J.-P.%20Tsai%20et%20al.&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B247">C. Y. Chiang, M. H. Huang, C. H. Hsieh et al., “Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses,” <i>PLOS Neglected Tropical Diseases</i>, vol. 6, no. 5, Article ID e1645, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1371/journal.pntd.0001645" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Dengue-1%20envelope%20protein%20domain%20III%20along%20with%20PELC%20and%20CpG%20oligodeoxynucleotides%20synergistically%20enhances%20immune%20responses&amp;author=C.%20Y.%20Chiang&amp;author=M.%20H.%20Huang&amp;author=C.%20H.%20Hsieh%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B248">S. B. Halstead, “Controversies in dengue pathogenesis,” <i>Paediatrics and International Child Health</i>, vol. 32, supplement 1, pp. 5–9, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1179/2046904712Z.00000000045" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Controversies%20in%20dengue%20pathogenesis&amp;author=S.%20B.%20Halstead&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B249">S. J. Thomas and T. P. Endy, “Critical issues in dengue vaccine development,” <i>Current Opinion in Infectious Diseases</i>, vol. 24, no. 5, pp. 442–450, 2011. <span class="reflinks">View at: <a href="https://doi.org/10.1097/QCO.0b013e32834a1b0b" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Critical%20issues%20in%20dengue%20vaccine%20development&amp;author=S.%20J.%20Thomas%20&amp;author=T.%20P.%20Endy&amp;publication_year=2011" target="_blank">Google Scholar</a></span></li><li id="B250">J. D. Brien, S. K. Austin, S. Sukupolvi-Petty et al., “Genotype-specific neutralization and protection by antibodies against dengue virus type 3,” <i>Journal of Virology</i>, vol. 84, no. 20, pp. 10630–10643, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.01190-10" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Genotype-specific%20neutralization%20and%20protection%20by%20antibodies%20against%20dengue%20virus%20type%203&amp;author=J.%20D.%20Brien&amp;author=S.%20K.%20Austin&amp;author=S.%20Sukupolvi-Petty%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B251">M. Bollati, K. Alvarez, R. Assenberg et al., “Structure and functionality in flavivirus NS-proteins: perspectives for drug design,” <i>Antiviral Research</i>, vol. 87, no. 2, pp. 125–148, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2009.11.009" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Structure%20and%20functionality%20in%20flavivirus%20NS-proteins:%20perspectives%20for%20drug%20design&amp;author=M.%20Bollati&amp;author=K.%20Alvarez&amp;author=R.%20Assenberg%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B252">E. A. Gould, T. Solomon, and J. S. Mackenzie, “Does antiviral therapy have a role in the control of Japanese encephalitis?” <i>Antiviral Research</i>, vol. 78, no. 1, pp. 140–149, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2007.10.005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Does%20antiviral%20therapy%20have%20a%20role%20in%20the%20control%20of%20Japanese%20encephalitis?&amp;author=E.%20A.%20Gould&amp;author=T.%20Solomon&amp;author=&amp;author=J.%20S.%20Mackenzie&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B253">R. M. Kinney, C. Y.-H. Huang, B. C. Rose et al., “Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers,” <i>Journal of Virology</i>, vol. 79, no. 8, pp. 5116–5128, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.79.8.5116-5128.2005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20dengue%20virus%20serotypes%201%20to%204%20in%20vero%20cell%20cultures%20with%20morpholino%20oligomers&amp;author=R.%20M.%20Kinney&amp;author=C.%20Y.-H.%20Huang&amp;author=B.%20C.%20Rose%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B254">D. A. Stein, C. Y.-H. Huang, S. Silengo et al., “Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus,” <i>Journal of Antimicrobial Chemotherapy</i>, vol. 62, no. 3, pp. 555–565, 2008. <span class="reflinks">View at: <a href="https://doi.org/10.1093/jac/dkn221" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Treatment%20of%20AG129%20mice%20with%20antisense%20morpholino%20oligomers%20increases%20survival%20time%20following%20challenge%20with%20dengue%202%20virus&amp;author=D.%20A.%20Stein&amp;author=C.%20Y.-H.%20Huang&amp;author=S.%20Silengo%20et%20al.&amp;publication_year=2008" target="_blank">Google Scholar</a></span></li><li id="B255">P. Kumar, H. Wu, J. L. McBride et al., “Transvascular delivery of small interfering RNA to the central nervous system,” <i>Nature</i>, vol. 448, no. 7149, pp. 39–43, 2007. <span class="reflinks">View at: <a href="https://doi.org/10.1038/nature05901" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Transvascular%20delivery%20of%20small%20interfering%20RNA%20to%20the%20central%20nervous%20system&amp;author=P.%20Kumar&amp;author=H.%20Wu&amp;author=J.%20L.%20McBride%20et%20al.&amp;publication_year=2007" target="_blank">Google Scholar</a></span></li><li id="B256">D. Ray and P.-Y. Shi, “Recent advances in flavivirus antiviral drug discovery and vaccine development,” <i>Recent Patents on Anti-Infective Drug Discovery</i>, vol. 1, no. 1, pp. 45–55, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.2174/157489106775244055" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20flavivirus%20antiviral%20drug%20discovery%20and%20vaccine%20development&amp;author=D.%20Ray%20&amp;author=P.-Y.%20Shi&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li><li id="B257">S. Shigeta, S. Mori, E. Kodama, J. Kodama, K. Takahashi, and T. Yamase, “Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates,” <i>Antiviral Research</i>, vol. 58, no. 3, pp. 265–271, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0166-3542(03)00009-3" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Broad%20spectrum%20anti-RNA%20virus%20activities%20of%20titanium%20and%20vanadium%20substituted%20polyoxotungstates&amp;author=S.%20Shigeta&amp;author=S.%20Mori&amp;author=E.%20Kodama&amp;author=J.%20Kodama&amp;author=K.%20Takahashi&amp;author=&amp;author=T.%20Yamase&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B258">L. B. Talarico, C. A. Pujol, R. G. M. Zibetti et al., “The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell,” <i>Antiviral Research</i>, vol. 66, no. 2-3, pp. 103–110, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2005.02.001" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20antiviral%20activity%20of%20sulfated%20polysaccharides%20against%20dengue%20virus%20is%20dependent%20on%20virus%20serotype%20and%20host%20cell&amp;author=L.%20B.%20Talarico&amp;author=C.%20A.%20Pujol&amp;author=R.%20G.%20M.%20Zibetti%20et%20al.&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B259">L. Ono, W. Wollinger, I. M. Rocco, T. L. M. Coimbra, P. A. J. Gorin, and M.-R. Sierakowski, “In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain),” <i>Antiviral Research</i>, vol. 60, no. 3, pp. 201–208, 2003. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0166-3542(03)00175-X" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=In%20vitro%20and%20in%20vivo%20antiviral%20properties%20of%20sulfated%20galactomannans%20against%20yellow%20fever%20virus%20(BeH111%20strain)%20and%20dengue%201%20virus%20(Hawaii%20strain)&amp;author=L.%20Ono&amp;author=W.%20Wollinger&amp;author=I.%20M.%20Rocco&amp;author=T.%20L.%20M.%20Coimbra&amp;author=P.%20A.%20J.%20Gorin&amp;author=&amp;author=M.-R.%20Sierakowski&amp;publication_year=2003" target="_blank">Google Scholar</a></span></li><li id="B260">P. Leyssen, A. Van Lommel, C. Drosten, H. Schmitz, E. De Clercq, and J. Neyts, “A novel model for the study of the therapy of flavivirus infections using the Modoc virus,” <i>Virology</i>, vol. 279, no. 1, pp. 27–37, 2001. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.2000.0723" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20novel%20model%20for%20the%20study%20of%20the%20therapy%20of%20flavivirus%20infections%20using%20the%20Modoc%20virus&amp;author=P.%20Leyssen&amp;author=A.%20Van%20Lommel&amp;author=C.%20Drosten&amp;author=H.%20Schmitz&amp;author=E.%20De%20Clercq&amp;author=&amp;author=J.%20Neyts&amp;publication_year=2001" target="_blank">Google Scholar</a></span></li><li id="B261">P. Leyssen, J. Balzarini, E. De Clercq, and J. Neyts, “The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase,” <i>Journal of Virology</i>, vol. 79, no. 3, pp. 1943–1947, 2005. <span class="reflinks">View at: <a href="https://doi.org/10.1128/JVI.79.3.1943-1947.2005" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=The%20predominant%20mechanism%20by%20which%20ribavirin%20exerts%20its%20antiviral%20activity%20in%20vitro%20against%20flaviviruses%20and%20paramyxoviruses%20is%20mediated%20by%20inhibition%20of%20IMP%20dehydrogenase&amp;author=P.%20Leyssen&amp;author=J.%20Balzarini&amp;author=E.%20De%20Clercq&amp;author=&amp;author=J.%20Neyts&amp;publication_year=2005" target="_blank">Google Scholar</a></span></li><li id="B262">J. D. Morrey, D. F. Smee, R. W. Sidwell, and C. Tseng, “Identification of active antiviral compounds against a New York isolate of West Nile virus,” <i>Antiviral Research</i>, vol. 55, no. 1, pp. 107–116, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0166-3542(02)00013-X" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Identification%20of%20active%20antiviral%20compounds%20against%20a%20New%20York%20isolate%20of%20West%20Nile%20virus&amp;author=J.%20D.%20Morrey&amp;author=D.%20F.%20Smee&amp;author=R.%20W.%20Sidwell&amp;author=&amp;author=C.%20Tseng&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B263">J. W. Huggins, “Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug,” <i>Reviews of Infectious Diseases</i>, vol. 11, pp. S750–761, 1989. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Prospects%20for%20treatment%20of%20viral%20hemorrhagic%20fevers%20with%20ribavirin,%20a%20broad-spectrum%20antiviral%20drug&amp;author=J.%20W.%20Huggins&amp;publication_year=1989" target="_blank">Google Scholar</a></span></li><li id="B264">J. W. Huggins, R. K. Robins, and P. G. Canonico, “Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses,” <i>Antimicrobial Agents and Chemotherapy</i>, vol. 26, no. 4, pp. 476–480, 1984. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Synergistic%20antiviral%20effects%20of%20ribavirin%20and%20the%20C-nucleoside%20analogs%20tiazofurin%20and%20selenazofurin%20against%20togaviruses,%20bunyaviruses,%20and%20arenaviruses&amp;author=J.%20W.%20Huggins&amp;author=R.%20K.%20Robins&amp;author=&amp;author=P.%20G.%20Canonico&amp;publication_year=1984" target="_blank">Google Scholar</a></span></li><li id="B265">J. Neyts, A. Meerbach, P. McKenna, and E. De Clercq, “Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections,” <i>Antiviral Research</i>, vol. 30, no. 2-3, pp. 125–132, 1996. <span class="reflinks">View at: <a href="https://doi.org/10.1016/0166-3542(96)89697-5" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Use%20of%20the%20yellow%20fever%20virus%20vaccine%20strain%2017D%20for%20the%20study%20of%20strategies%20for%20the%20treatment%20of%20yellow%20fever%20virus%20infections&amp;author=J.%20Neyts&amp;author=A.%20Meerbach&amp;author=P.%20McKenna&amp;author=&amp;author=E.%20De%20Clercq&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li><li id="B266">F. J. Malinoski, S. E. Hasty, M. A. Ussery, and J. M. Dalrymple, “Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys,” <i>Antiviral Research</i>, vol. 13, no. 3, pp. 139–150, 1990. <span class="reflinks">View at: <a href="https://doi.org/10.1016/0166-3542(90)90029-7" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Prophylactic%20ribavirin%20treatment%20of%20dengue%20type%201%20infection%20in%20rhesus%20monkeys&amp;author=F.%20J.%20Malinoski&amp;author=S.%20E.%20Hasty&amp;author=M.%20A.%20Ussery&amp;author=&amp;author=J.%20M.%20Dalrymple&amp;publication_year=1990" target="_blank">Google Scholar</a></span></li><li id="B267">W. C. Koff, R. D. Pratt, J. L. Elm Jr., C. N. Venkateshan, and S. B. Halstead, “Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin,” <i>Antimicrobial Agents and Chemotherapy</i>, vol. 24, no. 1, pp. 134–136, 1983. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Treatment%20of%20intracranial%20dengue%20virus%20infections%20in%20mice%20with%20a%20lipophilic%20derivative%20of%20ribavirin&amp;author=W.%20C.%20Koff&amp;author=R.%20D.%20Pratt&amp;author=J.%20L.%20Elm%20Jr.&amp;author=C.%20N.%20Venkateshan&amp;author=&amp;author=S.%20B.%20Halstead&amp;publication_year=1983" target="_blank">Google Scholar</a></span></li><li id="B268">P. LaColla and J. P. Sommadossi, “Methods and compositions for treating flaviviruses and pestiviruses,” US6812219, 2004. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Methods%20and%20compositions%20for%20treating%20flaviviruses%20and%20pestiviruses&amp;author=P.%20LaColla%20&amp;author=J.%20P.%20Sommadossi" target="_blank">Google Scholar</a></span></li><li id="B269">M. S. Diamond, M. Zachariah, and E. Harris, “Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA,” <i>Virology</i>, vol. 304, no. 2, pp. 211–221, 2002. <span class="reflinks">View at: <a href="https://doi.org/10.1006/viro.2002.1685" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Mycophenolic%20acid%20inhibits%20dengue%20virus%20infection%20by%20preventing%20replication%20of%20viral%20RNA&amp;author=M.%20S.%20Diamond&amp;author=M.%20Zachariah&amp;author=&amp;author=E.%20Harris&amp;publication_year=2002" target="_blank">Google Scholar</a></span></li><li id="B270">M. D. Sintchak, M. A. Fleming, O. Futer et al., “Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid,” <i>Cell</i>, vol. 85, no. 6, pp. 921–930, 1996. <span class="reflinks">View at: <a href="https://doi.org/10.1016/S0092-8674(00)81275-1" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Structure%20and%20mechanism%20of%20inosine%20monophosphate%20dehydrogenase%20in%20complex%20with%20the%20immunosuppressant%20mycophenolic%20acid&amp;author=M.%20D.%20Sintchak&amp;author=M.%20A.%20Fleming&amp;author=O.%20Futer%20et%20al.&amp;publication_year=1996" target="_blank">Google Scholar</a></span></li><li id="B271">D. P. Stamos and R. S. Bethiel, “Prodrugs of carbamate inhibitors of IMPDH,” US6825224, 2004. <span class="reflinks">View at: <a href="https://scholar.google.com/scholar_lookup?title=Prodrugs%20of%20carbamate%20inhibitors%20of%20IMPDH&amp;author=D.%20P.%20Stamos%20&amp;author=R.%20S.%20Bethiel" target="_blank">Google Scholar</a></span></li><li id="B272">V. Nair, G. Chi, Q. Shu, J. Julander, and D. F. Smee, “A heterocyclic molecule with significant activity against dengue virus,” <i>Bioorganic and Medicinal Chemistry Letters</i>, vol. 19, no. 5, pp. 1425–1427, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.bmcl.2009.01.031" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20heterocyclic%20molecule%20with%20significant%20activity%20against%20dengue%20virus&amp;author=V.%20Nair&amp;author=G.%20Chi&amp;author=Q.%20Shu&amp;author=J.%20Julander&amp;author=&amp;author=D.%20F.%20Smee&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B273">X. G. Zhang, P. W. Mason, E. J. Dubovi et al., “Antiviral activity of geneticin against dengue virus,” <i>Antiviral Research</i>, vol. 83, no. 1, pp. 21–27, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.antiviral.2009.02.204" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Antiviral%20activity%20of%20geneticin%20against%20dengue%20virus&amp;author=X.%20G.%20Zhang&amp;author=P.%20W.%20Mason&amp;author=E.%20J.%20Dubovi%20et%20al.&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B274">E. Mastrangelo, M. Pezzullo, T. De Burghgraeve et al., “Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug,” <i>Journal of Antimicrobial Chemotherapy</i>, vol. 67, no. 8, pp. 1884–1894, 2012. <span class="reflinks">View at: <a href="https://doi.org/10.1093/jac/dks147" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Ivermectin%20is%20a%20potent%20inhibitor%20of%20flavivirus%20replication%20specifically%20targeting%20NS3%20helicase%20activity:%20new%20prospects%20for%20an%20old%20drug&amp;author=E.%20Mastrangelo&amp;author=M.%20Pezzullo&amp;author=T.%20De%20Burghgraeve%20et%20al.&amp;publication_year=2012" target="_blank">Google Scholar</a></span></li><li id="B275">S. J. F. Kaptein, T. De Burghgraeve, M. Froeyen et al., “A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro,” <i>Antimicrobial Agents and Chemotherapy</i>, vol. 54, no. 12, pp. 5269–5280, 2010. <span class="reflinks">View at: <a href="https://doi.org/10.1128/AAC.00686-10" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20derivate%20of%20the%20antibiotic%20doxorubicin%20is%20a%20selective%20inhibitor%20of%20dengue%20and%20yellow%20fever%20virus%20replication%20in%20vitro&amp;author=S.%20J.%20F.%20Kaptein&amp;author=T.%20De%20Burghgraeve&amp;author=M.%20Froeyen%20et%20al.&amp;publication_year=2010" target="_blank">Google Scholar</a></span></li><li id="B276">D. Benarroch, M.-P. Egloff, L. Mulard, C. Guerreiro, J.-L. Romette, and B. Canard, “A structural basis for the inhibition of the NS5 dengue virus mRNA <math id="M5" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>2</mn><mo>′</mo></msup></mrow></math>-O-methyltransferase domain by ribavirin <math id="M6" xmlns="http://www.w3.org/1998/Math/MathML"><mrow><msup><mn>5</mn><mo>′</mo></msup></mrow></math>-triphosphate,” <i>Journal of Biological Chemistry</i>, vol. 279, no. 34, pp. 35638–35643, 2004. <span class="reflinks">View at: <a href="https://doi.org/10.1074/jbc.M400460200" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=A%20structural%20basis%20for%20the%20inhibition%20of%20the%20NS5%20dengue%20virus%20mRNA%20%3Cinline-formula%3E%3Cmml:math%20id=" m5"%20xmlns:mml="http://www.w3.org/1998/Math/MathML" target="_blank"><mml:mrow><mml:msup><mml:mn>2</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow>-O-methyltransferase%20domain%20by%20ribavirin%20<inline-formula><mml:math%20id="m6"%20xmlns:mml="http: www.w3.org="" 1998="" math="" mathml"=""><mml:mrow><mml:msup><mml:mn>5</mml:mn><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math%20id="m6"%20xmlns:mml="http:></inline-formula>-triphosphate&amp;author=D. Benarroch&amp;author=M.-P. Egloff&amp;author=L. Mulard&amp;author=C. Guerreiro&amp;author=J.-L. Romette&amp;author=&amp;author=B. Canard&amp;publication_year=2004" target="_blank"&gt;Google Scholar</a></span></li><li id="B277">J. G. Julander, K. Shafer, D. F. Smee, J. D. Morrey, and Y. Furuta, “Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106,” <i>Antimicrobial Agents and Chemotherapy</i>, vol. 53, no. 1, pp. 202–209, 2009. <span class="reflinks">View at: <a href="https://doi.org/10.1128/AAC.01074-08" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Activity%20of%20T-705%20in%20a%20hamster%20model%20of%20yellow%20fever%20virus%20infection%20in%20comparison%20with%20that%20of%20a%20chemically%20related%20compound,%20T-1106&amp;author=J.%20G.%20Julander&amp;author=K.%20Shafer&amp;author=D.%20F.%20Smee&amp;author=J.%20D.%20Morrey&amp;author=&amp;author=Y.%20Furuta&amp;publication_year=2009" target="_blank">Google Scholar</a></span></li><li id="B278">S. Cheenpracha, C. Karalai, C. Ponglimanont, S. Subhadhirasakul, and S. Tewtrakul, “Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata,” <i>Bioorganic and Medicinal Chemistry</i>, vol. 14, no. 6, pp. 1710–1714, 2006. <span class="reflinks">View at: <a href="https://doi.org/10.1016/j.bmc.2005.10.019" target="_blank">Publisher Site</a><span class="sep"> | </span><a href="https://scholar.google.com/scholar_lookup?title=Anti-HIV-1%20protease%20activity%20of%20compounds%20from%20Boesenbergia%20pandurata&amp;author=S.%20Cheenpracha&amp;author=C.%20Karalai&amp;author=C.%20Ponglimanont&amp;author=S.%20Subhadhirasakul&amp;author=&amp;author=S.%20Tewtrakul&amp;publication_year=2006" target="_blank">Google Scholar</a></span></li></ol></div><div class="xml-content"><h4 class="copyright" id="copyright">Copyright</h4><p>Copyright © 2013 Rosmari Rodriguez-Roche and Ernest A. Gould. This is an open access article distributed under the <a rel="license" href="http://creativecommons.org/licenses/by/3.0/" target="_blank">  Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></article></div></div></div></div></div><div class="threeColumn__RightWrapper-sc-1bf4078-2 sZeeW rightWrapper"><div id="rightSectionMenu" class="sc-hZSUBg hwTmaF journal_article__StickyRight-sc-12fk6zy-0 bzVmII" style="top: 180px;"><div class="journal_article__ArticleStickyTopToolbar-sc-12fk6zy-1 iKpUSJ article_sticky_top_toolbar"><div class="sc-jrIrqw deaPpH article_top_toolbar"><div class="sc-hjRWVT egqbDB article_toolbar_views">8040&nbsp;Views | 2161&nbsp;Downloads | 36&nbsp;Citations</div><a class="sc-htpNat bUhGXt link sc-cbkKFq dNPgJJ sc-iybRtq jghqNV pdf_desktop" href="http://downloads.hindawi.com/journals/bmri/2013/690835.pdf" aria-label="" target="_blank"><span><img alt=" " class="sc-EHOje fEOMwM sc-krvtoX isUmzT" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/pdf.svg" height="24"><span class="text">PDF</span></span><img alt=" " class="sc-EHOje ggEPYc sc-fYiAbW eBEQa fileArrow" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/downloadWhite.svg" height="20"></a><a class="sc-htpNat bUhGXt link sc-cbkKFq dNPgJJ sc-iQtOjA fozQPf ref_desktop" href="https://www.hindawi.com/journals/bmri/2013/690835.ris" aria-label="" target=""><span><img alt=" " class="sc-EHOje fEOMwM sc-krvtoX isUmzT" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/fileText.svg" height="24"><span class="text">Download Citation</span></span><img alt=" " class="sc-EHOje ggEPYc sc-fYiAbW eBEQa fileArrow" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/downloadGreen.svg" height="20"></a><a class="sc-htpNat bUhGXt link sc-cbkKFq dNPgJJ sc-fHxwqH iVtERa ref_desktop" href="https://www.hindawi.com/journals/bmri/2013/690835.ris" aria-label="" target=""><span><img alt=" " class="sc-EHOje fEOMwM sc-krvtoX isUmzT" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/fileText.svg" height="24"><span class="text">Citation</span></span><img alt=" " class="sc-EHOje ggEPYc sc-fYiAbW eBEQa fileArrow" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/downloadGreen.svg" height="20"></a></div></div><div class="journal_article__ArticleStickyBottomToolbar-sc-12fk6zy-2 gvAMNw article_sticky_bottom_toolbar"><div class="sc-fyjhYU bmCmNg article_bottom_toolbar"><div class="sc-ugnQR jArSbQ accordion" property="background-color" color="#D8D8D8"><span><img alt=" " class="sc-EHOje fEOMwM sc-iomxrj czMNsj" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/downloadBlack.svg" height="24"><span class="sc-iFMziU gCiAsp">Download other formats</span><span class="sc-keVrkP hYjHxB">More</span></span><img alt=" " class="sc-EHOje fEOMwM sc-dvCyap bivFoZ" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronDownGreen.svg" height="24"></div><div class="sc-eIHaNI qcTAH"><a class="sc-htpNat bUhGXt link sc-eTpRJs eqSlZb open_panel" href="http://downloads.hindawi.com/journals/bmri/2013/690835.epub" aria-label="ePub" property="background-color" color="#D8D8D8" target="_blank"><div class="sc-dxZgTM jwQjXi">ePub</div><img alt=" " class="sc-EHOje fEOMwM sc-iomxrj czMNsj" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/downloadGreen.svg" height="24"></a><a class="sc-htpNat bUhGXt link sc-eTpRJs eqSlZb open_panel" href="http://downloads.hindawi.com/journals/bmri/2013/690835.xml" aria-label="XML" property="background-color" color="#D8D8D8" target="_blank"><div class="sc-dxZgTM jwQjXi">XML</div><img alt=" " class="sc-EHOje fEOMwM sc-iomxrj czMNsj" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/downloadGreen.svg" height="24"></a></div><a class="sc-htpNat bUhGXt link sc-cBdUnI fDfgEX" href="https://reprints.hindawi.com/690835/confirm" aria-label="Order Printed Copies" target="_blank" property="background-color" color="#D8D8D8"><span><img alt=" " class="sc-EHOje fEOMwM sc-iomxrj czMNsj" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/orderPrintedCopies.svg" height="24"><span class="sc-iFMziU gCiAsp">Order printed copies</span><span class="sc-keVrkP hYjHxB">Order</span></span><img alt=" " class="sc-EHOje cPuqxU sc-dvCyap bivFoZ right__icon" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/rightArrowGreen.svg" height="16"></a><nav class="sc-gipzik kChCLZ sc-gVLVqr buUPyq"><h3 class="sc-jlyJG fqZLRe">Share Post</h3><ul class="sc-csuQGl ilZKno"><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://twitter.com/share?url=https://doi.org/10.1155/2013/690835&amp;via=Hindawi" aria-label="Sharing on Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje fEOMwM socialTwitter" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/socialTwitter.svg" height="24"></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.linkedin.com/shareArticle/?url=https://doi.org/10.1155/2013/690835" aria-label="Sharing on Linkedin" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje fEOMwM socialLinkedin" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/socialLinkedin.svg" height="24"></a></li><li class="iconBorder"><a class="sc-htpNat bUhGXt link" href="https://www.facebook.com/sharer/sharer.php?u=https://doi.org/10.1155/2013/690835" aria-label="Sharing on Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje fEOMwM socialFacebook" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/socialFacebook.svg" height="24"></a></li><li><a class="sc-htpNat bUhGXt link" href="mailto:?subject=Understanding%20the%20Dengue%20Viruses%20and%20Progress%20towards%20Their%20Control&amp;body=https://doi.org/10.1155/2013/690835" aria-label="Sharing on Mail"><img alt=" " class="sc-EHOje fEOMwM socialMail" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/socialMail.svg" height="24"></a></li></ul></nav></div></div></div></div></div></div></main><footer class="sc-kpOJdX fnXcho"><section class="sc-dxgOiQ jouXcH"><div class="sc-bZQynM bNmdOy E_HUmlU2Hj3PpkDmWzKPd primary__footer footer__bodypadding"><div class="sc-ckVGcZ gizesk mobile">Follow us:<nav role="navigation" class="sc-eNQAEJ kZcFWM"><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/twitterDark.svg" height="40"></a><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/linkedinDark.svg" height="40"></a><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/youtubeDark.svg" height="40"></a><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/facebookDark.svg" height="40"></a></nav></div><nav class="E_HUmlU2Hj3PpkDmWzKPd _3wm8FgzqRuRWouJG31YgKx" role="navigation"><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link about_us" href="https://www.hindawi.com/about/" aria-label="About us"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">About us</a></li><li><a class="sc-htpNat bUhGXt link contact_us" href="https://www.hindawi.com/about/contact/" aria-label="Contact us"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Contact us</a></li><li><a class="sc-htpNat bUhGXt link partnerships" href="https://www.hindawi.com/publishing-partnerships/" aria-label="Partnerships"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Partnerships</a></li><li><a class="sc-htpNat bUhGXt link blog" href="https://www.hindawi.com/blog/" aria-label="Blog"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Blog</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link journals" href="https://www.hindawi.com/journals/" aria-label="Journals"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Journals</a></li><li><a class="sc-htpNat bUhGXt link article_processing_charges" href="https://www.hindawi.com/publish-research/authors/article-processing-charges/" aria-label="Article Processing Charges"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Article Processing Charges</a></li><li><a class="sc-htpNat bUhGXt link subscriptions" href="https://www.hindawi.com/subscriptions/" aria-label="Subscriptions"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Subscriptions</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link authors" href="https://www.hindawi.com/publish-research/authors/" aria-label="Authors"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Authors</a></li><li><a class="sc-htpNat bUhGXt link editors" href="https://www.hindawi.com/publish-research/editors/" aria-label="Editors"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Editors</a></li><li><a class="sc-htpNat bUhGXt link reviewers" href="https://www.hindawi.com/publish-research/reviewers/" aria-label="Reviewers"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Reviewers</a></li></ul><ul class="_2k5c8zEhMT-84kRD4oDgAz _1SoDWGr_FVsil9klRfjnhb"><li><a class="sc-htpNat bUhGXt link hindawi_xml_corpus" href="https://www.hindawi.com/hindawi-xml-corpus/" aria-label="Hindawi XML Corpus"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Hindawi XML Corpus</a></li><li><a class="sc-htpNat bUhGXt link open_archives_initiative" href="https://www.hindawi.com/open-archives-initiative/" aria-label="Open Archives Initiative"><img alt=" " class="sc-EHOje jRIjVn" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/chevronLeftGreen.svg" height="14">Open Archives Initiative</a></li></ul></nav><div class="sc-ckVGcZ gizesk desktop">Follow us:<nav role="navigation" class="sc-eNQAEJ kZcFWM"><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://twitter.com/hindawi" aria-label="Twitter" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/twitterDark.svg" height="40"></a><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://www.linkedin.com/company/hindawilimited/" aria-label="LinkedIn" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/linkedinDark.svg" height="40"></a><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://www.youtube.com/channel/UCDIK_O7FATPEkhad_sQVaSg" aria-label="Youtube" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/youtubeDark.svg" height="40"></a><a class="sc-htpNat bUhGXt link sc-jKJlTe kkOZmp" href="https://www.facebook.com/HindawiLimited/" aria-label="Facebook" rel="noopener noreferrer" target="_blank"><img alt=" " class="sc-EHOje dyvnNv" title="" role="presentation" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/facebookDark.svg" height="40"></a></nav></div></div></section><div class="sc-bZQynM bNmdOy"><section class="sc-hMqMXs gwWYzB E_HUmlU2Hj3PpkDmWzKPd"><span class="_2k5c8zEhMT-84kRD4oDgAz _3YBvMs82CMJ-uNoH7JwwWl"><a class="sc-htpNat bUhGXt link" href="https://www.hindawi.com/privacy/" aria-label="Privacy Policy">Privacy Policy   |  </a><a class="sc-htpNat bUhGXt link" href="https://www.hindawi.com/terms/" aria-label="Terms of Service">Terms of Service   |  </a><a class="sc-htpNat bUhGXt link" href="https://www.hindawi.com/cookie-policy/" aria-label="Cookie Policy">Cookie Policy   |  </a><a class="sc-htpNat bUhGXt link" href="https://www.hindawi.com/copyright/" aria-label="Copyright">Copyright </a></span></section></div></footer></div></div><noscript>
        <iframe src="//www.googletagmanager.com/ns.html?id=GTM-MQ4MGW"
            height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript></div><script id="__NEXT_DATA__" type="application/json">{"dataManager":"[]","props":{"pageProps":{"isLiveUrl":true,"appConfig":{"journals":{"call_for_paper":{"title":"Call for papers","description":"\u003cp\u003eThis Issue is now open for submissions.\u003c/p\u003e\n\u003cp\u003ePapers are published upon acceptance, regardless of the Special Issue publication date.\u003c/p\u003e\n"},"article_left_nav_keywords":["Introduction","Materials and Methods","Results","Discussion","Conclusion","Abstract","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interests","Authors’ Contributions","Funding Statement","Acknowledgements","Acknowledgments","Supplementary Materials","Reference","Dataset Description","Dataset Files","Abstract","Introduction","Introduction and Materials","Introduction and Methods","Materials","Materials and Methods","Methods","Results","Discussion","Results and Discussion","Discussion and Conclusion","Results and Conclusion","Conclusion","Conclusions","Data Availability","Additional Points","Ethical Approval","Consent","Disclosure","Conflicts of Interest","Authors’ Contributions","Funding Statement","Acknowledgements","Supplementary Materials","References","Appendix","Abbreviations","Preliminaries","Introduction and Preliminaries","Notation","Proof of Theorem","Proofs","Analysis of Results","Examples","Numerical Example","Applications","Numerical Simulation","Model","Model Formulation","Systematic Palaeontology","Nomenclatural Acts","Taxonomic Implications","Experimental","Synthesis","Overview","Characterization","Background","Experimental","Theories","Calculations","Model Verification","Model Implementation","Geographic location","Study Area","Geological setting","Data Collection","Field Testing","Data and Sampling","Dataset","Literature Review","Related Works","Related Work","System Model","Methods and Data","Experimental Results","Results and Analysis","Evaluation","Implementation","Case Presentation","Case Report","Search Terms","Case Description","Case Series","Background","Limitations","Additional Points","Case","Case 1"," Case 2 etc.","Concern Details","Retraction Details"," Copyright"],"journal_nav_static_text":"","newsletters":{"text":"","link":{"url":""},"hide_marketing_msg":0},"si_message":{"open":{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}},"propose":{"title":"Special Issues","text":"Do you think there is an emerging area of research that really needs to be highlighted? Or an existing research area that has been overlooked or would benefit from deeper investigation? Raise the profile of a research area by leading a Special Issue.","type":"special","link":{"title":"Submit your proposal","url":"/si-proposal"}},"abstract":{"title":"Abstracting and Indexing","text":"This journal's articles appear in a wide range of abstracting and indexing databases, and are covered by numerous other services that aid discovery and access. Find out more about where and how the content of this journal is available.","type":"special","link":{"title":"Find out more","url":"/abstract-msg"}}},"menu":{"pe":"/publish-research/authors/publication-ethics","rar":"","ham":"","fr":"/publish-research/reviewers","fe":"/publish-research/editors","prsi":"/publish-research/editors/special-issues/proposing-special-issue","asi":"/publish-research/editors/special-issues"},"featured_article_message":{"ceased":{"title":"{journal_name} has ceased publication and is no longer accepting submissions.","summary":"All previously published articles are available through the Table of Contents. \r\n\r\nThe journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."},"sold":{"title":"{journal_name} is not currently considering new submissions.","summary":"All previously published articles are available through the Table of Contents. The journal is archived in Portico and via the LOCKSS initiative, which provides permanent archiving for electronic scholarly journals."}},"journal_manuscript_link":"https://mts.hindawi.com/submit/journals/{journal_subcode}","contact_us":{"title":"Contact","text":"\u003cp\u003eEditorial enquiries should be directed to \u003ca href=\"mailto:help@hindawi.com\" title=\"mailto:help@hindawi.com\"\u003ehelp@hindawi.com\u003c/a\u003e.\u0026nbsp;\u003c/p\u003e\r\n"},"default_image":{"small":"","large":""}},"manuscript_link":"https://mts.hindawi.com/","willey_link":"/publishing-partnerships/wiley-hindawi-publishing-partnership","gdpr_message":"","order_printed_url":"https://reprints.hindawi.com/{article_id}/confirm","adv_banner_message":"","GTM_ID":"GTM-MQ4MGW"},"data":{"id":6603,"title":"BioMed Research International","journal_manuscript_link":"","image":{"url":"https://static-01.hindawi.com/s3fs-public/styles/featured_hero_banner/public/2020-01/bmri_hero_0.jpg?itok=wJOUAZSY","alt":" BioMed Research International "},"text_colour_code":"#ffffff","about_journal":"/journals/bmri/about","is_wiley_partner":0,"metrics_data":{"id":6603,"title":"BioMed Research International","url":"/journals/bmri","apc":{"label":"APC","value":"$2200","link":{"text":"","url":""}},"image":{"url":"https://images.hindawi.com/journals/bmri/bmri.banner.small.jpg","alt":"BioMed Research International"},"metrics":[{"label":"Acceptance rate","value":"30%"},{"label":"Submission to final decision","value":"84 days"},{"label":"Acceptance to publication","value":"48 days"},{"label":"CiteScore","value":"2.41"},{"label":"Impact Factor","value":"2.197"}]},"links_block":[{"title":"Author guidelines","link":"/journals/bmri/guidelines","icon_class":"fileText"},{"title":"Editorial board","link":"/journals/bmri/editors","icon_class":"users"},{"title":"Databases and indexing","link":"/journals/bmri/ai","icon_class":"desktop"}],"featured_type":"automatic","status":1,"journal_level":4,"journal_subcode":"bmri","journal_issn":"2314-6133","hide_marketing_msg":0,"publishing_collaborations":[],"journal_blocks":[{"title":"Journal profile","text":"\u003cp\u003e\u003cem\u003eBioMed Research International\u003c/em\u003e publishes original research articles, review articles, and clinical studies covering a wide range of subjects within the biomedical sciences. The journal will accept both basic and translational research.\u003c/p\u003e\r\n","type":"profile","link":{"title":"About this journal","url":"/journals/bmri/about"}},{"title":"Editor spotlight","text":"\u003cp\u003e\u003cem\u003eBioMed Research International\u003c/em\u003e maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.\u003c/p\u003e\r\n","type":"spotlight","link":{"title":"Meet the editorial board","url":"/journals/bmri/editors"}},{"title":"Special Issues","text":"We currently have a number of Special Issues open for submission. Special Issues highlight emerging areas of research within a field, or provide a venue for a deeper investigation into an existing research area.","type":"special","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}}],"si_message_type":{"type":"open","link":{"title":"Submit to Special Issue","url":"/journals/bmri/osi"}},"wiley_url":"/publishing-partnerships/wiley-hindawi-publishing-partnership","global_manuscript_link":"https://mts.hindawi.com/submit/journals/bmri","newsletters":{"text":"","link":{"url":""},"hide_marketing_msg":0}},"meta":{"meta_data":[{"name":"title","content":"Understanding the Dengue Viruses and Progress towards Their Control"},{"rel":"canonical","href":"https://www.hindawi.com/journals/bmri/2013/690835/"},{"name":"description","content":"Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this \u0026#x201c;scourge\u0026#x201d; of the tropical and subtropical world."},{"property":"og:url","content":"current_url"},{"property":"og:type","content":"website"},{"property":"og:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"property":"og:image:type","content":"image/jpeg"},{"property":"og:image:width","content":"600"},{"property":"og:image:height","content":"315"},{"property":"og:title","content":"Understanding the Dengue Viruses and Progress towards Their Control"},{"name":"twitter:site","content":"website"},{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:image","content":"https://images.hindawi.com/journals/bmri/bmri.banner.jpg"},{"name":"twitter:title","content":"Understanding the Dengue Viruses and Progress towards Their Control"},{"property":"og:description","content":"Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this \u0026#x201c;scourge\u0026#x201d; of the tropical and subtropical world."},{"name":"twitter:description","content":"Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this \u0026#x201c;scourge\u0026#x201d; of the tropical and subtropical world."},{"name":"citation_author","content":"Rodriguez-Roche, Rosmari"},{"name":"citation_author","content":"Gould, Ernest A."},{"name":"citation_title","content":"Understanding the Dengue Viruses and Progress towards Their Control"},{"name":"citation_publisher","content":"Hindawi"},{"name":"citation_volume","content":2013},{"name":"citation_date","content":2013},{"name":"citation_year","content":2013},{"name":"citation_abstract","content":"Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this \u0026#x201c;scourge\u0026#x201d; of the tropical and subtropical world."},{"name":"citation_pdf_url","content":"http://downloads.hindawi.com/journals/bmri/2013/690835.pdf"},{"name":"citation_xml_url","content":"http://downloads.hindawi.com/journals/bmri/2013/690835.xml"},{"name":"citation_fulltext_html_url","content":"current_url"},{"name":"citation_doi","content":"https://doi.org/10.1155/2013/690835"},{"name":"citation_online_date","content":"2013/07/09"},{"name":"dcterms.issued","content":"2013/07/09"},{"name":"dc.creator","content":"Rodriguez-Roche, Rosmari"},{"name":"dc.creator","content":"Gould, Ernest A."},{"name":"dc.title","content":"Understanding the Dengue Viruses and Progress towards Their Control"},{"name":"dc.description","content":"Traditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this \u0026#x201c;scourge\u0026#x201d; of the tropical and subtropical world."},{"name":"dc.publisher","content":"Hindawi"},{"name":"dc.format","content":"text/html"},{"name":"dc.language","content":"en"},{"name":"dc.identifier","content":"https://doi.org/10.1155/2013/690835"},{"name":"dc.type","content":"Review Article"},{"name":"dc.date","content":"2013/07/09"},{"name":"dcterms.issued","content":"2013/07/09"},{"name":"prism.publicationDate","content":"2013/07/09"},{"name":"prism.volume","content":2013},{"name":"prism.number","content":""},{"name":"prism.startingPage","content":""},{"name":"prism.section","content":"Review Article"},{"name":"prism.doi","content":"https://doi.org/10.1155/2013/690835"},{"name":"citation_issn","content":"2314-6133"},{"name":"prism.issn","content":"2314-6133"},{"name":"dc.source","content":"BioMed Research International"},{"name":"citation_journal_title","content":"BioMed Research International"},{"name":"prism.publicationName","content":"BioMed Research International"},{"name":"authors","content":"Rosmari Rodriguez-Roche | Ernest A. Gould"}],"title":"Understanding the Dengue Viruses and Progress towards Their Control","current_url":"https://www.hindawi.com/journals/bmri/2013/690835/","site_url":"https://www.hindawi.com","gdprMsg":"","manuscript_link":"https://mts.hindawi.com/","footerData":{"status":200,"data":{"upper_menu_items":{"footer":[{"title":"About us","external":0,"relative":"/about","expanded":0,"enabled":1},{"title":"Contact us","external":0,"relative":"/about/contact","expanded":0,"enabled":1},{"title":"Partnerships","external":0,"relative":"/publishing-partnerships","expanded":0,"enabled":1},{"title":"Blog","external":0,"relative":"/blog","expanded":0,"enabled":1}],"footer-1":[{"title":"Journals","external":0,"relative":"/journals","expanded":0,"enabled":1},{"title":"Article Processing Charges","external":0,"relative":"/publish-research/authors/article-processing-charges","expanded":0,"enabled":1},{"title":"Subscriptions","external":0,"relative":"/subscriptions","expanded":0,"enabled":1}],"footer-2":[{"title":"Authors","external":0,"relative":"/publish-research/authors","expanded":0,"enabled":1},{"title":"Editors","external":0,"relative":"/publish-research/editors","expanded":0,"enabled":1},{"title":"Reviewers","external":0,"relative":"/publish-research/reviewers","expanded":0,"enabled":1}],"footer-3":[{"title":"Hindawi XML Corpus","external":0,"relative":"/hindawi-xml-corpus","expanded":0,"enabled":1},{"title":"Open Archives Initiative","external":0,"relative":"/open-archives-initiative","expanded":0,"enabled":1}]},"lower_menu_items":{"lower-footer":[{"title":"Privacy Policy","external":0,"relative":"/privacy","expanded":0,"enabled":1},{"title":"Terms of Service","external":0,"relative":"/terms","expanded":0,"enabled":1},{"title":"Cookie Policy","external":0,"relative":"/cookie-policy","expanded":0,"enabled":0},{"title":"Copyright","external":0,"relative":"/copyright","expanded":0,"enabled":1}]}},"headers":{}},"isLiveUrl":true,"advMsg":"","statusCode":false,"showPreviewButtons":false,"currentPath":"/journals/bmri/2013/690835/","bibblioKey":"0d7b3db3-a45f-4dfa-b751-991c0907e6ab","assetPrefix":"https://static-01.hindawi.com/next_assets/Jvy0o2KWP7OlB1-MPkheK"},"ceased":false,"journalAlias":"/journals/bmri","jouranlNavigationBarData":{"items":[{"title":"Journal overview","link":"/journals/bmri/jo","key":"jo","children":[{"title":"About this Journal","link":"/journals/bmri/about","key":"about"},{"title":"Editorial Board","link":"/journals/bmri/editors","key":"editors"},{"title":"Peer Review Process","link":"/journals/bmri/prp","key":"prp"},{"title":"Publication Ethics","link":"/publish-research/authors/publication-ethics","key":"pe"},{"title":"Abstracting and Indexing","link":"/journals/bmri/ai","key":"ai"},{"title":"Article Processing Charges","link":"/journals/bmri/apc","key":"apc"}]},{"title":"For authors","link":"/journals/bmri/guidelines","key":"guidelines","children":[]},{"title":"For reviewers","link":"/publish-research/reviewers","key":"fr","children":[]},{"title":"For editors","link":"/publish-research/editors","key":"fe","children":[]},{"title":"Table of Contents","link":"/journals/bmri/contents/year/2020","children":[]},{"title":"Special Issues","link":"/journals/bmri/si","children":[{"title":"Open Special Issues","link":"/journals/bmri/osi","key":"osi"},{"title":"Published Special Issues","link":"/journals/bmri/psi","key":"psi"},{"title":"Propose Special Issue","link":"/publish-research/editors/special-issues/proposing-special-issue","key":"prsi"},{"title":"About Special Issues","link":"/publish-research/editors/special-issues","key":"asi"}]}],"archived":false,"navText":""},"journalUrl":"/journals/bmri","article":{"retracted":false,"related_articles":[],"id":690835,"title":"Understanding the Dengue Viruses and Progress towards Their Control","type":"Review Article","volume":2013,"article_id":690835,"pages":20,"doi":"https://doi.org/10.1155/2013/690835","shorten_url":"https://doi.org/10.1155/2013/690835","academic_editors":[{"name":"Vittorio Sambri"}],"guest_editors":[],"published_date":"09 Jul 2013","received_date":"13 Mar 2013","revised_date":"","accepted_date":"08 May 2013","authors":[{"name":"Rosmari Rodriguez-Roche","email":"uc.dls.kpi@iramsor","orcid":"http://orcid.org/0000-0002-6851-4222","sup":["1"]},{"name":"Ernest A. Gould","email":"","orcid":"","sup":["2","3"]}],"affiliations":[{"id":"1","text":"“Pedro Kouri” Tropical Medicine Institute, WHO/PAHO Collaborating Centre for the Study of Dengue and Its Vector, Autopista Novia del Mediodía, Km 6 1/2, La Lisa, P.O. Box 601, Marianao 13, 11300 Havana, Cuba"},{"id":"2","text":"UMR190, Emergence des Pathologies Virales, Aix-Marseille Universite, Institut de Recherche pour le Développement, Ecole des Hautes Etudes en Santé Publique, Unité des Virus Emergents, Faculté de Médecine de Marseille, 27 Boulevard Jean Moulin, 13005 Marseille cedex 05, France"},{"id":"3","text":"CEH Wallingford, Maclean Building, Benson Lane, Crowmarsh Gifford, Oxfordshire OX10 8BB, UK"}],"is_special_issue":1,"special_issue_details":{"title":"Human Arthropod-Borne Viral Infections","url":"/journals/bmri/si/186796"},"body":"\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"header\" id=\"abstract\"\u003eAbstract\u003c/h4\u003e\u003cp\u003eTraditionally, the four dengue virus serotypes have been associated with fever, rash, and the more severe forms, haemorrhagic fever and shock syndrome. As our knowledge as well as understanding of these viruses increases, we now recognise not only that they are causing increasing numbers of human infections but also that they may cause neurological and other clinical complications, with sequelae or fatal consequences. In this review we attempt to highlight some of these features in the context of dengue virus pathogenesis. We also examine some of the efforts currently underway to control this “scourge” of the tropical and subtropical world.\u003c/p\u003e\u003cspan class=\"end-abs\"\u003e\u003c/span\u003e\u003ch4 id=\"introduction\"\u003e1. Introduction\u003c/h4\u003e\u003cp\u003eDengue fever is a mosquito-borne virus disease of humans. In terms of numbers of individuals infected, it is by far the most devastating of all the recognised arthropod-transmitted virus diseases. It is estimated that more than 3 billion humans live in dengue endemic regions of the world, and currently, more than 50 million infections occur annually with at least 500,000 individuals requiring hospitalisation [\u003ca href=\"#B1\"\u003e1\u003c/a\u003e]. Of these, tens of thousands have a high risk of developing haemorrhagic disease, potentially with fatal consequences depending to a large extent on the quality of the available medical services. \u003c/p\u003e\u003cp\u003eThe dengue viruses are positive stranded RNA viruses in the genus \u003ci\u003eFlavivirus\u003c/i\u003e, family \u003ci\u003eFlaviviridae \u003c/i\u003e[\u003ca href=\"#B2\"\u003e2\u003c/a\u003e]. There are four distinct dengue virus (DENV) serotypes that share antigenic relationships (DENV-1, DENV-2, DENV-3, and DENV-4), and although infection with one serotype confers lifelong protection against that serotype, it does not necessarily protect against a secondary infection with a heterologous serotype. Indeed, nonprotective but cross-reactive antibodies may enhance disease severity [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e]. Currently, there are no effective vaccines or antiviral drugs against these viruses. This problem is being addressed as a matter of urgency as failure to develop effective DENV control strategies will inevitably result in a further increase in the number of infected humans, as predicted more than a decade ago [\u003ca href=\"#B4\"\u003e4\u003c/a\u003e]. This problem is also exacerbated by the continuing dispersal of these viruses to new geographic regions. \u003c/p\u003e\u003cp\u003eThis review therefore focuses on our current understanding of dengue virus pathology, epidemiology, pathogenesis, evolution, biogeography, and disease control. \u003c/p\u003e\u003ch4 id=\"dengue-fever/haemorrhagic-fever/shock-syndrome\"\u003e2. Dengue Fever/Haemorrhagic Fever/Shock Syndrome\u003c/h4\u003e\u003ch5 id=\"sec2.1\"\u003e2.1. Clinical Picture\u003c/h5\u003e\u003cp\u003eIn most cases asymptomatic or relatively mild disease follows infection with dengue virus. However, to take into account the increasing number of clinical cases, the World Health Organization (WHO) produced guidelines [\u003ca href=\"#B5\"\u003e5\u003c/a\u003e] in which they identified the clinical pictures resulting from infection with dengue virus. The first, known as dengue fever (DF), is characterised by an abrupt onset of fever accompanied by frontal headache and retroorbital pain, followed by a variety of possible clinical symptoms such as myalgia, arthralgia, vomiting, and weakness. A generalised maculopapular rash appears one or two days after fever defervescence. Minor haemorrhagic manifestations such as petechiae may be observed in some patients. DF is generally self-limiting and rarely fatal. Most patients recover without complications around ten days after the onset of illness. \u003c/p\u003e\u003cp\u003eThe second clinical picture, dengue haemorrhagic fever (DHF), is a more severe form of the disease and occurs in up to 5% of dengue cases. It is initially characterized by the same variety of clinical symptoms as are seen in DF. The critical period in DHF starts at the moment of defervescence but haemorrhagic manifestations may occur 24 hours earlier. A positive tourniquet test indicates that the patient has increased capillary fragility. Petechiae, bleeding at venepuncture sites, epistaxis, gum bleeding, and haematemesis may also be observed. High fever, haemorrhagic manifestations, thrombocytopenia (platelet count 100 000/mm\u003csup\u003e3\u003c/sup\u003e or less), and haemoconcentration (\u0026gt;20% difference) characterize DHF. Plasma leakage is the most significant pathophysiological event in determining the severity of the disease. Signs of circulatory failure such as irritability, cold clammy extremities, flushed face, and restlessness may be observed. This crisis usually persists for 24–36 hours. With appropriate supportive medicine and carefully monitored intravenous isotonic crystalloid therapy, to ensure adequate fluid replacement, most patients recover. However, during this critical period, it is essential to look for characteristic warning signs of worse to come. Patients progressing to shock (dengue shock syndrome—DSS) show intense abdominal pain or tenderness, persistent vomiting, weak pulse, and hypotension. If increased vascular permeability progresses to vascular collapse the outcome is usually fatal as a result of irreversible DSS. In addition to DF, DHF, and DSS, it is now recognised that other clinical manifestations can be associated with infection by dengue virus, for example, encephalitis, myocarditis, hepatitis, cholecystitis, myelitis, and acute colitis [\u003ca href=\"#B6\"\u003e6\u003c/a\u003e–\u003ca href=\"#B11\"\u003e11\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eDespite the rigour of the DF/DHF/DSS classification and its intrinsic worth in clinical case management, in recent years, a growing number of clinicians and authors have argued that the 1997 WHO scheme for dengue clinical classification should be reassessed [\u003ca href=\"#B12\"\u003e12\u003c/a\u003e–\u003ca href=\"#B14\"\u003e14\u003c/a\u003e] because it distinguishes strictly between DF, DHF, and DSS, whereas it is now recognised that the point of transition between DF and DHF is not easily defined. The requirements for the WHO definition of DHF (fever, haemorrhage, thrombocytopenia, and signs of plasma leakage) are not always satisfied; severe thrombocytopenia may be observed in uncomplicated as well as severe cases associated with “unusual manifestations” and therefore may not be consistent with the DHF/DSS classification [\u003ca href=\"#B15\"\u003e15\u003c/a\u003e]. A WHO/TDR-supported prospective clinical multicentre study across dengue-endemic regions was established to collect and coordinate specific criteria for classifying clinical cases into levels of severity [\u003ca href=\"#B16\"\u003e16\u003c/a\u003e]. The study confirmed that, by using a set of clinical and/or laboratory parameters, one sees a clear-cut difference between patients with severe dengue fever and those with nonsevere dengue fever. However, for practical reasons it was considered necessary to split the large group of patients with nonsevere dengue into two subgroups: patients with warning signs (abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy, restlessness, liver enlargement \u0026gt;2 cm, and increase in hematocrit concurrent with rapid decrease in platelet count) and those without these warning signs. On the other hand, the criteria for severe dengue fever include extensive plasma leakage, severe bleeding, or severe organ impairment. \u003c/p\u003e\u003cp\u003eThe third and most recent edition of the WHO/TDR dengue guidelines for diagnosis, treatment, prevention, and control includes a new clinical classification [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. This publication serves as an authoritative reference source for health workers and researchers. These new guidelines provide a revised case classification which is intended to facilitate effective triage and patient management and collection of improved comparative surveillance data [\u003ca href=\"#B18\"\u003e18\u003c/a\u003e]. However, due to the recommendation that cases of dengue fever with warning signs and also cases of severe dengue fever should be admitted to hospital, there is concern that this could result in overadmission of patients to hospitals during epidemics, inevitably reducing the efficiency of patient triage and adversely affecting the quality of clinical case management [\u003ca href=\"#B19\"\u003e19\u003c/a\u003e, \u003ca href=\"#B20\"\u003e20\u003c/a\u003e]. Furthermore there is additional concern that the WHO/TDR classification may impact significantly on dengue pathogenesis research since it requires the identification and study of distinct dengue syndromes. Because the 2009 WHO case definitions do not require laboratory tests for the diagnosis of severe dengue, it is considered that retrospective identification of patients with clinically significant vascular permeability, from data on hospital charts, may be difficult if not impossible [\u003ca href=\"#B21\"\u003e21\u003c/a\u003e]. The previous discussion highlights the difficulties of designing a totally acceptable classification scheme for dengue pathogenesis.\u003c/p\u003e\u003ch5 id=\"sec2.2\"\u003e2.2. History of DF and DHF\u003c/h5\u003e\u003cp\u003eClinically diagnosed DF was widespread during the 18th and 19th centuries in North and South America, the Caribbean Basin, Asia, and Australia. In the Americas, this was largely due to the repeated introduction from Africa of \u003ci\u003eStegomyia (St.) aegypti \u003c/i\u003e(formerly \u003ci\u003eAedes aegypti\u003c/i\u003e) [\u003ca href=\"#B22\"\u003e22\u003c/a\u003e–\u003ca href=\"#B24\"\u003e24\u003c/a\u003e]. Moreover, together with yellow fever virus (YFV), DENV-infected humans and mosquitoes were introduced via the slave ships and other commercial vessels that crossed the Atlantic Ocean from Africa during the past five or more centuries [\u003ca href=\"#B25\"\u003e25\u003c/a\u003e–\u003ca href=\"#B31\"\u003e31\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eIt is also important to note that disease clinically compatible with the more severe and often fatal syndromes, DHF and DSS, was sporadically reported from 1780 onwards [\u003ca href=\"#B32\"\u003e32\u003c/a\u003e] although it is not clear if the more severe cases were confined to individuals of European descent. \u003c/p\u003e\u003cp\u003eDF thus became endemic in Latin America and the Caribbean region, periodically causing epidemics. At the same time, YFV was also causing epidemics in South America, prompting the Pan American Health Organisation (PAHO) to introduce a mosquito-eradication programme which lasted from 1946 until the late 1970s. Since both DENV and YFV are transmitted to humans via \u003ci\u003eSt. aegypti\u003c/i\u003e this eradication campaign in South America also resulted in a lower incidence of DF in South America. Thus, DF was confined mainly to the Caribbean basin [\u003ca href=\"#B33\"\u003e33\u003c/a\u003e, \u003ca href=\"#B34\"\u003e34\u003c/a\u003e]. Subsequently, the gradual decline of mosquito control measures and increasing introduction and dispersal of mosquitoes via transportation for commercial and military purposes led to the reemergence of dengue as a major health problem during the mid and later parts of the 20th Century. The incidence of dengue fever increased dramatically in Southeast Asia during World War II and continued to intensify with increased geographic spread of the viruses and the principal mosquito vector, \u003ci\u003eSt. aegypti\u003c/i\u003e. In addition to the major influence of increased shipping and air-traffic globally, other major factors for the reemergence of dengue fever include ecological and demographic changes in the tropical zones [\u003ca href=\"#B2\"\u003e2\u003c/a\u003e, \u003ca href=\"#B34\"\u003e34\u003c/a\u003e–\u003ca href=\"#B39\"\u003e39\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eDuring the 1980s and 1990s, rapidly expanding populations of \u003ci\u003eSt. aegypti\u003c/i\u003e in Brazil resulted in successive epidemics due to DENV-1, DENV-2, and DENV-3. In Brazil, these infections presented mostly as DF, with surprisingly few cases of DHF. This contrasts with Asia where the proportion of DHF cases was significantly higher during DF epidemics. These differences have been partly attributed to the widespread presence of dengue virus resistance genes in Latin Americans with African ancestry [\u003ca href=\"#B33\"\u003e33\u003c/a\u003e, \u003ca href=\"#B40\"\u003e40\u003c/a\u003e, \u003ca href=\"#B41\"\u003e41\u003c/a\u003e]. The differences may also be partly explained by the high levels of antibody against the American DENV-2 genotype and antigenically cross-reactive DENV-1, both of which had been endemic in Latin America for many years. \u003c/p\u003e\u003cp\u003eToday, all four DENV serotypes circulate in Africa, South and Southeast Asia, the Western Pacific region, the Caribbean basin, and Central and South America [\u003ca href=\"#B39\"\u003e39\u003c/a\u003e, \u003ca href=\"#B42\"\u003e42\u003c/a\u003e–\u003ca href=\"#B44\"\u003e44\u003c/a\u003e]. Frequent introductions into the Southern states of North America are also regularly recorded although to date they have not resulted in epidemic outbreaks in the USA; DF has the potential to become reestablished as an endemic disease in this country. In fact, sustained transmission of dengue has occurred in Florida during recent years. Conditions exist that could facilitate sustained dengue transmission, including environmental factors, competent mosquito vectors, limited vector and dengue surveillance, increased domestic outdoor daytime activities in warmer months, and low public awareness of the disease [\u003ca href=\"#B45\"\u003e45\u003c/a\u003e]. Indeed, dengue continues to spread more widely as demonstrated in 2010 by the first recorded cases of autochthonous dengue fever in southern France [\u003ca href=\"#B46\"\u003e46\u003c/a\u003e] and Croatia [\u003ca href=\"#B47\"\u003e47\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eMany countries in the tropics and subtropical regions show cocirculation of at least two DENV serotypes [\u003ca href=\"#B36\"\u003e36\u003c/a\u003e], and increasingly, cocirculation of all 4 serotypes is being recorded in individual countries. Taken together with the ecological and demographic changes, this partly explains why the pattern of epidemics is gradually increasing from a frequency of outbreaks every 3–5 years to approximately every 2 years [\u003ca href=\"#B48\"\u003e48\u003c/a\u003e]. Additional explanations for this increased incidence include the possibility that more highly pathogenic strains of DENV are also emerging [\u003ca href=\"#B44\"\u003e44\u003c/a\u003e, \u003ca href=\"#B49\"\u003e49\u003c/a\u003e–\u003ca href=\"#B51\"\u003e51\u003c/a\u003e]. Greater awareness of this disease, as the result of more extensive monitoring, is also impacting on our understanding of and the apparent increased periodicity of dengue virus epidemiology. \u003c/p\u003e\u003cp\u003eComparison of disease incidence in Asia and Latin America reveals a distinct difference in the age distribution of DF and DHF. In Asia, hospitalizations principally involve children, whereas in the Americas, they tend to involve a greater proportion of adults [\u003ca href=\"#B33\"\u003e33\u003c/a\u003e]. The reasons for this apparent difference have not been adequately defined. However, to complicate this issue, a recent epidemic in the State of Rio de Janeiro revealed that the incidence of DHF in children was significantly higher than in previous epidemics in Brazil [\u003ca href=\"#B52\"\u003e52\u003c/a\u003e, \u003ca href=\"#B53\"\u003e53\u003c/a\u003e]. \u003c/p\u003e\u003ch5 id=\"sec2.3\"\u003e2.3. Risk Factors Associated with the Development of Severe Dengue\u003c/h5\u003e\u003cp\u003eThe principal vector associated with all 4 DENV serotypes is the African mosquito \u003ci\u003eSt. aegypti \u003c/i\u003ean urban-dwelling anthropophilic mosquito. However, \u003ci\u003eSt. albopicta \u003c/i\u003ethe Asian “Tiger” mosquito is also competent to reproduce and transmit DENV between humans. In contrast with \u003ci\u003eSt. aegypti, St. albopicta \u003c/i\u003eis peridomestic, with a preference for the rural environment. In some parts of Asia and Africa, \u003ci\u003eSt. albopicta \u003c/i\u003ehas displaced \u003ci\u003eSt. aegypti \u003c/i\u003e[\u003ca href=\"#B54\"\u003e54\u003c/a\u003e, \u003ca href=\"#B55\"\u003e55\u003c/a\u003e]. A possible scenario of this changing pattern of mosquito distribution and the continuing dispersal of \u003ci\u003eSt. albopicta\u003c/i\u003e is that the dengue viruses will disperse even more widely, gradually establishing in the warmer regions of the temperate zones, including Europe [\u003ca href=\"#B46\"\u003e46\u003c/a\u003e, \u003ca href=\"#B47\"\u003e47\u003c/a\u003e, \u003ca href=\"#B56\"\u003e56\u003c/a\u003e, \u003ca href=\"#B57\"\u003e57\u003c/a\u003e], the southern regions of North America [\u003ca href=\"#B58\"\u003e58\u003c/a\u003e], and more northern regions of Asia [\u003ca href=\"#B59\"\u003e59\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eThe pathogenetic basis for DHF has been a subject of study for decades, and whilst significant progress has been made in understanding the most important risk factors involved, the precise biochemical and immunological pathways have not yet been defined [\u003ca href=\"#B60\"\u003e60\u003c/a\u003e–\u003ca href=\"#B62\"\u003e62\u003c/a\u003e]. Amongst the several possibilities that have been identified, there is compelling evidence that secondary infection with a heterologous DENV serotype, or primary infection in infants born to dengue-immune mothers, is an important individual risk factor for DHF/DSS [\u003ca href=\"#B63\"\u003e63\u003c/a\u003e–\u003ca href=\"#B70\"\u003e70\u003c/a\u003e]. During secondary infection with a different serotype, the presence of low levels of heterotypic neutralizing antibodies may reduce disease severity. Alternatively, in the absence of such neutralizing antibodies, heterotypic cross-reactive antibodies may form complexes with the virus and the Fc-receptors on these complexed antibodies may attach to mononuclear phagocytes, thus enhancing the efficiency of infection and thereby increasing the number of infected mononuclear phagocytes [\u003ca href=\"#B71\"\u003e71\u003c/a\u003e–\u003ca href=\"#B74\"\u003e74\u003c/a\u003e]. This phenomenon is known as antibody dependent enhancement (ADE) [\u003ca href=\"#B75\"\u003e75\u003c/a\u003e]. Humans infected with one serotype maintain a life-long protective immunity to infection by the homologous virus, but protective immunity to infection with heterologous serotypes is relatively short-lived [\u003ca href=\"#B76\"\u003e76\u003c/a\u003e]. The precise mechanism by which DENV replication is amplified in the infected cells remains unclear. One possibility is that there is a relationship between DENV-ADE infection, suppression of nitric oxide during the innate immune response, and the corresponding cytokine-expression pattern in THP-1 cells [\u003ca href=\"#B77\"\u003e77\u003c/a\u003e]. Recent evidence suggests that viral susceptibility or resistance to nitric oxide may be regulated by the viral NS5 protein [\u003ca href=\"#B78\"\u003e78\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e It has also been argued that strain differences in virulence may contribute to disease severity [\u003ca href=\"#B51\"\u003e51\u003c/a\u003e, \u003ca href=\"#B79\"\u003e79\u003c/a\u003e–\u003ca href=\"#B84\"\u003e84\u003c/a\u003e]. However, the fact that severe dengue disease is identified most consistently following secondary dengue infections supports the view that virulence must be defined in a two-infection context [\u003ca href=\"#B39\"\u003e39\u003c/a\u003e]. Host risk factors such as gender, ethnicity, the presence of chronic disease (bronchial asthma, diabetes mellitus, and sickle cell anaemia) [\u003ca href=\"#B85\"\u003e85\u003c/a\u003e–\u003ca href=\"#B87\"\u003e87\u003c/a\u003e] and also the genetic characteristics of the individual are also likely predisposing factors for severe illness. Human leukocyte antigen (HLA), Fc\u003ci\u003eγ\u003c/i\u003eR, tumor necrosis factor- (TNF-) \u003ci\u003eα\u003c/i\u003e, and dendritic cell-specific intracellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN), among other genes, have been associated with the pathogenesis of dengue [\u003ca href=\"#B41\"\u003e41\u003c/a\u003e, \u003ca href=\"#B66\"\u003e66\u003c/a\u003e, \u003ca href=\"#B86\"\u003e86\u003c/a\u003e, \u003ca href=\"#B88\"\u003e88\u003c/a\u003e–\u003ca href=\"#B93\"\u003e93\u003c/a\u003e]. In addition, T-cell mediated immune mechanisms, involving skewed cytokine responses resulting in plasma leakage, are also risk factors for DHF [\u003ca href=\"#B62\"\u003e62\u003c/a\u003e]. It has been proposed that an inappropriate immune response to the secondary virus infection, that in turn induces reactivation of cross-memory T cells specific for the first rather than the secondary DENV infection, results in delayed viral clearance [\u003ca href=\"#B94\"\u003e94\u003c/a\u003e, \u003ca href=\"#B95\"\u003e95\u003c/a\u003e]. More recently, it was suggested that the presence of an effective antiviral inflammatory response in the presence of adequate immune regulation could be associated with protection during dengue secondary infection [\u003ca href=\"#B96\"\u003e96\u003c/a\u003e]. However, as highlighted in a recent review on dengue pathogenesis, it is worth noting that other infectious diseases and inflammatory disorders result in elevated cytokines without the attendant increased vascular permeability seen in severe dengue [\u003ca href=\"#B97\"\u003e97\u003c/a\u003e]. Indeed, one of the major challenges in dengue, magnified due to absence of good animal models of disease, is to dissect those elements of the host immune response that are causally linked to capillary permeability from those that simply reflect the normal host immune response to a pathogen [\u003ca href=\"#B97\"\u003e97\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eIndependent of this, antibodies specific for the NS1 viral protein may form immune complexes with the NS1 protein in the circulation and on the surface of infected cells leading to complement activation [\u003ca href=\"#B98\"\u003e98\u003c/a\u003e]. An additional risk factor for DHF is believed to be dependent on autoimmune responses against cross-reactive viral components. For example, antibodies specific for dengue virus NS1 protein may induce platelet lysis and/or nitric oxide-mediated apoptosis of endothelial cells, contributing to thrombocytopenia and vascular damage [\u003ca href=\"#B99\"\u003e99\u003c/a\u003e–\u003ca href=\"#B104\"\u003e104\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eThe serious complications observed during dengue infection occur as plasma viremia is resolving. This is thought to be immunologically mediated. Tam et al. performed a randomised trial to verify the effects of short-course oral corticosteroid therapy in early dengue infection. No association between treatment allocation and any of the predefined clinical, hematological, or virological endpoints was found [\u003ca href=\"#B105\"\u003e105\u003c/a\u003e]. Unexpectedly, the steroid doses administered were not immunosuppressive. Based on these observations it was suggested that rather than dengue-mediated vascular permeability being T-cell mediated, an alternative pathogenetic mechanism could involve the dengue soluble complement fixing antigen or the viral NS1 protein. Indeed, it was recently proposed that during the late stages of clinically apparent dengue infection, secreted DENV NS1 protein may bind to prothrombin and inhibit its activation, which in turn could contribute to the prolongation of activated partial thromboplastin time and haemorrhage in DHF patients [\u003ca href=\"#B106\"\u003e106\u003c/a\u003e]. Also, previous studies on the virological course of dengue infections in monkeys have shown that the peak of cellular infection occurs at the end of the viremic phase. Accordingly, it was proposed that dengue vascular permeability syndrome could be the equivalent of a viral toxicosis induced by circulating NS1 protein [\u003ca href=\"#B107\"\u003e107\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eWhilst higher levels of viremia and circulating NS1 protein have been associated with dengue disease severity [\u003ca href=\"#B108\"\u003e108\u003c/a\u003e], collective results arising from different epidemiological settings are inconclusive, showing variations depending on the infecting serotype and patient immune status [\u003ca href=\"#B109\"\u003e109\u003c/a\u003e–\u003ca href=\"#B112\"\u003e112\u003c/a\u003e]. Therefore, the usefulness of these markers for the recognition of patients with increased risk of progression towards the more severe forms of dengue is still limited.\u003c/p\u003e\u003ch5 id=\"sec2.4\"\u003e2.4. Underlying Basis for the Emergence of DHF in Particular Epidemiological Settings\u003c/h5\u003e\u003cp\u003eTaking into account many of the factors described earlier and based on observations made during the 1981 Cuban epidemic of DF/DHF, Kouri and coworkers presented an integral hypothesis in which the association of different factors, such as immunological status, genetic background, host condition, viral strain, and epidemiological and ecological conditions, determines whether or not and to what extent, DHF will be involved in any particular epidemic [\u003ca href=\"#B113\"\u003e113\u003c/a\u003e]. Research conducted during the past 20 years strongly supports this unifying view of the situation [\u003ca href=\"#B3\"\u003e3\u003c/a\u003e, \u003ca href=\"#B39\"\u003e39\u003c/a\u003e, \u003ca href=\"#B48\"\u003e48\u003c/a\u003e, \u003ca href=\"#B114\"\u003e114\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eWith the exception of Chile, Uruguay, and Cuba, that experience occasional epidemics, resulting from introduced virus, DF is endemic in Latin America and the Caribbean region. Cuba is a relatively small island with a well-integrated medical health and research infrastructure. When combined with the epidemiological history of DF in Cuba, this situation has provided a unique opportunity to investigate the specific risk factors for severe illness in detail [\u003ca href=\"#B48\"\u003e48\u003c/a\u003e]. Firstly, it is important to realise that from the end of World War II until 1977, dengue virus was not evident in Cuba. This was supported by a national seroepidemiological survey in 1975, which identified only 2.6% of the population with DENV hemagglutination-inhibition (HI) antibodies. Importantly, most of the positives were individuals older than 45 years [\u003ca href=\"#B115\"\u003e115\u003c/a\u003e, \u003ca href=\"#B116\"\u003e116\u003c/a\u003e]. However, in 1977, based on serological evidence [\u003ca href=\"#B117\"\u003e117\u003c/a\u003e] it was estimated that up to 44.5% of all Cubans became infected by an introduced Asian strain of DENV-1. Nevertheless, no cases of DHF were recorded. These results demonstrate that in the absence of heterologous immunity, primary DENV-1 infections did not result in cases of DHF and, bearing in mind that subsequent DHF epidemics in Cuba all involved secondary infections (see later), the results strongly support the contention that secondary infections by heterologous serotypes are a very important risk factor for DHF as proposed previously [\u003ca href=\"#B118\"\u003e118\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eDuring the past 28 years, three DENV-epidemics involving DHF have occurred in Cuba. The first epidemic started in 1981 [\u003ca href=\"#B113\"\u003e113\u003c/a\u003e], the second was seen in 1997 [\u003ca href=\"#B65\"\u003e65\u003c/a\u003e], and the third occurred in 2001 [\u003ca href=\"#B63\"\u003e63\u003c/a\u003e]. During each epidemic, secondary infection was demonstrated as the most important host risk factor for DHF. Additionally, specific sequential virus serotypes were associated with severe disease, independent of the time-gap between the primary and secondary infection. For example, in Cuba, two epidemics of DHF have been associated with primary infections due to an Asian strain of DENV-1 and secondary infections due to DENV-2 (i.e., DENV-1/DENV-2) [\u003ca href=\"#B119\"\u003e119\u003c/a\u003e, \u003ca href=\"#B120\"\u003e120\u003c/a\u003e]. Significantly, during the 1997 Cuban epidemic, it was demonstrated for the first time that there was a higher risk of DHF in DENV-1/DENV-2 individuals when the average time gap between primary and secondary infections was about 20 years as opposed to 4 years, a more commonly reported timespan [\u003ca href=\"#B64\"\u003e64\u003c/a\u003e]. Moreover, comparison of attack rates and case fatality rates, in the same age groups, revealed that during the 1997 epidemic the rate in patients older than 15 years of age was 40 times higher than during the 1981 epidemic [\u003ca href=\"#B121\"\u003e121\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eSubsequently, another Cuban epidemic, caused by DENV-3 and involving cases of DHF, occurred in 2001. Thus, DHF occurred in DENV-3-infected Cubans 24 years after primary exposure to DENV-1 infection [\u003ca href=\"#B122\"\u003e122\u003c/a\u003e]. Interestingly, Cubans infected sequentially with DENV-1/DENV-3 were associated with severe disease whilst those infected sequentially with DENV-2/DENV-3 were associated with milder disease or asymptomatic infections [\u003ca href=\"#B63\"\u003e63\u003c/a\u003e, \u003ca href=\"#B123\"\u003e123\u003c/a\u003e]. Additionally, the DENV-3 immune individuals, infected during the 2001 Cuban epidemic, revealed differences in the neutralization capability of their sera to different DENV-3 strains belonging to different genotypes [\u003ca href=\"#B124\"\u003e124\u003c/a\u003e]. This observation might be anticipated taking into account that differences in neutralisation capability have been found using different genotypes of DENV-2. However, it was highly significant to find differences in neutralisation against strains belonging to the same genotype [\u003ca href=\"#B125\"\u003e125\u003c/a\u003e]. Moreover, the strains involved in the Cuban 1981, 1997, and 2001 epidemics [\u003ca href=\"#B80\"\u003e80\u003c/a\u003e, \u003ca href=\"#B125\"\u003e125\u003c/a\u003e, \u003ca href=\"#B126\"\u003e126\u003c/a\u003e] had previously been associated with severe epidemics and therefore had the potential to produce DHF. Nevertheless, in all of these epidemics, an extremely high number of primarily infected individuals were asymptomatic [\u003ca href=\"#B64\"\u003e64\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eUsing human volunteers, Dr. Albert Sabin was the first scientist to demonstrate that heterotypic immunity can prevent disease induced by a different dengue virus serotype [\u003ca href=\"#B127\"\u003e127\u003c/a\u003e]. Whilst DENV-1 immunity did not appear to prevent DENV-2 infections, partial immunity may have downregulated infections, thus reducing severity to mild disease during secondary dengue infections. It has been postulated that if virological factors are involved in determining disease severity, they may reflect common antigenic determinants shared between the first and second infecting viruses [\u003ca href=\"#B39\"\u003e39\u003c/a\u003e]. An exceptional illustration of this phenomenon is the neutralization of American genotype DENV-2 by human antibodies to DENV-1 [\u003ca href=\"#B81\"\u003e81\u003c/a\u003e]. These results suggest that the apparent lower virulence of American genotype DENV-2 results from a DENV-1 like surface epitope on the DENV-2 that permits partial neutralization (and downregulation of disease) by DENV-1 antibodies [\u003ca href=\"#B81\"\u003e81\u003c/a\u003e]. In contrast, Asian genotypes DENV-2 are poorly neutralised by human antibodies to DENV-1 [\u003ca href=\"#B128\"\u003e128\u003c/a\u003e]. Furthermore, a significant increase in the mean titre of homologous DENV-1 neutralizing antibodies and a significant decrease in heterologous antibodies to DENV-2 American genotype were reported in a long-term study in Cuba [\u003ca href=\"#B128\"\u003e128\u003c/a\u003e]. This finding may reflect time-dependent changes in severity of disease observed following secondary dengue infection.\u003c/p\u003e\u003cp\u003eOn the other hand, case fatality rates were observed to increase month by month during epidemics that were studied in Cuba. Taking into account that DENV-2 epidemics occurred in 1981 and 1997, Guzmán and coworkers proposed a neutralisation escape mutant hypothesis based on the association of severe disease with dengue secondary infection [\u003ca href=\"#B129\"\u003e129\u003c/a\u003e]. Furthermore, during the DENV-3 epidemic that occurred in Havana in 2001, the same sequential increase in case fatality rates was observed [\u003ca href=\"#B48\"\u003e48\u003c/a\u003e, \u003ca href=\"#B85\"\u003e85\u003c/a\u003e, \u003ca href=\"#B122\"\u003e122\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e Although specific viral factors alone probably do not determine the severity of dengue infection in individual cases, the demonstrated increasing severity of infection with time during a single epidemic strongly argues that significant changes occur in the virus causing the epidemic. Indeed, host factors do not appear to explain this observation of increasing severity with time, because it is not logical to assume that the most susceptible individuals would all be infected towards the end of the epidemic. \u003c/p\u003e\u003cp\u003e The 1997 Cuban epidemic was the most severe reported in Cuba to date. Nevertheless, a search for evidence of the appearance of neutralisation-escape mutants proved negative. The structural gene sequences were highly conserved in viruses isolated at different times during the epidemic [\u003ca href=\"#B126\"\u003e126\u003c/a\u003e]. However, nucleotide substitutions were found in the nonstructural genes and in general they correlated with the time of sampling, showing a clear pattern of virus evolution during the epidemic [\u003ca href=\"#B130\"\u003e130\u003c/a\u003e]. Therefore, at least in this study, antibody-driven selection of escape mutants in the structural genes was not the key selective force. On the other hand, cytotoxic T-lymphocytes (CTLs) play a crucial role in controlling infection in RNA viruses, including dengue viruses [\u003ca href=\"#B62\"\u003e62\u003c/a\u003e, \u003ca href=\"#B131\"\u003e131\u003c/a\u003e]. Variation in the epitopes recognized by CTL is common and frequently offers potential escape routes for mutant virus. Forthcoming studies will assess whether or not the reported mutations in NS1 and NS5 proteins [\u003ca href=\"#B130\"\u003e130\u003c/a\u003e] are represented in antibody inducing or CTL epitopes.\u003c/p\u003e\u003cp\u003eRegardless of which mechanism, that is, natural selection or genetic drift, is operating, it is likely that a fitter virus could be selected during the period of high transmission in individuals that have experienced secondary infections. However, it is a very difficult task to study dengue epidemiology because it is not only endemic in most tropical countries but there are four serotypes and many different genotypes often cocirculating. Nevertheless, Cuba represents a unique epidemiological setting for this kind of research because epidemics caused by only one serotype have occurred providing the opportunity for carefully defined epidemiological studies. \u003c/p\u003e\u003cp\u003eMutations in the nonstructural genes of DENV-2, isolated during the Santiago de Cuba epidemic, may correlate with increased efficiency of virus replication. Variation in nonstructural proteins has been also associated with increasing severity in epidemiological settings corresponding to endemic/epidemic transmission [\u003ca href=\"#B132\"\u003e132\u003c/a\u003e–\u003ca href=\"#B136\"\u003e136\u003c/a\u003e]. However, the specific relevance of these types of mutation has not yet been investigated thoroughly. This is in large part due to the lack of suitable animal models with which to study dengue virus “virulence” [\u003ca href=\"#B51\"\u003e51\u003c/a\u003e, \u003ca href=\"#B137\"\u003e137\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eDuring the most recent and severe DENV-4 epidemic in Puerto Rico in 1998, viruses were distinguished by three amino acid replacements in the NS2A protein (I14V, V54T, and P101T), which were fixed more rapidly than would have been expected by drift alone. This study demonstrates the significance of viral genetic turnover within a focal population and the potential importance of adaptive evolution during viral epidemic expansion [\u003ca href=\"#B132\"\u003e132\u003c/a\u003e]. In contrast, a retrospective phylogenetic study of events on the Southern Pacific islands three decades ago, where severe dengue was described in patients infected with the DENV-2 American genotype, recorded attenuation of this virus following a series of outbreaks involving nonsynonymous mutations, also in the NS2A gene [\u003ca href=\"#B138\"\u003e138\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eSimilarly, study of the population structure of dengue viruses transmitted in Aragua, Venezuela, during the period 2006-2007, under hyperendemic conditions also suggested that the nonstructural proteins could play an important role in DENV evolution. According to this particular epidemiological setting, changes in NS1, NS2A, and NS4B proteins were either favourable or adverse in terms of viral fitness. The authors argued that specific mutations could be associated with severe disease but some could be associated with mild disease due to the appearance of naturally attenuated strains [\u003ca href=\"#B139\"\u003e139\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eThe flavivirus NS2A protein is a small, hydrophobic, multifunctional membrane-associated protein involved in RNA replication [\u003ca href=\"#B140\"\u003e140\u003c/a\u003e, \u003ca href=\"#B141\"\u003e141\u003c/a\u003e], host-antiviral interferon response [\u003ca href=\"#B142\"\u003e142\u003c/a\u003e–\u003ca href=\"#B145\"\u003e145\u003c/a\u003e], and assembly/secretion of virus particles [\u003ca href=\"#B146\"\u003e146\u003c/a\u003e–\u003ca href=\"#B148\"\u003e148\u003c/a\u003e]. In addition, the NS2A and the NS4B proteins may participate in the modulation of vector competence [\u003ca href=\"#B149\"\u003e149\u003c/a\u003e]. According to previous reports, changes in NS1 and NS4 proteins could be involved in viral attenuation [\u003ca href=\"#B150\"\u003e150\u003c/a\u003e, \u003ca href=\"#B151\"\u003e151\u003c/a\u003e]. On the contrary, recent studies have demonstrated that mutations in the NS4B protein may increase the efficiency of DENV replication. In addition, it has been suggested that mutations in this protein may also be involved in species tropism of DENV and may even modulate the balance of efficient replication in mosquito and mammalian cells [\u003ca href=\"#B152\"\u003e152\u003c/a\u003e]. Moreover, it has been shown that a single amino acid in the nonstructural NS4B protein namely, L52F, confers virulence on DENV-2 in AG129 mice through enhancement of viral RNA synthesis [\u003ca href=\"#B153\"\u003e153\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eWhilst these results suggest a possible role for the NS genes in determining viral fitness, the importance of the structural genes should not be overlooked. The sequences compared in the cited studies represent a consensus of those observed within each patient and may not necessarily represent the dominant variant present in the original clinical sample. For example, virus isolation using mosquito cell lines [\u003ca href=\"#B154\"\u003e154\u003c/a\u003e] is known to perturb the distribution of variants in the original clinical sample. This is particularly important given that studies of dengue virus populations sampled from individual humans or mosquitoes have revealed significant sequence variation [\u003ca href=\"#B155\"\u003e155\u003c/a\u003e]. Consequently, a greater focus on studies of viral population variation during epidemics is needed and the data should be obtained directly from clinical samples. \u003c/p\u003e\u003cp\u003eThe demonstration of long-term transmission of defective dengue virus in humans and mosquitoes has added a new dimension to the study of dengue evolution. The increased frequency of the “stop-codon” strain was concomitant with a major reduction in DENV-1 prevalence in Myanmar. The authors suggested that complementation between defective variants might provide a mechanism for the survival of “hyperparasites,” and this process of viral complementation could impact on pathogen transmission and virulence [\u003ca href=\"#B156\"\u003e156\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eObviously, more comprehensive approaches, including sequencing of larger numbers of viral genomes obtained directly from diverse clinical samples corresponding to longitudinal studies, are needed to examine how the genetic structure of dengue virus is influenced by heterotypic antibodies. \u003c/p\u003e\u003cp\u003eData obtained in two carefully planned clinical studies of dengue in Nicaragua demonstrate that the complex interplay between viral genetics and serotype-specific immunity determines the risk of severe dengue disease. Indeed, these data provide insights into viral evolution and the interaction between viral and immunological determinants of fitness and virulence. The abrupt increase in disease severity across several epidemic seasons of DENV-2 transmission coincided with clade replacement events. Interestingly, DENV-2 strains corresponding to NI-1 clade caused severe disease specifically in children who were immune to DENV-1, whereas DENV-3 immunity was associated with more severe disease among NI-2B infections, signifying that mutations altering the neutralization profile of some DENV strains can lead to increased viral fitness [\u003ca href=\"#B157\"\u003e157\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003e  Most dengue virus genomic studies have been directed at identifying the origin and genetic relatedness of the viruses causing epidemics. Other studies have focussed on identifying genetic markers associated with severe disease and comparing viruses isolated from DF and DHF/DSS cases within the same epidemiological setting. However, genetic variations have not been consistently associated with differences in clinical outcome. Conversely, introduction of new genotypes/serotypes with replacement/displacement of the existing viruses or changes in viral populations during an interepidemic period, extinction events, and sustained transmission of dengue virus due to repeated introductions have all been related to changes in the severity pattern of local epidemics [\u003ca href=\"#B134\"\u003e134\u003c/a\u003e, \u003ca href=\"#B158\"\u003e158\u003c/a\u003e–\u003ca href=\"#B161\"\u003e161\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eRecently, in Vietnam, the introduction of the Asian 1 genotype of DENV-2 led to the complete replacement of the resident Asian/American genotype of DENV-2. The transmission fitness advantage of Asian 1 viruses was attributed to this virus attaining higher viremia levels in humans [\u003ca href=\"#B162\"\u003e162\u003c/a\u003e]. However, there are multiple factors implicated in the transmission dynamic of DENVs that remain unclear. Epidemiological data have suggested that fitness is always context dependent and that as the immunological landscape changes, viral lineages that evade cross-immunity will be at a selective advantage [\u003ca href=\"#B163\"\u003e163\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003e Clearly, there is still wide scope for research on the molecular basis of dengue virus epidemiology and pathogenesis. We need to know whether or not a circulating dengue virus that produces an asymptomatic infection in one host differs in sequence from the same virus that causes a fatal infection in another host. We also need to know if different tissues [\u003ca href=\"#B164\"\u003e164\u003c/a\u003e] within a single host house the same dominant dengue virus strain. Similarly, does the virus that circulates in a single epidemic have the same sequence in individuals with different histories of dengue infection?\u003c/p\u003e\u003ch5 id=\"sec2.5\"\u003e2.5. Intrahost Genetic Variation\u003c/h5\u003e\u003cp\u003eThe population genetics and evolutionary epidemiology of RNA viruses have been reviewed [\u003ca href=\"#B165\"\u003e165\u003c/a\u003e]. The authors describe migration or gene flow as a factor to consider during RNA virus evolution. Accordingly, they advocate that migration must not only be understood at a macroscopic level (i.e., among hosts within a population, among populations, or between host species), but also within a single infected individual. From the site of inoculation, viruses can be transported to several tissues, generating intrahost spatial variation. This has been studied in Hepatitis C virus, family\u003ci\u003e Flaviviridae\u003c/i\u003e [\u003ca href=\"#B166\"\u003e166\u003c/a\u003e]. However, the effect of a nonhomogeneous population distribution on the spread, fitness, and variability of virus populations has not been studied extensively. Nevertheless, a positive correlation between migration rate and average fitness of the population has been observed [\u003ca href=\"#B167\"\u003e167\u003c/a\u003e]. The outcome of acute Hepatitis C infection has been attributed to the evolution of viral quasispecies [\u003ca href=\"#B168\"\u003e168\u003c/a\u003e]. Large-scale sequencing of complete viral RNA genomes obtained directly from clinical samples is needed to investigate the role of variation in viral populations on dengue pathogenesis. The purifying selection that phylogenies have revealed [\u003ca href=\"#B169\"\u003e169\u003c/a\u003e] thus far may be misleading because most of the sequences analysed over the years were obtained from tissue culture viral isolates. Additionally, an intrinsic inadequacy of utilising consensus sequences to make inferences concerning the fitness of viral populations is that consensus sequences only reflect the majority nucleotide at any given position of the viral genome. Consequently, low frequency variants will remain undetected.\u003c/p\u003e\u003cp\u003eExamination of the viral population structure in mosquitoes and patients has revealed that the sequences of the major variants are the same but the extent of sequence variation seen with the mosquitoes is generally lower than that seen with the patients, suggesting that the mosquito contributes to the evolutionary conservation of dengue virus by maintaining a more homogenous viral population and a dominant variant during transmission [\u003ca href=\"#B170\"\u003e170\u003c/a\u003e]. In addition, by studying the evolutionary relationships of DENV-1 viruses that have circulated in French Polynesia and the viral intrahost genetic diversity according to clinical presentation, Descloux and coworkers suggested for the first time that clinical outcome may correlate with intrahost genetic diversity [\u003ca href=\"#B171\"\u003e171\u003c/a\u003e]. On the other hand, a recent study in Vietnam showed no relationship between the extent and pattern of DENV-1 genetic diversity and disease severity, immune status, or level of viremia. Interestingly, despite the high sequence conservation observed, clear evidence for mixed infection with the presence of multiple phylogenetically distinct lineages present within the same host was demonstrated [\u003ca href=\"#B172\"\u003e172\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eIndeed, most attempts to investigate intrahost genetic variation in DENV characterised only a few viral genes or a limited number of full-length genomes. A new study in Nicaragua using a whole-genome amplification approach coupled with deep sequencing to capture intrahost diversity across the entire coding region of DENV-2 showed significant genetic diversity among genes [\u003ca href=\"#B173\"\u003e173\u003c/a\u003e]. However, the extension of that diversity was less than expected, suggesting strong purifying selection across transmission events as have been proposed previously [\u003ca href=\"#B174\"\u003e174\u003c/a\u003e–\u003ca href=\"#B176\"\u003e176\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eAnother point of view is that there is no reason to ignore vector-driven selection [\u003ca href=\"#B177\"\u003e177\u003c/a\u003e]. However, the interaction between virus and vector has been less extensively explored. By comparing the ability of DENV-1 isolates from Thailand, spanning a 24-year period, to infect and be transmitted by \u003ci\u003eSt. aegypti\u003c/i\u003e, Lambrechts et al. found that a major clade replacement event in the mid-1990s was associated with a higher transmission potential of the isolates belonging to the new clade. Higher transmissibility was mainly due to a higher infectious titre of virus in the vector’s  haemocoel, which is predicted to result in a higher probability of transmission. This finding supports the hypothesis that major clade replacement events can be driven by natural selection and emphasizes the potentially important role of vector-virus interactions in DENV evolution [\u003ca href=\"#B178\"\u003e178\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eSince the 1900s, the extrinsic incubation period (EIP), that is the time taken for the viremic bloodmeal to be amplified in the mosquito and then transmitted to a new host, had been recognized as an important component of DENV transmission dynamics. The DENV EIP is generally considered to be between 8 and 12 days [\u003ca href=\"#B17\"\u003e17\u003c/a\u003e]. Nonetheless, different factors can induce variations in EIP. For example, considerable degrees of variation in EIP have been shown to vary depending on the specific DENV strain studied. Mosquitoes feeding on humans infected with an unadapted strain of DENV-1 had shorter EIPs (14 days) than mosquitoes feeding on humans infected with strains at low mouse passage levels, where the EIP was 22 days [\u003ca href=\"#B127\"\u003e127\u003c/a\u003e]. In addition, long EIPs have been observed with dengue virus attenuated strains [\u003ca href=\"#B179\"\u003e179\u003c/a\u003e, \u003ca href=\"#B180\"\u003e180\u003c/a\u003e]. Likewise, highly controlled laboratory studies have demonstrated the effect of distinct genotypes, serotypes, and mosquito population on the EIP [\u003ca href=\"#B181\"\u003e181\u003c/a\u003e, \u003ca href=\"#B182\"\u003e182\u003c/a\u003e]. Taking into account the advanced technologies available in molecular biology, new avenues for the study of virus-vector interactions should reveal new mechanisms involved in dengue virus transmission dynamics.\u003c/p\u003e\u003ch4 id=\"disease-control-strategies\"\u003e3. Disease Control Strategies\u003c/h4\u003e\u003cp\u003eIncreasing human and associated mosquito population densities and mobility of humans and commercial goods are the main factors that have determined the very successful reemergence of DF and DHF during recent decades. In contrast with YFV, which exploits the same mosquito species (\u003ci\u003eSt. aegypti\u003c/i\u003e) to infect humans, the dengue viruses have evolved to become independent of the need for a reservoir sylvatic environment with which to sustain their epidemicity. Thus, in the absence of effective control strategies we are faced with the prospect of further increases in morbidity and mortality due to the dengue viruses. Currently, several different approaches (reviewed after) are being developed in the future hope of alleviating this “scourge” of modern times.\u003c/p\u003e\u003ch5 id=\"sec3.1\"\u003e3.1. Vector Control\u003c/h5\u003e\u003cp\u003eHistory has shown that vector control measures can be effective in reducing arthropod-borne virus diseases [\u003ca href=\"#B120\"\u003e120\u003c/a\u003e, \u003ca href=\"#B183\"\u003e183\u003c/a\u003e–\u003ca href=\"#B186\"\u003e186\u003c/a\u003e]. However, many developing countries do not have the necessary resources and infrastructure for successful eradication measures to be implemented and sustainable in the manner that has been achieved in Singapore and Cuba [\u003ca href=\"#B187\"\u003e187\u003c/a\u003e]. This situation is exacerbated by the emergence of resistance to insecticides and the environmental issues arising from the use of potentially toxic chemicals [\u003ca href=\"#B188\"\u003e188\u003c/a\u003e]. Today, dissemination of insecticide resistance throughout vector populations is much faster than the rate of development of new insecticides. In addition, the existence of cross-resistance, based on the activation of general detoxifying mechanisms in the vector, can shorten the useful lifespan of alternative insecticides or even prevent their implementation [\u003ca href=\"#B189\"\u003e189\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eNew approaches to vector eradication including the use of naturally occurring plant insecticides/larvicides [\u003ca href=\"#B190\"\u003e190\u003c/a\u003e] and vaccines that induce antibodies to impair vital functions in mosquitoes [\u003ca href=\"#B191\"\u003e191\u003c/a\u003e] are being considered but such approaches are unlikely to provide effective vector control measures in the near future. \u003c/p\u003e\u003cp\u003ePrimary prevention of dengue is largely dependent on larval and adult mosquito control. \u003ci\u003eSt. aegypti\u003c/i\u003e surveillance has relied heavily upon larval indices. However, this has been strongly criticised as they provide little information to determine the risk of DENV transmission. The studies of Bisset Lazcano and colleagues used pupal surveillance for the \u003ci\u003eSt. aegypti \u003c/i\u003econtrol programme in Cuba and focused on the most productive mosquito water containers [\u003ca href=\"#B192\"\u003e192\u003c/a\u003e]. In urban areas, \u003ci\u003eSt. aegypti\u003c/i\u003e breed on water that collects in artificial containers such as plastic cups, used tyres, broken bottles, flowerpots, and other water traps. Elimination of these containers is the most effective way of reducing the mosquito breeding grounds. The use of insect repellents, mosquito traps, and mosquito nets in the home can also be moderately effective in reducing the number of bites due to mosquitoes.\u003c/p\u003e\u003cp\u003eNovel alternative approaches have also been investigated. In Vietnam, trials were conducted in which children and local communities were encouraged to place, a known mosquito predator, the crustacean \u003ci\u003eMesocyclops\u003c/i\u003e [\u003ca href=\"#B193\"\u003e193\u003c/a\u003e], in water tanks and discarded containers where \u003ci\u003eSt. aegypti\u003c/i\u003e are known to thrive [\u003ca href=\"#B194\"\u003e194\u003c/a\u003e]. The concept exploited the principle that this procedure might be more cost-effective and environmentally friendly than the use of pesticides. Over a period of years and in defined rural provinces of Viet Nam a reduction in mosquitoes and dengue fever was observed [\u003ca href=\"#B195\"\u003e195\u003c/a\u003e, \u003ca href=\"#B196\"\u003e196\u003c/a\u003e]. However, such approaches are only likely to be successful in regions of countries with the organisational infrastructure and appropriate community attitudes. A community education strategy is utilised to promote participation in dengue prevention in Cuba, resulting in reduced mosquito vector infestation levels. The main principle has been to increase community participation in decision-making and strengthening the competence of the medical teams and community working groups [\u003ca href=\"#B197\"\u003e197\u003c/a\u003e]. Whether or not a similar approach could be successfully applied to major cities and urban areas in other countries remains to be seen. \u003c/p\u003e\u003cp\u003eAn alternative approach involves infecting \u003ci\u003eSt. aegypti\u003c/i\u003e with the bacterium Wolbachia [\u003ca href=\"#B189\"\u003e189\u003c/a\u003e]. Early studies suggest that this reduces the adult lifespan of the mosquito by 50% [\u003ca href=\"#B198\"\u003e198\u003c/a\u003e]. This is important because the adult female mosquito is the primary vector of the virus. Insects infected by Wolbachia transmit them transovarially to the next generation. Thus, by reducing the lifespan of the mosquito, virus-vector competence, and virus transmission efficiency, a significant reduction of \u003ci\u003eSt. aegypti \u003c/i\u003eshould be observed. Another important feature of Wolbachia is its ability to induce resistance to a variety of pathogens, including DENV, in its insect hosts [\u003ca href=\"#B199\"\u003e199\u003c/a\u003e]. In the transinfected \u003ci\u003eSt. aegypti\u003c/i\u003e, all the three different types of Wolbachia, wAlbB, wMelPop-CLA, and wMel, induce significant inhibition of DENV replication and dissemination, resulting in either complete or partial block of virus transmission [\u003ca href=\"#B200\"\u003e200\u003c/a\u003e–\u003ca href=\"#B202\"\u003e202\u003c/a\u003e]. Recent studies also show that Wolbachia induces production of reactive-oxygen species which then activate the Toll-pathway to induce expression of antiviral effectors [\u003ca href=\"#B203\"\u003e203\u003c/a\u003e]. Interestingly, it was recently demonstrated that native Wolbachia symbionts limit transmission of DENV in \u003ci\u003eSt. albopictus\u003c/i\u003e by restricting the delivery of infectious viral particles from the mosquito saliva when biting. These results might therefore explain the low vector competence of \u003ci\u003eSt. albopictus\u003c/i\u003e for dengue and thus its relatively weak contribution as an epidemic dengue vector [\u003ca href=\"#B204\"\u003e204\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eUnderstanding how Wolbachia density is regulated by mosquito hosts and how the Wolbachia machinery controls its replication will facilitate the current effort to eliminate dengue through Wolbachia-based population replacement [\u003ca href=\"#B205\"\u003e205\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eThe genetic structure of \u003ci\u003eSt. aegypti \u003c/i\u003epopulations and its implications for potential mosquito releases have been studied in Queensland, Australia [\u003ca href=\"#B206\"\u003e206\u003c/a\u003e], and Tri Nguyen village, Vietnam [\u003ca href=\"#B207\"\u003e207\u003c/a\u003e, \u003ca href=\"#B208\"\u003e208\u003c/a\u003e]. Populations of \u003ci\u003eSt\u003c/i\u003e. \u003ci\u003eaegypti\u003c/i\u003e artificially infected with strains of \u003ci\u003eWolbachia pipientis\u003c/i\u003e that interfere with its vector competence are being backcrossed into wild mosquito genetic backgrounds from north Queensland and assessed as potential candidates for release [\u003ca href=\"#B209\"\u003e209\u003c/a\u003e]. In addition, a pilot release—\u003ca href=\"http://www.eliminatedengue.com/project/vietnem/progress\" target=\"_blank\"\u003ehttp://www.eliminatedengue.com/project/vietnem/progress\u003c/a\u003e—of infected mosquitoes has been authorised to take place from April 2013 on Tri Nguyen village (611 households) on Hon Mieu Island in central Vietnam. Subject to satisfactory results larger scale studies could be launched within five years [\u003ca href=\"#B210\"\u003e210\u003c/a\u003e].\u003c/p\u003e\u003cp\u003ePromisingly, studies related with the effect of Wolbachia on insecticide susceptibility in lines of \u003ci\u003eSt. aegypti\u003c/i\u003e have demonstrated that spreading Wolbachia infections are unlikely to affect the efficacy of traditional chemical methods of controlling mosquito outbreaks [\u003ca href=\"#B211\"\u003e211\u003c/a\u003e].\u003c/p\u003e\u003ch5 id=\"sec3.2\"\u003e3.2. Development of Vaccines against Dengue Viruses\u003c/h5\u003e\u003cp\u003e It is generally agreed that vaccination can provide an effective method with which to control virus diseases. In the case of the dengue viruses, the four serotypes are sufficiently antigenically different that it is considered necessary to produce four monovalent vaccines, which will then be mixed to produce a tetravalent immunological response. This is a logical approach that has previously been employed successfully with the three monovalent poliovirus vaccines. However, as discussed earlier, the dengue viruses also present the problem of antibody mediated enhancement of disease severity [\u003ca href=\"#B75\"\u003e75\u003c/a\u003e, \u003ca href=\"#B118\"\u003e118\u003c/a\u003e, \u003ca href=\"#B212\"\u003e212\u003c/a\u003e]. Long-term protection is essential as severe dengue has been observed in individuals secondarily infected more than 20 years after the primary infection [\u003ca href=\"#B63\"\u003e63\u003c/a\u003e, \u003ca href=\"#B85\"\u003e85\u003c/a\u003e]. As it is virtually impossible to test whether or not the tetravalent formula would overcome this potential problem, an element of uncertainty might prevail following the introduction of the vaccines in Asia and/or Latin America where dengue viruses are most prevalent. In addition, although the protective role of neutralizing antibodies is recognised, correlates of protection need to be defined [\u003ca href=\"#B213\"\u003e213\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eSeveral different approaches are being employed to develop dengue virus vaccines. The vaccine pipeline includes live empirically attenuated vaccines, newer live attenuated vaccines developed using infectious clone technology, genetic vaccines using virus and plasmid vectors, and many recombinant subunit vaccine candidates [\u003ca href=\"#B214\"\u003e214\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e Potential vaccines already progressing through clinical trials include a live attenuated tetravalent vaccine, produced via serial subculture in primary dog kidney cells [\u003ca href=\"#B215\"\u003e215\u003c/a\u003e–\u003ca href=\"#B217\"\u003e217\u003c/a\u003e]. Another approach involves the use of genetic modification of dengue viruses to attenuate their virulence [\u003ca href=\"#B218\"\u003e218\u003c/a\u003e–\u003ca href=\"#B222\"\u003e222\u003c/a\u003e]. Although vaccine candidates based on infectious virus have shown the greatest progress amongst different dengue vaccine approaches, there are safety concerns associated with their use based on potential reactogenicity, interference amongst the viruses, possible reversion to native virus, and possible increase of virus infectivity and/or virulence via antibody dependent enhancement [\u003ca href=\"#B223\"\u003e223\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e  An alternative approach is based on the use of the live attenuated YFV 17D vaccine as a backbone for the production of four chimaeric live attenuated viruses in which the prM and E genes of the 17D vaccine virus are replaced by the corresponding genes of the four dengue virus serotypes [\u003ca href=\"#B224\"\u003e224\u003c/a\u003e–\u003ca href=\"#B226\"\u003e226\u003c/a\u003e]. Preclinical studies demonstrated that the tetravalent vaccine is genetically and phenotypically stable, nonhepatotropic, less neurovirulent than the tried and tested YFV 17D vaccine, and does not infect mosquitoes by the oral route. Vaccine reactogenicity, viremia induction, and antibody responses have been investigated in phase 1 trials in the USA, the Philippines, and Mexico. Preclinical and clinical trials showed favourable immunogenicity and short-term safety of this vaccine [\u003ca href=\"#B227\"\u003e227\u003c/a\u003e]. Relatively favourable results of phase 2 trials were published recently. A surprising lack of efficacy against DENV2 was observed, and the fact that DENV2 was the prevalent serotype during the study diminished the overall vaccine efficacy in this setting [\u003ca href=\"#B228\"\u003e228\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e Several possible causes of this apparent failure have been proposed including significant genetic differences between the circulating DENV-2 genotype and the strain incorporated in the yellow fever chimaeric vaccine, imbalanced viraemias, or immune responses due to interference. Nevertheless, Sanofi’s CYD dengue vaccine has been discussed as a potential “75% solution” referring to the vaccine’s efficacy towards three of the four DENVs in the context of potential antibody-dependent enhancement. The general view seems to be that this approach would be inappropriate [\u003ca href=\"#B229\"\u003e229\u003c/a\u003e]. Probably, the most relevant issue is related to the long-term safety of such vaccines. DENV-2 has been associated with severe disease in several epidemiological settings. In fact, studies in Cuba demonstrated that disease severity increased notably when infection with DENV-2 follows infection with DENV-1 at an interval of 20 years [\u003ca href=\"#B64\"\u003e64\u003c/a\u003e], probably due to a significant decrease in mean titre of heterologous neutralizing antibodies [\u003ca href=\"#B128\"\u003e128\u003c/a\u003e]. Thus, there is justified concern that CYD vaccinated individuals could develop severe disease if infection with DENV-2 occurs after a relatively long interval of time. On the other hand, depending on the DENV-2 genotype that might subsequently circulate, it cannot be ruled out that heterologous neutralisation might lead to a satisfactory immune outcome, as occurred in Cuba during the 2001-2002 epidemic caused by DENV-3, where most DENV-2 immune individuals (infected in 1981) developed asymptomatic DENV-3 infections whilst a high proportion of the DENV-1 immune cases suffered overt disease [\u003ca href=\"#B63\"\u003e63\u003c/a\u003e, \u003ca href=\"#B230\"\u003e230\u003c/a\u003e]. In summary our limited understanding of the underlying processes of the immunopathological response to primary and successive infections with the four DENV largely determines our inability to predict the clinical outcome [\u003ca href=\"#B231\"\u003e231\u003c/a\u003e, \u003ca href=\"#B232\"\u003e232\u003c/a\u003e]. Nevertheless, ongoing large-scale phase 3 studies in more than 30,000 volunteers in ten countries in Latin America and Asia should provide critical data with which to overcome initial problems identified with the CYD dengue vaccine candidate.\u003c/p\u003e\u003cp\u003eA similar approach is being developed based on the attenuated DENV-2 virus, DENV-2 PDK-53, and three chimaeric viruses containing the prM and E genes of DENV-1, DENV-3, and DENV-4 virus in the genetic backbone of the DENV-2 PDK-53 virus (termed DENVax). Based on the safety, immunogenicity, and efficacy in preclinical studies in animal models, phase 1 clinical testing of tetravalent DENVax has been initiated [\u003ca href=\"#B233\"\u003e233\u003c/a\u003e–\u003ca href=\"#B235\"\u003e235\u003c/a\u003e]. This candidate might have advantages as the DENV backbone could reduce the risk of unanticipated effects due to the YFV NS proteins present in the Sanofi vaccine candidate [\u003ca href=\"#B228\"\u003e228\u003c/a\u003e].\u003c/p\u003e\u003cp\u003ePotential vaccines not yet progressing through clinical trials include the development of subunit vaccines based on domain III of the dengue virus envelope protein. Recombinant fusion proteins formed by domain III and P64k protein from Neisseria meningitides expressed in \u003ci\u003eE. coli\u003c/i\u003e induce functional and protective immunity in mice and nonhuman primate models inducing highly serotype specific immune responses [\u003ca href=\"#B236\"\u003e236\u003c/a\u003e–\u003ca href=\"#B238\"\u003e238\u003c/a\u003e]. Additionally, the domains of each serotype have been engineered in tandem in a yeast expression system [\u003ca href=\"#B239\"\u003e239\u003c/a\u003e]. A recombinant adenovirus system has been utilised to express the DENV NS1 proteins [\u003ca href=\"#B240\"\u003e240\u003c/a\u003e].  The paediatric measles vaccine has been modified to express a fragment of the DENV-1 M protein together with domain III of the envelope protein [\u003ca href=\"#B241\"\u003e241\u003c/a\u003e]. More recently, the evaluation in mice of a novel domain III-capsid chimaeric protein expressed in \u003ci\u003eE. coli\u003c/i\u003e provides additional evidence for a crucial role of cell-mediated immunity in protection against dengue virus [\u003ca href=\"#B242\"\u003e242\u003c/a\u003e–\u003ca href=\"#B245\"\u003e245\u003c/a\u003e]. Finally, a  novel single-dose lipidated consensus dengue virus envelope protein domain III (LcEDIII) subunit vaccine was shown to induce humoral and cellular immune responses in mice [\u003ca href=\"#B246\"\u003e246\u003c/a\u003e]. This group also evaluated the efficacy of the newly developed water-in-oil-in-water multiphase emulsion system, termed PELC plus CpG oligodeoxynucleotides, in potentiating the protective capacity of dengue-1 envelope protein domain III concluding that it could be a promising adjuvant for recombinant protein candidates [\u003ca href=\"#B247\"\u003e247\u003c/a\u003e].\u003c/p\u003e\u003cp\u003e Whilst subunit vaccines may have some advantages in terms of type-specific neutralisation with a low potential for inducing ADE via cross-reactive antibodies and low reactogenicity, multiple doses are usually needed to ensure long-term immune protection. However, it has been suggested that recombinant domain III vaccine could function as a booster if used in combination with live vaccine [\u003ca href=\"#B223\"\u003e223\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eIt is anticipated that within the next five years, increased understanding of the basis for dengue pathogenesis [\u003ca href=\"#B248\"\u003e248\u003c/a\u003e] and the protective immune response to DENV will improve our ability to develop safer and more effective vaccines [\u003ca href=\"#B223\"\u003e223\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eCritical issues in dengue vaccine development have been reviewed [\u003ca href=\"#B249\"\u003e249\u003c/a\u003e]. Of relevance is the potential impact of vaccination on the evolution of naturally occurring DENVs. Vaccination could ultimately produce an environment where relatively low transmission of natural DENV occurs. This is especially relevant if vaccination is focused on a selected portion of the population, thereby increasing stochastic events that will allow new DENV genotypes to emerge possibly with greater virulence. Furthermore, dengue vaccination may produce a background of low titres of enhancing antibody to specific DENV serotypes, resulting in the emergence of specific serotypes in a population. Recent studies suggest that strain diversity may limit the efficacy of monoclonal antibody therapy or tetravalent vaccines against DENV as neutralization potency generally correlates with a narrowed genotype specificity [\u003ca href=\"#B250\"\u003e250\u003c/a\u003e]. Consequently, a better understanding of dengue immunopathogenesis will assist not only development of therapeutic interventions but also the understanding of dengue vaccine efficacy or vaccine adverse events [\u003ca href=\"#B97\"\u003e97\u003c/a\u003e]. Therefore, laboratory surveillance of dengue needs to be improved considerably to increase our knowledge of the circulating viruses at the molecular level, preferably before the introduction of a vaccine on a large-scale.\u003c/p\u003e\u003ch5 id=\"sec3.3\"\u003e3.3. Development of Antivirals against Dengue Viruses\u003c/h5\u003e\u003cp\u003eWhilst no approved antiviral therapeutic agents are available to treat individuals presenting with symptoms of DF/DHF, several potential virus inhibitors are under consideration for further development. The dengue viruses provide a variety of potential targets for inhibitors of infection/replication. As Hepatitis C virus (HCV) is also a member of the \u003ci\u003eFlaviviridae\u003c/i\u003e, antivirals under development to control disease due to HCV may also prove to be effective against the dengue viruses. One of the major problems likely to be encountered is drug resistance. Consequently, the discovery and development of at least two antivirals that attack different viral targets should be a minimum goal. Another major hurdle for dengue viruses is the lack of availability of a validated animal model that faithfully reflects DHF and DSS observed in patients. \u003c/p\u003e\u003cp\u003eThe NS5 viral RNA dependent RNA polymerase (RdRp) and the methyl transferase, as well as the NS3 protease and helicase, are considered good targets for inhibitors of dengue infection, because they are all major components of the replicative viral complex [\u003ca href=\"#B251\"\u003e251\u003c/a\u003e]. The viral envelope (E) protein is also a good target for antivirals. The use of E protein-specific monoclonal antibodies has been shown to have some potential in this context [\u003ca href=\"#B252\"\u003e252\u003c/a\u003e]. The NS1, prM, and capsid protein of the dengue viruses have not been studied at the same level of intensity, and thus there are few if any potential antivirals against these targets. \u003c/p\u003e\u003cp\u003eOne approach that appears quite successful both \u003ci\u003ein vitro \u003c/i\u003eand \u003ci\u003ein vivo\u003c/i\u003e has been the demonstration that specific antisense morpholino oligomers can inhibit dengue virus replication [\u003ca href=\"#B253\"\u003e253\u003c/a\u003e, \u003ca href=\"#B254\"\u003e254\u003c/a\u003e]. However, major efforts are required to reduce the risk of toxicity and to provide safe and effective delivery systems for these oligomers [\u003ca href=\"#B252\"\u003e252\u003c/a\u003e, \u003ca href=\"#B255\"\u003e255\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eOther approaches are being utilised to identify flavivirus chemotherapeutic agents, including screening known inhibitors of other viruses, rational design based on protein crystal structures or secondary viral RNA structures, optimization of known viral inhibitors, use of humanized antibodies, use of immunoglobulins, and nucleic acid-based therapy [\u003ca href=\"#B256\"\u003e256\u003c/a\u003e].\u003c/p\u003e\u003cp\u003ePolyoxotungstates and sulphated polysaccharides show some potential as viral inhibitors. They impair flavivirus adsorption and entry into host cells \u003ci\u003ein vitro\u003c/i\u003e, apparently by binding to the cell surface [\u003ca href=\"#B257\"\u003e257\u003c/a\u003e, \u003ca href=\"#B258\"\u003e258\u003c/a\u003e]. Sulphated galactomannans protected mice from lethal YFV infection when inoculated simultaneously with the virus [\u003ca href=\"#B259\"\u003e259\u003c/a\u003e].\u003c/p\u003e\u003cp\u003eThe licensed drug Ribavirin has been used to treat a number of RNA viral infections. It functions as an RNA cap analogue and mutagen, causing errors in synthetic pathways [\u003ca href=\"#B260\"\u003e260\u003c/a\u003e–\u003ca href=\"#B262\"\u003e262\u003c/a\u003e]. However, the \u003ci\u003ein vitro\u003c/i\u003e and \u003ci\u003ein vivo \u003c/i\u003eactivity of Ribavirin against YFV and DENV was poor [\u003ca href=\"#B263\"\u003e263\u003c/a\u003e–\u003ca href=\"#B265\"\u003e265\u003c/a\u003e]. Prophylactic Ribavirin treatment of rhesus monkeys infected with DENV had little effect on viremia [\u003ca href=\"#B266\"\u003e266\u003c/a\u003e] and in mice, intraperitoneal administration of Ribavirin had no effect on survival following intracerebral inoculation with DENV. However, treatment with Ribavirin-2′,3′,5′-triacetate, a prodrug of Ribavirin, resulted in a significantly increased survival time and rate, possibly due to its higher ability to cross the blood-brain barrier [\u003ca href=\"#B267\"\u003e267\u003c/a\u003e]. \u003c/p\u003e\u003cp\u003eNucleoside analogues, characterized for chemotherapeutic use against HIV and Hepatitis B virus, show inhibitory activity in cell culture against YFV, DENV, and West Nile virus (WNV) [\u003ca href=\"#B268\"\u003e268\u003c/a\u003e]. Rather than blocking RNA replication, some analogues inhibit flaviviruses by inhibiting nucleoside triphosphate synthesis in host cells. For example, 6-azauridine acetate, pyrazofurin, and 2 thio-azauridine inhibit orotidine monophosphate decarboxylase (OMPDC). In contrast, mycophenolic acid and Ribavirin-2′,3′,5′-triacetate inhibit inosine monophosphate dehydrogenase (IMPDH) and block viral RNA synthesis [\u003ca href=\"#B269\"\u003e269\u003c/a\u003e, \u003ca href=\"#B270\"\u003e270\u003c/a\u003e]. Carbamate prodrugs have also been recommended as IMPDH inhibitors since they show \u003ci\u003ein vivo \u003c/i\u003eactivity [\u003ca href=\"#B271\"\u003e271\u003c/a\u003e]. Recently a uracil-based multifunctional compound was shown to have strong activity against dengue virus. It is likely that the mechanism of action of the antiviral activity of this compound is through inhibition of the enzyme, IMPDH [\u003ca href=\"#B272\"\u003e272\u003c/a\u003e].  \u003c/p\u003e\u003cp\u003eAn alternative strategy in the search for effective antivirals that potentially reduces the lead-time for their development is to identify drugs already licensed for use to control diseases other than those caused by the target virus. For example, the aminoglycoside, Geneticin (G418), was recently shown to have antiviral activity against bovine viral diarrhea virus (BVDV). Since BVDV, DENV, and YFV all belong to the virus family \u003ci\u003eFlaviviridae\u003c/i\u003e, it seems possible that a common step in their life cycle might be affected by this aminoglycoside. Geneticin prevented the cytopathic effect resulting from DENV-2 infection of BHK cells, in a dose-dependent manner [\u003ca href=\"#B273\"\u003e273\u003c/a\u003e]. However, Geneticin had no detectable effect on YFV in BHK cells. \u003c/p\u003e\u003cp\u003eIvermectin, a broadly used antihelmintic drug, displays specific inhibitory unwinding activity against helicases from several flaviviruses, including YFV, DENV, and WNV with the half maximal inhibitory concentration (IC\u003csub\u003e50\u003c/sub\u003e) values in the submicromolar range [\u003ca href=\"#B274\"\u003e274\u003c/a\u003e]. Preliminary studies indicate higher binding efficiency with YFV than with DENV. Nevertheless, disappointingly, Ivermectin did not protect hamsters against infection with YFV. Structure-based optimization may result in analogues exerting potent activity against flaviviruses both \u003ci\u003ein vitro \u003c/i\u003eand \u003ci\u003ein vivo\u003c/i\u003e.\u003c/p\u003e\u003cp\u003eDoxorubicin is an antineoplastic antibiotic obtained from \u003ci\u003eStreptomyces peucetius\u003c/i\u003e. This antibiotic exhibits \u003ci\u003ein vitro \u003c/i\u003eantiviral activity against the YFV17D vaccine strain and the DENV-2 NGC strain. Doxorubicin proved to be cytotoxic in uninfected host cells. However, a novel derivative of doxorubicin, SA-17, showed excellent antiviral activity against DENV and markedly reduced cytopathogenicity [\u003ca href=\"#B275\"\u003e275\u003c/a\u003e]. Dose-dependent anti-DENV activity was confirmed using a dengue reporter virus. Time-of-drug addition studies indicated that SA-17 acts at an early stage of the replication cycle. It does not inhibit the replication of the replicon and thus does not work at the level of the viral replication machinery. Further studies revealed that SA-17 exerts it activity \u003ci\u003evia \u003c/i\u003ea virucidal effect, even when using very high titres of the virus as the inoculum. \u003c/p\u003e\u003cp\u003eA large number of small molecules derived by computer modelling of known enzyme domains were screened for inhibitory activity against DENV-2 virus. Two of these molecules, ARDP0006 and ARDP0009, inhibited DENV-2 with high efficiency. ARDP0009 had no apparent toxicity at the concentrations tested. Selectivity indices calculated for ARDP0006 and ARDP0009 were comparable to those calculated for Ribavirin which has demonstrated inhibition of the DENV-2-O-methyltransferase NS5 [\u003ca href=\"#B276\"\u003e276\u003c/a\u003e] and HCV replication when used in combination with interferon. Antiviral activity, \u003ci\u003ein vitro,\u003c/i\u003e of 3′,5′ di-\u003ci\u003eO\u003c/i\u003e-trityluridine has also been identified. The compound inhibits DENV and YFV replication by targeting the elongation process of the viral NS5 RNA-dependent RNA polymerase. A nucleoside analogue (T-705) which is a substituted pyrazine compound that has been used in clinical trials for the treatment of human influenza virus infection is an analogue of T-1106, a known HCV polymerase inhibitor [\u003ca href=\"#B277\"\u003e277\u003c/a\u003e]. T-705 significantly improved survival and disease parameters in YFV-infected hamsters despite the lack of good \u003ci\u003ein vitro \u003c/i\u003eantiviral activity. These studies highlight the possibility that nucleoside analogues could potentially be developed for flavivirus therapy although more potent compounds with reduced toxic effects on the host cells will need to be generated.\u003c/p\u003e\u003cp\u003eFlaviviral inhibitory activity has also been observed with plant extracts. Boesenbergia rotunda (L.) Mansf. Kulturpfl. (BR) is a common spice belonging to a member of the ginger family (Zingiberaceae). Some of the BR compounds, such as flavanoids and chalcones, have been shown to be pharmaceutically active. The chalcone, cardamonin, isolated from BR, was recently reported to exhibit appreciable anti-HIV-1 protease inhibition [\u003ca href=\"#B278\"\u003e278\u003c/a\u003e]. Moreover, inhibitory activity by six compounds isolated from BR has also been demonstrated on DENV-2 virus NS3 protease activity.\u003c/p\u003e\u003cp\u003eIn conclusion, whilst mosquito control strategies have been shown to be successful in reducing the incidence of dengue infections, such methods are most effective in those tropical/subtropical countries that have well-developed human and environmental health infrastructures. Clearly, there is a real need for more effort to understand the complex epidemiology and pathogenesis of the dengue viruses to expedite the development of suitable vaccines and/or antiviral therapies. Although some vaccine candidates appear promising, as yet none has been licensed. Due to the presence of the four DENV serotypes, these viruses present a different situation from YFV, tick-borne encephalitis virus, and Japanese encephalitis virus. The question of whether or not deteriorating antibody levels will leave vaccinated people liable to the development of DHF via ADE will need to be addressed. Moreover, the relationships between the presence of neutralizing antibodies, the level of protection afforded and the duration of protection by each of the four serotypes will need to be critically assessed. There is a pressing need for global collective efforts to develop antiviral therapeutics with which to combat dengue viruses. The current trend of expanding our efforts on antiviral drug discovery is encouraging in this respect.\u003c/p\u003e\u003ch4 id=\"acknowledgments\"\u003eAcknowledgments\u003c/h4\u003e\u003cp\u003eThe authors wish to thank Dr. Maria G Guzman for helpful advice and criticism in the preparation of this review. Professor Gould is supported under the EU 7th Framework-Health Programmes (Grant Agreement no. 260644 - SILVER and Grant Agreement no. 278433 - PREDEMICS), and Dr. Rodriguez-Roche is supported by the Cuban Ministry of Public Health and under the EU 7th Framework-Health Programme (Grant Agreement no. 282378 - DENFREE).\u003c/p\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"references\" id=\"references\"\u003eReferences\u003c/h4\u003e\u003col\u003e\u003cli id=\"B1\"\u003eF. P. Pinheiro and S. J. Corber, “Global situation of dengue and dengue haemorrhagic fever, and its emergence in the Americas,” \u003ci\u003eWorld Health Statistics Quarterly\u003c/i\u003e, vol. 50, no. 3-4, pp. 161–169, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Global%20situation%20of%20dengue%20and%20dengue%20haemorrhagic%20fever,%20and%20its%20emergence%20in%20the%20Americas\u0026author=F. P. Pinheiro \u0026author=S. J. Corber\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B2\"\u003eD. J. Gubler, “The global emergence/resurgence of arboviral diseases as public health problems,” \u003ci\u003eArchives of Medical Research\u003c/i\u003e, vol. 33, no. 4, pp. 330–342, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0188-4409(02)00378-8\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20global%20emergence/resurgence%20of%20arboviral%20diseases%20as%20public%20health%20problems\u0026author=D. J. Gubler\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B3\"\u003eS. B. Halstead, “Dengue,” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 370, no. 9599, pp. 1644–1652, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0140-6736(07)61687-0\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue\u0026author=S. B. Halstead\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B4\"\u003eP. M. De A. Zanotto, E. A. Gould, G. F. Gao, P. H. Harvey, and E. C. Holmes, “Population dynamics of flaviviruses revealed by molecular phylogenies,” \u003ci\u003eProceedings of the National Academy of Sciences of the United States of America\u003c/i\u003e, vol. 93, no. 2, pp. 548–553, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1073/pnas.93.2.548\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Population%20dynamics%20of%20flaviviruses%20revealed%20by%20molecular%20phylogenies\u0026author=P. M. De A. Zanotto\u0026author=E. A. Gould\u0026author=G. F. Gao\u0026author=P. H. Harvey\u0026author=\u0026author=E. C. Holmes\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B5\"\u003e WHO, \u003ci\u003eDengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control\u003c/i\u003e, WHO, Geneva, Switzerland, 2nd edition, 1997. \u003cspan class=\"reflinks\"\u003e\u003c/span\u003e\u003cli id=\"B6\"\u003eL. M. Ling, A. Wilder-Smith, and Y. S. Leo, “Fulminant hepatitis in dengue haemorrhagic fever,” \u003ci\u003eJournal of Clinical Virology\u003c/i\u003e, vol. 38, no. 3, pp. 265–268, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.jcv.2006.12.011\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Fulminant%20hepatitis%20in%20dengue%20haemorrhagic%20fever\u0026author=L. M. Ling\u0026author=A. Wilder-Smith\u0026author=\u0026author=Y. S. Leo\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B7\"\u003eS. Gulati and A. Maheshwari, “Atypical manifestations of dengue,” \u003ci\u003eTropical Medicine and International Health\u003c/i\u003e, vol. 12, no. 9, pp. 1087–1095, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1365-3156.2007.01891.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Atypical%20manifestations%20of%20dengue\u0026author=S. Gulati \u0026author=A. Maheshwari\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B8\"\u003eR. Kumar, S. Tripathi, J. J. Tambe, V. Arora, A. Srivastava, and V. L. Nag, “Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue,” \u003ci\u003eJournal of the Neurological Sciences\u003c/i\u003e, vol. 269, no. 1-2, pp. 41–48, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.jns.2007.12.018\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20encephalopathy%20in%20children%20in%20Northern%20India:%20clinical%20features%20and%20comparison%20with%20non%20dengue\u0026author=R. Kumar\u0026author=S. Tripathi\u0026author=J. J. Tambe\u0026author=V. Arora\u0026author=A. Srivastava\u0026author=\u0026author=V. L. Nag\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B9\"\u003eM. Wasay, R. Channa, M. Jumani, G. Shabbir, M. Azeemuddin, and A. Zafar, “Encephalitis and myelitis associated with dengue viral infection. Clinical and neuroimaging features,” \u003ci\u003eClinical Neurology and Neurosurgery\u003c/i\u003e, vol. 110, no. 6, pp. 635–640, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.clineuro.2008.03.011\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Encephalitis%20and%20myelitis%20associated%20with%20dengue%20viral%20infection.%20Clinical%20and%20neuroimaging%20features\u0026author=M. Wasay\u0026author=R. Channa\u0026author=M. Jumani\u0026author=G. Shabbir\u0026author=M. Azeemuddin\u0026author=\u0026author=A. Zafar\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B10\"\u003eT. Solomon, N. M. Dung, D. W. Vaughn et al., “Neurological manifestations of dengue infection,” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 355, no. 9209, pp. 1053–1059, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Neurological%20manifestations%20of%20dengue%20infection\u0026author=T. Solomon\u0026author=N. M. Dung\u0026author=D. W. Vaughn et al.\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B11\"\u003eS. B. Park, S. Y. Ryu, K. B. Jin et al., “Acute colitis associated with dengue fever in a renal transplant recipient,” \u003ci\u003eTransplantation Proceedings\u003c/i\u003e, vol. 40, no. 7, pp. 2431–2432, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.transproceed.2008.07.037\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Acute%20colitis%20associated%20with%20dengue%20fever%20in%20a%20renal%20transplant%20recipient\u0026author=S. B. Park\u0026author=S. Y. Ryu\u0026author=K. B. Jin et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B12\"\u003eA. Balmaseda, S. N. Hammond, M. A. P\u0026#xe9;rez et al., “Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 73, no. 6, pp. 1059–1062, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Short%20report:%20assessment%20of%20the%20World%20Health%20Organization%20scheme%20for%20classification%20of%20dengue%20severity%20in%20Nicaragua\u0026author=A. Balmaseda\u0026author=S. N. Hammond\u0026author=M. A. Pérez et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B13\"\u003eS. Bandyopadhyay, L. C. S. Lum, and A. Kroeger, “Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever,” \u003ci\u003eTropical Medicine and International Health\u003c/i\u003e, vol. 11, no. 8, pp. 1238–1255, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1365-3156.2006.01678.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Classifying%20dengue:%20a%20review%20of%20the%20difficulties%20in%20using%20the%20WHO%20case%20classification%20for%20dengue%20haemorrhagic%20fever\u0026author=S. Bandyopadhyay\u0026author=L. C. S. Lum\u0026author=\u0026author=A. Kroeger\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B14\"\u003eJ. G. Rigau-P\u0026#xe9;rez, “Severe dengue: the need for new case definitions,” \u003ci\u003eLancet Infectious Diseases\u003c/i\u003e, vol. 6, no. 5, pp. 297–302, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S1473-3099(06)70465-0\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Severe%20dengue:%20the%20need%20for%20new%20case%20definitions\u0026author=J. G. Rigau-Pérez\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B15\"\u003eJ. L. Deen, E. Harris, B. Wills et al., “The WHO dengue classification and case definitions: time for a reassessment,” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 368, no. 9530, pp. 170–173, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0140-6736(06)69006-5\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20WHO%20dengue%20classification%20and%20case%20definitions:%20time%20for%20a%20reassessment\u0026author=J. L. Deen\u0026author=E. Harris\u0026author=B. Wills et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B16\"\u003eN. Alexander, A. Balmaseda, I. C. B. Coelho et al., “Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries,” \u003ci\u003eTropical Medicine and International Health\u003c/i\u003e, vol. 16, no. 8, pp. 936–948, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1365-3156.2011.02793.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Multicentre%20prospective%20study%20on%20dengue%20classification%20in%20four%20South-east%20Asian%20and%20three%20Latin%20American%20countries\u0026author=N. Alexander\u0026author=A. Balmaseda\u0026author=I. C. B. Coelho et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B17\"\u003e WHO/TDR, \u003ci\u003eDengue Guidelines for Diagnosis, Treatment, Prevention and Control\u003c/i\u003e, WHO Press, Geneva, Switzerland, 2009. \u003cspan class=\"reflinks\"\u003e\u003c/span\u003e\u003cli id=\"B18\"\u003eN. A. Akbar, I. Allende, A. Balmaseda et al., “Regarding \u0026#x201c;Dengue\u0026#x2014;how best to classify it\u0026#x201d;,” \u003ci\u003eClinical Infectious Diseases\u003c/i\u003e, vol. 54, no. 12, pp. 1820–1821, 2012, author reply 1821-1822. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/cid/cis328\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Regarding%20“Dengue—how%20best%20to%20classify%20it”\u0026author=N. A. Akbar\u0026author=I. Allende\u0026author=A. Balmaseda et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B19\"\u003eA. Srikiatkhachorn, A. L. Rothman, R. V. Gibbons et al., “Dengue-how best to classify it,” \u003ci\u003eClinical Infectious Diseases\u003c/i\u003e, vol. 53, no. 6, pp. 563–567, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/cid/cir451\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue-how%20best%20to%20classify%20it\u0026author=A. Srikiatkhachorn\u0026author=A. L. Rothman\u0026author=R. V. Gibbons et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B20\"\u003eS. Kalayanarooj, “Dengue classification: current WHO vs. the newly suggested classification for better clinical application?” \u003ci\u003eJournal of the Medical Association of Thailand\u003c/i\u003e, vol. 94, pp. S74–84, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20classification:%20current%20WHO%20vs.%20the%20newly%20suggested%20classification%20for%20better%20clinical%20application?\u0026author=S. Kalayanarooj\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B21\"\u003eS. B. Halstead, “Dengue: the syndromic basis to pathogenesis research. Inutility of the 2009 WHO case definition,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 88, no. 2, pp. 212–215, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4269/ajtmh.12-0197\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue:%20the%20syndromic%20basis%20to%20pathogenesis%20research.%20Inutility%20of%20the%202009%20WHO%20case%20definition\u0026author=S. B. Halstead\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B22\"\u003eJ. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Ochlerotatus and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” \u003ci\u003eZoological Journal of the Linnean Society\u003c/i\u003e, vol. 153, no. 1, pp. 29–114, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1096-3642.2008.00382.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Ochlerotatus%20and%20allied%20taxa%20(Diptera:%20Culicidae:%20Aedini)%20based%20on%20morphological%20data%20from%20all%20life%20stages\u0026author=J. F. Reinert\u0026author=R. E. Harbach\u0026author=\u0026author=I. J. Kitching\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B23\"\u003eJ. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Aedini (Diptera: Culicidae), based on morphological characters of all life stages,” \u003ci\u003eZoological Journal of the Linnean Society\u003c/i\u003e, vol. 142, no. 3, pp. 289–368, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1096-3642.2004.00144.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Aedini%20(Diptera:%20Culicidae),%20based%20on%20morphological%20characters%20of%20all%20life%20stages\u0026author=J. F. Reinert\u0026author=R. E. Harbach\u0026author=\u0026author=I. J. Kitching\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B24\"\u003eJ. F. Reinert, R. E. Harbach, and I. J. Kitching, “Phylogeny and classification of Finlaya and allied taxa (Diptera: Culicidae: Aedini) based on morphological data from all life stages,” \u003ci\u003eZoological Journal of the Linnean Society\u003c/i\u003e, vol. 148, no. 1, pp. 1–101, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1096-3642.2006.00254.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Phylogeny%20and%20classification%20of%20Finlaya%20and%20allied%20taxa%20(Diptera:%20Culicidae:%20Aedini)%20based%20on%20morphological%20data%20from%20all%20life%20stages\u0026author=J. F. Reinert\u0026author=R. E. Harbach\u0026author=\u0026author=I. J. Kitching\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B25\"\u003eE. A. Gould, X. de Lamballerie, P. M. D. A. Zanotto, and E. C. Holmes, “Origins, evolution, and vector{plus 45 degree rule}host coadaptations within the Genus Flavivirus,” \u003ci\u003eAdvances in Virus Research\u003c/i\u003e, vol. 59, pp. 277–314, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0065-3527(03)59008-X\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Origins,%20evolution,%20and%20vector{plus%2045%20degree%20rule}host%20coadaptations%20within%20the%20Genus%20Flavivirus\u0026author=E. A. Gould\u0026author=X. de Lamballerie\u0026author=P. M. D. A. Zanotto\u0026author=\u0026author=E. C. Holmes\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B26\"\u003eG. K. Strode, \u003ci\u003eYellow Fever\u003c/i\u003e, McGraw-Hill, New York, NY, USA, 1951. \u003cspan class=\"reflinks\"\u003e\u003c/span\u003e\u003cli id=\"B27\"\u003eW. J. Tabachnick, “Evolutionary genetics and arthropod-borne diseases. The yellow fever mosquito, \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003eAmerican Journal of Entomology\u003c/i\u003e, vol. 37, pp. 14–24, 1991. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Evolutionary%20genetics%20and%20arthropod-borne%20diseases.%20The%20yellow%20fever%20mosquito,%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=W. J. Tabachnick\u0026publication_year=1991\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B28\"\u003eL. P. Lounibos, “Invasions by insect vectors of human disease,” \u003ci\u003eAnnual Review of Entomology\u003c/i\u003e, vol. 47, pp. 233–266, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1146/annurev.ento.47.091201.145206\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Invasions%20by%20insect%20vectors%20of%20human%20disease\u0026author=L. P. Lounibos\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B29\"\u003eX. De Lamballerie, E. Leroy, R. N. Charrel, K. Ttsetsarkin, S. Higgs, and E. A. Gould, “Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?” \u003ci\u003eVirology Journal\u003c/i\u003e, vol. 5, article 33, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1186/1743-422X-5-33\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Chikungunya%20virus%20adapts%20to%20tiger%20mosquito%20via%20evolutionary%20convergence:%20a%20sign%20of%20things%20to%20come?\u0026author=X. De Lamballerie\u0026author=E. Leroy\u0026author=R. N. Charrel\u0026author=K. Ttsetsarkin\u0026author=S. Higgs\u0026author=\u0026author=E. A. Gould\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B30\"\u003eA. J. Tatem, R. W. Snow, and S. I. Hay, “Mapping the environmental coverage of the INDEPTH demographic surveillance system network in rural Africa,” \u003ci\u003eTropical Medicine and International Health\u003c/i\u003e, vol. 11, no. 8, pp. 1318–1326, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1365-3156.2006.01681.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mapping%20the%20environmental%20coverage%20of%20the%20INDEPTH%20demographic%20surveillance%20system%20network%20in%20rural%20Africa\u0026author=A. J. Tatem\u0026author=R. W. Snow\u0026author=\u0026author=S. I. Hay\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B31\"\u003eK. J. Bloom, \u003ci\u003eThe Mississippi Valley's Great Yellow Fever Epidemic of 1978\u003c/i\u003e, Louisiana State University Press, Baton Rouge, Lo, USA, 1993. \u003cspan class=\"reflinks\"\u003e\u003c/span\u003e\u003cli id=\"B32\"\u003eB. Rush, “An account of the bilious remitting fever. As it appeared in philadelphia, in the summer and autumn of the year 1780,” \u003ci\u003eThe American Journal of Medicine\u003c/i\u003e, vol. 11, no. 5, pp. 546–550, 1951. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=An%20account%20of%20the%20bilious%20remitting%20fever.%20As%20it%20appeared%20in%20philadelphia,%20in%20the%20summer%20and%20autumn%20of%20the%20year%201780\u0026author=B. Rush\u0026publication_year=1951\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B33\"\u003eS. B. Halstead, “Dengue in the Americas and Southeast Asia: do they differ?” \u003ci\u003eRevista Panamericana de Salud Publica\u003c/i\u003e, vol. 20, no. 6, pp. 407–415, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20in%20the%20Americas%20and%20Southeast%20Asia:%20do%20they%20differ?\u0026author=S. B. Halstead\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B34\"\u003eD. Gubler, “Dengue and dengue hemorrhagic fever: its history and resurgence as a global public health problem,” in \u003ci\u003eDengue and Dengue Hemorrhagic Fever\u003c/i\u003e, D. Gubler and G. Kuno, Eds., pp. 1–22, CAB International, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20hemorrhagic%20fever:%20its%20history%20and%20resurgence%20as%20a%20global%20public%20health%20problem\u0026author=D. Gubler\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B35\"\u003eD. J. Gubler, “The emergence of dengue/dengue haemorrhagic fever as a global public health problem,” in \u003ci\u003eFactors in the Emergence of Arbovirus Diseases\u003c/i\u003e, J. F. Saluzzo and B. Dodet, Eds., pp. 83–92, Elsevier, Paris, France, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20emergence%20of%20dengue/dengue%20haemorrhagic%20fever%20as%20a%20global%20public%20health%20problem\u0026author=D. J. Gubler\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B36\"\u003eD. J. Gubler, “Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century,” \u003ci\u003eTrends in Microbiology\u003c/i\u003e, vol. 10, no. 2, pp. 100–103, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0966-842X(01)02288-0\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Epidemic%20dengue/dengue%20hemorrhagic%20fever%20as%20a%20public%20health,%20social%20and%20economic%20problem%20in%20the%2021st%20century\u0026author=D. J. Gubler\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B37\"\u003eD. J. Gubler, “Dengue/dengue haemorrhagic fever: history and current status,” \u003ci\u003eNovartis Foundation Symposium\u003c/i\u003e, vol. 277, pp. 3–16, 2006, discussion 16\u0026#x2013;22, 71\u0026#x2013;13, 251\u0026#x2013;253. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue/dengue%20haemorrhagic%20fever:%20history%20and%20current%20status\u0026author=D. J. Gubler\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B38\"\u003eS. B. Halstead, “Dengue hemorrhagic fever: two infections and antibody dependent enhancement, a brief history and personal memoir,” \u003ci\u003eRevista Cubana de Medicina Tropical\u003c/i\u003e, vol. 54, no. 3, pp. 171–179, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever:%20two%20infections%20and%20antibody%20dependent%20enhancement,%20a%20brief%20history%20and%20personal%20memoir\u0026author=S. B. Halstead\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B39\"\u003eS. B. Halstead, “Dengue virus-mosquito interactions,” \u003ci\u003eAnnual Review of Entomology\u003c/i\u003e, vol. 53, pp. 273–291, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1146/annurev.ento.53.103106.093326\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus-mosquito%20interactions\u0026author=S. B. Halstead\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B40\"\u003eR. E. Blanton, L. K. Silva, V. G. Morato et al., “Genetic ancestry and income are associated with dengue hemorrhagic fever in a highly admixed population,” \u003ci\u003eEuropean Journal of Human Genetics\u003c/i\u003e, vol. 16, no. 6, pp. 762–765, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/ejhg.2008.4\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Genetic%20ancestry%20and%20income%20are%20associated%20with%20dengue%20hemorrhagic%20fever%20in%20a%20highly%20admixed%20population\u0026author=R. E. Blanton\u0026author=L. K. Silva\u0026author=V. G. Morato et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B41\"\u003eB. D. L. C. Sierra, G. Kour\u0026#xed;, and M. G. Guzm\u0026#xe1;n, “Race: a risk factor for dengue hemorrhagic fever,” \u003ci\u003eArchives of Virology\u003c/i\u003e, vol. 152, no. 3, pp. 533–542, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s00705-006-0869-x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Race:%20a%20risk%20factor%20for%20dengue%20hemorrhagic%20fever\u0026author=B. D. L. C. Sierra\u0026author=G. Kourí\u0026author=\u0026author=M. G. Guzmán\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B42\"\u003eM. G. Guzman and G. Kouri, “Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges,” \u003ci\u003eJournal of Clinical Virology\u003c/i\u003e, vol. 27, no. 1, pp. 1–13, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S1386-6532(03)00010-6\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20hemorrhagic%20fever%20in%20the%20Americas:%20lessons%20and%20challenges\u0026author=M. G. Guzman \u0026author=G. Kouri\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B43\"\u003eN. Singh, T. Kiedrzynski, C. Lepers, and E. K. Benyon, “Dengue in the Pacific\u0026#x2014;an update of the current situation,” \u003ci\u003ePacific Health Dialog\u003c/i\u003e, vol. 12, no. 2, pp. 111–119, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20in%20the%20Pacific—an%20update%20of%20the%20current%20situation\u0026author=N. Singh\u0026author=T. Kiedrzynski\u0026author=C. Lepers\u0026author=\u0026author=E. K. Benyon\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B44\"\u003eA. Wilder-Smith and D. J. Gubler, “Geographic expansion of dengue: the impact of international travel,” \u003ci\u003eMedical Clinics of North America\u003c/i\u003e, vol. 92, no. 6, pp. 1377–1390, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.mcna.2008.07.002\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Geographic%20expansion%20of%20dengue:%20the%20impact%20of%20international%20travel\u0026author=A. Wilder-Smith \u0026author=D. J. Gubler\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B45\"\u003eC. Franco, N. A. Hynes, N. Bouri, and D. A. Henderson, “The dengue threat to the United States,” \u003ci\u003eBiosecurity and Bioterrorism\u003c/i\u003e, vol. 8, no. 3, pp. 273–276, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/bsp.2010.0032\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20dengue%20threat%20to%20the%20United%20States\u0026author=C. Franco\u0026author=N. A. Hynes\u0026author=N. Bouri\u0026author=\u0026author=D. A. Henderson\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B46\"\u003eE. A. Gould, P. Gallian, X. De Lamballerie, and R. N. Charrel, “First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality!,” \u003ci\u003eClinical Microbiology and Infection\u003c/i\u003e, vol. 16, no. 12, pp. 1702–1704, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1469-0691.2010.03386.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=First%20cases%20of%20autochthonous%20dengue%20fever%20and%20chikungunya%20fever%20in%20France:%20from%20bad%20dream%20to%20reality!\u0026author=E. A. Gould\u0026author=P. Gallian\u0026author=X. De Lamballerie\u0026author=\u0026author=R. N. Charrel\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B47\"\u003eI. C. Kurolt, L. Betica-Radic, O. Dakovic-Rode et al., “Molecular characterization of dengue virus 1 from autochthonous dengue fever cases in Croatia,” \u003ci\u003eClinical Microbiology and Infection\u003c/i\u003e, vol. 19, no. 3, pp. 163–165, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Molecular%20characterization%20of%20dengue%20virus%201%20from%20autochthonous%20dengue%20fever%20cases%20in%20Croatia\u0026author=I. C. Kurolt\u0026author=L. Betica-Radic\u0026author=O. Dakovic-Rode et al.\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B48\"\u003eM. G. Guzman and G. Kouri, “Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987\u0026#x2013;2007,” \u003ci\u003eTransactions of the Royal Society of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 102, no. 6, pp. 522–523, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.trstmh.2008.03.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20haemorrhagic%20fever%20integral%20hypothesis:%20confirming%20observations,%201987–2007\u0026author=M. G. Guzman \u0026author=G. Kouri\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B49\"\u003eM. G. Guzman, S. Vazquez, E. Martinez et al., “Dengue in Nicaragua, 1994: reintroduction of serotype 3 in the Americas,” \u003ci\u003eBoletin de la Oficina Sanitaria Panamericana\u003c/i\u003e, vol. 121, no. 2, pp. 102–110, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20in%20Nicaragua,%201994:%20reintroduction%20of%20serotype%203%20in%20the%20Americas\u0026author=M. G. Guzman\u0026author=S. Vazquez\u0026author=E. Martinez et al.\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B50\"\u003eM. G. Guzm\u0026#xe1;n, D. Rosario, M. Mun\u0026#xe9;, M. Alvarez, R. Rodr\u0026#xed;guez, and G. Kour\u0026#xed;, “Genetic relatedness of the dengue 3 virus isolated in the outbreak of dengue hemorrhagic fever in Nicaragua, 1994,” \u003ci\u003eRevista Cubana de Medicina Tropical\u003c/i\u003e, vol. 48, no. 2, pp. 114–117, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Genetic%20relatedness%20of%20the%20dengue%203%20virus%20isolated%20in%20the%20outbreak%20of%20dengue%20hemorrhagic%20fever%20in%20Nicaragua,%201994\u0026author=M. G. Guzmán\u0026author=D. Rosario\u0026author=M. Muné\u0026author=M. Alvarez\u0026author=R. Rodríguez\u0026author=\u0026author=G. Kourí\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B51\"\u003eR. Rico-Hesse, “Microevolution and virulence of dengue viruses,” \u003ci\u003eAdvances in Virus Research\u003c/i\u003e, vol. 59, pp. 315–341, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0065-3527(03)59009-1\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Microevolution%20and%20virulence%20of%20dengue%20viruses\u0026author=R. Rico-Hesse\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B52\"\u003eM. G. Teixeira, M. C. N. Costa, G. Coelho, and M. L. Barreto, “Recent shift in age pattern of dengue hemorrhagic fever, Brazil,” \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 14, no. 10, p. 1663, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3201/eid1410.071164\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Recent%20shift%20in%20age%20pattern%20of%20dengue%20hemorrhagic%20fever,%20Brazil\u0026author=M. G. Teixeira\u0026author=M. C. N. Costa\u0026author=G. Coelho\u0026author=\u0026author=M. L. Barreto\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B53\"\u003eL. P. Cavalcanti, D. Vilar, R. Souza-Santos, and M. G. Teixeira, “Change in age pattern of persons with dengue, Northeastern Brazil,” \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 17, no. 1, pp. 132–134, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3201/eid1701.100321\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Change%20in%20age%20pattern%20of%20persons%20with%20dengue,%20Northeastern%20Brazil\u0026author=L. P. Cavalcanti\u0026author=D. Vilar\u0026author=R. Souza-Santos\u0026author=\u0026author=M. G. Teixeira\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B54\"\u003eM. Q. Benedict, R. S. Levine, W. A. Hawley, and L. P. Lounibos, “Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus,” \u003ci\u003eVector-Borne and Zoonotic Diseases\u003c/i\u003e, vol. 7, no. 1, pp. 76–85, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/vbz.2006.0562\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Spread%20of%20the%20tiger:%20global%20risk%20of%20invasion%20by%20the%20mosquito%20Aedes%20albopictus\u0026author=M. Q. Benedict\u0026author=R. S. Levine\u0026author=W. A. Hawley\u0026author=\u0026author=L. P. Lounibos\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B55\"\u003eR. N. Charrel, X. De Lamballerie, and D. Raoult, “Chikungunya outbreaks\u0026#x2014;the globalization of vectorborne diseases,” \u003ci\u003eThe New England Journal of Medicine\u003c/i\u003e, vol. 356, no. 8, pp. 769–771, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1056/NEJMp078013\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Chikungunya%20outbreaks—the%20globalization%20of%20vectorborne%20diseases\u0026author=R. N. Charrel\u0026author=X. De Lamballerie\u0026author=\u0026author=D. Raoult\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B56\"\u003eC. Sousa, M. Clairouin, G. Seixas et al., “Ongoing outbreak of dengue type 1 in the Autonomous Region of Madeira, Portugal: preliminary report,” \u003ci\u003eEurosurveillance\u003c/i\u003e, vol. 17, no. 49, article 3, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Ongoing%20outbreak%20of%20dengue%20type%201%20in%20the%20Autonomous%20Region%20of%20Madeira,%20Portugal:%20preliminary%20report\u0026author=C. Sousa\u0026author=M. Clairouin\u0026author=G. Seixas et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B57\"\u003eC. Caminade, J. M. Medlock, E. Ducheyne et al., “Suitability of European climate for the Asian tiger mosquito \u003ci\u003eAedes albopictus\u003c/i\u003e: recent trends and future scenarios,” \u003ci\u003eJournal of the Royal Society Interface\u003c/i\u003e, vol. 9, no. 75, pp. 2708–2717, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1098/rsif.2012.0138\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Suitability%20of%20European%20climate%20for%20the%20Asian%20tiger%20mosquito%20\u003ci\u003eAedes%20albopictus\u003c/i\u003e:%20recent%20trends%20and%20future%20scenarios\u0026author=C. Caminade\u0026author=J. M. Medlock\u0026author=E. Ducheyne et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B58\"\u003eW. F. Wright and B. S. Pritt, “Update: the diagnosis and management of dengue virus infection in North America,” \u003ci\u003eDiagnostic Microbiology and Infectious Disease\u003c/i\u003e, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.diagmicrobio.2012.03.021\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Update:%20the%20diagnosis%20and%20management%20of%20dengue%20virus%20infection%20in%20North%20America\u0026author=W. F. Wright \u0026author=B. S. Pritt\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B59\"\u003eF. Wu, Q. Liu, L. Lu, J. Wang, X. Song, and D. Ren, “Distribution of Aedes albopictus (Diptera: Culicidae) in northwestern China,” \u003ci\u003eVector-Borne and Zoonotic Diseases\u003c/i\u003e, vol. 11, no. 8, pp. 1181–1186, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/vbz.2010.0032\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Distribution%20of%20Aedes%20albopictus%20(Diptera:%20Culicidae)%20in%20northwestern%20China\u0026author=F. Wu\u0026author=Q. Liu\u0026author=L. Lu\u0026author=J. Wang\u0026author=X. Song\u0026author=\u0026author=D. Ren\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B60\"\u003eM. G. Guzm\u0026#xe1;n, “Deciphering dengue: the Cuban experience,” \u003ci\u003eScience\u003c/i\u003e, vol. 309, no. 5740, pp. 1495–1497, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1126/science.1115177\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Deciphering%20dengue:%20the%20Cuban%20experience\u0026author=M. G. Guzmán\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B61\"\u003eG. K. Tan and S. Alonso, “Pathogenesis and prevention of dengue virus infection: state-of-the-art,” \u003ci\u003eCurrent Opinion in Infectious Diseases\u003c/i\u003e, vol. 22, no. 3, pp. 302–308, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1097/QCO.0b013e328329ae32\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Pathogenesis%20and%20prevention%20of%20dengue%20virus%20infection:%20state-of-the-art\u0026author=G. K. Tan \u0026author=S. Alonso\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B62\"\u003eA. Mathew and A. L. Rothman, “Understanding the contribution of cellular immunity to dengue disease pathogenesis,” \u003ci\u003eImmunological Reviews\u003c/i\u003e, vol. 225, no. 1, pp. 300–313, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1600-065X.2008.00678.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Understanding%20the%20contribution%20of%20cellular%20immunity%20to%20dengue%20disease%20pathogenesis\u0026author=A. Mathew \u0026author=A. L. Rothman\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B63\"\u003eM. Alvarez, R. Rodriguez-Roche, L. Bernardo et al., “Dengue hemorrhagic fever caused by sequential dengue 1\u0026#x2013;3 virus infections over a long time interval: Havana epidemic, 2001-2002,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 75, no. 6, pp. 1113–1117, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20caused%20by%20sequential%20dengue%201–3%20virus%20infections%20over%20a%20long%20time%20interval:%20Havana%20epidemic,%202001-2002\u0026author=M. Alvarez\u0026author=R. Rodriguez-Roche\u0026author=L. Bernardo et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B64\"\u003eM. G. Guzm\u0026#xe1;n, G. Kouri, L. Valdes et al., “Epidemiologic studies on dengue in Santiago de Cuba, 1997,” \u003ci\u003eAmerican Journal of Epidemiology\u003c/i\u003e, vol. 152, no. 9, pp. 793–799, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/aje/152.9.793\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Epidemiologic%20studies%20on%20dengue%20in%20Santiago%20de%20Cuba,%201997\u0026author=M. G. Guzmán\u0026author=G. Kouri\u0026author=L. Valdes et al.\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B65\"\u003eM. G. Guzman, M. Alvarez, R. Rodriguez et al., “Fatal dengue hemorrhagic fever in Cuba,” \u003ci\u003eInternational Journal of Infectious Diseases\u003c/i\u003e, vol. 3, no. 3, pp. 130–135, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Fatal%20dengue%20hemorrhagic%20fever%20in%20Cuba\u0026author=M. G. Guzman\u0026author=M. Alvarez\u0026author=R. Rodriguez et al.\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B66\"\u003eM. G. Guzman, G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier, “Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 42, no. 2, pp. 179–184, 1990. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20hemorrhagic%20fever%20in%20Cuba,%201981:%20a%20retrospective%20seroepidemiologic%20study\u0026author=M. G. Guzman\u0026author=G. P. Kouri\u0026author=J. Bravo\u0026author=M. Soler\u0026author=S. Vazquez\u0026author=\u0026author=L. Morier\u0026publication_year=1990\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B67\"\u003eJ. R. Bravo, M. G. Guzm\u0026#xe1;n, and G. P. Kouri, “Why dengue haemorrhagic fever in Cuba? I. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS),” \u003ci\u003eTransactions of the Royal Society of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 81, no. 5, pp. 816–820, 1987. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Why%20dengue%20haemorrhagic%20fever%20in%20Cuba?%20I.%20Individual%20risk%20factors%20for%20dengue%20haemorrhagic%20fever/dengue%20shock%20syndrome%20(DHF/DSS)\u0026author=J. R. Bravo\u0026author=M. G. Guzmán\u0026author=\u0026author=G. P. Kouri\u0026publication_year=1987\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B68\"\u003eL. Vald\u0026#xe9;s, M. G. Guzm\u0026#xe1;n, G. Kour\u0026#xed; et al., “The epidemiology of dengue and dengue hemorrhagic fever in Santiago de Cuba, 1997,” \u003ci\u003eRevista Panamericana de Salud Publica\u003c/i\u003e, vol. 6, no. 1, pp. 16–25, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20epidemiology%20of%20dengue%20and%20dengue%20hemorrhagic%20fever%20in%20Santiago%20de%20Cuba,%201997\u0026author=L. Valdés\u0026author=M. G. Guzmán\u0026author=G. Kourí et al.\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B69\"\u003eN. Sangkawibha, S. Rojanasuphot, and S. Ahandrik, “Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak,” \u003ci\u003eAmerican Journal of Epidemiology\u003c/i\u003e, vol. 120, no. 5, pp. 653–669, 1984. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Risk%20factors%20in%20dengue%20shock%20syndrome:%20a%20prospective%20epidemiologic%20study%20in%20Rayong,%20Thailand.%20I.%20The%201980%20outbreak\u0026author=N. Sangkawibha\u0026author=S. Rojanasuphot\u0026author=\u0026author=S. Ahandrik\u0026publication_year=1984\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B70\"\u003eS. B. Halstead, S. Nimmannitya, and M. R. Margiotta, “Dengue d chikungunya virus infection in man in Thailand, 1962\u0026#x2013;1964. II. Observations on disease in outpatients,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 18, no. 6, pp. 972–983, 1969. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20d%20chikungunya%20virus%20infection%20in%20man%20in%20Thailand,%201962–1964.%20II.%20Observations%20on%20disease%20in%20outpatients\u0026author=S. B. Halstead\u0026author=S. Nimmannitya\u0026author=\u0026author=M. R. Margiotta\u0026publication_year=1969\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B71\"\u003eS. B. Halstead, “The pathogenesis of dengue. Molecular epidemiology in infectious disease,” \u003ci\u003eAmerican Journal of Epidemiology\u003c/i\u003e, vol. 114, no. 5, pp. 632–648, 1981. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue.%20Molecular%20epidemiology%20in%20infectious%20disease\u0026author=S. B. Halstead\u0026publication_year=1981\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B72\"\u003eD. M. Morens, “Antibody-dependent enhancement of infection and the pathogenesis of viral disease,” \u003ci\u003eClinical Infectious Diseases\u003c/i\u003e, vol. 19, no. 3, pp. 500–512, 1994. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antibody-dependent%20enhancement%20of%20infection%20and%20the%20pathogenesis%20of%20viral%20disease\u0026author=D. M. Morens\u0026publication_year=1994\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B73\"\u003eB. J. Mady, D. V. Erbe, I. Kurane, M. W. Fanger, and F. A. Ennis, “Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc\u003ci\u003e\u0026#x3b3;\u003c/i\u003e receptors,” \u003ci\u003eJournal of Immunology\u003c/i\u003e, vol. 147, no. 9, pp. 3139–3144, 1991. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antibody-dependent%20enhancement%20of%20dengue%20virus%20infection%20mediated%20by%20bispecific%20antibodies%20against%20cell%20surface%20molecules%20other%20than%20Fc\u003ci\u003eγ\u003c/i\u003e%20receptors\u0026author=B. J. Mady\u0026author=D. V. Erbe\u0026author=I. Kurane\u0026author=M. W. Fanger\u0026author=\u0026author=F. A. Ennis\u0026publication_year=1991\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B74\"\u003eI. Kurane, B. J. Mady, and F. A. Ennis, “Antibody-dependent enhancement of dengue virus infection,” \u003ci\u003eReviews in Medical Virology\u003c/i\u003e, vol. 1, no. 4, pp. 211–221, 1991. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antibody-dependent%20enhancement%20of%20dengue%20virus%20infection\u0026author=I. Kurane\u0026author=B. J. Mady\u0026author=\u0026author=F. A. Ennis\u0026publication_year=1991\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B75\"\u003eS. Halstead, \u003ci\u003eAntibody-Dependent Enhancement of Infection: a mechanism for Indirect Virus Entry into Cells. Cellular Receptors for Animal Viruses\u003c/i\u003e, Harbor Laboraty Press, Cold Spring Harbor, NY, USA, 1994. \u003cspan class=\"reflinks\"\u003e\u003c/span\u003e\u003cli id=\"B76\"\u003eA. B. Sabin and R. Walter Schlesinger, “Production of immunity to dengue with virus modified by propagation in mice1,” \u003ci\u003eScience\u003c/i\u003e, vol. 101, no. 2634, pp. 640–642, 1945. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Production%20of%20immunity%20to%20dengue%20with%20virus%20modified%20by%20propagation%20in%20mice1\u0026author=A. B. Sabin \u0026author=R. Walter Schlesinger\u0026publication_year=1945\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B77\"\u003eT. Chareonsirisuthigul, S. Kalayanarooj, and S. Ubol, “Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells,” \u003ci\u003eJournal of General Virology\u003c/i\u003e, vol. 88, no. 2, pp. 365–375, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1099/vir.0.82537-0\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20(DENV)%20antibody-dependent%20enhancement%20of%20infection%20upregulates%20the%20production%20of%20anti-inflammatory%20cytokines,%20but%20suppresses%20anti-DENV%20free%20radical%20and%20pro-inflammatory%20cytokine%20production,%20in%20THP-1%20cells\u0026author=T. Chareonsirisuthigul\u0026author=S. Kalayanarooj\u0026author=\u0026author=S. Ubol\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B78\"\u003eS. Ubol, T. Chareonsirisuthigul, J. Kasisith, and C. Klungthong, “Clinical isolates of dengue virus with distinctive susceptibility to nitric oxide radical induce differential gene responses in THP-1 cells,” \u003ci\u003eVirology\u003c/i\u003e, vol. 376, no. 2, pp. 290–296, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virol.2008.03.030\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Clinical%20isolates%20of%20dengue%20virus%20with%20distinctive%20susceptibility%20to%20nitric%20oxide%20radical%20induce%20differential%20gene%20responses%20in%20THP-1%20cells\u0026author=S. Ubol\u0026author=T. Chareonsirisuthigul\u0026author=J. Kasisith\u0026author=\u0026author=C. Klungthong\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B79\"\u003eR. Cologna, P. M. Armstrong, and R. Rico-Hesse, “Selection for virulent dengue viruses occurs in humans and mosquitoes,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 79, no. 2, pp. 853–859, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.79.2.853-859.2005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Selection%20for%20virulent%20dengue%20viruses%20occurs%20in%20humans%20and%20mosquitoes\u0026author=R. Cologna\u0026author=P. M. Armstrong\u0026author=\u0026author=R. Rico-Hesse\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B80\"\u003eM. G. Guzman, V. Deubel, J. L. Pelegrino et al., “Partial nucleotide and amino acid sequences of the envelope and the envelope/nonstructural protein-1 gene junction of four dengue-2 virus strains isolated during the 1981 Cuban epidemic,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 52, no. 3, pp. 241–246, 1995. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Partial%20nucleotide%20and%20amino%20acid%20sequences%20of%20the%20envelope%20and%20the%20envelope/nonstructural%20protein-1%20gene%20junction%20of%20four%20dengue-2%20virus%20strains%20isolated%20during%20the%201981%20Cuban%20epidemic\u0026author=M. G. Guzman\u0026author=V. Deubel\u0026author=J. L. Pelegrino et al.\u0026publication_year=1995\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B81\"\u003eT. J. Kochel, D. M. Watts, S. B. Halstead et al., “Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever,” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 360, no. 9329, pp. 310–312, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0140-6736(02)09522-3\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effect%20of%20dengue-1%20antibodies%20on%20American%20dengue-2%20viral%20infection%20and%20dengue%20haemorrhagic%20fever\u0026author=T. J. Kochel\u0026author=D. M. Watts\u0026author=S. B. Halstead et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B82\"\u003eD. M. Watts, K. R. Porter, P. Putvatana et al., “Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever,” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 354, no. 9188, pp. 1431–1434, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0140-6736(99)04015-5\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Failure%20of%20secondary%20infection%20with%20American%20genotype%20dengue%202%20to%20cause%20dengue%20haemorrhagic%20fever\u0026author=D. M. Watts\u0026author=K. R. Porter\u0026author=P. Putvatana et al.\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B83\"\u003eR. Rico-Hesse, L. M. Harrison, R. A. Salas et al., “Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas,” \u003ci\u003eVirology\u003c/i\u003e, vol. 230, no. 2, pp. 244–251, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1006/viro.1997.8504\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Origins%20of%20dengue%20type%202%20viruses%20associated%20with%20increased%20pathogenicity%20in%20the%20Americas\u0026author=R. Rico-Hesse\u0026author=L. M. Harrison\u0026author=R. A. Salas et al.\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B84\"\u003eK. C. Leitmeyer, D. W. Vaughn, D. M. Watts et al., “Dengue virus structural differences that correlate with pathogenesis,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 73, no. 6, pp. 4738–4747, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20structural%20differences%20that%20correlate%20with%20pathogenesis\u0026author=K. C. Leitmeyer\u0026author=D. W. Vaughn\u0026author=D. M. Watts et al.\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B85\"\u003eD. Gonz\u0026#xe1;lez, O. E. Castro, G. Kour\u0026#xed; et al., “Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002,” \u003ci\u003eInternational Journal of Infectious Diseases\u003c/i\u003e, vol. 9, no. 5, pp. 280–285, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ijid.2004.07.012\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Classical%20dengue%20hemorrhagic%20fever%20resulting%20from%20two%20dengue%20infections%20spaced%2020%20years%20or%20more%20apart:%20Havana,%20Dengue%203%20epidemic,%202001-2002\u0026author=D. González\u0026author=O. E. Castro\u0026author=G. Kourí et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B86\"\u003eD. Limonta, D. Gonz\u0026#xe1;lez, V. Cap\u0026#xf3; et al., “Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic,” \u003ci\u003eInternational Journal of Infectious Diseases\u003c/i\u003e, vol. 13, no. 2, pp. e77–e78, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ijid.2008.06.028\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Fatal%20severe%20dengue%20and%20cell%20death%20in%20sickle%20cell%20disease%20during%20the%202001-2002%20Havana%20dengue%20epidemic\u0026author=D. Limonta\u0026author=D. González\u0026author=V. Capó et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B87\"\u003eM.-S. Lee, K.-P. Hwang, T.-C. Chen, P.-L. Lu, and T.-P. Chen, “Clinical characteristics of dengue and dengue hemorrhagic fever in a medical center of southern Taiwan during the 2002 epidemic,” \u003ci\u003eJournal of Microbiology, Immunology and Infection\u003c/i\u003e, vol. 39, no. 2, pp. 121–129, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Clinical%20characteristics%20of%20dengue%20and%20dengue%20hemorrhagic%20fever%20in%20a%20medical%20center%20of%20southern%20Taiwan%20during%20the%202002%20epidemic\u0026author=M.-S. Lee\u0026author=K.-P. Hwang\u0026author=T.-C. Chen\u0026author=P.-L. Lu\u0026author=\u0026author=T.-P. Chen\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B88\"\u003eB. Sierra, R. Alegre, A. B. P\u0026#xe9;rez et al., “HLA-A, -B, -C, and -DRB1 allele frequencies in Cuban individuals with antecedents of dengue 2 disease: advantages of the Cuban population for HLA studies of dengue virus infection,” \u003ci\u003eHuman Immunology\u003c/i\u003e, vol. 68, no. 6, pp. 531–540, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.humimm.2007.03.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=HLA-A,%20-B,%20-C,%20and%20-DRB1%20allele%20frequencies%20in%20Cuban%20individuals%20with%20antecedents%20of%20dengue%202%20disease:%20advantages%20of%20the%20Cuban%20population%20for%20HLA%20studies%20of%20dengue%20virus%20infection\u0026author=B. Sierra\u0026author=R. Alegre\u0026author=A. B. Pérez et al.\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B89\"\u003eC. LaFleur, J. Granados, G. Vargas-Alarcon et al., “HLA-DR antigen frequencies in Mexican patients with dengue virus infection: HLA-DR4 as a possible genetic resistance factor for dengue hemorrhagic fever,” \u003ci\u003eHuman Immunology\u003c/i\u003e, vol. 63, no. 11, pp. 1039–1044, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0198-8859(02)00682-1\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=HLA-DR%20antigen%20frequencies%20in%20Mexican%20patients%20with%20dengue%20virus%20infection:%20HLA-DR4%20as%20a%20possible%20genetic%20resistance%20factor%20for%20dengue%20hemorrhagic%20fever\u0026author=C. LaFleur\u0026author=J. Granados\u0026author=G. Vargas-Alarcon et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B90\"\u003eH. A. F. Stephens, R. Klaythong, M. Sirikong et al., “HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais,” \u003ci\u003eTissue Antigens\u003c/i\u003e, vol. 60, no. 4, pp. 309–318, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1034/j.1399-0039.2002.600405.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=HLA-A%20and%20-B%20allele%20associations%20with%20secondary%20dengue%20virus%20infections%20correlate%20with%20disease%20severity%20and%20the%20infecting%20viral%20serotype%20in%20ethnic%20Thais\u0026author=H. A. F. Stephens\u0026author=R. Klaythong\u0026author=M. Sirikong et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B91\"\u003eM. L. Paradoa P\u0026#xe9;rez, Y. Trujillo, and P. Basanta, “Association of dengue hemorrhagic fever with the HLA system,” \u003ci\u003eHaematologia\u003c/i\u003e, vol. 20, no. 2, pp. 83–87, 1987. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Association%20of%20dengue%20hemorrhagic%20fever%20with%20the%20HLA%20system\u0026author=M. L. Paradoa Pérez\u0026author=Y. Trujillo\u0026author=\u0026author=P. Basanta\u0026publication_year=1987\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B92\"\u003eU. C. Chaturvedi, R. Nagar, and R. Shrivastava, “Dengue and dengue haemorrhagic fever: implications of host genetics,” \u003ci\u003eFEMS Immunology and Medical Microbiology\u003c/i\u003e, vol. 47, no. 2, pp. 155–166, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1574-695X.2006.00058.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20and%20dengue%20haemorrhagic%20fever:%20implications%20of%20host%20genetics\u0026author=U. C. Chaturvedi\u0026author=R. Nagar\u0026author=\u0026author=R. Shrivastava\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B93\"\u003eG. Garc\u0026#xed;a, B. Sierra, A. B. P\u0026#xe9;rez et al., “Asymptomatic dengue infection in a cuban population confirms the protective role of the RR variant of the Fc\u003ci\u003e\u0026#x3b3;\u003c/i\u003eRIIa polymorphism,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 82, no. 6, pp. 1153–1156, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4269/ajtmh.2010.09-0353\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Asymptomatic%20dengue%20infection%20in%20a%20cuban%20population%20confirms%20the%20protective%20role%20of%20the%20RR%20variant%20of%20the%20Fc\u003ci\u003eγ\u003c/i\u003eRIIa%20polymorphism\u0026author=G. García\u0026author=B. Sierra\u0026author=A. B. Pérez et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B94\"\u003eJ. Mongkolsapaya, T. Duangchinda, W. Dejnirattisai et al., “T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?” \u003ci\u003eJournal of Immunology\u003c/i\u003e, vol. 176, no. 6, pp. 3821–3829, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=T%20cell%20responses%20in%20dengue%20hemorrhagic%20fever:%20are%20cross-reactive%20T%20cells%20suboptimal?\u0026author=J. Mongkolsapaya\u0026author=T. Duangchinda\u0026author=W. Dejnirattisai et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B95\"\u003eK. Clyde, J. L. Kyle, and E. Harris, “Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 80, no. 23, pp. 11418–11431, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.01257-06\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20deciphering%20viral%20and%20host%20determinants%20of%20dengue%20virus%20replication%20and%20pathogenesis\u0026author=K. Clyde\u0026author=J. L. Kyle\u0026author=\u0026author=E. Harris\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B96\"\u003eB. Sierra, A. B. Perez, K. Vogt et al., “Secondary heterologous dengue infection risk: disequilibrium between immune regulation and inflammation?” \u003ci\u003eCellular Immunology\u003c/i\u003e, vol. 262, no. 2, pp. 134–140, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.cellimm.2010.02.005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Secondary%20heterologous%20dengue%20infection%20risk:%20disequilibrium%20between%20immune%20regulation%20and%20inflammation?\u0026author=B. Sierra\u0026author=A. B. Perez\u0026author=K. Vogt et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B97\"\u003eJ. Whitehorn and C. P. Simmons, “The pathogenesis of dengue,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 29, no. 42, pp. 7221–7228, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2011.07.022\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20pathogenesis%20of%20dengue\u0026author=J. Whitehorn \u0026author=C. P. Simmons\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B98\"\u003eP. Avirutnan, N. Punyadee, S. Noisakran et al., “Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement,” \u003ci\u003eJournal of Infectious Diseases\u003c/i\u003e, vol. 193, no. 8, pp. 1078–1088, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1086/500949\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Vascular%20leakage%20in%20severe%20dengue%20virus%20infections:%20a%20potential%20role%20for%20the%20nonstructural%20viral%20protein%20NS1%20and%20complement\u0026author=P. Avirutnan\u0026author=N. Punyadee\u0026author=S. Noisakran et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B99\"\u003eC.-F. Lin, S.-W. Wan, M.-C. Chen et al., “Liver injury caused by antibodies against dengue virus nonstructural protein 1 in a murine model,” \u003ci\u003eLaboratory Investigation\u003c/i\u003e, vol. 88, no. 10, pp. 1079–1089, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/labinvest.2008.70\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Liver%20injury%20caused%20by%20antibodies%20against%20dengue%20virus%20nonstructural%20protein%201%20in%20a%20murine%20model\u0026author=C.-F. Lin\u0026author=S.-W. Wan\u0026author=M.-C. Chen et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B100\"\u003eH.-J. Cheng, C.-F. Lin, H.-Y. Lei et al., “Proteomic analysis of endothelial cell autoantigens recognized by anti-dengue virus nonstructural protein 1 antibodies,” \u003ci\u003eExperimental Biology and Medicine\u003c/i\u003e, vol. 234, no. 1, pp. 63–73, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3181/0805-RM-147\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Proteomic%20analysis%20of%20endothelial%20cell%20autoantigens%20recognized%20by%20anti-dengue%20virus%20nonstructural%20protein%201%20antibodies\u0026author=H.-J. Cheng\u0026author=C.-F. Lin\u0026author=H.-Y. Lei et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B101\"\u003eC.-F. Lin, S.-W. Wan, H.-J. Cheng, H.-Y. Lei, and Y.-S. Lin, “Autoimmune pathogenesis in dengue virus infection,” \u003ci\u003eViral Immunology\u003c/i\u003e, vol. 19, no. 2, pp. 127–132, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/vim.2006.19.127\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Autoimmune%20pathogenesis%20in%20dengue%20virus%20infection\u0026author=C.-F. Lin\u0026author=S.-W. Wan\u0026author=H.-J. Cheng\u0026author=H.-Y. Lei\u0026author=\u0026author=Y.-S. Lin\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B102\"\u003eM. G. Brown, Y. Y. Huang, J. S. Marshall, C. A. King, D. W. Hoskin, and R. Anderson, “Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells,” \u003ci\u003eJournal of Leukocyte Biology\u003c/i\u003e, vol. 85, no. 1, pp. 71–80, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1189/jlb.0308167\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dramatic%20caspase-dependent%20apoptosis%20in%20antibody-enhanced%20dengue%20virus%20infection%20of%20human%20mast%20cells\u0026author=M. G. Brown\u0026author=Y. Y. Huang\u0026author=J. S. Marshall\u0026author=C. A. King\u0026author=D. W. Hoskin\u0026author=\u0026author=R. Anderson\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B103\"\u003eM. G. Brown, C. A. King, C. Sherren, J. S. Marshall, and R. Anderson, “A dominant role for Fc\u003ci\u003e\u0026#x3b3;\u003c/i\u003eRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release,” \u003ci\u003eJournal of Leukocyte Biology\u003c/i\u003e, vol. 80, no. 6, pp. 1242–1250, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1189/jlb.0805441\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20dominant%20role%20for%20Fc\u003ci\u003eγ\u003c/i\u003eRII%20in%20antibody-enhanced%20dengue%20virus%20infection%20of%20human%20mast%20cells%20and%20associated%20CCL5%20release\u0026author=M. G. Brown\u0026author=C. A. King\u0026author=C. Sherren\u0026author=J. S. Marshall\u0026author=\u0026author=R. Anderson\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B104\"\u003eA. K. I. Falconar, “The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesin proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis,” \u003ci\u003eArchives of Virology\u003c/i\u003e, vol. 142, no. 5, pp. 897–916, 1997. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s007050050127\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20dengue%20virus%20nonstructural-1%20protein%20(NS1)%20generates%20antibodies%20to%20common%20epitopes%20on%20human%20blood%20clotting,%20integrin/adhesin%20proteins%20and%20binds%20to%20human%20endothelial%20cells:%20potential%20implications%20in%20haemorrhagic%20fever%20pathogenesis\u0026author=A. K. I. Falconar\u0026publication_year=1997\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B105\"\u003eD. T. Tam, T. V. Ngoc, N. T. Tien et al., “Effects of short-course oral corticosteroid therapy in early dengue infection in Vietnamese patients: a randomized, placebo-controlled trial,” \u003ci\u003eClinical Infectious Diseases\u003c/i\u003e, vol. 55, no. 9, pp. 1216–1224, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/cid/cis655\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effects%20of%20short-course%20oral%20corticosteroid%20therapy%20in%20early%20dengue%20infection%20in%20Vietnamese%20patients:%20a%20randomized,%20placebo-controlled%20trial\u0026author=D. T. Tam\u0026author=T. V. Ngoc\u0026author=N. T. Tien et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B106\"\u003eS.-W. Lin, Y.-C. Chuang, Y.-S. Lin, H.-Y. Lei, H.-S. Liu, and T.-M. Yeh, “Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation,” \u003ci\u003eJournal of Infection\u003c/i\u003e, vol. 64, no. 3, pp. 325–334, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.jinf.2011.11.023\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20nonstructural%20protein%20NS1%20binds%20to%20prothrombin/thrombin%20and%20inhibits%20prothrombin%20activation\u0026author=S.-W. Lin\u0026author=Y.-C. Chuang\u0026author=Y.-S. Lin\u0026author=H.-Y. Lei\u0026author=H.-S. Liu\u0026author=\u0026author=T.-M. Yeh\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B107\"\u003eS. B. Halstead, “Dengue vascular permeability syndrome: what, no T cells?” \u003ci\u003eClinical Infectious Diseases\u003c/i\u003e, vol. 56, no. 6, pp. 900–901, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/cid/cis1047\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20vascular%20permeability%20syndrome:%20what,%20no%20T%20cells?\u0026author=S. B. Halstead\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B108\"\u003eD. H. Libraty, P. R. Young, D. Pickering et al., “High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever,” \u003ci\u003eJournal of Infectious Diseases\u003c/i\u003e, vol. 186, no. 8, pp. 1165–1168, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1086/343813\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=High%20circulating%20levels%20of%20the%20dengue%20virus%20nonstructural%20protein%20NS1%20early%20in%20dengue%20illness%20correlate%20with%20the%20development%20of%20dengue%20hemorrhagic%20fever\u0026author=D. H. Libraty\u0026author=P. R. Young\u0026author=D. Pickering et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B109\"\u003eH. T. L. Duyen, T. V. Ngoc, D. T. Ha et al., “Kinetics of plasma viremia and soluble nonstructural protein 1 concentrations in dengue: differential effects according to serotype and immune status,” \u003ci\u003eJournal of Infectious Diseases\u003c/i\u003e, vol. 203, no. 9, pp. 1292–1300, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/infdis/jir014\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Kinetics%20of%20plasma%20viremia%20and%20soluble%20nonstructural%20protein%201%20concentrations%20in%20dengue:%20differential%20effects%20according%20to%20serotype%20and%20immune%20status\u0026author=H. T. L. Duyen\u0026author=T. V. Ngoc\u0026author=D. T. Ha et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B110\"\u003eV. Tricou, N. N. Minh, J. Farrar, H. T. Tran, and C. P. Simmons, “Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue,” \u003ci\u003ePLoS Neglected Tropical Diseases\u003c/i\u003e, vol. 5, no. 9, Article ID e1309, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0001309\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Kinetics%20of%20viremia%20and%20NS1%20antigenemia%20are%20shaped%20by%20immune%20status%20and%20virus%20serotype%20in%20adults%20with%20dengue\u0026author=V. Tricou\u0026author=N. N. Minh\u0026author=J. Farrar\u0026author=H. T. Tran\u0026author=\u0026author=C. P. Simmons\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B111\"\u003eS. I. de la Cruz-Hernandez, H. Flores-Aguilar, S. Gonzalez-Mateos et al., “Determination of viremia and concentration of circulating nonstructural protein 1 in patients infected with dengue virus in Mexico,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 88, no. 3, pp. 446–454, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4269/ajtmh.12-0023\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Determination%20of%20viremia%20and%20concentration%20of%20circulating%20nonstructural%20protein%201%20in%20patients%20infected%20with%20dengue%20virus%20in%20Mexico\u0026author=S. I. de la Cruz-Hernandez\u0026author=H. Flores-Aguilar\u0026author=S. Gonzalez-Mateos et al.\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B112\"\u003eA. Fox, L. N. M. Hoa, C. P. Simmons et al., “Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam,” \u003ci\u003ePLoS Neglected Tropical Diseases\u003c/i\u003e, vol. 5, no. 3, article e967, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0000967\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Immunological%20and%20viral%20determinants%20of%20dengue%20severity%20in%20hospitalized%20adults%20in%20Ha%20Noi,%20Viet%20Nam\u0026author=A. Fox\u0026author=L. N. M. Hoa\u0026author=C. P. Simmons et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B113\"\u003eG. P. Kouri, M. G. Guzm\u0026#xe1;n, and J. R. Bravo, “Why dengue haemorrhagic fever in Cuba? 2. An integral analysis,” \u003ci\u003eTransactions of the Royal Society of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 81, no. 5, pp. 821–823, 1987. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Why%20dengue%20haemorrhagic%20fever%20in%20Cuba?%202.%20An%20integral%20analysis\u0026author=G. P. Kouri\u0026author=M. G. Guzmán\u0026author=\u0026author=J. R. Bravo\u0026publication_year=1987\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B114\"\u003eJ. L. Kyle and E. Harris, “Global spread and persistence of dengue,” \u003ci\u003eAnnual Review of Microbiology\u003c/i\u003e, vol. 62, pp. 71–92, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1146/annurev.micro.62.081307.163005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Global%20spread%20and%20persistence%20of%20dengue\u0026author=J. L. Kyle \u0026author=E. Harris\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B115\"\u003eP. Mas Lago, “Dengue fever in Cuba in 1977: some laboratory aspects,” \u003ci\u003ePAHO Scientific Publication\u003c/i\u003e, vol. 375, pp. 40–43, 1979. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20fever%20in%20Cuba%20in%201977:%20some%20laboratory%20aspects\u0026author=P. Mas Lago\u0026publication_year=1979\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B116\"\u003eP. Mas Lago, R. Palomera, and M. Jacobo, “Dengue: some epidemiologic aspects,” \u003ci\u003eRevista Cubana de Medicina Tropical\u003c/i\u003e, vol. 22, no. 6, 1983. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue:%20some%20epidemiologic%20aspects\u0026author=P. Mas Lago\u0026author=R. Palomera\u0026author=\u0026author=M. Jacobo\u0026publication_year=1983\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B117\"\u003eN. Cantelar de Francisco, A. Fern\u0026#xe1;ndez, L. Albert Molina, and E. P\u0026#xe9;rez Balbis, “Survey of dengue in Cuba. 1978-1979,” \u003ci\u003eRevista Cubana de Medicina Tropical\u003c/i\u003e, vol. 33, no. 1, pp. 72–78, 1981. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Survey%20of%20dengue%20in%20Cuba.%201978-1979\u0026author=N. Cantelar de Francisco\u0026author=A. Fernández\u0026author=L. Albert Molina\u0026author=\u0026author=E. Pérez Balbis\u0026publication_year=1981\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B118\"\u003eS. B. Halstead, S. Nimmannitya, and S. N. Cohen, “Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered,” \u003ci\u003eYale Journal of Biology and Medicine\u003c/i\u003e, vol. 42, no. 5, pp. 311–328, 1970. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Observations%20related%20to%20pathogenesis%20of%20dengue%20hemorrhagic%20fever.%20IV.%20Relation%20of%20disease%20severity%20to%20antibody%20response%20and%20virus%20recovered\u0026author=S. B. Halstead\u0026author=S. Nimmannitya\u0026author=\u0026author=S. N. Cohen\u0026publication_year=1970\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B119\"\u003eM. G. Guzm\u0026#xe1;n, G. Kouri, J. Bravo, M. Soler, and E. Mart\u0026#xed;nez, “Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic,” \u003ci\u003eMemorias do Instituto Oswaldo Cruz\u003c/i\u003e, vol. 86, no. 3, p. 367, 1991. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Sequential%20infection%20as%20risk%20factor%20for%20dengue%20hemorrhagic%20fever/dengue%20shock%20syndrome%20(DHF/DSS)%20during%20the%201981%20dengue%20hemorrhagic%20Cuban%20epidemic\u0026author=M. G. Guzmán\u0026author=G. Kouri\u0026author=J. Bravo\u0026author=M. Soler\u0026author=\u0026author=E. Martínez\u0026publication_year=1991\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B120\"\u003eG. Kour\u0026#xed;, M. G. Guzm\u0026#xe1;n, L. Vald\u0026#xe9;s et al., “Reemergence of dengue in Cuba: a 1997 epidemic in Santiago de Cuba,” \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 4, no. 1, pp. 89–92, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Reemergence%20of%20dengue%20in%20Cuba:%20a%201997%20epidemic%20in%20Santiago%20de%20Cuba\u0026author=G. Kourí\u0026author=M. G. Guzmán\u0026author=L. Valdés et al.\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B121\"\u003eM. G. Guzm\u0026#xe1;n, G. Kour\u0026#xed;, L. Vald\u0026#xe9;s, J. Bravo, S. V\u0026#xe1;zquez, and S. B. Halstead, “Enhanced severity of secondary dengue-2 infections: death rates in 1981 and 1997 Cuban outbreaks,” \u003ci\u003eRevista Panamericana de Salud Publica\u003c/i\u003e, vol. 11, no. 4, pp. 223–227, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Enhanced%20severity%20of%20secondary%20dengue-2%20infections:%20death%20rates%20in%201981%20and%201997%20Cuban%20outbreaks\u0026author=M. G. Guzmán\u0026author=G. Kourí\u0026author=L. Valdés\u0026author=J. Bravo\u0026author=S. Vázquez\u0026author=\u0026author=S. B. Halstead\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B122\"\u003eO. Pel\u0026#xe1;ez, M. G. Guzm\u0026#xe1;n, G. Kouri et al., “Dengue 3 epidemic, Havana, 2001,” \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 10, no. 4, pp. 719–722, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3201/eid1004.030271\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%203%20epidemic,%20Havana,%202001\u0026author=O. Peláez\u0026author=M. G. Guzmán\u0026author=G. Kouri et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B123\"\u003eM. \u0026#xc1;lvarez, A. Pav\u0026#xf3;n-Oro, S. V\u0026#xe1;zquez, L. Morier, \u0026#xc1;. M. \u0026#xc1;lvarez, and M. G. Guzm\u0026#xe1;n, “Viral infection sequences related to dengue fever in dengue 3 epidemics occurred in the City of Havana, 2001-2002,” \u003ci\u003eRevista Cubana de Medicina Tropical\u003c/i\u003e, vol. 60, no. 1, pp. 18–23, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Viral%20infection%20sequences%20related%20to%20dengue%20fever%20in%20dengue%203%20epidemics%20occurred%20in%20the%20City%20of%20Havana,%202001-2002\u0026author=M. Álvarez\u0026author=A. Pavón-Oro\u0026author=S. Vázquez\u0026author=L. Morier\u0026author=Á. M. Álvarez\u0026author=\u0026author=M. G. Guzmán\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B124\"\u003eM. Alvarez, A. Pavon-Oro, R. Rodriguez-Roche et al., “Neutralizing antibody response variation against dengue 3 strains,” \u003ci\u003eJournal of Medical Virology\u003c/i\u003e, vol. 80, no. 10, pp. 1783–1789, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1002/jmv.21234\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibody%20response%20variation%20against%20dengue%203%20strains\u0026author=M. Alvarez\u0026author=A. Pavon-Oro\u0026author=R. Rodriguez-Roche et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B125\"\u003eR. Rodriguez-Roche, M. Alvarez, E. C. Holmes et al., “Dengue virus type 3, Cuba, 2000\u0026#x2013;2002,” \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 11, no. 5, pp. 773–774, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%203,%20Cuba,%202000–2002\u0026author=R. Rodriguez-Roche\u0026author=M. Alvarez\u0026author=E. C. Holmes et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B126\"\u003eR. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Dengue virus type 2 in Cuba, 1997: conservation of E gene sequence in isolates obtained at different times during the epidemic,” \u003ci\u003eArchives of Virology\u003c/i\u003e, vol. 150, no. 3, pp. 415–425, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s00705-004-0445-1\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%202%20in%20Cuba,%201997:%20conservation%20of%20E%20gene%20sequence%20in%20isolates%20obtained%20at%20different%20times%20during%20the%20epidemic\u0026author=R. Rodriguez-Roche\u0026author=M. Alvarez\u0026author=T. Gritsun et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B127\"\u003eA. B. Sabin, “Research on dengue during World War II,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 1, no. 1, pp. 30–50, 1952. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Research%20on%20dengue%20during%20World%20War%20II\u0026author=A. B. Sabin\u0026publication_year=1952\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B128\"\u003eM. G. Guzman, M. Alvarez, R. Rodriguez-Roche et al., “Neutralizing antibodies after infection with dengue 1 virus,” \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 13, no. 2, pp. 282–286, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Neutralizing%20antibodies%20after%20infection%20with%20dengue%201%20virus\u0026author=M. G. Guzman\u0026author=M. Alvarez\u0026author=R. Rodriguez-Roche et al.\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B129\"\u003eM. G. Guzm\u0026#xe1;n, G. Kour\u0026#xed;, and S. B. Halstead, “Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics?” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 355, no. 9218, pp. 1902–1903, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Do%20escape%20mutants%20explain%20rapid%20increases%20in%20dengue%20case-fatality%20rates%20within%20epidemics?\u0026author=M. G. Guzmán\u0026author=G. Kourí\u0026author=\u0026author=S. B. Halstead\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B130\"\u003eR. Rodriguez-Roche, M. Alvarez, T. Gritsun et al., “Virus evolution during a severe dengue epidemic in Cuba, 1997,” \u003ci\u003eVirology\u003c/i\u003e, vol. 334, no. 2, pp. 154–159, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virol.2005.01.037\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Virus%20evolution%20during%20a%20severe%20dengue%20epidemic%20in%20Cuba,%201997\u0026author=R. Rodriguez-Roche\u0026author=M. Alvarez\u0026author=T. Gritsun et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B131\"\u003eJ. Mongkolsapaya, W. Dejnirattisai, X.-N. Xu et al., “Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever,” \u003ci\u003eNature Medicine\u003c/i\u003e, vol. 9, no. 7, pp. 921–927, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/nm887\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Original%20antigenic%20sin%20and%20apoptosis%20in%20the%20pathogenesis%20of%20dengue%20hemorrhagic%20fever\u0026author=J. Mongkolsapaya\u0026author=W. Dejnirattisai\u0026author=X.-N. Xu et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B132\"\u003eS. N. Bennett, E. C. Holmes, M. Chirivella et al., “Selection-driven evolution of emergent dengue virus,” \u003ci\u003eMolecular Biology and Evolution\u003c/i\u003e, vol. 20, no. 10, pp. 1650–1658, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/molbev/msg182\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Selection-driven%20evolution%20of%20emergent%20dengue%20virus\u0026author=S. N. Bennett\u0026author=E. C. Holmes\u0026author=M. Chirivella et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B133\"\u003eC. Klungthong, C. Zhang, M. P. Mammen Jr., S. Ubol, and E. C. Holmes, “The molecular epidemiology of dengue virus serotype 4 in Bangkok, Thailand,” \u003ci\u003eVirology\u003c/i\u003e, vol. 329, no. 1, pp. 168–179, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virol.2004.08.003\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20molecular%20epidemiology%20of%20dengue%20virus%20serotype%204%20in%20Bangkok,%20Thailand\u0026author=C. Klungthong\u0026author=C. Zhang\u0026author=M. P. Mammen Jr.\u0026author=S. Ubol\u0026author=\u0026author=E. C. Holmes\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B134\"\u003eH.-L. Chen, S.-R. Lin, H.-F. Liu, C.-C. King, S.-C. Hsieh, and W.-K. Wang, “Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in Southern Taiwan in 2001-2002,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 79, no. 4, pp. 495–504, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Evolution%20of%20dengue%20virus%20type%202%20during%20two%20consecutive%20outbreaks%20with%20an%20increase%20in%20severity%20in%20Southern%20Taiwan%20in%202001-2002\u0026author=H.-L. Chen\u0026author=S.-R. Lin\u0026author=H.-F. Liu\u0026author=C.-C. King\u0026author=S.-C. Hsieh\u0026author=\u0026author=W.-K. Wang\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B135\"\u003eY. Tang, P. Rodpradit, P. Chinnawirotpisan et al., “Comparative analysis of full-length genomic sequences of 10 dengue serotype 1 viruses associated with different genotypes, epidemics, and disease severity isolated in Thailand over 22 years,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 83, no. 5, pp. 1156–1165, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4269/ajtmh.2010.10-0052\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Comparative%20analysis%20of%20full-length%20genomic%20sequences%20of%2010%20dengue%20serotype%201%20viruses%20associated%20with%20different%20genotypes,%20epidemics,%20and%20disease%20severity%20isolated%20in%20Thailand%20over%2022%20years\u0026author=Y. Tang\u0026author=P. Rodpradit\u0026author=P. Chinnawirotpisan et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B136\"\u003eR. Zhao, P. Chinnawirotpisan, C. Klungthong, C. Zhang, and R. Putnak, “Evidence for inter- and intra-genotypic variations in dengue serotype 4 viruses representing predominant and non-predominant genotypes co-circulating in Thailand from 1977 to 2001,” \u003ci\u003eVirus Genes\u003c/i\u003e, vol. 41, no. 1, pp. 5–13, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s11262-010-0473-8\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Evidence%20for%20inter-%20and%20intra-genotypic%20variations%20in%20dengue%20serotype%204%20viruses%20representing%20predominant%20and%20non-predominant%20genotypes%20co-circulating%20in%20Thailand%20from%201977%20to%202001\u0026author=R. Zhao\u0026author=P. Chinnawirotpisan\u0026author=C. Klungthong\u0026author=C. Zhang\u0026author=\u0026author=R. Putnak\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B137\"\u003eR. Rico-Hesse, “Dengue virus evolution and virulence models,” \u003ci\u003eClinical Infectious Diseases\u003c/i\u003e, vol. 44, no. 11, pp. 1462–1466, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1086/517587\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20evolution%20and%20virulence%20models\u0026author=R. Rico-Hesse\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B138\"\u003eA. Steel, D. J. Gubler, and S. N. Bennett, “Natural attenuation of dengue virus type-2 after a series of island outbreaks: a retrospective phylogenetic study of events in the South Pacific three decades ago,” \u003ci\u003eVirology\u003c/i\u003e, vol. 405, no. 2, pp. 505–512, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virol.2010.05.033\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Natural%20attenuation%20of%20dengue%20virus%20type-2%20after%20a%20series%20of%20island%20outbreaks:%20a%20retrospective%20phylogenetic%20study%20of%20events%20in%20the%20South%20Pacific%20three%20decades%20ago\u0026author=A. Steel\u0026author=D. J. Gubler\u0026author=\u0026author=S. N. Bennett\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B139\"\u003eR. Rodriguez-Roche, E. Villegas, S. Cook et al., “Population structure of the dengue viruses, Aragua, Venezuela, 2006-2007. Insights into dengue evolution under hyperendemic transmission,” \u003ci\u003eInfection, Genetics and Evolution\u003c/i\u003e, vol. 12, no. 2, pp. 332–344, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.meegid.2011.12.005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Population%20structure%20of%20the%20dengue%20viruses,%20Aragua,%20Venezuela,%202006-2007.%20Insights%20into%20dengue%20evolution%20under%20hyperendemic%20transmission\u0026author=R. Rodriguez-Roche\u0026author=E. Villegas\u0026author=S. Cook et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B140\"\u003eT. J. Chambers, D. W. McCourt, and C. M. Rice, “Yellow fever virus proteins NS2A, NS2B, and NS4B: identification and partial N-terminal amino acid sequence analysis,” \u003ci\u003eVirology\u003c/i\u003e, vol. 169, no. 1, pp. 100–109, 1989. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Yellow%20fever%20virus%20proteins%20NS2A,%20NS2B,%20and%20NS4B:%20identification%20and%20partial%20N-terminal%20amino%20acid%20sequence%20analysis\u0026author=T. J. Chambers\u0026author=D. W. McCourt\u0026author=\u0026author=C. M. Rice\u0026publication_year=1989\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B141\"\u003eJ. M. MacKenzie, A. A. Khromykh, M. K. Jones, and E. G. Westaway, “Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A,” \u003ci\u003eVirology\u003c/i\u003e, vol. 245, no. 2, pp. 203–215, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1006/viro.1998.9156\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Subcellular%20localization%20and%20some%20biochemical%20properties%20of%20the%20flavivirus%20Kunjin%20nonstructural%20proteins%20NS2A%20and%20NS4A\u0026author=J. M. MacKenzie\u0026author=A. A. Khromykh\u0026author=M. K. Jones\u0026author=\u0026author=E. G. Westaway\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B142\"\u003eJ. L. Wen, B. C. Hua, J. W. Xiang, H. Huang, and A. A. Khromykh, “Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 78, no. 22, pp. 12225–12235, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.78.22.12225-12235.2004\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Analysis%20of%20adaptive%20mutations%20in%20Kunjin%20virus%20replicon%20RNA%20reveals%20a%20novel%20role%20for%20the%20flavivirus%20nonstructural%20protein%20NS2A%20in%20inhibition%20of%20beta%20interferon%20promoter-driven%20transcription\u0026author=J. L. Wen\u0026author=B. C. Hua\u0026author=J. W. Xiang\u0026author=H. Huang\u0026author=\u0026author=A. A. Khromykh\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B143\"\u003eW. J. Liu, X. J. Wang, D. C. Clark, M. Lobigs, R. A. Hall, and A. A. Khromykh, “A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 80, no. 5, pp. 2396–2404, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.80.5.2396-2404.2006\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20single%20amino%20acid%20substitution%20in%20the%20West%20Nile%20virus%20nonstructural%20protein%20NS2A%20disables%20its%20ability%20to%20inhibit%20alpha/beta%20interferon%20induction%20and%20attenuates%20virus%20virulence%20in%20mice\u0026author=W. J. Liu\u0026author=X. J. Wang\u0026author=D. C. Clark\u0026author=M. Lobigs\u0026author=R. A. Hall\u0026author=\u0026author=A. A. Khromykh\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B144\"\u003eJ. L. Mu\u0026#xf1;oz-Jord\u0026#xe1;n, G. G. S\u0026#xe1;nchez-Burgos, M. Laurent-Rolle, and A. Garc\u0026#xed;a-Sastre, “Inhibition of interferon signaling by dengue virus,” \u003ci\u003eProceedings of the National Academy of Sciences of the United States of America\u003c/i\u003e, vol. 100, no. 2, pp. 14333–14338, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1073/pnas.2335168100\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20interferon%20signaling%20by%20dengue%20virus\u0026author=J. L. Muñoz-Jordán\u0026author=G. G. Sánchez-Burgos\u0026author=M. Laurent-Rolle\u0026author=\u0026author=A. García-Sastre\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B145\"\u003eW. J. Liu, X. J. Wang, V. V. Mokhonov, P.-Y. Shi, R. Randall, and A. A. Khromykh, “Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 79, no. 3, pp. 1934–1942, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.79.3.1934-1942.2005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20interferon%20signaling%20by%20the%20New%20York%2099%20strain%20and%20Kunjin%20subtype%20of%20West%20Nile%20virus%20involves%20blockage%20of%20STAT1%20and%20STAT2%20activation%20by%20nonstructural%20proteins\u0026author=W. J. Liu\u0026author=X. J. Wang\u0026author=V. V. Mokhonov\u0026author=P.-Y. Shi\u0026author=R. Randall\u0026author=\u0026author=A. A. Khromykh\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B146\"\u003eB. M. K\u0026#xfc;mmerer and C. M. Rice, “Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 76, no. 10, pp. 4773–4784, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.76.10.4773-4784.2002\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mutations%20in%20the%20yellow%20fever%20virus%20nonstructural%20protein%20NS2A%20selectively%20block%20production%20of%20infectious%20particles\u0026author=B. M. Kümmerer \u0026author=C. M. Rice\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B147\"\u003eW. J. Liu, H. B. Chen, and A. A. Khromykh, “Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 77, no. 14, pp. 7804–7813, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.77.14.7804-7813.2003\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Molecular%20and%20functional%20analyses%20of%20Kunjin%20virus%20infectious%20cDNA%20clones%20demonstrate%20the%20essential%20roles%20for%20NS2A%20in%20virus%20assembly%20and%20for%20a%20nonconservative%20residue%20in%20NS3%20in%20RNA%20replication\u0026author=W. J. Liu\u0026author=H. B. Chen\u0026author=\u0026author=A. A. Khromykh\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B148\"\u003eJ. Y. Leung, G. P. Pijlman, N. Kondratieva, J. Hyde, J. M. Mackenzie, and A. A. Khromykh, “Role of nonstructural protein NS2A in flavivirus assembly,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 82, no. 10, pp. 4731–4741, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.00002-08\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Role%20of%20nonstructural%20protein%20NS2A%20in%20flavivirus%20assembly\u0026author=J. Y. Leung\u0026author=G. P. Pijlman\u0026author=N. Kondratieva\u0026author=J. Hyde\u0026author=J. M. Mackenzie\u0026author=\u0026author=A. A. Khromykh\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B149\"\u003eK. L. McElroy, K. A. Tsetsarkin, D. L. Vanlandingham, and S. Higgs, “Manipulation of the yellow fever virus non-structural genes 2A and 4B and the \u003cmath id=\"M1\" xmlns=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmrow\u003e\u003cmsup\u003e\u003cmn\u003e3\u003c/mn\u003e\u003cmo\u003e\u0026#x2032;\u003c/mo\u003e\u003c/msup\u003e\u003c/mrow\u003e\u003c/math\u003e non-coding region to evaluate genetic determinants of viral dissemination from the \u003ci\u003eAedes aegypti\u003c/i\u003e midgut,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 75, no. 6, pp. 1158–1164, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Manipulation%20of%20the%20yellow%20fever%20virus%20non-structural%20genes%202A%20and%204B%20and%20the%20\u003cinline-formula\u003e\u003cmml:math%20id=\"M1\"%20xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmml:mrow\u003e\u003cmml:msup\u003e\u003cmml:mn\u003e3\u003c/mml:mn\u003e\u003cmml:mo\u003e′\u003c/mml:mo\u003e\u003c/mml:msup\u003e\u003c/mml:mrow\u003e\u003c/mml:math\u003e\u003c/inline-formula\u003e%20non-coding%20region%20to%20evaluate%20genetic%20determinants%20of%20viral%20dissemination%20from%20the%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20midgut\u0026author=K. L. McElroy\u0026author=K. A. Tsetsarkin\u0026author=D. L. Vanlandingham\u0026author=\u0026author=S. Higgs\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B150\"\u003eK. A. Hanley, L. R. Manlucu, L. E. Gilmore et al., “A trade-off in replication in mosquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4,” \u003ci\u003eVirology\u003c/i\u003e, vol. 312, no. 1, pp. 222–232, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0042-6822(03)00197-1\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20trade-off%20in%20replication%20in%20mosquito%20versus%20mammalian%20systems%20conferred%20by%20a%20point%20mutation%20in%20the%20NS4B%20protein%20of%20dengue%20virus%20type%204\u0026author=K. A. Hanley\u0026author=L. R. Manlucu\u0026author=L. E. Gilmore et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B151\"\u003eE. P. Kelly, B. Puri, W. Sun, and B. Falgout, “Identification of mutations in a candidate dengue 4 vaccine strain 341750 PDK20 and construction of a full-length cDNA clone of the PDK20 vaccine candidate,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 28, no. 17, pp. 3030–3037, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2009.10.084\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Identification%20of%20mutations%20in%20a%20candidate%20dengue%204%20vaccine%20strain%20341750%20PDK20%20and%20construction%20of%20a%20full-length%20cDNA%20clone%20of%20the%20PDK20%20vaccine%20candidate\u0026author=E. P. Kelly\u0026author=B. Puri\u0026author=W. Sun\u0026author=\u0026author=B. Falgout\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B152\"\u003eS. Tajima, T. Takasaki, and I. Kurane, “Restoration of replication-defective dengue type 1 virus bearing mutations in the N-terminal cytoplasmic portion of NS4A by additional mutations in NS4B,” \u003ci\u003eArchives of Virology\u003c/i\u003e, vol. 156, no. 1, pp. 63–69, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/s00705-010-0816-8\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Restoration%20of%20replication-defective%20dengue%20type%201%20virus%20bearing%20mutations%20in%20the%20N-terminal%20cytoplasmic%20portion%20of%20NS4A%20by%20additional%20mutations%20in%20NS4B\u0026author=S. Tajima\u0026author=T. Takasaki\u0026author=\u0026author=I. Kurane\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B153\"\u003eD. Grant, G. K. Tan, M. Qing et al., “A single amino acid in nonstructural protein NS4B Confers virulence to dengue virus in AG129 mice through enhancement of viral RNA synthesis,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 85, no. 15, pp. 7775–7787, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.00665-11\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20single%20amino%20acid%20in%20nonstructural%20protein%20NS4B%20Confers%20virulence%20to%20dengue%20virus%20in%20AG129%20mice%20through%20enhancement%20of%20viral%20RNA%20synthesis\u0026author=D. Grant\u0026author=G. K. Tan\u0026author=M. Qing et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B154\"\u003eR. R. Roche, M. Alvarez, M. G. Guzman, L. Morier, and G. Kouri, “Comparison of rapid centrifugation assay with conventional tissue culture method for isolation of dengue 2 virus in C6/36-HT cells,” \u003ci\u003eJournal of Clinical Microbiology\u003c/i\u003e, vol. 38, no. 9, pp. 3508–3510, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Comparison%20of%20rapid%20centrifugation%20assay%20with%20conventional%20tissue%20culture%20method%20for%20isolation%20of%20dengue%202%20virus%20in%20C6/36-HT%20cells\u0026author=R. R. Roche\u0026author=M. Alvarez\u0026author=M. G. Guzman\u0026author=L. Morier\u0026author=\u0026author=G. Kouri\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B155\"\u003eW.-K. Wang, S.-R. Lin, C.-M. Lee, C.-C. King, and S.-C. Chang, “Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 76, no. 9, pp. 4662–4665, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.76.9.4662-4665.2002\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20type%203%20virus%20in%20plasma%20is%20a%20population%20of%20closely%20related%20genomes:%20quasispecies\u0026author=W.-K. Wang\u0026author=S.-R. Lin\u0026author=C.-M. Lee\u0026author=C.-C. King\u0026author=\u0026author=S.-C. Chang\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B156\"\u003eJ. Aaskov, K. Buzacott, H. M. Thu, K. Lowry, and E. C. Holmes, “Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes,” \u003ci\u003eScience\u003c/i\u003e, vol. 311, no. 5758, pp. 236–238, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1126/science.1115030\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Long-term%20transmission%20of%20defective%20RNA%20viruses%20in%20humans%20and%20Aedes%20mosquitoes\u0026author=J. Aaskov\u0026author=K. Buzacott\u0026author=H. M. Thu\u0026author=K. Lowry\u0026author=\u0026author=E. C. Holmes\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B157\"\u003eM. OhAinle, A. Balmaseda, A. R. Macalalad et al., “Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity,” \u003ci\u003eScience Translational Medicine\u003c/i\u003e, vol. 3, no. 114, Article ID 114ra128, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1126/scitranslmed.3003084\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dynamics%20of%20dengue%20disease%20severity%20determined%20by%20the%20interplay%20between%20viral%20genetics%20and%20serotype-specific%20immunity\u0026author=M. OhAinle\u0026author=A. Balmaseda\u0026author=A. R. Macalalad et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B158\"\u003eJ. E. Foster, S. N. Bennett, C. V. F. Carrington, H. Vaughan, and W. O. McMillan, “Phylogeography and molecular evolution of dengue 2 in the Caribbean basin, 1981\u0026#x2013;2000,” \u003ci\u003eVirology\u003c/i\u003e, vol. 324, no. 1, pp. 48–59, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virol.2004.03.020\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Phylogeography%20and%20molecular%20evolution%20of%20dengue%202%20in%20the%20Caribbean%20basin,%201981–2000\u0026author=J. E. Foster\u0026author=S. N. Bennett\u0026author=C. V. F. Carrington\u0026author=H. Vaughan\u0026author=\u0026author=W. O. McMillan\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B159\"\u003eW. B. Messer, U. T. Vitarana, K. Sivananthan et al., “Epidemiology of dengue in Sri lanka before and after the emergence of epidemic dengue hemorrhagic fever,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 66, no. 6, pp. 765–773, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Epidemiology%20of%20dengue%20in%20Sri%20lanka%20before%20and%20after%20the%20emergence%20of%20epidemic%20dengue%20hemorrhagic%20fever\u0026author=W. B. Messer\u0026author=U. T. Vitarana\u0026author=K. Sivananthan et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B160\"\u003eH. M. Thu, K. Lowry, L. Jiang, T. Hlaing, E. C. Holmes, and J. Aaskov, “Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection,” \u003ci\u003eVirology\u003c/i\u003e, vol. 336, no. 2, pp. 163–172, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virol.2005.03.018\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Lineage%20extinction%20and%20replacement%20in%20dengue%20type%201%20virus%20populations%20are%20due%20to%20stochastic%20events%20rather%20than%20to%20natural%20selection\u0026author=H. M. Thu\u0026author=K. Lowry\u0026author=L. Jiang\u0026author=T. Hlaing\u0026author=E. C. Holmes\u0026author=\u0026author=J. Aaskov\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B161\"\u003eL. T. D. Salda, M. D. C. Parquet, R. R. Matias, F. F. Natividad, N. Kobayashi, and K. Morita, “Molecular epidemiology of dengue 2 viruses in the Philippines: genotype shift and local evolution,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 73, no. 4, pp. 796–802, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Molecular%20epidemiology%20of%20dengue%202%20viruses%20in%20the%20Philippines:%20genotype%20shift%20and%20local%20evolution\u0026author=L. T. D. Salda\u0026author=M. D. C. Parquet\u0026author=R. R. Matias\u0026author=F. F. Natividad\u0026author=N. Kobayashi\u0026author=\u0026author=K. Morita\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B162\"\u003eT. T. H. Vu, E. C. Holmes, V. Duong et al., “Emergence of the Asian 1 genotype of dengue virus serotype 2 in viet nam: in vivo fitness advantage and lineage replacement in South-East Asia,” \u003ci\u003ePLoS Neglected Tropical Diseases\u003c/i\u003e, vol. 4, no. 7, p. e757, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0000757\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Emergence%20of%20the%20Asian%201%20genotype%20of%20dengue%20virus%20serotype%202%20in%20viet%20nam:%20in%20vivo%20fitness%20advantage%20and%20lineage%20replacement%20in%20South-East%20Asia\u0026author=T. T. H. Vu\u0026author=E. C. Holmes\u0026author=V. Duong et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B163\"\u003eE. C. Holmes, “RNA virus genomics: a world of possibilities,” \u003ci\u003eJournal of Clinical Investigation\u003c/i\u003e, vol. 119, no. 9, pp. 2488–2495, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1172/JCI38050\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=RNA%20virus%20genomics:%20a%20world%20of%20possibilities\u0026author=E. C. Holmes\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B164\"\u003eD. Limonta, V. Cap\u0026#xf3;, G. Torres, A. B. P\u0026#xe9;rez, and M. G. Guzm\u0026#xe1;n, “Apoptosis in tissues from fatal dengue shock syndrome,” \u003ci\u003eJournal of Clinical Virology\u003c/i\u003e, vol. 40, no. 1, pp. 50–54, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.jcv.2007.04.024\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Apoptosis%20in%20tissues%20from%20fatal%20dengue%20shock%20syndrome\u0026author=D. Limonta\u0026author=V. Capó\u0026author=G. Torres\u0026author=A. B. Pérez\u0026author=\u0026author=M. G. Guzmán\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B165\"\u003eA. Moya, E. C. Holmes, and F. Gonz\u0026#xe1;lez-Candelas, “The population genetics and evolutionary epidemiology of RNA viruses,” \u003ci\u003eNature Reviews Microbiology\u003c/i\u003e, vol. 2, no. 4, pp. 279–288, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/nrmicro863\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20population%20genetics%20and%20evolutionary%20epidemiology%20of%20RNA%20viruses\u0026author=A. Moya\u0026author=E. C. Holmes\u0026author=\u0026author=F. González-Candelas\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B166\"\u003eS. Navas, J. Mart\u0026#xed;n, J. A. Quiroga, I. Castillo, and V. Carre\u0026#xf1;o, “Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 72, no. 2, pp. 1640–1646, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Genetic%20diversity%20and%20tissue%20compartmentalization%20of%20the%20hepatitis%20C%20virus%20genome%20in%20blood%20mononuclear%20cells,%20liver,%20and%20serum%20from%20chronic%20hepatitis%20C%20patients\u0026author=S. Navas\u0026author=J. Martín\u0026author=J. A. Quiroga\u0026author=I. Castillo\u0026author=\u0026author=V. Carreño\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B167\"\u003eR. Miralles, A. Moya, and S. F. Elena, “Effect of population patchiness and migration rates on the adaptation and divergence of vesicular stomatitis virus quasispecies populations,” \u003ci\u003eJournal of General Virology\u003c/i\u003e, vol. 80, no. 8, pp. 2051–2059, 1999. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effect%20of%20population%20patchiness%20and%20migration%20rates%20on%20the%20adaptation%20and%20divergence%20of%20vesicular%20stomatitis%20virus%20quasispecies%20populations\u0026author=R. Miralles\u0026author=A. Moya\u0026author=\u0026author=S. F. Elena\u0026publication_year=1999\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B168\"\u003eP. Farci, A. Shimoda, A. Coiana et al., “The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies,” \u003ci\u003eScience\u003c/i\u003e, vol. 288, no. 5464, pp. 339–344, 2000. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1126/science.288.5464.339\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20outcome%20of%20acute%20hepatitis%20C%20predicted%20by%20the%20evolution%20of%20the%20viral%20quasispecies\u0026author=P. Farci\u0026author=A. Shimoda\u0026author=A. Coiana et al.\u0026publication_year=2000\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B169\"\u003eE. C. Holmes, “Patterns of intra- and interhost nonsynonymous variation reveal strong purifying selection in dengue virus,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 77, no. 20, pp. 11296–11298, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.77.20.11296-11298.2003\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Patterns%20of%20intra-%20and%20interhost%20nonsynonymous%20variation%20reveal%20strong%20purifying%20selection%20in%20dengue%20virus\u0026author=E. C. Holmes\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B170\"\u003eS.-R. Lin, S.-C. Hsieh, Y.-Y. Yueh et al., “Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 78, no. 22, pp. 12717–12721, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.78.22.12717-12721.2004\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Study%20of%20sequence%20variation%20of%20dengue%20type%203%20virus%20in%20naturally%20infected%20mosquitoes%20and%20human%20hosts:%20implications%20for%20transmission%20and%20evolution\u0026author=S.-R. Lin\u0026author=S.-C. Hsieh\u0026author=Y.-Y. Yueh et al.\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B171\"\u003eE. Descloux, V.-M. Cao-Lormeau, C. Roche, and X. De Lamballerie, “Dengue 1 diversity and microevolution, French Polynesia 2001\u0026#x2013;2006: connection with epidemiology and clinics,” \u003ci\u003ePLoS Neglected Tropical Diseases\u003c/i\u003e, vol. 3, no. 8, article e493, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0000493\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%201%20diversity%20and%20microevolution,%20French%20Polynesia%202001–2006:%20connection%20with%20epidemiology%20and%20clinics\u0026author=E. Descloux\u0026author=V.-M. Cao-Lormeau\u0026author=C. Roche\u0026author=\u0026author=X. De Lamballerie\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B172\"\u003eK. T. D. Thai, M. R. Henn, M. C. Zody et al., “High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 86, no. 2, pp. 835–843, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.05985-11\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=High-resolution%20analysis%20of%20intrahost%20genetic%20diversity%20in%20dengue%20virus%20serotype%201%20infection%20identifies%20mixed%20infections\u0026author=K. T. D. Thai\u0026author=M. R. Henn\u0026author=M. C. Zody et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B173\"\u003eP. Parameswaran, P. Charlebois, Y. Tellez et al., “Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 86, no. 16, pp. 8546–8558, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.00736-12\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Genome-wide%20patterns%20of%20intrahuman%20dengue%20virus%20diversity%20reveal%20associations%20with%20viral%20phylogenetic%20clade%20and%20interhost%20diversity\u0026author=P. Parameswaran\u0026author=P. Charlebois\u0026author=Y. Tellez et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B174\"\u003eR. L. Costa, C. M. Voloch, and C. G. Schrago, “Comparative evolutionary epidemiology of dengue virus serotypes,” \u003ci\u003eInfection, Genetics and Evolution\u003c/i\u003e, vol. 12, no. 2, pp. 309–314, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.meegid.2011.12.011\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Comparative%20evolutionary%20epidemiology%20of%20dengue%20virus%20serotypes\u0026author=R. L. Costa\u0026author=C. M. Voloch\u0026author=\u0026author=C. G. Schrago\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B175\"\u003eJ. Louren\u0026#xe7;o and M. Recker, “Viral and epidemiological determinants of the invasion dynamics of Novel Dengue Genotypes,” \u003ci\u003ePLoS Neglected Tropical Diseases\u003c/i\u003e, vol. 4, no. 11, article e894, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0000894\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Viral%20and%20epidemiological%20determinants%20of%20the%20invasion%20dynamics%20of%20Novel%20Dengue%20Genotypes\u0026author=J. Lourenço \u0026author=M. Recker\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B176\"\u003eV. Wittke, T. E. Robb, H. M. Thu et al., “Extinction and rapid emergence of strains of dengue 3 virus during an interepidemic period,” \u003ci\u003eVirology\u003c/i\u003e, vol. 301, no. 1, pp. 148–156, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1006/viro.2002.1549\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Extinction%20and%20rapid%20emergence%20of%20strains%20of%20dengue%203%20virus%20during%20an%20interepidemic%20period\u0026author=V. Wittke\u0026author=T. E. Robb\u0026author=H. M. Thu et al.\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B177\"\u003eC. Chevillon and A.-B. Failloux, “Questions on viral population biology to complete dengue puzzle,” \u003ci\u003eTrends in Microbiology\u003c/i\u003e, vol. 11, no. 9, pp. 415–421, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0966-842X(03)00206-3\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Questions%20on%20viral%20population%20biology%20to%20complete%20dengue%20puzzle\u0026author=C. Chevillon \u0026author=A.-B. Failloux\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B178\"\u003eL. Lambrechts, T. Fansiri, A. Pongsiri et al., “Dengue-1 virus clade replacement in Thailand associated with enhanced mosquito transmission,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 86, no. 3, pp. 1853–1861, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.06458-11\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue-1%20virus%20clade%20replacement%20in%20Thailand%20associated%20with%20enhanced%20mosquito%20transmission\u0026author=L. Lambrechts\u0026author=T. Fansiri\u0026author=A. Pongsiri et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B179\"\u003eW. H. Bancroft, R. M. Scott, and W. E. Brandt, “Dengue-2 vaccine: infection of \u003ci\u003eAedes aegypti\u003c/i\u003e mosquitoes by feeding on viremic recipients,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 31, no. 6, pp. 1229–1231, 1982. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue-2%20vaccine:%20infection%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20mosquitoes%20by%20feeding%20on%20viremic%20recipients\u0026author=W. H. Bancroft\u0026author=R. M. Scott\u0026author=\u0026author=W. E. Brandt\u0026publication_year=1982\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B180\"\u003eB. R. Miller, B. J. Beaty, and T. H. G. Aitken, “Dengue-2 vaccine: oral infection, transmission, and lack of evidence for reversion in the mosquito, \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 31, no. 6, pp. 1232–1237, 1982. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue-2%20vaccine:%20oral%20infection,%20transmission,%20and%20lack%20of%20evidence%20for%20reversion%20in%20the%20mosquito,%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=B. R. Miller\u0026author=B. J. Beaty\u0026author=\u0026author=T. H. G. Aitken\u0026publication_year=1982\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B181\"\u003eD. J. Gubler, S. Nalim, and R. Tan, “Variation in susceptibility to oral infection with dengue viruses among geographic strains of \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 28, no. 6, pp. 1045–1052, 1979. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Variation%20in%20susceptibility%20to%20oral%20infection%20with%20dengue%20viruses%20among%20geographic%20strains%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=D. J. Gubler\u0026author=S. Nalim\u0026author=\u0026author=R. Tan\u0026publication_year=1979\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B182\"\u003eP. M. Armstrong and R. Rico-Hesse, “Differential susceptibility of \u003ci\u003eAedes aegypti\u003c/i\u003e to infection by the American and Southeast Asian genotypes of dengue type 2 virus,” \u003ci\u003eVector Borne Zoonotic Dis\u003c/i\u003e, vol. 1, no. 2, pp. 159–168, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Differential%20susceptibility%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20to%20infection%20by%20the%20American%20and%20Southeast%20Asian%20genotypes%20of%20dengue%20type%202%20virus\u0026author=P. M. Armstrong \u0026author=R. Rico-Hesse\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B183\"\u003eF. L. Soper, “\u003ci\u003eAedes aegypti\u003c/i\u003e and yellow fever,” \u003ci\u003eBulletin of the World Health Organization\u003c/i\u003e, vol. 36, no. 4, pp. 521–527, 1967. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20and%20yellow%20fever\u0026author=F. L. Soper\u0026publication_year=1967\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B184\"\u003eD. J. Gubler, “\u003ci\u003eAedes aegypti\u003c/i\u003e and \u003ci\u003eAedes aegypti\u003c/i\u003e-borne disease control in the 1990s: top down or bottom up. Charles Franklin Craig Lecture,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 40, no. 6, pp. 571–578, 1989. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20and%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e-borne%20disease%20control%20in%20the%201990s:%20top%20down%20or%20bottom%20up.%20Charles%20Franklin%20Craig%20Lecture\u0026author=D. J. Gubler\u0026publication_year=1989\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B185\"\u003eE.-E. Ooi, K.-T. Goh, and D. J. Gubler, “Dengue prevention and 35 years of vector control in Singapore,” \u003ci\u003eEmerging Infectious Diseases\u003c/i\u003e, vol. 12, no. 6, pp. 887–893, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20prevention%20and%2035%20years%20of%20vector%20control%20in%20Singapore\u0026author=E.-E. Ooi\u0026author=K.-T. Goh\u0026author=\u0026author=D. J. Gubler\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B186\"\u003eM. G. Guzman, O. Pelaez, G. Kouri et al., “Final characterization of and lessons learned from the dengue 3 epidemic in Cuba, 2001-2002,” \u003ci\u003eRevista Panamericana de Salud P\u0026#xfa;blica\u003c/i\u003e, vol. 19, no. 4, pp. 282–289, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Final%20characterization%20of%20and%20lessons%20learned%20from%20the%20dengue%203%20epidemic%20in%20Cuba,%202001-2002\u0026author=M. G. Guzman\u0026author=O. Pelaez\u0026author=G. Kouri et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B187\"\u003eM. Bonet, J. M. Spiegel, A. M. Ibarra, G. Kouri, A. Pintre Lic, and A. Yassi, “An integrated ecosystem approach for sustainable prevention and control of dengue in Central Havana,” \u003ci\u003eInternational Journal of Occupational and Environmental Health\u003c/i\u003e, vol. 13, no. 2, pp. 188–194, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=An%20integrated%20ecosystem%20approach%20for%20sustainable%20prevention%20and%20control%20of%20dengue%20in%20Central%20Havana\u0026author=M. Bonet\u0026author=J. M. Spiegel\u0026author=A. M. Ibarra\u0026author=G. Kouri\u0026author=A. Pintre Lic\u0026author=\u0026author=A. Yassi\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B188\"\u003eJ. A. Bisset, M. M. Rodr\u0026#xed;guez, Y. Ricardo et al., “Temephos resistance and esterase activity in the mosquito \u003ci\u003eAedes aegypti\u003c/i\u003e in Havana, Cuba increased dramatically between 2006 and 2008,” \u003ci\u003eMedical and Veterinary Entomology\u003c/i\u003e, vol. 25, no. 3, pp. 233–239, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1111/j.1365-2915.2011.00959.x\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Temephos%20resistance%20and%20esterase%20activity%20in%20the%20mosquito%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20in%20Havana,%20Cuba%20increased%20dramatically%20between%202006%20and%202008\u0026author=J. A. Bisset\u0026author=M. M. Rodríguez\u0026author=Y. Ricardo et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B189\"\u003eR. Maciel-de-Freitas, R. Aguiar, R. V. Bruno et al., “Why do we need alternative tools to control mosquito-borne diseases in Latin America?” \u003ci\u003eMem\u0026#xf3;rias do Instituto Oswaldo Cruz\u003c/i\u003e, vol. 107, no. 6, pp. 828–829, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Why%20do%20we%20need%20alternative%20tools%20to%20control%20mosquito-borne%20diseases%20in%20Latin%20America?\u0026author=R. Maciel-de-Freitas\u0026author=R. Aguiar\u0026author=R. V. Bruno et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B190\"\u003eR. A. S\u0026#xe1;, N. D. D. L. Santos, C. S. B. D. Silva et al., “Larvicidal activity of lectins from Myracrodruon urundeuva on \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003eComparative Biochemistry and Physiology Part C\u003c/i\u003e, vol. 149, no. 3, pp. 300–306, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.cbpc.2008.08.004\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Larvicidal%20activity%20of%20lectins%20from%20Myracrodruon%20urundeuva%20on%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=R. A. Sá\u0026author=N. D. D. L. Santos\u0026author=C. S. B. D. Silva et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B191\"\u003eP. F. Billingsley, B. Foy, and J. L. Rasgon, “Mosquitocidal vaccines: a neglected addition to malaria and dengue control strategies,” \u003ci\u003eTrends in Parasitology\u003c/i\u003e, vol. 24, no. 9, pp. 396–400, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.pt.2008.06.003\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mosquitocidal%20vaccines:%20a%20neglected%20addition%20to%20malaria%20and%20dengue%20control%20strategies\u0026author=P. F. Billingsley\u0026author=B. Foy\u0026author=\u0026author=J. L. Rasgon\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B192\"\u003eJ. A. Bisset Lazcano, M. C. Marquetti, A. Garcia et al., “Pupal surveillance of \u003ci\u003eAedes aegypti\u003c/i\u003e as a tool for control of the vector in a municipality with low density of La Habana City, Cuba,” \u003ci\u003eRevista Biom\u0026#xe9;dica\u003c/i\u003e, vol. 19, pp. 92–103, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Pupal%20surveillance%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20as%20a%20tool%20for%20control%20of%20the%20vector%20in%20a%20municipality%20with%20low%20density%20of%20La%20Habana%20City,%20Cuba\u0026author=J. A. Bisset Lazcano\u0026author=M. C. Marquetti\u0026author=A. Garcia et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B193\"\u003eT. T. Tuyet Hanh, P. S. Hill, B. H. Kay, and M. Q. Tran, “Development of a framework for evaluating the sustainability of community-based dengue control projects,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 80, no. 2, pp. 312–318, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Development%20of%20a%20framework%20for%20evaluating%20the%20sustainability%20of%20community-based%20dengue%20control%20projects\u0026author=T. T. Tuyet Hanh\u0026author=P. S. Hill\u0026author=B. H. Kay\u0026author=\u0026author=M. Q. Tran\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B194\"\u003eS. N. Vu, T. Y. Nguyen, B. H. Kay, G. G. Marten, and J. W. Reid, “Eradication of \u003ci\u003eAedes aegypti\u003c/i\u003e from a village in Vietnam, using copepods and community participation,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 59, no. 4, pp. 657–660, 1998. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Eradication%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20from%20a%20village%20in%20Vietnam,%20using%20copepods%20and%20community%20participation\u0026author=S. N. Vu\u0026author=T. Y. Nguyen\u0026author=B. H. Kay\u0026author=G. G. Marten\u0026author=\u0026author=J. W. Reid\u0026publication_year=1998\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B195\"\u003eV. S. Nam, N. T. Yen, T. V. Phong et al., “Elimination of dengue by community programs using Mesocyclops (copepoda) against \u003ci\u003eAedes aegypti\u003c/i\u003e in central Vietnam,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 72, no. 1, pp. 67–73, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Elimination%20of%20dengue%20by%20community%20programs%20using%20Mesocyclops%20(copepoda)%20against%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20in%20central%20Vietnam\u0026author=V. S. Nam\u0026author=N. T. Yen\u0026author=T. V. Phong et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B196\"\u003eB. Kay and V. S. Nam, “New strategy against \u003ci\u003eAedes aegypti\u003c/i\u003e in Vietnam,” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 365, no. 9459, pp. 613–617, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0140-6736(05)17913-6\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=New%20strategy%20against%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20in%20Vietnam\u0026author=B. Kay \u0026author=V. S. Nam\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B197\"\u003eL. S\u0026#xe1;nchez, D. P\u0026#xe9;rez, L. Alfonso et al., “A community education strategy to promote participation in dengue prevention in Cuba,” \u003ci\u003eRevista Panamericana de Salud Publica\u003c/i\u003e, vol. 24, no. 1, pp. 61–69, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20community%20education%20strategy%20to%20promote%20participation%20in%20dengue%20prevention%20in%20Cuba\u0026author=L. Sánchez\u0026author=D. Pérez\u0026author=L. Alfonso et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B198\"\u003eC. J. McMeniman, R. V. Lane, B. N. Cass et al., “Stable introduction of a life-shortening Wolbachia infection into the mosquito \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003eScience\u003c/i\u003e, vol. 323, no. 5910, pp. 141–144, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1126/science.1165326\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Stable%20introduction%20of%20a%20life-shortening%20Wolbachia%20infection%20into%20the%20mosquito%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=C. J. McMeniman\u0026author=R. V. Lane\u0026author=B. N. Cass et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B199\"\u003eP. Lu, G. Bian, X. Pan, and Z. Xi, “Wolbachia induces density-dependent inhibition to dengue virus in mosquito cells,” \u003ci\u003ePLOS Neglected Tropical Diseases\u003c/i\u003e, vol. 6, no. 7, Article ID e1754, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Wolbachia%20induces%20density-dependent%20inhibition%20to%20dengue%20virus%20in%20mosquito%20cells\u0026author=P. Lu\u0026author=G. Bian\u0026author=X. Pan\u0026author=\u0026author=Z. Xi\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B200\"\u003eT. Walker, P. H. Johnson, L. A. Moreira et al., “The wMel Wolbachia strain blocks dengue and invades caged \u003ci\u003eAedes aegypti\u003c/i\u003e populations,” \u003ci\u003eNature\u003c/i\u003e, vol. 476, no. 7361, pp. 450–455, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/nature10355\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20wMel%20Wolbachia%20strain%20blocks%20dengue%20and%20invades%20caged%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20populations\u0026author=T. Walker\u0026author=P. H. Johnson\u0026author=L. A. Moreira et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B201\"\u003eG. Bian, Y. Xu, P. Lu, Y. Xie, and Z. Xi, “The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003ePLoS Pathogens\u003c/i\u003e, vol. 6, no. 4, Article ID e1000833, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20endosymbiotic%20bacterium%20Wolbachia%20induces%20resistance%20to%20dengue%20virus%20in%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=G. Bian\u0026author=Y. Xu\u0026author=P. Lu\u0026author=Y. Xie\u0026author=\u0026author=Z. Xi\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B202\"\u003eL. A. Moreira, I. Iturbe-Ormaetxe, J. A. Jeffery et al., “A Wolbachia Symbiont in \u003ci\u003eAedes aegypti\u003c/i\u003e Limits Infection with Dengue, Chikungunya, and Plasmodium,” \u003ci\u003eCell\u003c/i\u003e, vol. 139, no. 7, pp. 1268–1278, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.cell.2009.11.042\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20Wolbachia%20Symbiont%20in%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20Limits%20Infection%20with%20Dengue,%20Chikungunya,%20and%20Plasmodium\u0026author=L. A. Moreira\u0026author=I. Iturbe-Ormaetxe\u0026author=J. A. Jeffery et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B203\"\u003eX. Pan, G. Zhou, J. Wu et al., “Wolbachia induces reactive oxygen species (ROS)-dependent activation of the Toll pathway to control dengue virus in the mosquito \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003eProceedings of the National Academy of Sciences of the United States of America\u003c/i\u003e, vol. 109, no. 1, pp. E23–E31, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1073/pnas.1116932108\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Wolbachia%20induces%20reactive%20oxygen%20species%20(ROS)-dependent%20activation%20of%20the%20Toll%20pathway%20to%20control%20dengue%20virus%20in%20the%20mosquito%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=X. Pan\u0026author=G. Zhou\u0026author=J. Wu et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B204\"\u003eL. Mousson, K. Zouache, C. Arias-Goeta, V. Raquin, P. Mavingui, and A. B. Failloux, “The native wolbachia symbionts limit transmission of dengue virus in \u003ci\u003eAedes albopictus\u003c/i\u003e,” \u003ci\u003ePLOS Neglected Tropical Diseases\u003c/i\u003e, vol. 6, no. 12, Article ID e1989, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20native%20wolbachia%20symbionts%20limit%20transmission%20of%20dengue%20virus%20in%20\u003ci\u003eAedes%20albopictus\u003c/i\u003e\u0026author=L. Mousson\u0026author=K. Zouache\u0026author=C. Arias-Goeta\u0026author=V. Raquin\u0026author=P. Mavingui\u0026author=\u0026author=A. B. Failloux\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B205\"\u003eP. E. Cook, C. J. McMeniman, and S. L. O'Neill, “Modifying insect population age structure to control vector-borne disease,” \u003ci\u003eAdvances in Experimental Medicine and Biology\u003c/i\u003e, vol. 627, pp. 126–140, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1007/978-0-387-78225-6-11\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Modifying%20insect%20population%20age%20structure%20to%20control%20vector-borne%20disease\u0026author=P. E. Cook\u0026author=C. J. McMeniman\u0026author=\u0026author=S. L. O'Neill\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B206\"\u003eN. M. Endersby, A. A. Hoffmann, V. L. White, S. A. Ritchie, P. H. Johnson, and A. R. Weeks, “Changes in the genetic structure of \u003ci\u003eAedes aegypti\u003c/i\u003e (Diptera: Culicidae) populations in Queensland, Australia, across two seasons: implications for potential mosquito releases,” \u003ci\u003eJournal of Medical Entomology\u003c/i\u003e, vol. 48, no. 5, pp. 999–1007, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1603/ME10264\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Changes%20in%20the%20genetic%20structure%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20(Diptera:%20Culicidae)%20populations%20in%20Queensland,%20Australia,%20across%20two%20seasons:%20implications%20for%20potential%20mosquito%20releases\u0026author=N. M. Endersby\u0026author=A. A. Hoffmann\u0026author=V. L. White\u0026author=S. A. Ritchie\u0026author=P. H. Johnson\u0026author=\u0026author=A. R. Weeks\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B207\"\u003eN. M. Endersby, A. A. Hoffmann, V. L. White et al., “Genetic structure of \u003ci\u003eAedes aegypti\u003c/i\u003e in Australia and Vietnam revealed by microsatellite and exon primed intron crossing markers suggests feasibility of local control options,” \u003ci\u003eJournal of Medical Entomology\u003c/i\u003e, vol. 46, no. 5, pp. 1074–1083, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1603/033.046.0514\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Genetic%20structure%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20in%20Australia%20and%20Vietnam%20revealed%20by%20microsatellite%20and%20exon%20primed%20intron%20crossing%20markers%20suggests%20feasibility%20of%20local%20control%20options\u0026author=N. M. Endersby\u0026author=A. A. Hoffmann\u0026author=V. L. White et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B208\"\u003eJ. A. L. Jeffery, N. T. Yen, V. S. Nam et al., “Characterizing the \u003ci\u003eAedes aegypti\u003c/i\u003e population in a Vietnamese village in preparation for a Wolbachia-based mosquito control strategy to eliminate dengue,” \u003ci\u003ePLoS Neglected Tropical Diseases\u003c/i\u003e, vol. 3, no. 11, Article ID e0000552, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0000552\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Characterizing%20the%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20population%20in%20a%20Vietnamese%20village%20in%20preparation%20for%20a%20Wolbachia-based%20mosquito%20control%20strategy%20to%20eliminate%20dengue\u0026author=J. A. L. Jeffery\u0026author=N. T. Yen\u0026author=V. S. Nam et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B209\"\u003eH. L. Yeap, P. Mee, T. Walker et al., “Dynamics of the \u0026#x201c;popcorn\u0026#x201d; Wolbachia infection in outbred \u003ci\u003eAedes aegypti\u003c/i\u003e informs prospects for mosquito vector control,” \u003ci\u003eGenetics\u003c/i\u003e, vol. 187, no. 2, pp. 583–595, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1534/genetics.110.122390\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dynamics%20of%20the%20“popcorn”%20Wolbachia%20infection%20in%20outbred%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e%20informs%20prospects%20for%20mosquito%20vector%20control\u0026author=H. L. Yeap\u0026author=P. Mee\u0026author=T. Walker et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B210\"\u003eR. Macey, “Dengue fever breakthrough,” Sydney Morning Herald, 2009, \u003ca target=\"_blank\" href=\"http://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/02/1230681699070.html\"\u003ehttp://www.smh.com.au/news/specials/science/dengue-fever-breakthrough/2009/01/02/1230681699070.html\u003c/a\u003e. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20fever%20breakthrough\u0026author=R. Macey\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B211\"\u003eN. M. Endersby and A. A. Hoffmann, “Effect of Wolbachia on insecticide susceptibility in lines of \u003ci\u003eAedes aegypti\u003c/i\u003e,” \u003ci\u003eBulletin of Entomological Research\u003c/i\u003e, pp. 1–9, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Effect%20of%20Wolbachia%20on%20insecticide%20susceptibility%20in%20lines%20of%20\u003ci\u003eAedes%20aegypti\u003c/i\u003e\u0026author=N. M. Endersby \u0026author=A. A. Hoffmann\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B212\"\u003eS. B. Halstead, “Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade,” \u003ci\u003eReviews of Infectious Diseases\u003c/i\u003e, vol. 11, pp. S830–839, 1989. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antibody,%20macrophages,%20dengue%20virus%20infection,%20shock,%20and%20hemorrhage:%20a%20pathogenetic%20cascade\u0026author=S. B. Halstead\u0026publication_year=1989\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B213\"\u003eJ. Hombach, M. Jane Cardosa, A. Sabchareon, D. W. Vaughn, and A. D. T. Barrett, “Scientific consultation on immunological correlates of protection induced by dengue vaccines. Report from a meeting held at the World Health Organization 17-18 November 2005,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 25, no. 21, pp. 4130–4139, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2007.02.079\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Scientific%20consultation%20on%20immunological%20correlates%20of%20protection%20induced%20by%20dengue%20vaccines.%20Report%20from%20a%20meeting%20held%20at%20the%20World%20Health%20Organization%2017-18%20November%202005\u0026author=J. Hombach\u0026author=M. Jane Cardosa\u0026author=A. Sabchareon\u0026author=D. W. Vaughn\u0026author=\u0026author=A. D. T. Barrett\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B214\"\u003eS. Swaminathan, G. Batra, and N. Khanna, “Dengue vaccines: state of the art,” \u003ci\u003eExpert Opinion on Therapeutic Patents\u003c/i\u003e, vol. 20, no. 6, pp. 819–835, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1517/13543771003767476\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20vaccines:%20state%20of%20the%20art\u0026author=S. Swaminathan\u0026author=G. Batra\u0026author=\u0026author=N. Khanna\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B215\"\u003eR. Edelman, S. S. Wasserman, S. A. Bodison et al., “Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 69, no. 6, pp. 48–60, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Phase%20I%20trial%20of%2016%20formulations%20of%20a%20tetravalent%20live-attenuated%20dengue%20vaccine\u0026author=R. Edelman\u0026author=S. S. Wasserman\u0026author=S. A. Bodison et al.\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B216\"\u003eS. Simasathien, S. J. Thomas, V. Watanaveeradej et al., “Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 78, no. 3, pp. 426–433, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Safety%20and%20immunogenicity%20of%20a%20tetravalent%20live-attenuated%20dengue%20vaccine%20in%20flavivirus%20naive%20children\u0026author=S. Simasathien\u0026author=S. J. Thomas\u0026author=V. Watanaveeradej et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B217\"\u003eW. Sun, D. Cunningham, S. S. Wasserman et al., “Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-na\u0026#xef;ve adults,” \u003ci\u003eHuman Vaccines\u003c/i\u003e, vol. 5, no. 1, pp. 33–40, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4161/hv.5.1.6348\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Phase%202%20clinical%20trial%20of%20three%20formulations%20of%20tetravalent%20live-attenuated%20dengue%20vaccine%20in%20flavivirus-naïve%20adults\u0026author=W. Sun\u0026author=D. Cunningham\u0026author=S. S. Wasserman et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B218\"\u003eA. P. Durbin, S. S. Whitehead, J. McArthur et al., “rDEN4\u003ci\u003e\u0026#x3c3;\u003c/i\u003e30, a live attenuated dengue virus type 4 vaccine candidate, is safe, immunogenic, and highly infectious in healthy adult volunteers,” \u003ci\u003eJournal of Infectious Diseases\u003c/i\u003e, vol. 191, no. 5, pp. 710–718, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1086/427780\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=rDEN4\u003ci\u003eσ\u003c/i\u003e30,%20a%20live%20attenuated%20dengue%20virus%20type%204%20vaccine%20candidate,%20is%20safe,%20immunogenic,%20and%20highly%20infectious%20in%20healthy%20adult%20volunteers\u0026author=A. P. Durbin\u0026author=S. S. Whitehead\u0026author=J. McArthur et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B219\"\u003eA. P. Durbin, J. McArthur, J. A. Marron et al., “The live attenuated dengue serotype 1 vaccine rDEN1\u0026#x394;30 is safe and highly immunogenic in healthy adult volunteers,” \u003ci\u003eHuman Vaccines\u003c/i\u003e, vol. 2, no. 4, pp. 167–173, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20live%20attenuated%20dengue%20serotype%201%20vaccine%20rDEN1Δ30%20is%20safe%20and%20highly%20immunogenic%20in%20healthy%20adult%20volunteers\u0026author=A. P. Durbin\u0026author=J. McArthur\u0026author=J. A. Marron et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B220\"\u003eA. P. Durbin, J. H. McArthur, J. A. Marron et al., “rDEN2/4\u0026#x394;30(ME), a live attenuated chimeric dengue serotype 2 vaccine, is safe and highly immunogenic in healthy dengue-na\u0026#xef;ve adults,” \u003ci\u003eHuman Vaccines\u003c/i\u003e, vol. 2, no. 6, pp. 255–260, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=rDEN2/4Δ30(ME),%20a%20live%20attenuated%20chimeric%20dengue%20serotype%202%20vaccine,%20is%20safe%20and%20highly%20immunogenic%20in%20healthy%20dengue-naïve%20adults\u0026author=A. P. Durbin\u0026author=J. H. McArthur\u0026author=J. A. Marron et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B221\"\u003eJ. H. McArthur, A. P. Durbin, J. A. Marron et al., “Phase I clinical evaluation of rDEN4\u0026#x394;30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 79, no. 5, pp. 678–684, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Phase%20I%20clinical%20evaluation%20of%20rDEN4Δ30-200,201:%20a%20live%20attenuated%20dengue%204%20vaccine%20candidate%20designed%20for%20decreased%20hepatotoxicity\u0026author=J. H. McArthur\u0026author=A. P. Durbin\u0026author=J. A. Marron et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B222\"\u003eJ. E. Blaney Jr., N. S. Sathe, L. Goddard et al., “Dengue virus type 3 vaccine candidates generated by introduction of deletions in the \u003cmath id=\"M2\" xmlns=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmrow\u003e\u003cmsup\u003e\u003cmn\u003e3\u003c/mn\u003e\u003cmo\u003e\u0026#x2032;\u003c/mo\u003e\u003c/msup\u003e\u003c/mrow\u003e\u003c/math\u003e untranslated region (\u003cmath id=\"M3\" xmlns=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmrow\u003e\u003cmsup\u003e\u003cmn\u003e3\u003c/mn\u003e\u003cmo\u003e\u0026#x2032;\u003c/mo\u003e\u003c/msup\u003e\u003c/mrow\u003e\u003c/math\u003e-UTR) or by exchange of the DENV-3 \u003cmath id=\"M4\" xmlns=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmrow\u003e\u003cmsup\u003e\u003cmn\u003e3\u003c/mn\u003e\u003cmo\u003e\u0026#x2032;\u003c/mo\u003e\u003c/msup\u003e\u003c/mrow\u003e\u003c/math\u003e-UTR with that of DENV-4,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 26, no. 6, pp. 817–828, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2007.11.082\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20virus%20type%203%20vaccine%20candidates%20generated%20by%20introduction%20of%20deletions%20in%20the%20\u003cinline-formula\u003e\u003cmml:math%20id=\"M2\"%20xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmml:mrow\u003e\u003cmml:msup\u003e\u003cmml:mn\u003e3\u003c/mml:mn\u003e\u003cmml:mo\u003e′\u003c/mml:mo\u003e\u003c/mml:msup\u003e\u003c/mml:mrow\u003e\u003c/mml:math\u003e\u003c/inline-formula\u003e%20untranslated%20region%20(\u003cinline-formula\u003e\u003cmml:math%20id=\"M3\"%20xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmml:mrow\u003e\u003cmml:msup\u003e\u003cmml:mn\u003e3\u003c/mml:mn\u003e\u003cmml:mo\u003e′\u003c/mml:mo\u003e\u003c/mml:msup\u003e\u003c/mml:mrow\u003e\u003c/mml:math\u003e\u003c/inline-formula\u003e-UTR)%20or%20by%20exchange%20of%20the%20DENV-3%20\u003cinline-formula\u003e\u003cmml:math%20id=\"M4\"%20xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmml:mrow\u003e\u003cmml:msup\u003e\u003cmml:mn\u003e3\u003c/mml:mn\u003e\u003cmml:mo\u003e′\u003c/mml:mo\u003e\u003c/mml:msup\u003e\u003c/mml:mrow\u003e\u003c/mml:math\u003e\u003c/inline-formula\u003e-UTR%20with%20that%20of%20DENV-4\u0026author=J. E. Blaney Jr.\u0026author=N. S. Sathe\u0026author=L. Goddard et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B223\"\u003eM. G. Guzman, L. Hermida, L. Bernardo, R. Ramirez, and G. Guill\u0026#xe9;n, “Domain III of the envelope protein as a dengue vaccine target,” \u003ci\u003eExpert Review of Vaccines\u003c/i\u003e, vol. 9, no. 2, pp. 137–147, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1586/erv.09.139\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Domain%20III%20of%20the%20envelope%20protein%20as%20a%20dengue%20vaccine%20target\u0026author=M. G. Guzman\u0026author=L. Hermida\u0026author=L. Bernardo\u0026author=R. Ramirez\u0026author=\u0026author=G. Guillén\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B224\"\u003eF. Guirakhoo, S. Kitckener, D. Morrison et al., “Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial for safety and immunogenicity\u0026#x2014;effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes,” \u003ci\u003eHuman Vaccines\u003c/i\u003e, vol. 2, no. 2, pp. 60–67, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Live%20attenuated%20chimeric%20yellow%20fever%20dengue%20type%202%20(ChimeriVax-DEN2)%20vaccine:%20phase%20I%20clinical%20trial%20for%20safety%20and%20immunogenicity—effect%20of%20yellow%20fever%20pre-immunity%20in%20induction%20of%20cross%20neutralizing%20antibody%20responses%20to%20all%204%20dengue%20serotypes\u0026author=F. Guirakhoo\u0026author=S. Kitckener\u0026author=D. Morrison et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B225\"\u003eB. Guy, N. Nougarede, S. Begue et al., “Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 26, no. 45, pp. 5712–5721, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2008.08.019\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Cell-mediated%20immunity%20induced%20by%20chimeric%20tetravalent%20dengue%20vaccine%20in%20naive%20or%20flavivirus-primed%20subjects\u0026author=B. Guy\u0026author=N. Nougarede\u0026author=S. Begue et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B226\"\u003eB. Guy, F. Guirakhoo, V. Barban, S. Higgs, T. P. Monath, and J. Lang, “Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 28, no. 3, pp. 632–649, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2009.09.098\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Preclinical%20and%20clinical%20development%20of%20YFV%2017D-based%20chimeric%20vaccines%20against%20dengue,%20West%20Nile%20and%20Japanese%20encephalitis%20viruses\u0026author=B. Guy\u0026author=F. Guirakhoo\u0026author=V. Barban\u0026author=S. Higgs\u0026author=T. P. Monath\u0026author=\u0026author=J. Lang\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B227\"\u003eB. Guy, M. Saville, and J. Lang, “Development of Sanofi Pasteur tetravalent dengue vaccine,” \u003ci\u003eHuman Vaccines\u003c/i\u003e, vol. 6, no. 9, pp. 696–705, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4161.hv.6.9.12739\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Development%20of%20Sanofi%20Pasteur%20tetravalent%20dengue%20vaccine\u0026author=B. Guy\u0026author=M. Saville\u0026author=\u0026author=J. Lang\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B228\"\u003eA. Sabchareon, D. Wallace, C. Sirivichayakul et al., “Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial,” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 380, no. 9853, pp. 1559–1567, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Protective%20efficacy%20of%20the%20recombinant,%20live-attenuated,%20CYD%20tetravalent%20dengue%20vaccine%20in%20Thai%20schoolchildren:%20a%20randomised,%20controlled%20phase%202b%20trial\u0026author=A. Sabchareon\u0026author=D. Wallace\u0026author=C. Sirivichayakul et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B229\"\u003eS. Swaminathan, N. Khanna, B. Herring, and S. Mahalingam, “Dengue vaccine efficacy trial: does interference cause failure?” \u003ci\u003eThe Lancet Infectious Diseases\u003c/i\u003e, vol. 13, no. 3, pp. 191–192, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20vaccine%20efficacy%20trial:%20does%20interference%20cause%20failure?\u0026author=S. Swaminathan\u0026author=N. Khanna\u0026author=B. Herring\u0026author=\u0026author=S. Mahalingam\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B230\"\u003eM. G. Guzman, A. Alvarez, S. Vazquez et al., “Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002,” \u003ci\u003eInternational Journal of Infectious Diseases\u003c/i\u003e, vol. 16, no. 3, pp. e198–e203, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.ijid.2011.09.026\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Epidemiological%20studies%20on%20dengue%20virus%20type%203%20in%20Playa%20municipality,%20Havana,%20Cuba,%202001-2002\u0026author=M. G. Guzman\u0026author=A. Alvarez\u0026author=S. Vazquez et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B231\"\u003eS. B. Halstead, “Dengue vaccine development: a 75\u0026#x25; solution?” \u003ci\u003eThe Lancet\u003c/i\u003e, vol. 380, no. 9853, pp. 1535–1536, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue%20vaccine%20development:%20a%2075%%20solution?\u0026author=S. B. Halstead\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B232\"\u003eW. M. P. B. Wahala and A. M. de Silva, “The human antibody response to dengue virus infection,” \u003ci\u003eViruses\u003c/i\u003e, vol. 3, no. 12, pp. 2374–2395, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.3390/v3122374\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20human%20antibody%20response%20to%20dengue%20virus%20infection\u0026author=W. M. P. B. Wahala \u0026author=A. M. de Silva\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B233\"\u003eJ. E. Osorio, C. Y.-H. Huang, R. M. Kinney, and D. T. Stinchcomb, “Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 29, no. 42, pp. 7251–7260, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2011.07.020\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Development%20of%20DENVax:%20a%20chimeric%20dengue-2%20PDK-53-based%20tetravalent%20vaccine%20for%20protection%20against%20dengue%20fever\u0026author=J. E. Osorio\u0026author=C. Y.-H. Huang\u0026author=R. M. Kinney\u0026author=\u0026author=D. T. Stinchcomb\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B234\"\u003eJ. E. Osorio, J. N. Brewoo, S. J. Silengo et al., “Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in cynomolgus macaques,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 84, no. 6, pp. 978–987, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.4269/ajtmh.2011.10-0592\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Efficacy%20of%20a%20tetravalent%20chimeric%20dengue%20vaccine%20(DENVax)%20in%20cynomolgus%20macaques\u0026author=J. E. Osorio\u0026author=J. N. Brewoo\u0026author=S. J. Silengo et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B235\"\u003eJ. N. Brewoo, R. M. Kinney, T. D. Powell et al., “Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 30, no. 8, pp. 1513–1520, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2011.11.072\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Immunogenicity%20and%20efficacy%20of%20chimeric%20dengue%20vaccine%20(DENVax)%20formulations%20in%20interferon-deficient%20AG129%20mice\u0026author=J. N. Brewoo\u0026author=R. M. Kinney\u0026author=T. D. Powell et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B236\"\u003eL. Hermida, L. Bernardo, J. Mart\u0026#xed;n et al., “A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates,” \u003ci\u003eVaccine\u003c/i\u003e, vol. 24, no. 16, pp. 3165–3171, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.vaccine.2006.01.036\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20recombinant%20fusion%20protein%20containing%20the%20domain%20III%20of%20the%20dengue-2%20envelope%20protein%20is%20immunogenic%20and%20protective%20in%20nonhuman%20primates\u0026author=L. Hermida\u0026author=L. Bernardo\u0026author=J. Martín et al.\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B237\"\u003eL. Bernardo, A. Izquierdo, M. Alvarez et al., “Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 80, no. 2, pp. 194–199, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.antiviral.2008.06.005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Immunogenicity%20and%20protective%20efficacy%20of%20a%20recombinant%20fusion%20protein%20containing%20the%20domain%20III%20of%20the%20dengue%201%20envelope%20protein%20in%20non-human%20primates\u0026author=L. Bernardo\u0026author=A. Izquierdo\u0026author=M. Alvarez et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B238\"\u003eA. Izquierdo, L. Bernardo, J. Martin et al., “Serotype-specificity of recombinant fusion proteins containing domain III of dengue virus,” \u003ci\u003eVirus Research\u003c/i\u003e, vol. 138, no. 1-2, pp. 135–138, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virusres.2008.08.008\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Serotype-specificity%20of%20recombinant%20fusion%20proteins%20containing%20domain%20III%20of%20dengue%20virus\u0026author=A. Izquierdo\u0026author=L. Bernardo\u0026author=J. Martin et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B239\"\u003eB. Etemad, G. Batra, R. Raut et al., “An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes,” \u003ci\u003eThe American Journal of Tropical Medicine and Hygiene\u003c/i\u003e, vol. 79, no. 3, pp. 353–363, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=An%20envelope%20domain%20III-based%20chimeric%20antigen%20produced%20in%20Pichia%20pastoris%20elicits%20neutralizing%20antibodies%20against%20all%20four%20dengue%20virus%20serotypes\u0026author=B. Etemad\u0026author=G. Batra\u0026author=R. Raut et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B240\"\u003eG. Gao, Q. Wang, Z. Dai et al., “Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes,” \u003ci\u003eHuman Gene Therapy\u003c/i\u003e, vol. 19, no. 9, pp. 927–936, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1089/hum.2008.011\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Adenovirus-based%20vaccines%20generate%20cytotoxic%20T%20lymphocytes%20to%20epitopes%20of%20NS1%20from%20dengue%20virus%20that%20are%20present%20in%20all%20major%20serotypes\u0026author=G. Gao\u0026author=Q. Wang\u0026author=Z. Dai et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B241\"\u003eS. Brandler, M. Lucas-Hourani, A. Moris et al., “Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus,” \u003ci\u003ePLoS Neglected Tropical Diseases\u003c/i\u003e, vol. 1, no. 3, article e96, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0000096\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Pediatric%20measles%20vaccine%20expressing%20a%20dengue%20antigen%20induces%20durable%20serotype-specific%20neutralizing%20antibodies%20to%20dengue%20virus\u0026author=S. Brandler\u0026author=M. Lucas-Hourani\u0026author=A. Moris et al.\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B242\"\u003eI. Vald\u0026#xe9;s, L. Bernardo, L. Gil et al., “A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice,” \u003ci\u003eVirology\u003c/i\u003e, vol. 394, no. 2, pp. 249–258, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.virol.2009.08.029\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20novel%20fusion%20protein%20domain%20III-capsid%20from%20dengue-2,%20in%20a%20highly%20aggregated%20form,%20induces%20a%20functional%20immune%20response%20and%20protection%20in%20mice\u0026author=I. Valdés\u0026author=L. Bernardo\u0026author=L. Gil et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B243\"\u003eE. Marcos, L. Gil, L. Lazo et al., “Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus,” \u003ci\u003eArchives of Virology\u003c/i\u003e, vol. 158, no. 1, pp. 225–230, 2013. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Purified%20and%20highly%20aggregated%20chimeric%20protein%20DIIIC-2%20induces%20a%20functional%20immune%20response%20in%20mice%20against%20dengue%202%20virus\u0026author=E. Marcos\u0026author=L. Gil\u0026author=L. Lazo et al.\u0026publication_year=2013\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B244\"\u003eL. Lazo, L. Gil, C. Lopez et al., “A vaccine formulation consisting of nucleocapsid-like particles from Dengue-2 and the fusion protein P64k-domain III from Dengue-1 induces a protective immune response against the homologous serotypes in mice,” \u003ci\u003eActa Tropica\u003c/i\u003e, vol. 124, no. 2, pp. 107–112, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.actatropica.2012.06.006\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20vaccine%20formulation%20consisting%20of%20nucleocapsid-like%20particles%20from%20Dengue-2%20and%20the%20fusion%20protein%20P64k-domain%20III%20from%20Dengue-1%20induces%20a%20protective%20immune%20response%20against%20the%20homologous%20serotypes%20in%20mice\u0026author=L. Lazo\u0026author=L. Gil\u0026author=C. Lopez et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B245\"\u003eL. Gil, L. Bernardo, A. Pavon et al., “Recombinant nucleocapsid-like particles from dengue-2 induce functional serotype-specific cell-mediated immunity in mice,” \u003ci\u003eJournal of General Virology\u003c/i\u003e, vol. 93, part 6, pp. 1204–1214, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Recombinant%20nucleocapsid-like%20particles%20from%20dengue-2%20induce%20functional%20serotype-specific%20cell-mediated%20immunity%20in%20mice\u0026author=L. Gil\u0026author=L. Bernardo\u0026author=A. Pavon et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B246\"\u003eC.-Y. Chiang, S.-J. Liu, J.-P. Tsai et al., “A novel single-dose dengue subunit vaccine induces memory immune responses,” \u003ci\u003ePLoS ONE\u003c/i\u003e, vol. 6, no. 8, Article ID e23319, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pone.0023319\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20novel%20single-dose%20dengue%20subunit%20vaccine%20induces%20memory%20immune%20responses\u0026author=C.-Y. Chiang\u0026author=S.-J. Liu\u0026author=J.-P. Tsai et al.\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B247\"\u003eC. Y. Chiang, M. H. Huang, C. H. Hsieh et al., “Dengue-1 envelope protein domain III along with PELC and CpG oligodeoxynucleotides synergistically enhances immune responses,” \u003ci\u003ePLOS Neglected Tropical Diseases\u003c/i\u003e, vol. 6, no. 5, Article ID e1645, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1371/journal.pntd.0001645\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Dengue-1%20envelope%20protein%20domain%20III%20along%20with%20PELC%20and%20CpG%20oligodeoxynucleotides%20synergistically%20enhances%20immune%20responses\u0026author=C. Y. Chiang\u0026author=M. H. Huang\u0026author=C. H. Hsieh et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B248\"\u003eS. B. Halstead, “Controversies in dengue pathogenesis,” \u003ci\u003ePaediatrics and International Child Health\u003c/i\u003e, vol. 32, supplement 1, pp. 5–9, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1179/2046904712Z.00000000045\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Controversies%20in%20dengue%20pathogenesis\u0026author=S. B. Halstead\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B249\"\u003eS. J. Thomas and T. P. Endy, “Critical issues in dengue vaccine development,” \u003ci\u003eCurrent Opinion in Infectious Diseases\u003c/i\u003e, vol. 24, no. 5, pp. 442–450, 2011. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1097/QCO.0b013e32834a1b0b\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Critical%20issues%20in%20dengue%20vaccine%20development\u0026author=S. J. Thomas \u0026author=T. P. Endy\u0026publication_year=2011\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B250\"\u003eJ. D. Brien, S. K. Austin, S. Sukupolvi-Petty et al., “Genotype-specific neutralization and protection by antibodies against dengue virus type 3,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 84, no. 20, pp. 10630–10643, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.01190-10\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Genotype-specific%20neutralization%20and%20protection%20by%20antibodies%20against%20dengue%20virus%20type%203\u0026author=J. D. Brien\u0026author=S. K. Austin\u0026author=S. Sukupolvi-Petty et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B251\"\u003eM. Bollati, K. Alvarez, R. Assenberg et al., “Structure and functionality in flavivirus NS-proteins: perspectives for drug design,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 87, no. 2, pp. 125–148, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.antiviral.2009.11.009\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Structure%20and%20functionality%20in%20flavivirus%20NS-proteins:%20perspectives%20for%20drug%20design\u0026author=M. Bollati\u0026author=K. Alvarez\u0026author=R. Assenberg et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B252\"\u003eE. A. Gould, T. Solomon, and J. S. Mackenzie, “Does antiviral therapy have a role in the control of Japanese encephalitis?” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 78, no. 1, pp. 140–149, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.antiviral.2007.10.005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Does%20antiviral%20therapy%20have%20a%20role%20in%20the%20control%20of%20Japanese%20encephalitis?\u0026author=E. A. Gould\u0026author=T. Solomon\u0026author=\u0026author=J. S. Mackenzie\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B253\"\u003eR. M. Kinney, C. Y.-H. Huang, B. C. Rose et al., “Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 79, no. 8, pp. 5116–5128, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.79.8.5116-5128.2005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Inhibition%20of%20dengue%20virus%20serotypes%201%20to%204%20in%20vero%20cell%20cultures%20with%20morpholino%20oligomers\u0026author=R. M. Kinney\u0026author=C. Y.-H. Huang\u0026author=B. C. Rose et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B254\"\u003eD. A. Stein, C. Y.-H. Huang, S. Silengo et al., “Treatment of AG129 mice with antisense morpholino oligomers increases survival time following challenge with dengue 2 virus,” \u003ci\u003eJournal of Antimicrobial Chemotherapy\u003c/i\u003e, vol. 62, no. 3, pp. 555–565, 2008. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/jac/dkn221\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Treatment%20of%20AG129%20mice%20with%20antisense%20morpholino%20oligomers%20increases%20survival%20time%20following%20challenge%20with%20dengue%202%20virus\u0026author=D. A. Stein\u0026author=C. Y.-H. Huang\u0026author=S. Silengo et al.\u0026publication_year=2008\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B255\"\u003eP. Kumar, H. Wu, J. L. McBride et al., “Transvascular delivery of small interfering RNA to the central nervous system,” \u003ci\u003eNature\u003c/i\u003e, vol. 448, no. 7149, pp. 39–43, 2007. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1038/nature05901\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Transvascular%20delivery%20of%20small%20interfering%20RNA%20to%20the%20central%20nervous%20system\u0026author=P. Kumar\u0026author=H. Wu\u0026author=J. L. McBride et al.\u0026publication_year=2007\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B256\"\u003eD. Ray and P.-Y. Shi, “Recent advances in flavivirus antiviral drug discovery and vaccine development,” \u003ci\u003eRecent Patents on Anti-Infective Drug Discovery\u003c/i\u003e, vol. 1, no. 1, pp. 45–55, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.2174/157489106775244055\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Recent%20advances%20in%20flavivirus%20antiviral%20drug%20discovery%20and%20vaccine%20development\u0026author=D. Ray \u0026author=P.-Y. Shi\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B257\"\u003eS. Shigeta, S. Mori, E. Kodama, J. Kodama, K. Takahashi, and T. Yamase, “Broad spectrum anti-RNA virus activities of titanium and vanadium substituted polyoxotungstates,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 58, no. 3, pp. 265–271, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0166-3542(03)00009-3\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Broad%20spectrum%20anti-RNA%20virus%20activities%20of%20titanium%20and%20vanadium%20substituted%20polyoxotungstates\u0026author=S. Shigeta\u0026author=S. Mori\u0026author=E. Kodama\u0026author=J. Kodama\u0026author=K. Takahashi\u0026author=\u0026author=T. Yamase\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B258\"\u003eL. B. Talarico, C. A. Pujol, R. G. M. Zibetti et al., “The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 66, no. 2-3, pp. 103–110, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.antiviral.2005.02.001\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20antiviral%20activity%20of%20sulfated%20polysaccharides%20against%20dengue%20virus%20is%20dependent%20on%20virus%20serotype%20and%20host%20cell\u0026author=L. B. Talarico\u0026author=C. A. Pujol\u0026author=R. G. M. Zibetti et al.\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B259\"\u003eL. Ono, W. Wollinger, I. M. Rocco, T. L. M. Coimbra, P. A. J. Gorin, and M.-R. Sierakowski, “In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain),” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 60, no. 3, pp. 201–208, 2003. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0166-3542(03)00175-X\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=In%20vitro%20and%20in%20vivo%20antiviral%20properties%20of%20sulfated%20galactomannans%20against%20yellow%20fever%20virus%20(BeH111%20strain)%20and%20dengue%201%20virus%20(Hawaii%20strain)\u0026author=L. Ono\u0026author=W. Wollinger\u0026author=I. M. Rocco\u0026author=T. L. M. Coimbra\u0026author=P. A. J. Gorin\u0026author=\u0026author=M.-R. Sierakowski\u0026publication_year=2003\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B260\"\u003eP. Leyssen, A. Van Lommel, C. Drosten, H. Schmitz, E. De Clercq, and J. Neyts, “A novel model for the study of the therapy of flavivirus infections using the Modoc virus,” \u003ci\u003eVirology\u003c/i\u003e, vol. 279, no. 1, pp. 27–37, 2001. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1006/viro.2000.0723\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20novel%20model%20for%20the%20study%20of%20the%20therapy%20of%20flavivirus%20infections%20using%20the%20Modoc%20virus\u0026author=P. Leyssen\u0026author=A. Van Lommel\u0026author=C. Drosten\u0026author=H. Schmitz\u0026author=E. De Clercq\u0026author=\u0026author=J. Neyts\u0026publication_year=2001\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B261\"\u003eP. Leyssen, J. Balzarini, E. De Clercq, and J. Neyts, “The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase,” \u003ci\u003eJournal of Virology\u003c/i\u003e, vol. 79, no. 3, pp. 1943–1947, 2005. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/JVI.79.3.1943-1947.2005\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=The%20predominant%20mechanism%20by%20which%20ribavirin%20exerts%20its%20antiviral%20activity%20in%20vitro%20against%20flaviviruses%20and%20paramyxoviruses%20is%20mediated%20by%20inhibition%20of%20IMP%20dehydrogenase\u0026author=P. Leyssen\u0026author=J. Balzarini\u0026author=E. De Clercq\u0026author=\u0026author=J. Neyts\u0026publication_year=2005\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B262\"\u003eJ. D. Morrey, D. F. Smee, R. W. Sidwell, and C. Tseng, “Identification of active antiviral compounds against a New York isolate of West Nile virus,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 55, no. 1, pp. 107–116, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0166-3542(02)00013-X\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Identification%20of%20active%20antiviral%20compounds%20against%20a%20New%20York%20isolate%20of%20West%20Nile%20virus\u0026author=J. D. Morrey\u0026author=D. F. Smee\u0026author=R. W. Sidwell\u0026author=\u0026author=C. Tseng\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B263\"\u003eJ. W. Huggins, “Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug,” \u003ci\u003eReviews of Infectious Diseases\u003c/i\u003e, vol. 11, pp. S750–761, 1989. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Prospects%20for%20treatment%20of%20viral%20hemorrhagic%20fevers%20with%20ribavirin,%20a%20broad-spectrum%20antiviral%20drug\u0026author=J. W. Huggins\u0026publication_year=1989\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B264\"\u003eJ. W. Huggins, R. K. Robins, and P. G. Canonico, “Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses,” \u003ci\u003eAntimicrobial Agents and Chemotherapy\u003c/i\u003e, vol. 26, no. 4, pp. 476–480, 1984. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Synergistic%20antiviral%20effects%20of%20ribavirin%20and%20the%20C-nucleoside%20analogs%20tiazofurin%20and%20selenazofurin%20against%20togaviruses,%20bunyaviruses,%20and%20arenaviruses\u0026author=J. W. Huggins\u0026author=R. K. Robins\u0026author=\u0026author=P. G. Canonico\u0026publication_year=1984\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B265\"\u003eJ. Neyts, A. Meerbach, P. McKenna, and E. De Clercq, “Use of the yellow fever virus vaccine strain 17D for the study of strategies for the treatment of yellow fever virus infections,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 30, no. 2-3, pp. 125–132, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/0166-3542(96)89697-5\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Use%20of%20the%20yellow%20fever%20virus%20vaccine%20strain%2017D%20for%20the%20study%20of%20strategies%20for%20the%20treatment%20of%20yellow%20fever%20virus%20infections\u0026author=J. Neyts\u0026author=A. Meerbach\u0026author=P. McKenna\u0026author=\u0026author=E. De Clercq\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B266\"\u003eF. J. Malinoski, S. E. Hasty, M. A. Ussery, and J. M. Dalrymple, “Prophylactic ribavirin treatment of dengue type 1 infection in rhesus monkeys,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 13, no. 3, pp. 139–150, 1990. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/0166-3542(90)90029-7\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Prophylactic%20ribavirin%20treatment%20of%20dengue%20type%201%20infection%20in%20rhesus%20monkeys\u0026author=F. J. Malinoski\u0026author=S. E. Hasty\u0026author=M. A. Ussery\u0026author=\u0026author=J. M. Dalrymple\u0026publication_year=1990\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B267\"\u003eW. C. Koff, R. D. Pratt, J. L. Elm Jr., C. N. Venkateshan, and S. B. Halstead, “Treatment of intracranial dengue virus infections in mice with a lipophilic derivative of ribavirin,” \u003ci\u003eAntimicrobial Agents and Chemotherapy\u003c/i\u003e, vol. 24, no. 1, pp. 134–136, 1983. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Treatment%20of%20intracranial%20dengue%20virus%20infections%20in%20mice%20with%20a%20lipophilic%20derivative%20of%20ribavirin\u0026author=W. C. Koff\u0026author=R. D. Pratt\u0026author=J. L. Elm Jr.\u0026author=C. N. Venkateshan\u0026author=\u0026author=S. B. Halstead\u0026publication_year=1983\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B268\"\u003eP. LaColla and J. P. Sommadossi, “Methods and compositions for treating flaviviruses and pestiviruses,” US6812219, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Methods%20and%20compositions%20for%20treating%20flaviviruses%20and%20pestiviruses\u0026author=P. LaColla \u0026author=J. P. Sommadossi\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B269\"\u003eM. S. Diamond, M. Zachariah, and E. Harris, “Mycophenolic acid inhibits dengue virus infection by preventing replication of viral RNA,” \u003ci\u003eVirology\u003c/i\u003e, vol. 304, no. 2, pp. 211–221, 2002. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1006/viro.2002.1685\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Mycophenolic%20acid%20inhibits%20dengue%20virus%20infection%20by%20preventing%20replication%20of%20viral%20RNA\u0026author=M. S. Diamond\u0026author=M. Zachariah\u0026author=\u0026author=E. Harris\u0026publication_year=2002\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B270\"\u003eM. D. Sintchak, M. A. Fleming, O. Futer et al., “Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid,” \u003ci\u003eCell\u003c/i\u003e, vol. 85, no. 6, pp. 921–930, 1996. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/S0092-8674(00)81275-1\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Structure%20and%20mechanism%20of%20inosine%20monophosphate%20dehydrogenase%20in%20complex%20with%20the%20immunosuppressant%20mycophenolic%20acid\u0026author=M. D. Sintchak\u0026author=M. A. Fleming\u0026author=O. Futer et al.\u0026publication_year=1996\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B271\"\u003eD. P. Stamos and R. S. Bethiel, “Prodrugs of carbamate inhibitors of IMPDH,” US6825224, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://scholar.google.com/scholar_lookup?title=Prodrugs%20of%20carbamate%20inhibitors%20of%20IMPDH\u0026author=D. P. Stamos \u0026author=R. S. Bethiel\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B272\"\u003eV. Nair, G. Chi, Q. Shu, J. Julander, and D. F. Smee, “A heterocyclic molecule with significant activity against dengue virus,” \u003ci\u003eBioorganic and Medicinal Chemistry Letters\u003c/i\u003e, vol. 19, no. 5, pp. 1425–1427, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.bmcl.2009.01.031\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20heterocyclic%20molecule%20with%20significant%20activity%20against%20dengue%20virus\u0026author=V. Nair\u0026author=G. Chi\u0026author=Q. Shu\u0026author=J. Julander\u0026author=\u0026author=D. F. Smee\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B273\"\u003eX. G. Zhang, P. W. Mason, E. J. Dubovi et al., “Antiviral activity of geneticin against dengue virus,” \u003ci\u003eAntiviral Research\u003c/i\u003e, vol. 83, no. 1, pp. 21–27, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.antiviral.2009.02.204\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Antiviral%20activity%20of%20geneticin%20against%20dengue%20virus\u0026author=X. G. Zhang\u0026author=P. W. Mason\u0026author=E. J. Dubovi et al.\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B274\"\u003eE. Mastrangelo, M. Pezzullo, T. De Burghgraeve et al., “Ivermectin is a potent inhibitor of flavivirus replication specifically targeting NS3 helicase activity: new prospects for an old drug,” \u003ci\u003eJournal of Antimicrobial Chemotherapy\u003c/i\u003e, vol. 67, no. 8, pp. 1884–1894, 2012. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1093/jac/dks147\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Ivermectin%20is%20a%20potent%20inhibitor%20of%20flavivirus%20replication%20specifically%20targeting%20NS3%20helicase%20activity:%20new%20prospects%20for%20an%20old%20drug\u0026author=E. Mastrangelo\u0026author=M. Pezzullo\u0026author=T. De Burghgraeve et al.\u0026publication_year=2012\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B275\"\u003eS. J. F. Kaptein, T. De Burghgraeve, M. Froeyen et al., “A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro,” \u003ci\u003eAntimicrobial Agents and Chemotherapy\u003c/i\u003e, vol. 54, no. 12, pp. 5269–5280, 2010. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/AAC.00686-10\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20derivate%20of%20the%20antibiotic%20doxorubicin%20is%20a%20selective%20inhibitor%20of%20dengue%20and%20yellow%20fever%20virus%20replication%20in%20vitro\u0026author=S. J. F. Kaptein\u0026author=T. De Burghgraeve\u0026author=M. Froeyen et al.\u0026publication_year=2010\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B276\"\u003eD. Benarroch, M.-P. Egloff, L. Mulard, C. Guerreiro, J.-L. Romette, and B. Canard, “A structural basis for the inhibition of the NS5 dengue virus mRNA \u003cmath id=\"M5\" xmlns=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmrow\u003e\u003cmsup\u003e\u003cmn\u003e2\u003c/mn\u003e\u003cmo\u003e\u0026#x2032;\u003c/mo\u003e\u003c/msup\u003e\u003c/mrow\u003e\u003c/math\u003e-O-methyltransferase domain by ribavirin \u003cmath id=\"M6\" xmlns=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmrow\u003e\u003cmsup\u003e\u003cmn\u003e5\u003c/mn\u003e\u003cmo\u003e\u0026#x2032;\u003c/mo\u003e\u003c/msup\u003e\u003c/mrow\u003e\u003c/math\u003e-triphosphate,” \u003ci\u003eJournal of Biological Chemistry\u003c/i\u003e, vol. 279, no. 34, pp. 35638–35643, 2004. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1074/jbc.M400460200\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=A%20structural%20basis%20for%20the%20inhibition%20of%20the%20NS5%20dengue%20virus%20mRNA%20\u003cinline-formula\u003e\u003cmml:math%20id=\"M5\"%20xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmml:mrow\u003e\u003cmml:msup\u003e\u003cmml:mn\u003e2\u003c/mml:mn\u003e\u003cmml:mo\u003e′\u003c/mml:mo\u003e\u003c/mml:msup\u003e\u003c/mml:mrow\u003e\u003c/mml:math\u003e\u003c/inline-formula\u003e-O-methyltransferase%20domain%20by%20ribavirin%20\u003cinline-formula\u003e\u003cmml:math%20id=\"M6\"%20xmlns:mml=\"http://www.w3.org/1998/Math/MathML\"\u003e\u003cmml:mrow\u003e\u003cmml:msup\u003e\u003cmml:mn\u003e5\u003c/mml:mn\u003e\u003cmml:mo\u003e′\u003c/mml:mo\u003e\u003c/mml:msup\u003e\u003c/mml:mrow\u003e\u003c/mml:math\u003e\u003c/inline-formula\u003e-triphosphate\u0026author=D. Benarroch\u0026author=M.-P. Egloff\u0026author=L. Mulard\u0026author=C. Guerreiro\u0026author=J.-L. Romette\u0026author=\u0026author=B. Canard\u0026publication_year=2004\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B277\"\u003eJ. G. Julander, K. Shafer, D. F. Smee, J. D. Morrey, and Y. Furuta, “Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106,” \u003ci\u003eAntimicrobial Agents and Chemotherapy\u003c/i\u003e, vol. 53, no. 1, pp. 202–209, 2009. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1128/AAC.01074-08\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Activity%20of%20T-705%20in%20a%20hamster%20model%20of%20yellow%20fever%20virus%20infection%20in%20comparison%20with%20that%20of%20a%20chemically%20related%20compound,%20T-1106\u0026author=J. G. Julander\u0026author=K. Shafer\u0026author=D. F. Smee\u0026author=J. D. Morrey\u0026author=\u0026author=Y. Furuta\u0026publication_year=2009\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003cli id=\"B278\"\u003eS. Cheenpracha, C. Karalai, C. Ponglimanont, S. Subhadhirasakul, and S. Tewtrakul, “Anti-HIV-1 protease activity of compounds from Boesenbergia pandurata,” \u003ci\u003eBioorganic and Medicinal Chemistry\u003c/i\u003e, vol. 14, no. 6, pp. 1710–1714, 2006. \u003cspan class=\"reflinks\"\u003eView at: \u003ca href=\"https://doi.org/10.1016/j.bmc.2005.10.019\"\u003ePublisher Site\u003c/a\u003e\u003cspan class =\"sep\"\u003e | \u003c/span\u003e\u003ca href=\"https://scholar.google.com/scholar_lookup?title=Anti-HIV-1%20protease%20activity%20of%20compounds%20from%20Boesenbergia%20pandurata\u0026author=S. Cheenpracha\u0026author=C. Karalai\u0026author=C. Ponglimanont\u0026author=S. Subhadhirasakul\u0026author=\u0026author=S. Tewtrakul\u0026publication_year=2006\" target=\"_blank\"\u003eGoogle Scholar\u003c/a\u003e\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e\u003c/div\u003e\u003cdiv class=\"xml-content\"\u003e\u003ch4 class=\"copyright\" id=\"copyright\"\u003eCopyright\u003c/h4\u003e\u003cp\u003eCopyright \u0026#xa9; 2013 Rosmari Rodriguez-Roche and Ernest A. Gould. This is an open access article distributed under the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/3.0/\"\u003e  Creative Commons Attribution License\u003c/a\u003e, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\u003c/p\u003e\u003c/div\u003e","section_links":[{"hash":"abstract","title":"Abstract"},{"hash":"introduction","title":"Introduction"},{"hash":"dengue-fever/haemorrhagic-fever/shock-syndrome","title":"Dengue Fever/Haemorrhagic Fever/Shock Syndrome"},{"hash":"disease-control-strategies","title":"Disease Control Strategies"},{"hash":"acknowledgments","title":"Acknowledgments"},{"hash":"references","title":"References"},{"hash":"copyright","title":"Copyright"}],"style":"","block_links":[{"title":"PDF","type":"PDF","url":"downloads.hindawi.com/journals/bmri/2013/690835.pdf","childrens":[]},{"title":"Download Reference","type":"RIS","url":"/journals/bmri/2013/690835.ris","childrens":[]},{"title":"Download other formats","type":"","url":"","childrens":[{"title":"ePub","type":"ePUB","url":"downloads.hindawi.com/journals/bmri/2013/690835.epub"},{"title":"XML","type":"XML","url":"downloads.hindawi.com/journals/bmri/2013/690835.xml"}]}],"articleStats":{"no_of_views":8040,"no_of_downloads":2161,"no_of_citations":36},"relatedArticleChildren":{"articles":[]},"alertMessage":{"HIGH":[],"MODERATE":[],"LOW":[]}},"year":"2013","statusCode":false},"currentUrl":"https://www.hindawi.com/journals/bmri/2013/690835/","siteUrl":"https://www.hindawi.com","currentPath":"/journals/bmri/2013/690835/","host":"www.hindawi.com"},"page":"/journal_article","query":{},"buildId":"Jvy0o2KWP7OlB1-MPkheK","dynamicBuildId":false,"assetPrefix":"https://static-01.hindawi.com/next_assets/Jvy0o2KWP7OlB1-MPkheK"}</script><script async="" id="__NEXT_PAGE__/journal_article" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/journal_article.js.download"></script><script async="" id="__NEXT_PAGE__/_app" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/_app.js.download"></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/webpack-8ed9452df514b4d17d80.js.download" async=""></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/common.2a9dff3f2099883d2806.js.download" async=""></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/_error.js_stat_b7deff4b.0ab4c1ff25f2c21719fe.js.download" async=""></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/main-842359be17b4237f7e99.js.download" async=""></script><script src="./Understanding the Dengue Viruses and Progress towards Their Control_files/main.js.e4b62d8672acbfaed35d.js.download" async=""></script><iframe name="__tcfapiLocator" title="CMP Locator" __idm_frm__="207" style="display: none;" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/saved_resource.html"></iframe><script type="text/javascript" id="">!function(d,e){var b="00710028145582dfb23e09a1e9f3ca4d73";if(d.obApi){var c=function(a){return"[object Array]"===Object.prototype.toString.call(a)?a:[a]};d.obApi.marketerId=c(d.obApi.marketerId).concat(c(b))}else{var a=d.obApi=function(){a.dispatch?a.dispatch.apply(a,arguments):a.queue.push(arguments)};a.version="1.1";a.loaded=!0;a.marketerId=b;a.queue=[];b=e.createElement("script");b.async=!0;b.src="//amplify.outbrain.com/cp/obtp.js";b.type="text/javascript";c=e.getElementsByTagName("script")[0];
c.parentNode.insertBefore(b,c)}}(window,document);obApi("track","PAGEVIEW");</script>
<script type="text/javascript" id="">!function(d,e){var b="00710028145582dfb23e09a1e9f3ca4d73";if(d.obApi){var c=function(a){return"[object Array]"===Object.prototype.toString.call(a)?a:[a]};d.obApi.marketerId=c(d.obApi.marketerId).concat(c(b))}else{var a=d.obApi=function(){a.dispatch?a.dispatch.apply(a,arguments):a.queue.push(arguments)};a.version="1.1";a.loaded=!0;a.marketerId=b;a.queue=[];b=e.createElement("script");b.async=!0;b.src="//amplify.outbrain.com/cp/obtp.js";b.type="text/javascript";c=e.getElementsByTagName("script")[0];
c.parentNode.insertBefore(b,c)}}(window,document);obApi("track","PAGE_VIEW");</script>

<script type="text/javascript" id="">!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version="2.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://connect.facebook.net/en_US/fbevents.js");fbq("init","355556641464051");fbq("track","PageView");</script>
<script type="text/javascript" id="">(function(d,a,b,f,e){d[e]=d[e]||[];d[e].push({projectId:"10000",properties:{pixelId:"10076247"}});var c=a.createElement(b);c.src=f;c.async=!0;c.onload=c.onreadystatechange=function(){var a=this.readyState,c=d[e];if(!a||"complete"==a||"loaded"==a)try{var b=YAHOO.ywa.I13N.fireBeacon;d[e]=[];d[e].push=function(a){b([a])};b(c)}catch(g){}};a=a.getElementsByTagName(b)[0];b=a.parentNode;b.insertBefore(c,a)})(window,document,"script","https://s.yimg.com/wi/ytc.js","dotq");</script><script type="text/javascript" id="">(function(c,d,e,f,g,a,b){c[e]=c[e]||[];a=d.createElement(f);a.async=1;a.src=g;b=d.getElementsByTagName(f)[0];b.parentNode.insertBefore(a,b)})(window,document,"_gscq","script","//widgets.getsitecontrol.com/191208/script.js");</script><link rel="stylesheet" type="text/css" href="./Understanding the Dengue Viruses and Progress towards Their Control_files/bib-related-content.min.css">
<script type="text/javascript" id="bib--rcm-src" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/bib-related-content.min.js.download"></script><div style="width:0px; height:0px; display:none; visibility:hidden;" id="batBeacon0.6225607856161675"><img style="width:0px; height:0px; display:none; visibility:hidden;" id="batBeacon0.9703227288854674" width="0" height="0" alt="" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/0"></div><iframe name="_hjRemoteVarsFrame" title="_hjRemoteVarsFrame" id="_hjRemoteVarsFrame" src="./Understanding the Dengue Viruses and Progress towards Their Control_files/box-469cf41adb11dc78be68c1ae7f9457a4.html" style="display: none !important; width: 1px !important; height: 1px !important; opacity: 0 !important; pointer-events: none !important;"></iframe><div id="onetrust-consent-sdk"><div class="onetrust-pc-dark-filter hide fade-in"></div><div id="onetrust-pc-sdk" class="ot-sdk-container otPcTab hide fade-in" lang="en"><!-- pc header --><div class="pc-header"><!-- Header logo --><div class="pc-logo-container"><div class="pc-logo" style="background-image: url(&quot;https://cdn.cookielaw.org/logos/7e91e77d-7186-49a0-8459-f4a0113627ee/6155aa7c-fbb2-454e-a360-220e655eb7f6/hindawi-logo-png.png&quot;)"></div></div><div class="pc-title-container"><h2 id="pc-title">Privacy Preference Center</h2><div class="pc-close-btn-container"><a href="javascript:void(0)" id="close-pc-btn-handler" class="pc-close-button close-icon" role="button" aria-label="Close Button" title="Close"></a></div></div></div><!-- content --><div id="content"><!-- Groups / Sub groups with cookies --><div class="main-content pc-content"><div class="ot-sdk-container groups-container"><div class="ot-sdk-row"><!-- About Privacy container --><div class="ot-sdk-column"><div class="ot-sdk-four ot-sdk-columns group active-group category-menu-switch-handler"><h3 id="privacy-text">Your Privacy</h3></div></div><div class="ot-sdk-eight ot-sdk-columns description-container"><h3 id="pc-privacy-header">Your Privacy</h3><p id="pc-policy-text" class="group-description">When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
                        <a href="https://cookiepedia.co.uk/giving-consent-to-cookies" class="privacy-notice-link" target="_blank" aria-label="This opens cookie policy in a new window">More information</a></p></div><ul class="category-group"><li class="category-item" data-optanongroupid="C0001"><div class="ot-sdk-column"><div class="ot-sdk-four ot-sdk-columns group category-menu-switch-handler" role="button"><h3 id="ot-header-id-C0001">Strictly Necessary Cookies</h3></div></div><div class="ot-sdk-eight ot-sdk-columns description-container hide"><div class="group-toggle"><h3 class="category-header">Strictly Necessary Cookies</h3><div class="toggle-group"><div class="always-active">Always Active</div></div></div><p class="group-description">These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. &nbsp; &nbsp;You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.</p><!-- sub groups --><div class="category-vendors-list-container"></div><div class="category-host-list-container"></div></div></li><li class="category-item" data-optanongroupid="C0002"><div class="ot-sdk-column"><div class="ot-sdk-four ot-sdk-columns group category-menu-switch-handler" role="button"><h3 id="ot-header-id-C0002">Performance Cookies</h3></div></div><div class="ot-sdk-eight ot-sdk-columns description-container hide"><div class="group-toggle"><h3 class="category-header">Performance Cookies</h3><div class="toggle-group"><div class="toggle"><div class="checkbox"><!-- DYNAMICALLY GENERATE Input ID  --> <input id="ot-group-id-C0002" class="category-switch-handler" title="Location Based Ads Toggle" type="checkbox" aria-label="personalization-cookies" name="ot-group-id-C0002" data-optanongroupid="C0002" aria-describedby="ot-header-id-C0002"> <label for="ot-group-id-C0002"><span class="label-text">Performance Cookies</span></label><!-- DYNAMICALLY GENERATE Input ID  --></div></div></div></div><p class="group-description">These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. &nbsp; &nbsp;All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.</p><!-- sub groups --><div class="category-vendors-list-container"></div><div class="category-host-list-container"></div></div></li><li class="category-item" data-optanongroupid="C0004"><div class="ot-sdk-column"><div class="ot-sdk-four ot-sdk-columns group category-menu-switch-handler" role="button"><h3 id="ot-header-id-C0004">Targeting Cookies</h3></div></div><div class="ot-sdk-eight ot-sdk-columns description-container hide"><div class="group-toggle"><h3 class="category-header">Targeting Cookies</h3><div class="toggle-group"><div class="toggle"><div class="checkbox"><!-- DYNAMICALLY GENERATE Input ID  --> <input id="ot-group-id-C0004" class="category-switch-handler" title="Location Based Ads Toggle" type="checkbox" aria-label="personalization-cookies" name="ot-group-id-C0004" data-optanongroupid="C0004" aria-describedby="ot-header-id-C0004"> <label for="ot-group-id-C0004"><span class="label-text">Targeting Cookies</span></label><!-- DYNAMICALLY GENERATE Input ID  --></div></div></div></div><p class="group-description">These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. &nbsp; &nbsp;They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.</p><!-- sub groups --><div class="category-vendors-list-container"></div><div class="category-host-list-container"></div></div></li></ul></div></div></div><!-- Vendors / Hosts --><section id="vendors-list" class="hide"><div class="vendor-content"><nav id="vendors-list-header"><div class="navigation-container"><a class="back-btn-handler" role="button" href="javascript:void(0)"><div id="back-arrow"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" width="15px" height="15px" viewBox="0 0 444.531 444.531" xml:space="preserve"><title>Back Button</title><g><path fill="#2c3643" d="M213.13,222.409L351.88,83.653c7.05-7.043,10.567-15.657,10.567-25.841c0-10.183-3.518-18.793-10.567-25.835
                    l-21.409-21.416C323.432,3.521,314.817,0,304.637,0s-18.791,3.521-25.841,10.561L92.649,196.425
                    c-7.044,7.043-10.566,15.656-10.566,25.841s3.521,18.791,10.566,25.837l186.146,185.864c7.05,7.043,15.66,10.564,25.841,10.564
                    s18.795-3.521,25.834-10.564l21.409-21.412c7.05-7.039,10.567-15.604,10.567-25.697c0-10.085-3.518-18.746-10.567-25.978
                    L213.13,222.409z"></path></g></svg></div><h3 id="vendors-list-title">Advertising Cookies</h3></a></div><div class="action-container"><div id="search-container"><input id="vendor-search-handler" title="Vendor Search" type="text" placeholder="Search..." name="vendor-search-handler"> <svg width="30" height="30" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" viewBox="0 -30 110 110"><path fill="#2e3644" d="M55.146,51.887L41.588,37.786c3.486-4.144,5.396-9.358,5.396-14.786c0-12.682-10.318-23-23-23s-23,10.318-23,23
              s10.318,23,23,23c4.761,0,9.298-1.436,13.177-4.162l13.661,14.208c0.571,0.593,1.339,0.92,2.162,0.92
              c0.779,0,1.518-0.297,2.079-0.837C56.255,54.982,56.293,53.08,55.146,51.887z M23.984,6c9.374,0,17,7.626,17,17s-7.626,17-17,17
              s-17-7.626-17-17S14.61,6,23.984,6z"></path></svg></div><div id="filter-container"><a id="filter-btn-handler" role="button" href="javascript:void(0)"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" width="15" height="15" viewBox="0 0 402.577 402.577" style="enable-background:new 0 0 402.577 402.577;" xml:space="preserve"><title>Filter Button</title><g><path fill="#2c3643" d="M400.858,11.427c-3.241-7.421-8.85-11.132-16.854-11.136H18.564c-7.993,0-13.61,3.715-16.846,11.136
                            c-3.234,7.801-1.903,14.467,3.999,19.985l140.757,140.753v138.755c0,4.955,1.809,9.232,5.424,12.854l73.085,73.083
                            c3.429,3.614,7.71,5.428,12.851,5.428c2.282,0,4.66-0.479,7.135-1.43c7.426-3.238,11.14-8.851,11.14-16.845V172.166L396.861,31.413
                            C402.765,25.895,404.093,19.231,400.858,11.427z"></path></g></svg></a></div></div></nav><section id="vendor-list-content"><div class="ot-sdk-row"><div class="ot-sdk-column"><div id="select-all-container"><div class="ot-checkbox"><!-- Vendors select all input container  --><div id="select-all-vendors-input-container"><input title="Select All" id="select-all-vendor-groups-handler" class="group-option-box" type="checkbox"> <label for="select-all-vendor-groups-handler"><span class="label-text">Select All Vendors</span></label></div><!-- Hosts select all input container --><div id="select-all-hosts-input-container"><input title="Select All" id="select-all-hosts-groups-handler" class="group-option-box" type="checkbox"> <label for="select-all-hosts-groups-handler"><span class="label-text">Select All Hosts</span></label></div><div id="select-all-text-container"><p>Select All</p></div></div></div><ul id="hosts-list-container"><li class="host-item"><input title="Host Accordion" type="checkbox" class="host-box"><section class="accordion-header"><div class="toggle-group"><!-- Checkbox --><div class="ot-checkbox"><input id="REPLACE-WITH-DYANMIC-HOST-ID" class="host-checkbox-handler group-option-box" type="checkbox"> <label for="REPLACE-WITH-DYANMIC-HOST-ID"><span class="label-text">REPLACE-WITH-DYANMIC-HOST-ID</span></label></div><!-- Checkbox END --><div class="host-info"><h3 class="host-title">33Across</h3><h4 class="host-description">33Across</h4></div></div><div class="host-notice"><div class="third-party-cookies-container"><a class="third-party-cookie-notice" href="javascript:void(0)" role="button">View Third Party Cookies</a></div><div class="arrow-container"><svg class="arrow" x="0px" y="0px" width="10px" height="10px" viewBox="0 0 451.846 451.847" style="enable-background:new 0 0 451.846 451.847;" xml:space="preserve"><g><path fill="#7b7b7b" d="M345.441,248.292L151.154,442.573c-12.359,12.365-32.397,12.365-44.75,0c-12.354-12.354-12.354-32.391,0-44.744
                        L278.318,225.92L106.409,54.017c-12.354-12.359-12.354-32.394,0-44.748c12.354-12.359,32.391-12.359,44.75,0l194.287,194.284
                        c6.177,6.18,9.262,14.271,9.262,22.366C354.708,234.018,351.617,242.115,345.441,248.292z"></path></g></svg></div></div></section><div class="accordion-text"><div class="host-options"><!-- HOST LIST VIEW UPDATE *** --><ul class="host-option-group"><li class="vendor-host"><div class="cookie-name-container"><div>Name</div><div>cookie name</div></div><div class="cookie-host-container"><div>Host</div><div>cookie host</div></div><div class="cookie-duration-container"><div>Duration</div><div>cookie duration</div></div><div class="cookie-type-container"><div>Type</div><div>cookie type</div></div><div class="cookie-category-container"><div>Category</div><div>cookie category</div></div><div class="cookie-description-container"><div>Description</div><div>cookie category</div></div></li></ul><!-- HOST LIST VIEW UPDATE END *** --></div></div></li></ul><ul id="vendors-list-container"><li><input title="Vendor Accordion" type="checkbox" class="vendor-box"><section class="accordion-header"><div class="toggle-group"><!-- Checkbox --><div class="ot-checkbox"><input id="REPLACE-WITH-DYANMIC-VENDOR-ID" class="vendor-checkbox-handler group-option-box" type="checkbox"> <label for="REPLACE-WITH-DYANMIC-VENDOR-ID"><span class="label-text">REPLACE-WITH-DYANMIC-VENDOR-ID</span></label></div><!-- Checkbox END --><div class="vendor-info"><h3 class="vendor-title">33Across</h3><div class="vendor-purposes"><p>3 Purposes</p></div></div></div><div class="vendor-notice"><div class="vendor-privacy-notice-container"><a class="vendor-privacy-notice" href="https://www.hindawi.com/journals/bmri/2013/690835/#">View Privacy Notice</a></div><div class="arrow-container"><svg class="arrow" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" width="10px" height="10px" viewBox="0 0 451.846 451.847" style="enable-background:new 0 0 451.846 451.847;" xml:space="preserve"><g><path fill="#7b7b7b" d="M345.441,248.292L151.154,442.573c-12.359,12.365-32.397,12.365-44.75,0c-12.354-12.354-12.354-32.391,0-44.744
                                    L278.318,225.92L106.409,54.017c-12.354-12.359-12.354-32.394,0-44.748c12.354-12.359,32.391-12.359,44.75,0l194.287,194.284
                                    c6.177,6.18,9.262,14.271,9.262,22.366C354.708,234.018,351.617,242.115,345.441,248.292z"></path></g></svg></div></div></section><div class="accordion-text"><div class="vendor-options"><!-- VENDOR PURPOSE UPDATE *** --><div class="vendor-purpose-groups"><!-- vendor purposes --><div class="vendor-option-purpose"><p>Consent Purposes</p></div><div class="vendor-consent-group"><p class="consent-category">Location Based Ads</p><p class="consent-status">Consent Allowed</p></div><!-- vendor legitimate interest purposes --><div class="vendor-option-purpose legitimate-interest"><p>Legitimate Interest Purposes</p></div><div class="vendor-consent-group legitimate-interest-group"><p class="consent-category">Personalize</p><a href="https://www.hindawi.com/journals/bmri/2013/690835/#" class="vendor-opt-out-handler"><div class="op-out-group"><span>Require Opt-Out</span> <svg x="0px" y="0px" width="15" height="15" viewBox="0 0 511.626 511.627" style="enable-background:new 0 0 511.626 511.627;" xml:space="preserve"><g fill="#1a73e8"><g><path d="M392.857,292.354h-18.274c-2.669,0-4.859,0.855-6.563,2.573c-1.718,1.708-2.573,3.897-2.573,6.563v91.361
                                      c0,12.563-4.47,23.315-13.415,32.262c-8.945,8.945-19.701,13.414-32.264,13.414H82.224c-12.562,0-23.317-4.469-32.264-13.414
                                      c-8.945-8.946-13.417-19.698-13.417-32.262V155.31c0-12.562,4.471-23.313,13.417-32.259c8.947-8.947,19.702-13.418,32.264-13.418
                                      h200.994c2.669,0,4.859-0.859,6.57-2.57c1.711-1.713,2.566-3.9,2.566-6.567V82.221c0-2.662-0.855-4.853-2.566-6.563
                                      c-1.711-1.713-3.901-2.568-6.57-2.568H82.224c-22.648,0-42.016,8.042-58.102,24.125C8.042,113.297,0,132.665,0,155.313v237.542
                                      c0,22.647,8.042,42.018,24.123,58.095c16.086,16.084,35.454,24.13,58.102,24.13h237.543c22.647,0,42.017-8.046,58.101-24.13
                                      c16.085-16.077,24.127-35.447,24.127-58.095v-91.358c0-2.669-0.856-4.859-2.574-6.57
                                      C397.709,293.209,395.519,292.354,392.857,292.354z"></path><path d="M506.199,41.971c-3.617-3.617-7.905-5.424-12.85-5.424H347.171c-4.948,0-9.233,1.807-12.847,5.424
                                      c-3.617,3.615-5.428,7.898-5.428,12.847s1.811,9.233,5.428,12.85l50.247,50.248L198.424,304.067
                                      c-1.906,1.903-2.856,4.093-2.856,6.563c0,2.479,0.953,4.668,2.856,6.571l32.548,32.544c1.903,1.903,4.093,2.852,6.567,2.852
                                      s4.665-0.948,6.567-2.852l186.148-186.148l50.251,50.248c3.614,3.617,7.898,5.426,12.847,5.426s9.233-1.809,12.851-5.426
                                      c3.617-3.616,5.424-7.898,5.424-12.847V54.818C511.626,49.866,509.813,45.586,506.199,41.971z"></path></g></g></svg></div></a></div><!-- Vendor features --><div class="vendor-option-purpose vendor-feature"><p>Features</p></div><div class="vendor-consent-group vendor-feature-group"><p class="consent-category">Location Based Ads</p></div></div><!-- VENDOR PURPOSE UPDATE END *** --></div></div></li></ul></div></div></section></div><div id="triangle"></div><section id="filter-modal"><div id="options"><div id="clear-filters-container"><a href="javascript:void(0)" id="clear-filters-handler" role="button"><p>Clear Fliters</p></a></div><div class="group-options"><div class="group-option"><div class="ot-checkbox"><input title="Information storage and access" id="storage-access-group" class="group-option-box category-filter-handler" type="checkbox"> <label for="storage-access-group"><span>Information storage and access</span></label></div></div></div><button id="filter-apply-handler" class="pill">Apply</button></div></section></section></div><!-- footer --><div class="button-group-parent"><div class="button-group"><button id="accept-recommended-btn-handler" aria-label="Allow All" role="button">Allow All</button> <button class="save-preference-btn-handler onetrust-close-btn-handler" aria-label="Confirm My Choices" role="button">Confirm My Choices</button></div><div class="footer-logo"><a class="powered-by-logo" href="https://onetrust.com/poweredbyonetrust" target="_blank" rel="noopener" aria-label="Powered by Onetrust"></a></div></div></div><div id="onetrust-banner-sdk" class="otFlat bottom" style="bottom: -99px; animation-name: slide-down-custom; animation-duration: 1000ms; animation-fill-mode: forwards; animation-timing-function: ease-out;"><div class="ot-sdk-container"><div class="ot-sdk-row"><div id="onetrust-group-container" class="ot-sdk-eight ot-sdk-columns"><div class="banner_logo"></div><div id="onetrust-policy"><!-- Mobile Close Button --><div id="onetrust-close-btn-container-mobile" class="hide-large"><a class="onetrust-close-btn-handler onetrust-close-btn-ui banner-close-button mobile close-icon" role="button" href="javascript:void(0)" title="Close" aria-label="Close Banner Button"></a></div><!-- Mobile Close Button END--><p id="onetrust-policy-text">By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. </p></div></div><div id="onetrust-button-group-parent" class="ot-sdk-three ot-sdk-columns"><div id="onetrust-button-group"><button id="onetrust-pc-btn-handler" title="Open Preference Center Button" class="cookie-setting-link" tabindex="0">Cookies Settings</button>  <button id="onetrust-accept-btn-handler" title="Accept Cookies Button" tabindex="0">Accept Cookies</button></div></div><!-- Close Button --><div id="onetrust-close-btn-container" class="ot-sdk-one ot-sdk-column hide-small"><a class="onetrust-close-btn-handler onetrust-close-btn-ui banner-close-button onetrust-lg close-icon" role="button" href="javascript:void(0)" title="Close" aria-label="Close Banner Button" tabindex="0"></a></div><!-- Close Button END--></div></div></div></div></body></html>